Unnamed: 0,Unnamed: 1,Unnamed: 2,Unnamed: 3,April,May,June,July,August,September,October,November,December,January,February,March,Total
District,,,,,,,,,,,,,,,,
Adilabad,1.1,Total number of pregnant women Registered for ANC,TOTAL,4918.0,4822.0,4744.0,4250.0,4409.0,3797.0,3410.0,4014.0,4106.0,4405.0,4464.0,4272.0,51611.0
Adilabad,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,3682.0,3467.0,3415.0,3125.0,3161.0,2691.0,2507.0,2787.0,2735.0,3052.0,3247.0,3090.0,36959.0
Adilabad,1.2,Number of Pregnant women registered under JSY,TOTAL,3252.0,3038.0,3150.0,2698.0,3011.0,2489.0,2365.0,2803.0,2962.0,3052.0,3096.0,3098.0,35014.0
Adilabad,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,4040.0,3794.0,4608.0,4519.0,4508.0,4258.0,3996.0,4069.0,3692.0,4197.0,3915.0,4095.0,49691.0
Adilabad,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,4909.0,4818.0,4702.0,4216.0,4354.0,3748.0,3353.0,3988.0,3952.0,4306.0,4436.0,4249.0,51031.0
Adilabad,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,3890.0,4701.0,4766.0,4495.0,4032.0,3971.0,3554.0,3566.0,3791.0,3807.0,4066.0,4185.0,48824.0
Adilabad,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,4579.0,4558.0,4828.0,4483.0,4407.0,4300.0,3906.0,4160.0,4207.0,4327.0,4169.0,4296.0,52220.0
Adilabad,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,296.0,295.0,256.0,206.0,164.0,140.0,136.0,187.0,182.0,214.0,173.0,226.0,2475.0
Adilabad,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,19.0,8.0,16.0,13.0,16.0,7.0,16.0,21.0,27.0,28.0,14.0,14.0,199.0
Adilabad,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1743.0,2014.0,1295.0,1033.0,1306.0,2064.0,1003.0,1394.0,1510.0,1565.0,1664.0,1652.0,18243.0
Adilabad,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,360.0,367.0,102.0,107.0,252.0,502.0,172.0,170.0,267.0,242.0,232.0,212.0,2985.0
Adilabad,1.8,Number of pregnancy test kits used at SC level,TOTAL,694.0,707.0,710.0,818.0,877.0,835.0,825.0,990.0,1041.0,1123.0,1138.0,1147.0,10905.0
Adilabad,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,155.0,160.0,208.0,210.0,254.0,205.0,174.0,280.0,161.0,139.0,98.0,82.0,2126.0
Adilabad,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,167.0,145.0,143.0,116.0,134.0,212.0,238.0,237.0,157.0,162.0,104.0,87.0,1902.0
Adilabad,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,322.0,305.0,351.0,326.0,388.0,417.0,412.0,517.0,318.0,301.0,202.0,169.0,4028.0
Adilabad,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,178.0,191.0,171.0,178.0,203.0,254.0,262.0,234.0,220.0,209.0,143.0,124.0,2367.0
Adilabad,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,26.0,44.0,42.0,42.0,58.0,21.0,42.0,16.0,36.0,35.0,17.0,19.0,398.0
Adilabad,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1347.0,1469.0,1368.0,1384.0,1691.0,1420.0,1570.0,1518.0,1481.0,1371.0,1189.0,1310.0,17118.0
Adilabad,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,698.0,762.0,737.0,612.0,892.0,749.0,902.0,708.0,880.0,813.0,867.0,418.0,9038.0
Adilabad,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,37.0,15.0,30.0,21.0,20.0,12.0,6.0,11.0,9.0,14.0,16.0,1.0,192.0
Adilabad,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,26.0,69.0,119.0,63.0,61.0,39.0,2.0,8.0,5.0,27.0,17.0,9.0,445.0
Adilabad,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,17.0,31.0,2.0,7.0,34.0,8.0,3.0,2.0,0.0,9.0,1.0,0.0,114.0
Adilabad,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,1830.0,1858.0,1746.0,1743.0,2000.0,1998.0,2033.0,2220.0,2100.0,2012.0,2120.0,2040.0,23700.0
Adilabad,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Adilabad,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Adilabad,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Adilabad,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Adilabad,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Adilabad,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,332.0,327.0,284.0,308.0,361.0,332.0,384.0,366.0,361.0,377.0,279.0,357.0,4068.0
Adilabad,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Adilabad,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,332.0,327.0,284.0,308.0,361.0,332.0,384.0,366.0,361.0,377.0,279.0,357.0,4068.0
Adilabad,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,1580.0,1602.0,1475.0,1519.0,1669.0,1695.0,1686.0,1839.0,1743.0,1692.0,1727.0,1676.0,19903.0
Adilabad,4.1.1.a,Number of male live births,TOTAL,1978.0,2220.0,1913.0,1982.0,2299.0,1929.0,2010.0,2142.0,1933.0,1817.0,1734.0,1746.0,23703.0
Adilabad,4.1.1.b,Number of female live births,TOTAL,1761.0,1906.0,1892.0,1838.0,2213.0,1858.0,1972.0,2098.0,1946.0,1839.0,1762.0,1764.0,22849.0
Adilabad,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,3739.0,4126.0,3805.0,3820.0,4512.0,3787.0,3982.0,4240.0,3879.0,3656.0,3496.0,3510.0,46552.0
Adilabad,4.1.2,Number of still births,TOTAL,48.0,39.0,45.0,55.0,60.0,51.0,39.0,30.0,40.0,31.0,25.0,31.0,494.0
Adilabad,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,67.0,67.0,69.0,61.0,69.0,53.0,62.0,95.0,49.0,50.0,37.0,51.0,730.0
Adilabad,4.2.1,Number of Newborns weighed at birth,TOTAL,3466.0,3685.0,3441.0,3421.0,3678.0,3581.0,3878.0,4082.0,3721.0,3536.0,3399.0,3331.0,43219.0
Adilabad,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,264.0,217.0,236.0,250.0,306.0,300.0,219.0,236.0,205.0,190.0,215.0,203.0,2841.0
Adilabad,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,3502.0,3723.0,3357.0,3499.0,4127.0,3610.0,3918.0,4135.0,3818.0,3592.0,3410.0,3413.0,44104.0
Adilabad,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,6.0,8.0,2.0,4.0,0.0,4.0,0.0,2.0,4.0,6.0,5.0,3.0,44.0
Adilabad,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Adilabad,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,98.0,73.0,41.0,95.0,94.0,70.0,47.0,83.0,72.0,90.0,99.0,82.0,944.0
Adilabad,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Adilabad,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,104.0,81.0,43.0,99.0,94.0,74.0,47.0,85.0,76.0,96.0,104.0,85.0,988.0
Adilabad,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Adilabad,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,102.0,77.0,36.0,59.0,84.0,54.0,27.0,43.0,42.0,60.0,63.0,2.0,649.0
Adilabad,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,28.0,73.0,43.0,45.0,94.0,70.0,35.0,53.0,35.0,62.0,76.0,0.0,614.0
Adilabad,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,25.0,78.0,36.0,43.0,82.0,54.0,27.0,72.0,69.0,72.0,101.0,58.0,717.0
Adilabad,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,102.0,65.0,35.0,87.0,56.0,60.0,20.0,54.0,50.0,64.0,68.0,82.0,743.0
Adilabad,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,2732.0,3207.0,1503.0,1594.0,3280.0,3230.0,1765.0,1665.0,1576.0,1559.0,1443.0,1542.0,25096.0
Adilabad,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,2631.0,2959.0,2775.0,2558.0,2962.0,3072.0,3329.0,3842.0,3576.0,3152.0,2899.0,2599.0,36354.0
Adilabad,6.3,PNC maternal complications attended,TOTAL,17.0,68.0,51.0,5.0,6.0,3.0,125.0,1.0,59.0,58.0,60.0,31.0,484.0
Adilabad,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,9.0,9.0,1.0,6.0,3.0,2.0,3.0,2.0,2.0,5.0,2.0,2.0,46.0
Adilabad,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,18.0,21.0,18.0,2.0,14.0,21.0,24.0,4.0,2.0,5.0,4.0,3.0,136.0
Adilabad,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,27.0,30.0,19.0,8.0,17.0,23.0,27.0,6.0,4.0,10.0,6.0,5.0,182.0
Adilabad,7.2,Number of MTPs conducted at Private Facilities,TOTAL,5.0,5.0,8.0,2.0,1.0,1.0,0.0,1.0,4.0,7.0,3.0,0.0,37.0
Adilabad,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,186.0,233.0,190.0,203.0,232.0,215.0,233.0,271.0,245.0,217.0,247.0,219.0,2691.0
Adilabad,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,742.0,731.0,799.0,657.0,865.0,835.0,689.0,375.0,884.0,614.0,635.0,473.0,8299.0
Adilabad,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,928.0,964.0,989.0,860.0,1097.0,1050.0,922.0,646.0,1129.0,831.0,882.0,692.0,10990.0
Adilabad,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,4.0,0.0,3.0,2.0,12.0,7.0,4.0,0.0,0.0,0.0,6.0,0.0,38.0
Adilabad,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,17.0,1.0,3.0,1.0,5.0,0.0,0.0,0.0,1.0,0.0,2.0,2.0,32.0
Adilabad,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Adilabad,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,2.0,1.0,7.0,5.0,4.0,0.0,5.0,24.0
Adilabad,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Adilabad,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,17.0,1.0,3.0,1.0,5.0,2.0,1.0,7.0,6.0,4.0,2.0,7.0,56.0
Adilabad,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Adilabad,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Adilabad,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Adilabad,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Adilabad,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Adilabad,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Adilabad,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Adilabad,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,174.0,0.0,87.0,82.0,52.0,39.0,0.0,229.0,159.0,77.0,79.0,161.0,1139.0
Adilabad,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Adilabad,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,50.0,56.0,112.0,160.0,364.0,414.0,323.0,320.0,1799.0
Adilabad,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Adilabad,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,174.0,0.0,87.0,82.0,102.0,95.0,112.0,389.0,523.0,491.0,402.0,481.0,2938.0
Adilabad,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,31.0,45.0,18.0,32.0,18.0,19.0,27.0,54.0,50.0,65.0,125.0,70.0,554.0
Adilabad,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Adilabad,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Adilabad,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,50.0,19.0,0.0,0.0,0.0,48.0,103.0,220.0
Adilabad,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Adilabad,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,50.0,19.0,0.0,0.0,0.0,48.0,103.0,220.0
Adilabad,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,180.0,258.0,100.0,178.0,144.0,142.0,180.0,201.0,279.0,367.0,627.0,362.0,3018.0
Adilabad,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,19.0,29.0,35.0,32.0,18.0,16.0,15.0,22.0,15.0,11.0,6.0,12.0,230.0
Adilabad,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,17.0,10.0,30.0,15.0,26.0,19.0,12.0,6.0,10.0,12.0,9.0,31.0,197.0
Adilabad,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Adilabad,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,25.0,21.0,9.0,1.0,3.0,21.0,19.0,22.0,20.0,21.0,23.0,24.0,209.0
Adilabad,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Adilabad,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,61.0,60.0,74.0,48.0,47.0,56.0,46.0,50.0,45.0,44.0,38.0,67.0,636.0
Adilabad,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,12.0,22.0,1.0,5.0,12.0,5.0,10.0,1.0,1.0,11.0,11.0,0.0,91.0
Adilabad,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Adilabad,9.06,Number of IUCD removals,TOTAL,65.0,71.0,33.0,54.0,67.0,34.0,21.0,37.0,30.0,34.0,51.0,32.0,529.0
Adilabad,9.07,Number of Oral Pills cycles distributed,TOTAL,1078.0,1040.0,926.0,1201.0,940.0,1192.0,964.0,1103.0,1055.0,1092.0,996.0,1448.0,13035.0
Adilabad,9.08,Number of Condom pieces distributed,TOTAL,2603.0,2020.0,3264.0,4118.0,4143.0,3614.0,4095.0,4702.0,4507.0,5280.0,4722.0,5018.0,48086.0
Adilabad,9.09,Number of Centchroman (weekly) pills given,TOTAL,36.0,50.0,35.0,49.0,42.0,34.0,37.0,44.0,40.0,49.0,45.0,39.0,500.0
Adilabad,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,17.0,31.0,14.0,11.0,17.0,9.0,19.0,26.0,7.0,16.0,18.0,22.0,207.0
Adilabad,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Adilabad,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Adilabad,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Adilabad,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Adilabad,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Adilabad,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Adilabad,9.12,Number of Institutions having NSV trained doctors,TOTAL,74.0,63.0,61.0,62.0,62.0,64.0,66.0,64.0,66.0,67.0,68.0,72.0,-1.0
Adilabad,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,3663.0,3769.0,3804.0,3726.0,4031.0,3782.0,3966.0,4235.0,3877.0,3656.0,3494.0,3508.0,45511.0
Adilabad,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,3401.0,3397.0,3367.0,1891.0,869.0,487.0,307.0,274.0,182.0,221.0,94.0,125.0,14615.0
Adilabad,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,3570.0,3599.0,3626.0,3238.0,1596.0,693.0,322.0,258.0,172.0,213.0,81.0,101.0,17469.0
Adilabad,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,3978.0,3733.0,3756.0,3503.0,2961.0,1323.0,495.0,267.0,227.0,239.0,98.0,118.0,20698.0
Adilabad,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,57.0,112.0,246.0,1686.0,2714.0,2856.0,3208.0,3629.0,3832.0,4166.0,4044.0,3783.0,30333.0
Adilabad,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,60.0,55.0,71.0,380.0,2006.0,2751.0,3015.0,3474.0,3798.0,4151.0,4291.0,4165.0,28217.0
Adilabad,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,52.0,72.0,90.0,165.0,550.0,2110.0,2827.0,3158.0,3634.0,4112.0,4195.0,4291.0,25256.0
Adilabad,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,3170.0,3463.0,3159.0,3388.0,3405.0,3171.0,3612.0,4111.0,3864.0,3651.0,3136.0,2830.0,40960.0
Adilabad,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,3510.0,3440.0,3450.0,3019.0,3110.0,3139.0,3363.0,3804.0,4015.0,4213.0,4011.0,3776.0,42850.0
Adilabad,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,3616.0,3597.0,3678.0,3439.0,3186.0,3260.0,3223.0,3607.0,3911.0,4173.0,4263.0,4163.0,44116.0
Adilabad,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,4000.0,3720.0,3783.0,3526.0,3287.0,3169.0,3032.0,3307.0,3769.0,4099.0,4183.0,4692.0,44567.0
Adilabad,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,2006.0,2261.0,2274.0,2476.0,2515.0,2332.0,2829.0,3042.0,3019.0,3103.0,2456.0,1910.0,30223.0
Adilabad,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,3387.0,3382.0,3330.0,1776.0,790.0,574.0,299.0,323.0,162.0,221.0,71.0,66.0,14381.0
Adilabad,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,3574.0,3550.0,3622.0,3252.0,1561.0,648.0,299.0,226.0,147.0,206.0,50.0,59.0,17194.0
Adilabad,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,3931.0,3744.0,3825.0,3522.0,2895.0,1325.0,435.0,235.0,191.0,195.0,83.0,82.0,20463.0
Adilabad,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,3775.0,4275.0,4388.0,3794.0,3768.0,3594.0,3484.0,3663.0,3313.0,3678.0,3770.0,3663.0,45165.0
Adilabad,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,1793.0,2780.0,2734.0,2415.0,2204.0,2413.0,2574.0,2851.0,2568.0,3001.0,3072.0,3263.0,31668.0
Adilabad,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,1955.0,2178.0,2447.0,2580.0,2596.0,2797.0,2965.0,3029.0,2861.0,3029.0,3114.0,3100.0,32651.0
Adilabad,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1961.0,2211.0,2224.0,1978.0,1975.0,1829.0,1801.0,1909.0,1726.0,1920.0,1932.0,1913.0,23379.0
Adilabad,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1814.0,2064.0,2164.0,1816.0,1793.0,1765.0,1683.0,1754.0,1587.0,1758.0,1838.0,1750.0,21786.0
Adilabad,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,3775.0,4275.0,4388.0,3794.0,3768.0,3594.0,3484.0,3663.0,3313.0,3678.0,3770.0,3663.0,45165.0
Adilabad,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,4403.0,5458.0,4791.0,3577.0,3006.0,3046.0,3117.0,3566.0,3418.0,3601.0,3713.0,3825.0,45521.0
Adilabad,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,4403.0,5436.0,4776.0,3572.0,3003.0,3034.0,3122.0,3575.0,3378.0,3610.0,3699.0,3810.0,45418.0
Adilabad,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,694.0,651.0,603.0,355.0,246.0,279.0,184.0,339.0,354.0,323.0,386.0,327.0,4741.0
Adilabad,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1578.0,1865.0,1448.0,1412.0,1418.0,1224.0,832.0,1063.0,806.0,896.0,879.0,912.0,14333.0
Adilabad,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1535.0,1753.0,1360.0,1317.0,1358.0,1051.0,807.0,985.0,820.0,815.0,805.0,869.0,13475.0
Adilabad,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,3113.0,3618.0,2808.0,2729.0,2776.0,2275.0,1639.0,2048.0,1626.0,1711.0,1684.0,1781.0,27808.0
Adilabad,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,2708.0,3032.0,3097.0,2970.0,2921.0,2977.0,2626.0,3158.0,3228.0,3213.0,3107.0,3015.0,36052.0
Adilabad,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,2458.0,2551.0,2633.0,2991.0,3023.0,3530.0,2774.0,3567.0,3341.0,3199.0,3234.0,3376.0,36677.0
Adilabad,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,2320.0,2290.0,2334.0,2711.0,2820.0,2935.0,2354.0,3758.0,3230.0,3033.0,2936.0,3230.0,33951.0
Adilabad,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Adilabad,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Adilabad,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Adilabad,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,3215.0,3272.0,3263.0,3169.0,3144.0,3223.0,3335.0,3242.0,3165.0,3154.0,3195.0,3167.0,38544.0
Adilabad,10.4.2,Number of Immunisation sessions held during the month,TOTAL,3194.0,3287.0,3237.0,3113.0,3110.0,3162.0,3313.0,3231.0,3130.0,3134.0,3139.0,3179.0,38229.0
Adilabad,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,2878.0,2839.0,2791.0,2739.0,2685.0,1263.0,479.0,285.0,884.0,2556.0,2592.0,2531.0,24522.0
Adilabad,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,1239.0,2209.0,1949.0,1722.0,1640.0,2026.0,2022.0,2200.0,2180.0,2251.0,2356.0,2341.0,24135.0
Adilabad,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,3095.0,3306.0,3581.0,3300.0,3230.0,3046.0,2954.0,3023.0,2836.0,2792.0,3001.0,2872.0,37036.0
Adilabad,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,2408.0,2554.0,2720.0,2253.0,2237.0,2120.0,2240.0,2332.0,2235.0,2129.0,2122.0,2051.0,27401.0
Adilabad,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,1349.0,1410.0,1509.0,1498.0,1500.0,1541.0,1408.0,1903.0,1887.0,1713.0,1668.0,1524.0,18910.0
Adilabad,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Adilabad,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Adilabad,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Adilabad,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Adilabad,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Adilabad,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,51.0,41.0,13.0,27.0,1.0,13.0,8.0,6.0,9.0,17.0,9.0,3.0,198.0
Adilabad,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,570.0,593.0,489.0,796.0,653.0,671.0,588.0,514.0,410.0,317.0,385.0,582.0,6568.0
Adilabad,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,14.0,8.0,3.0,3.0,44.0,38.0,24.0,28.0,25.0,16.0,17.0,14.0,234.0
Adilabad,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,24.0,50.0,28.0,30.0,17.0,19.0,0.0,36.0,31.0,8.0,2.0,2.0,247.0
Adilabad,13.1,Number of Patients operated for cataract,TOTAL,86.0,48.0,58.0,215.0,216.0,1109.0,1025.0,1099.0,324.0,307.0,354.0,360.0,5201.0
Adilabad,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,40.0,48.0,51.0,208.0,209.0,1108.0,1025.0,1099.0,114.0,305.0,337.0,341.0,4885.0
Adilabad,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,293.0,649.0,462.0,271.0,457.0,152.0,343.0,461.0,270.0,3358.0
Adilabad,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,40.0,123.0,120.0,12.0,122.0,63.0,62.0,396.0,17.0,955.0
Adilabad,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Adilabad,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Adilabad,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,8.0,7.0,7.0,6.0,6.0,8.0,9.0,8.0,7.0,7.0,8.0,7.0,-1.0
Adilabad,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,67.0,58.0,58.0,58.0,58.0,58.0,58.0,60.0,60.0,58.0,62.0,60.0,-1.0
Adilabad,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,2052.0,2064.0,2497.0,2363.0,2526.0,2275.0,2755.0,2179.0,2444.0,2731.0,2277.0,2114.0,-1.0
Adilabad,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,8.0,7.0,7.0,5.0,6.0,6.0,8.0,8.0,8.0,7.0,7.0,8.0,-1.0
Adilabad,14.05,Number of RKS meetings held during the month,TOTAL,6.0,8.0,5.0,13.0,13.0,10.0,10.0,7.0,13.0,8.0,4.0,11.0,108.0
Adilabad,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,68.0,58.0,60.0,58.0,56.0,53.0,61.0,58.0,56.0,59.0,59.0,59.0,-1.0
Adilabad,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,109.0,101.0,108.0,81.0,78.0,142.0,118.0,151.0,139.0,123.0,324.0,108.0,1582.0
Adilabad,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,10.0,8.0,8.0,7.0,9.0,8.0,9.0,9.0,9.0,8.0,9.0,8.0,-1.0
Adilabad,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,-1.0
Adilabad,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,,,,,,,,,,,,,
Adilabad,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,,,,,,,,,,,,,
Adilabad,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,,,,,,,,,,,,,
Adilabad,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,933.0,1111.0,1122.0,1418.0,1772.0,2010.0,1838.0,1320.0,1943.0,920.0,903.0,1283.0,16573.0
Adilabad,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,3663.0,4721.0,3991.0,4770.0,6026.0,8552.0,6600.0,4853.0,5150.0,3442.0,3577.0,4484.0,59829.0
Adilabad,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,908.0,1084.0,1085.0,1344.0,1609.0,2154.0,1905.0,1459.0,1892.0,1008.0,828.0,1344.0,16620.0
Adilabad,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,4044.0,5535.0,4493.0,6004.0,6644.0,9144.0,8121.0,5395.0,5773.0,3823.0,3948.0,5453.0,68377.0
Adilabad,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,1841.0,2195.0,2207.0,2762.0,3381.0,4164.0,3743.0,2779.0,3835.0,1928.0,1731.0,2627.0,33193.0
Adilabad,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,7707.0,10256.0,8484.0,10774.0,12670.0,17696.0,14721.0,10248.0,10923.0,7265.0,7525.0,9937.0,128206.0
Adilabad,14.10.2.a,Number of death cases of Inpatient males,TOTAL,70.0,64.0,70.0,102.0,105.0,65.0,61.0,67.0,41.0,74.0,60.0,29.0,808.0
Adilabad,14.10.2.b,Number of death cases of Inpatient females,TOTAL,47.0,66.0,47.0,35.0,44.0,42.0,30.0,59.0,23.0,35.0,34.0,32.0,494.0
Adilabad,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,117.0,130.0,117.0,137.0,149.0,107.0,91.0,126.0,64.0,109.0,94.0,61.0,1302.0
Adilabad,14.11,In-Patient Head Count at midnight,TOTAL,13035.0,15346.0,13001.0,13099.0,21658.0,15179.0,15027.0,11700.0,12582.0,10408.0,10344.0,12590.0,163969.0
Adilabad,14.12.1,OPD attendance (All),TOTAL,339665.0,336404.0,322387.0,356044.0,394585.0,442970.0,396168.0,418430.0,441096.0,356556.0,355012.0,348028.0,4507345.0
Adilabad,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,507.0,411.0,458.0,32.0,574.0,269.0,510.0,511.0,523.0,585.0,412.0,793.0,5585.0
Adilabad,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,12.0,6.0,6.0,2.0,9.0,9.0,7.0,10.0,7.0,5.0,4.0,1.0,78.0
Adilabad,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,,,,,,,,,,,,,
Adilabad,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,978.0,842.0,1005.0,676.0,433.0,701.0,640.0,540.0,864.0,832.0,893.0,521.0,8925.0
Adilabad,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,,,,,,,,,,,,,
Adilabad,14.14.a,Number of patients given AYUSH treatment,TOTAL,6761.0,7945.0,7541.0,6178.0,8811.0,9109.0,7783.0,8627.0,9377.0,8277.0,8765.0,7921.0,97095.0
Adilabad,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,359.0,311.0,279.0,315.0,279.0,160.0,277.0,363.0,282.0,321.0,327.0,335.0,3608.0
Adilabad,14.14.c,Number of Adolescents counselled,TOTAL,80.0,142.0,359.0,323.0,420.0,774.0,778.0,622.0,581.0,546.0,553.0,905.0,6083.0
Adilabad,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,,,,,,,,,,,,,
Adilabad,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,8955.0,7259.0,7723.0,7293.0,8362.0,9271.0,7654.0,8913.0,7887.0,7636.0,7825.0,7180.0,95958.0
Adilabad,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,803.0,861.0,726.0,830.0,903.0,1045.0,673.0,876.0,721.0,670.0,860.0,667.0,9635.0
Adilabad,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,1980.0,1841.0,1885.0,2159.0,1897.0,2147.0,2510.0,2559.0,2059.0,2092.0,2263.0,2248.0,25640.0
Adilabad,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,27.0,23.0,20.0,27.0,24.0,20.0,21.0,27.0,11.0,17.0,31.0,23.0,271.0
Adilabad,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,2224.0,1317.0,1652.0,1745.0,1347.0,1299.0,1529.0,1798.0,2577.0,2227.0,2322.0,2338.0,22375.0
Adilabad,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,20.0,19.0,16.0,20.0,13.0,7.0,9.0,12.0,10.0,22.0,18.0,23.0,189.0
Adilabad,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,3245.0,2301.0,2737.0,2598.0,2194.0,2126.0,2568.0,2128.0,2135.0,2108.0,2397.0,2388.0,28925.0
Adilabad,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,4.0,4.0,3.0,4.0,16.0,6.0,4.0,4.0,0.0,1.0,3.0,4.0,53.0
Adilabad,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,7449.0,5459.0,6274.0,6502.0,5438.0,5572.0,6607.0,6485.0,6771.0,6427.0,6982.0,6974.0,76940.0
Adilabad,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,51.0,46.0,39.0,51.0,53.0,33.0,34.0,43.0,21.0,40.0,52.0,50.0,513.0
Adilabad,15.2,Number of Widal tests conducted,Number tested,2960.0,2781.0,1953.0,1618.0,4502.0,6305.0,4856.0,4417.0,3494.0,4101.0,3348.0,3265.0,43600.0
Adilabad,15.3.a,Number of VDRL tests conducted on males,Number tested,53.0,53.0,20.0,34.0,51.0,102.0,90.0,39.0,64.0,214.0,261.0,38.0,1019.0
Adilabad,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,602.0,277.0,514.0,67.0,90.0,423.0,502.0,36.0,66.0,119.0,274.0,103.0,3073.0
Adilabad,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,1164.0,1133.0,984.0,317.0,264.0,1059.0,955.0,161.0,347.0,334.0,477.0,290.0,7485.0
Adilabad,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,1819.0,1463.0,1518.0,418.0,405.0,1584.0,1547.0,236.0,477.0,667.0,1012.0,431.0,11577.0
Adilabad,15.4.1,Number of blood smears examined for Malaria,TOTAL,11771.0,11007.0,9053.0,14203.0,24060.0,40080.0,32589.0,19344.0,15327.0,12390.0,12456.0,10812.0,213092.0
Adilabad,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,10.0,12.0,127.0,27.0,162.0,189.0,63.0,63.0,16.0,42.0,10.0,19.0,740.0
Adilabad,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,92.0,25.0,9.0,66.0,338.0,338.0,875.0,867.0,532.0,58.0,18.0,31.0,3249.0
Adilabad,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,21660.0,32600.0,24700.0,27280.0,5830.0,9680.0,26180.0,11280.0,,,,,159210.0
Adilabad,16.1.1,Stock position of DPT vaccines,2. Stocks Received,30000.0,30000.0,12000.0,0.0,20000.0,20000.0,0.0,15000.0,,,,,127000.0
Adilabad,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Adilabad,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,19000.0,37900.0,9420.0,21450.0,16150.0,3500.0,14900.0,3500.0,,,,,125820.0
Adilabad,16.1.1,Stock position of DPT vaccines,5. Total Stock,32660.0,24700.0,27280.0,5830.0,9680.0,26180.0,11280.0,22780.0,0.0,0.0,0.0,0.0,160390.0
Adilabad,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,0.0,40320.0,27600.0,15380.0,21340.0,18440.0,5320.0,,,,,128400.0
Adilabad,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,40320.0,,0.0,20160.0,6000.0,0.0,17280.0,,,,,83760.0
Adilabad,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Adilabad,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,0.0,12720.0,12220.0,14200.0,8900.0,13120.0,6780.0,,,,,67940.0
Adilabad,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,40320.0,27600.0,15380.0,21340.0,18440.0,5320.0,15820.0,0.0,0.0,0.0,0.0,144220.0
Adilabad,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,13200.0,37100.0,14400.0,34800.0,2100.0,13000.0,45200.0,3200.0,,,,,163000.0
Adilabad,16.1.2,Stock position of OPV vaccines,2. Stocks Received,40000.0,38000.0,40000.0,0.0,40000.0,40000.0,0.0,50000.0,,,,,248000.0
Adilabad,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Adilabad,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,16100.0,60700.0,19600.0,32700.0,29100.0,7800.0,42000.0,16600.0,,,,,224600.0
Adilabad,16.1.2,Stock position of OPV vaccines,5. Total Stock,37100.0,14400.0,34800.0,2100.0,13000.0,45200.0,3200.0,36600.0,0.0,0.0,0.0,0.0,186400.0
Adilabad,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,24200.0,46600.0,41400.0,48100.0,23800.0,34800.0,30800.0,1050.0,,,,,250750.0
Adilabad,16.1.3,Stock position of TT vaccines,2. Stocks Received,45000.0,30000.0,20000.0,0.0,30000.0,5000.0,0.0,20000.0,,,,,150000.0
Adilabad,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Adilabad,16.1.3,Stock position of TT vaccines,4. Stock Distributed,22600.0,35190.0,13300.0,24300.0,19000.0,9000.0,29750.0,7900.0,,,,,161040.0
Adilabad,16.1.3,Stock position of TT vaccines,5. Total Stock,46600.0,41410.0,48100.0,23800.0,34800.0,30800.0,1050.0,13150.0,0.0,0.0,0.0,0.0,239710.0
Adilabad,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Adilabad,16.1.4,Stock position of DT vaccines,2. Stocks Received,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Adilabad,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Adilabad,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Adilabad,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Adilabad,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,33600.0,31800.0,31700.0,34550.0,15050.0,7950.0,30450.0,13150.0,,,,,198250.0
Adilabad,16.1.5,Stock position of BCG vaccines,2. Stocks Received,10000.0,20000.0,10000.0,0.0,20000.0,28000.0,0.0,20000.0,,,,,108000.0
Adilabad,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Adilabad,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,11800.0,20100.0,7150.0,19500.0,27100.0,5500.0,17300.0,5850.0,,,,,114300.0
Adilabad,16.1.5,Stock position of BCG vaccines,5. Total Stock,31800.0,31700.0,34550.0,15050.0,7950.0,30450.0,13150.0,27300.0,0.0,0.0,0.0,0.0,191950.0
Adilabad,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,20560.0,25110.0,16435.0,22885.0,5935.0,12785.0,21735.0,7235.0,,,,,132680.0
Adilabad,16.1.6,Stock position of Measles vaccines,2. Stocks Received,15000.0,15000.0,15000.0,0.0,20000.0,15000.0,0.0,15000.0,,,,,95000.0
Adilabad,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Adilabad,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,10450.0,23675.0,8550.0,16950.0,13150.0,6050.0,14500.0,5200.0,,,,,98525.0
Adilabad,16.1.6,Stock position of Measles vaccines,5. Total Stock,25110.0,16435.0,22885.0,5935.0,12785.0,21735.0,7235.0,17035.0,0.0,0.0,0.0,0.0,129155.0
Adilabad,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,11275.0,18425.0,12525.0,22275.0,7175.0,13675.0,21325.0,5875.0,,,,,112550.0
Adilabad,16.1.7,Stock position of JE vaccines,2. Stocks Received,19000.0,22500.0,20000.0,0.0,20000.0,15000.0,0.0,18000.0,,,,,114500.0
Adilabad,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Adilabad,16.1.7,Stock position of JE vaccines,4. Stock Distributed,11850.0,28400.0,10250.0,15100.0,13500.0,7350.0,15450.0,5850.0,,,,,107750.0
Adilabad,16.1.7,Stock position of JE vaccines,5. Total Stock,18425.0,12525.0,22275.0,7175.0,13675.0,21325.0,5875.0,18025.0,0.0,0.0,0.0,0.0,119300.0
Adilabad,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,33200.0,38700.0,26300.0,31400.0,15000.0,13500.0,29700.0,18600.0,,,,,206400.0
Adilabad,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,22500.0,10000.0,12000.0,0.0,12000.0,19500.0,0.0,10000.0,,,,,86000.0
Adilabad,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Adilabad,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,17000.0,22400.0,6900.0,16400.0,13500.0,3300.0,11100.0,2600.0,,,,,93200.0
Adilabad,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,38700.0,26300.0,31400.0,15000.0,13500.0,29700.0,18600.0,26000.0,0.0,0.0,0.0,0.0,199200.0
Adilabad,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,3000.0,,,,,,0.0,1200.0,,,,,4200.0
Adilabad,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,1200.0,0.0,,,,,1200.0
Adilabad,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,0.0,0.0,,,,,0.0
Adilabad,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,3000.0,,,,,,0.0,0.0,,,,,3000.0
Adilabad,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,1200.0,1200.0,0.0,0.0,0.0,0.0,2400.0
Adilabad,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,465420.0,455340.0,440220.0,430140.0,178140.0,11820.0,0.0,573600.0,,,,,2554680.0
Adilabad,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,0.0,0.0,0.0,573600.0,0.0,,,,,573600.0
Adilabad,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Adilabad,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,10080.0,15120.0,10080.0,252000.0,166320.0,11820.0,0.0,0.0,,,,,465420.0
Adilabad,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,455340.0,440220.0,430140.0,178140.0,11820.0,0.0,573600.0,573600.0,0.0,0.0,0.0,0.0,2662860.0
Adilabad,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Adilabad,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Adilabad,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Adilabad,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Adilabad,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Adilabad,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Adilabad,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Adilabad,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Adilabad,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Adilabad,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Adilabad,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Adilabad,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Adilabad,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Adilabad,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Adilabad,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Adilabad,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Adilabad,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Adilabad,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Adilabad,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Adilabad,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Adilabad,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Adilabad,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Adilabad,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Adilabad,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Adilabad,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Adilabad,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Adilabad,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Adilabad,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Adilabad,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Adilabad,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Adilabad,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Adilabad,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Adilabad,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Adilabad,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Adilabad,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Adilabad,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Adilabad,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Adilabad,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Adilabad,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Adilabad,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Adilabad,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Adilabad,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Adilabad,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Adilabad,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Adilabad,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Adilabad,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Adilabad,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Adilabad,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Adilabad,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Adilabad,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Adilabad,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Adilabad,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Adilabad,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Adilabad,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Adilabad,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Adilabad,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Adilabad,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Adilabad,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Adilabad,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Adilabad,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Adilabad,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,1929.0,,,,,,,,,,,,1929.0
Adilabad,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Adilabad,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Adilabad,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,1929.0,,,,,,,,,,,,1929.0
Adilabad,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Adilabad,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,5400.0,,,,,,,,,,,,5400.0
Adilabad,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Adilabad,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Adilabad,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,5400.0,,,,,,,,,,,,5400.0
Adilabad,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Adilabad,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,4900.0,280.0,1370.0,8710.0,3365.0,9095.0,7095.0,12595.0,,,,,47410.0
Adilabad,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,3300.0,9900.0,0.0,9900.0,0.0,13200.0,0.0,,,,,36300.0
Adilabad,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,0.0,0.0,0.0,,0.0,,,,,0.0
Adilabad,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,4620.0,2210.0,2560.0,5345.0,4170.0,2000.0,7700.0,1950.0,,,,,30555.0
Adilabad,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,280.0,1370.0,8710.0,3365.0,9095.0,7095.0,12595.0,10645.0,0.0,0.0,0.0,0.0,53155.0
Adilabad,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,301700.0,272500.0,149300.0,208200.0,114800.0,51600.0,185600.0,268000.0,,,,,1551700.0
Adilabad,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,126000.0,0.0,0.0,150000.0,165000.0,75000.0,,,,,516000.0
Adilabad,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Adilabad,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,29200.0,123200.0,67100.0,93400.0,63200.0,16000.0,82600.0,57600.0,,,,,532300.0
Adilabad,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,272500.0,149300.0,208200.0,114800.0,51600.0,185600.0,268000.0,285400.0,0.0,0.0,0.0,0.0,1535400.0
Adilabad,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,23500.0,19300.0,24700.0,17600.0,12600.0,5800.0,13500.0,16600.0,,,,,133600.0
Adilabad,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,7200.0,,0.0,0.0,10000.0,10000.0,0.0,,,,,27200.0
Adilabad,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Adilabad,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,4200.0,1800.0,7100.0,5000.0,6800.0,2300.0,6900.0,1600.0,,,,,35700.0
Adilabad,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,19300.0,24700.0,17600.0,12600.0,5800.0,13500.0,16600.0,15000.0,0.0,0.0,0.0,0.0,125100.0
Adilabad,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,1.0,,,,,,,,,1.0
Adilabad,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Adilabad,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Adilabad,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Adilabad,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,1.0,,,,1.0,,,,,,,2.0
Adilabad,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Adilabad,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,1.0,,,,1.0,,,,,,,2.0
Adilabad,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,2.0,2.0,,,,1.0,2.0,,,2.0,9.0
Adilabad,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Adilabad,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,2.0,2.0,,,,1.0,2.0,,,2.0,9.0
Adilabad,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,3.0,,1.0,,2.0,,1.0,7.0,2.0,3.0,3.0,1.0,23.0
Adilabad,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,2.0,1.0,,,,,,,,,,3.0
Adilabad,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,3.0,2.0,2.0,,2.0,,1.0,7.0,2.0,3.0,3.0,1.0,26.0
Adilabad,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Adilabad,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,1.0,,,,,,,,,,,1.0
Adilabad,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,1.0,,,,,,,,,,,1.0
Adilabad,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Adilabad,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Adilabad,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Adilabad,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Adilabad,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,1.0,,,,,,,1.0
Adilabad,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,1.0,,,,,,,1.0
Adilabad,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Adilabad,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Adilabad,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Adilabad,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,1.0,,1.0,1.0,2.0,2.0,1.0,3.0,,1.0,,1.0,13.0
Adilabad,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,2.0,2.0,,1.0,1.0,2.0,,3.0,3.0,3.0,2.0,2.0,21.0
Adilabad,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,3.0,2.0,1.0,2.0,3.0,4.0,1.0,6.0,3.0,4.0,2.0,3.0,34.0
Adilabad,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Adilabad,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,1.0,,,,,1.0,,,,,,,2.0
Adilabad,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Adilabad,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,1.0,,,,,1.0,,,,,,,2.0
Adilabad,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,1.0,1.0
Adilabad,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,2.0,3.0,1.0,3.0,,1.0,2.0,5.0,1.0,1.0,,2.0,21.0
Adilabad,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,1.0,,,,2.0,1.0,1.0,1.0,3.0,2.0,2.0,,13.0
Adilabad,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,3.0,3.0,1.0,3.0,2.0,2.0,3.0,6.0,4.0,3.0,2.0,3.0,35.0
Adilabad,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Adilabad,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,1.0,1.0,,2.0,2.0,1.0,1.0,,,3.0,11.0
Adilabad,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,7.0,5.0,5.0,6.0,6.0,3.0,4.0,4.0,10.0,7.0,4.0,8.0,69.0
Adilabad,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,7.0,5.0,6.0,7.0,6.0,5.0,6.0,5.0,11.0,7.0,4.0,11.0,80.0
Adilabad,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Adilabad,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Adilabad,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Adilabad,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Adilabad,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Adilabad,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,1.0,,,,,,,,1.0
Adilabad,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Adilabad,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,1.0,,,,,,,,1.0
Adilabad,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Adilabad,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,2.0,2.0,1.0,1.0,2.0,,,,,1.0,9.0
Adilabad,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Adilabad,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,2.0,2.0,1.0,1.0,2.0,,,,,1.0,9.0
Adilabad,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,1.0,,,,,,,,1.0
Adilabad,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,2.0,2.0,4.0,2.0,10.0,4.0,5.0,7.0,3.0,8.0,9.0,6.0,62.0
Adilabad,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,7.0,10.0,10.0,6.0,10.0,5.0,3.0,7.0,7.0,11.0,7.0,1.0,84.0
Adilabad,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,9.0,12.0,14.0,8.0,21.0,9.0,8.0,14.0,10.0,19.0,16.0,7.0,147.0
Adilabad,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,1.0,1.0
Adilabad,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,1.0,2.0,3.0,1.0,,,,,7.0
Adilabad,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,4.0,3.0,,2.0,2.0,1.0,1.0,2.0,,,15.0
Adilabad,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,4.0,3.0,1.0,4.0,5.0,2.0,1.0,2.0,,1.0,23.0
Adilabad,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Adilabad,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Adilabad,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Adilabad,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Adilabad,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Adilabad,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Adilabad,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Adilabad,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Adilabad,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Adilabad,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,1.0,,,,,,,,1.0
Adilabad,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Adilabad,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,1.0,,,,,,,,1.0
Adilabad,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Adilabad,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,1.0,,,1.0,2.0,,,,,,,4.0
Adilabad,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Adilabad,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,1.0,,,1.0,2.0,,,,,,,4.0
Adilabad,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Adilabad,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Adilabad,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Adilabad,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Adilabad,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Adilabad,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,1.0,2.0,3.0,1.0,4.0,3.0,1.0,1.0,2.0,,,,18.0
Adilabad,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Adilabad,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,1.0,2.0,3.0,1.0,4.0,3.0,1.0,1.0,2.0,,,,18.0
Adilabad,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,1.0,,,,1.0,,,,,,1.0,,3.0
Adilabad,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,1.0,3.0,2.0,3.0,5.0,1.0,5.0,7.0,6.0,3.0,7.0,5.0,48.0
Adilabad,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,2.0,2.0,1.0,1.0,,,1.0,2.0,,1.0,1.0,11.0
Adilabad,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,2.0,5.0,4.0,4.0,7.0,1.0,5.0,8.0,8.0,3.0,9.0,6.0,62.0
Adilabad,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,2.0,,,,,,,,,2.0
Adilabad,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,6.0,2.0,5.0,7.0,8.0,5.0,4.0,3.0,7.0,9.0,7.0,4.0,67.0
Adilabad,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,2.0,1.0,1.0,,1.0,1.0,1.0,1.0,8.0
Adilabad,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,6.0,2.0,5.0,9.0,10.0,6.0,5.0,3.0,8.0,10.0,8.0,5.0,77.0
Adilabad,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,1.0,1.0,,,,1.0,1.0,1.0,1.0,6.0
Adilabad,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,1.0,,,1.0,,5.0,2.0,,1.0,,1.0,1.0,12.0
Adilabad,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,1.0,,,,1.0,,2.0
Adilabad,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,1.0,,,2.0,1.0,5.0,3.0,,2.0,1.0,3.0,2.0,20.0
Adilabad,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Adilabad,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,4.0,,1.0,1.0,3.0,3.0,1.0,1.0,2.0,1.0,17.0
Adilabad,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,1.0,2.0,1.0,1.0,2.0,6.0,4.0,13.0,4.0,10.0,6.0,,50.0
Adilabad,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,1.0,2.0,5.0,1.0,3.0,7.0,7.0,16.0,5.0,11.0,8.0,1.0,67.0
Adilabad,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,1.0,,,,,,,,1.0,,,2.0
Adilabad,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,2.0,1.0,3.0,2.0,,4.0,3.0,2.0,1.0,2.0,3.0,4.0,27.0
Adilabad,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,5.0,2.0,3.0,,2.0,3.0,6.0,,,2.0,2.0,2.0,27.0
Adilabad,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,7.0,4.0,6.0,2.0,2.0,7.0,9.0,2.0,1.0,5.0,5.0,6.0,56.0
Adilabad,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,1.0,,2.0,,,1.0,2.0,,,3.0,,2.0,11.0
Adilabad,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,32.0,21.0,22.0,24.0,30.0,34.0,18.0,30.0,25.0,31.0,16.0,28.0,311.0
Adilabad,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,65.0,50.0,77.0,41.0,67.0,55.0,51.0,61.0,68.0,73.0,54.0,54.0,716.0
Adilabad,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,98.0,71.0,101.0,65.0,97.0,90.0,71.0,91.0,93.0,107.0,70.0,84.0,1038.0
BHADRADRI KOTHAGUDEM,1.1,Total number of pregnant women Registered for ANC,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,1.2,Number of Pregnant women registered under JSY,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,1.8,Number of pregnancy test kits used at SC level,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,4.1.1.a,Number of male live births,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,4.1.1.b,Number of female live births,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,4.1.2,Number of still births,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,4.2.1,Number of Newborns weighed at birth,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,6.3,PNC maternal complications attended,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,7.2,Number of MTPs conducted at Private Facilities,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,9.06,Number of IUCD removals,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,9.07,Number of Oral Pills cycles distributed,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,9.08,Number of Condom pieces distributed,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,9.09,Number of Centchroman (weekly) pills given,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,9.11.2.a,Number of failures following male sterilization,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,9.11.2.b,Number of failures following female sterilization,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,9.11.3.a,Number of deaths following male sterilization,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,9.11.3.b,Number of deaths following female sterilization,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,,,,,,,,,,,-1.0
BHADRADRI KOTHAGUDEM,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,10.4.2,Number of Immunisation sessions held during the month,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,13.1,Number of Patients operated for cataract,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,13.3,Number of School children detected with Refractive errors,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,13.4,Number of children provided free glasses,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,13.5,Number of eyes collected through eye donation,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,13.6,Number of eyes utilised for corneal transplant,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,,,,,,,,,,,,-1.0
BHADRADRI KOTHAGUDEM,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,,,,,,,,,,-1.0
BHADRADRI KOTHAGUDEM,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,,,,,,,,,,,,,-1.0
BHADRADRI KOTHAGUDEM,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,,,,,,,,,,,,,-1.0
BHADRADRI KOTHAGUDEM,14.05,Number of RKS meetings held during the month,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,,,,,,,,,,,,,-1.0
BHADRADRI KOTHAGUDEM,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,,,,,,,,,-1.0
BHADRADRI KOTHAGUDEM,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,,,,,,,,,,,,,-1.0
BHADRADRI KOTHAGUDEM,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,14.10.2.a,Number of death cases of Inpatient males,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,14.10.2.b,Number of death cases of Inpatient females,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,14.11,In-Patient Head Count at midnight,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,14.12.1,OPD attendance (All),TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,14.14.a,Number of patients given AYUSH treatment,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,14.14.c,Number of Adolescents counselled,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,15.2,Number of Widal tests conducted,Number tested,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,15.3.a,Number of VDRL tests conducted on males,Number tested,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,15.4.1,Number of blood smears examined for Malaria,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
BHADRADRI KOTHAGUDEM,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
BHADRADRI KOTHAGUDEM,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
BHADRADRI KOTHAGUDEM,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
BHADRADRI KOTHAGUDEM,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
BHADRADRI KOTHAGUDEM,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
BHADRADRI KOTHAGUDEM,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
BHADRADRI KOTHAGUDEM,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
BHADRADRI KOTHAGUDEM,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
BHADRADRI KOTHAGUDEM,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
BHADRADRI KOTHAGUDEM,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
BHADRADRI KOTHAGUDEM,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
BHADRADRI KOTHAGUDEM,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
BHADRADRI KOTHAGUDEM,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
BHADRADRI KOTHAGUDEM,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
BHADRADRI KOTHAGUDEM,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
BHADRADRI KOTHAGUDEM,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
BHADRADRI KOTHAGUDEM,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
BHADRADRI KOTHAGUDEM,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
BHADRADRI KOTHAGUDEM,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
BHADRADRI KOTHAGUDEM,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
BHADRADRI KOTHAGUDEM,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
BHADRADRI KOTHAGUDEM,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
BHADRADRI KOTHAGUDEM,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
BHADRADRI KOTHAGUDEM,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
BHADRADRI KOTHAGUDEM,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
BHADRADRI KOTHAGUDEM,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
BHADRADRI KOTHAGUDEM,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
BHADRADRI KOTHAGUDEM,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
BHADRADRI KOTHAGUDEM,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
Hyderabad,1.1,Total number of pregnant women Registered for ANC,TOTAL,23258.0,22638.0,24163.0,24109.0,24587.0,21943.0,16301.0,24962.0,23234.0,17757.0,18366.0,17802.0,259120.0
Hyderabad,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,6368.0,6866.0,7076.0,6724.0,8010.0,7285.0,5734.0,6394.0,5583.0,7122.0,5856.0,6276.0,79294.0
Hyderabad,1.2,Number of Pregnant women registered under JSY,TOTAL,6226.0,4716.0,5519.0,5478.0,6090.0,6741.0,4309.0,6827.0,7207.0,5672.0,6806.0,5893.0,71484.0
Hyderabad,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,24525.0,27552.0,26251.0,26488.0,24920.0,25900.0,20390.0,25708.0,25935.0,24834.0,27371.0,28298.0,308172.0
Hyderabad,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,9750.0,10957.0,10633.0,11457.0,11301.0,9531.0,10224.0,10535.0,10044.0,10099.0,11166.0,10094.0,125791.0
Hyderabad,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,10031.0,10676.0,10202.0,10388.0,10964.0,9300.0,10087.0,9833.0,10313.0,9835.0,10608.0,9998.0,122235.0
Hyderabad,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,20918.0,27968.0,30567.0,24276.0,30518.0,25255.0,21510.0,24142.0,30394.0,24283.0,25292.0,22832.0,307955.0
Hyderabad,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,516.0,487.0,592.0,580.0,559.0,662.0,492.0,461.0,497.0,453.0,423.0,568.0,6290.0
Hyderabad,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,56.0,62.0,59.0,53.0,35.0,51.0,34.0,70.0,75.0,103.0,33.0,49.0,680.0
Hyderabad,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,7053.0,6491.0,4736.0,4837.0,7235.0,4948.0,2928.0,5788.0,5261.0,5770.0,5913.0,6563.0,67523.0
Hyderabad,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,2026.0,1123.0,2503.0,2167.0,2378.0,1231.0,1722.0,2410.0,2354.0,269.0,495.0,376.0,19054.0
Hyderabad,1.8,Number of pregnancy test kits used at SC level,TOTAL,,,,,,,,,,,,,
Hyderabad,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,,,,,,,,,,,,,
Hyderabad,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,,,,,,,,,,,,,
Hyderabad,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,,,,,,,,,,,,,
Hyderabad,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,,,,,,,,,,,,,
Hyderabad,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,,,,,,,,,,,,,
Hyderabad,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,5447.0,6779.0,5749.0,6669.0,5769.0,5181.0,4938.0,5417.0,4297.0,4371.0,4068.0,3928.0,62613.0
Hyderabad,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,2170.0,1827.0,1986.0,2559.0,2226.0,3059.0,1696.0,2502.0,2273.0,2448.0,2707.0,2107.0,27560.0
Hyderabad,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1630.0,1621.0,1550.0,1281.0,1381.0,1667.0,408.0,1954.0,1940.0,2465.0,2779.0,2527.0,21203.0
Hyderabad,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,0.0,0.0,12.0,12.0,12.0,36.0,11.0,6.0,16.0,18.0,19.0,26.0,168.0
Hyderabad,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,6.0,0.0,0.0,0.0,4.0,6.0,0.0,0.0,16.0
Hyderabad,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,1634.0,1330.0,1329.0,1454.0,1606.0,2456.0,3395.0,3781.0,3147.0,3816.0,4123.0,3246.0,31317.0
Hyderabad,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Hyderabad,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Hyderabad,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Hyderabad,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,156.0,496.0,411.0,289.0,480.0,263.0,137.0,135.0,136.0,149.0,193.0,157.0,3002.0
Hyderabad,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,58.0,53.0,51.0,56.0,56.0,45.0,56.0,57.0,53.0,49.0,50.0,64.0,648.0
Hyderabad,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,1050.0,1056.0,995.0,1378.0,1271.0,1059.0,1637.0,1941.0,1274.0,1228.0,1224.0,1191.0,15304.0
Hyderabad,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Hyderabad,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,1264.0,1605.0,1457.0,1723.0,1807.0,1367.0,1830.0,2133.0,1463.0,1426.0,1467.0,1412.0,18954.0
Hyderabad,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
Hyderabad,4.1.1.a,Number of male live births,TOTAL,4804.0,5110.0,4930.0,5990.0,5564.0,5439.0,5428.0,5616.0,5630.0,5262.0,5307.0,5156.0,64236.0
Hyderabad,4.1.1.b,Number of female live births,TOTAL,4548.0,4917.0,4721.0,5109.0,5076.0,5104.0,5217.0,5490.0,4924.0,4940.0,5203.0,5002.0,60251.0
Hyderabad,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,9352.0,10027.0,9651.0,11099.0,10640.0,10543.0,10645.0,11106.0,10554.0,10202.0,10510.0,10158.0,124487.0
Hyderabad,4.1.2,Number of still births,TOTAL,68.0,673.0,631.0,814.0,143.0,776.0,207.0,124.0,152.0,191.0,106.0,103.0,3988.0
Hyderabad,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,48.0,98.0,96.0,146.0,141.0,73.0,103.0,83.0,167.0,50.0,57.0,97.0,1159.0
Hyderabad,4.2.1,Number of Newborns weighed at birth,TOTAL,6271.0,7950.0,6023.0,8251.0,8288.0,7230.0,6643.0,6370.0,6156.0,5915.0,6014.0,6284.0,81395.0
Hyderabad,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,512.0,594.0,589.0,709.0,578.0,459.0,556.0,604.0,821.0,885.0,694.0,799.0,7800.0
Hyderabad,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,5702.0,6070.0,7432.0,8189.0,7424.0,7154.0,6382.0,6878.0,5265.0,5062.0,5898.0,6375.0,77831.0
Hyderabad,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,2.0,4.0,0.0,0.0,8.0,0.0,2.0,8.0,2.0,2.0,28.0
Hyderabad,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,61.0,71.0,57.0,37.0,38.0,41.0,19.0,46.0,33.0,41.0,30.0,48.0,522.0
Hyderabad,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,611.0,160.0,144.0,85.0,296.0,77.0,28.0,77.0,54.0,70.0,126.0,76.0,1804.0
Hyderabad,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Hyderabad,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,672.0,231.0,203.0,126.0,334.0,118.0,55.0,123.0,89.0,119.0,158.0,126.0,2354.0
Hyderabad,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Hyderabad,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,259.0,77.0,84.0,54.0,142.0,47.0,21.0,56.0,44.0,45.0,46.0,43.0,918.0
Hyderabad,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,121.0,21.0,37.0,15.0,44.0,12.0,1.0,3.0,3.0,13.0,17.0,14.0,301.0
Hyderabad,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,628.0,158.0,137.0,106.0,315.0,39.0,13.0,63.0,38.0,77.0,73.0,57.0,1704.0
Hyderabad,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,128.0,54.0,44.0,35.0,34.0,43.0,6.0,18.0,17.0,9.0,48.0,14.0,450.0
Hyderabad,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,5818.0,6766.0,5520.0,5329.0,6841.0,6135.0,5681.0,5061.0,5653.0,5112.0,4868.0,5565.0,68349.0
Hyderabad,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,5706.0,6656.0,6676.0,3683.0,5461.0,5892.0,5875.0,4773.0,5165.0,4967.0,3971.0,4781.0,63606.0
Hyderabad,6.3,PNC maternal complications attended,TOTAL,97.0,5.0,0.0,36.0,0.0,17.0,1.0,71.0,50.0,28.0,32.0,165.0,502.0
Hyderabad,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,34.0,67.0,54.0,85.0,70.0,66.0,39.0,42.0,62.0,32.0,28.0,87.0,666.0
Hyderabad,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,14.0,0.0,18.0,31.0,0.0,15.0,7.0,63.0,0.0,25.0,0.0,173.0
Hyderabad,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,34.0,81.0,54.0,103.0,101.0,66.0,54.0,49.0,125.0,32.0,53.0,87.0,839.0
Hyderabad,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0
Hyderabad,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,1245.0,1482.0,1518.0,1414.0,1305.0,1392.0,1351.0,1437.0,1453.0,1553.0,1438.0,1220.0,16808.0
Hyderabad,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,2518.0,2944.0,2438.0,2636.0,2529.0,2488.0,2214.0,3078.0,2628.0,2613.0,2638.0,2733.0,31457.0
Hyderabad,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,3763.0,4426.0,3956.0,4050.0,3834.0,3880.0,3565.0,4515.0,4081.0,4166.0,4076.0,3953.0,48265.0
Hyderabad,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,70.0,458.0,70.0,77.0,100.0,423.0,91.0,236.0,75.0,65.0,63.0,2.0,1730.0
Hyderabad,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,38.0,36.0,55.0,175.0,14.0,79.0,37.0,2.0,36.0,108.0,54.0,12.0,646.0
Hyderabad,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,,1.0,,,,0.0,17.0,0.0,0.0,0.0,0.0,0.0,18.0
Hyderabad,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,1.0,0.0,0.0,5.0,7.0,2.0,72.0,7.0,150.0,1.0,4.0,1.0,250.0
Hyderabad,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Hyderabad,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,39.0,37.0,55.0,180.0,21.0,81.0,126.0,9.0,186.0,109.0,58.0,13.0,914.0
Hyderabad,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Hyderabad,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,516.0,456.0,396.0,421.0,313.0,412.0,334.0,403.0,240.0,234.0,315.0,222.0,4262.0
Hyderabad,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,37.0,101.0,62.0,43.0,32.0,38.0,16.0,44.0,48.0,36.0,63.0,35.0,555.0
Hyderabad,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,131.0,139.0,184.0,195.0,245.0,241.0,38.0,264.0,186.0,105.0,172.0,180.0,2080.0
Hyderabad,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Hyderabad,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,684.0,696.0,642.0,659.0,590.0,691.0,388.0,711.0,474.0,375.0,550.0,437.0,6897.0
Hyderabad,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,9.0,,,,,,,,,,,,9.0
Hyderabad,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,116.0,90.0,91.0,143.0,103.0,105.0,126.0,94.0,127.0,139.0,92.0,230.0,1456.0
Hyderabad,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,38.0,63.0,19.0,19.0,38.0,39.0,33.0,47.0,25.0,67.0,29.0,50.0,467.0
Hyderabad,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,82.0,109.0,306.0,112.0,125.0,73.0,55.0,275.0,330.0,351.0,231.0,234.0,2283.0
Hyderabad,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Hyderabad,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,236.0,262.0,416.0,274.0,266.0,217.0,214.0,416.0,482.0,557.0,352.0,514.0,4206.0
Hyderabad,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,561.0,535.0,570.0,477.0,549.0,555.0,627.0,752.0,557.0,590.0,555.0,,6328.0
Hyderabad,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,120.0,214.0,159.0,188.0,202.0,158.0,197.0,112.0,95.0,190.0,75.0,91.0,1801.0
Hyderabad,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,27.0,27.0,41.0,34.0,25.0,26.0,41.0,42.0,24.0,0.0,25.0,16.0,328.0
Hyderabad,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,977.0,248.0,257.0,161.0,358.0,510.0,460.0,426.0,403.0,397.0,510.0,359.0,5066.0
Hyderabad,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Hyderabad,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,1124.0,489.0,457.0,383.0,585.0,694.0,698.0,580.0,522.0,587.0,610.0,466.0,7195.0
Hyderabad,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,6.0,,,,,,,,,,,,6.0
Hyderabad,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,,,,,,,,,,,,,
Hyderabad,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,851.0,926.0,966.0,1032.0,967.0,863.0,831.0,783.0,777.0,820.0,893.0,725.0,10434.0
Hyderabad,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,13.0,14.0,13.0,28.0,25.0,18.0,20.0,12.0,19.0,16.0,21.0,23.0,222.0
Hyderabad,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,172.0,156.0,235.0,287.0,279.0,287.0,373.0,146.0,323.0,292.0,293.0,125.0,2968.0
Hyderabad,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Hyderabad,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,1036.0,1096.0,1214.0,1347.0,1271.0,1168.0,1224.0,941.0,1119.0,1128.0,1207.0,873.0,13624.0
Hyderabad,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,28.0,5.0,78.0,219.0,309.0,345.0,253.0,167.0,123.0,84.0,88.0,177.0,1876.0
Hyderabad,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,17.0,,,,,,,,,,,,17.0
Hyderabad,9.06,Number of IUCD removals,TOTAL,609.0,327.0,803.0,950.0,449.0,383.0,1076.0,387.0,331.0,478.0,618.0,456.0,6867.0
Hyderabad,9.07,Number of Oral Pills cycles distributed,TOTAL,4617.0,4706.0,9406.0,4058.0,6354.0,4778.0,8555.0,4399.0,4634.0,4421.0,8149.0,7325.0,71402.0
Hyderabad,9.08,Number of Condom pieces distributed,TOTAL,28222.0,27753.0,33223.0,24733.0,25265.0,30632.0,29065.0,38723.0,36954.0,30636.0,32626.0,27516.0,365348.0
Hyderabad,9.09,Number of Centchroman (weekly) pills given,TOTAL,378.0,60.0,55.0,57.0,103.0,101.0,0.0,61.0,182.0,10.0,101.0,98.0,1206.0
Hyderabad,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,33.0,34.0,10.0,60.0,60.0,21.0,50.0,0.0,36.0,56.0,65.0,0.0,425.0
Hyderabad,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hyderabad,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hyderabad,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hyderabad,9.11.2.b,Number of failures following female sterilization,TOTAL,1.0,0.0,0.0,1.0,0.0,0.0,1.0,1.0,0.0,1.0,0.0,1.0,6.0
Hyderabad,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hyderabad,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hyderabad,9.12,Number of Institutions having NSV trained doctors,TOTAL,30.0,33.0,34.0,30.0,34.0,21.0,27.0,23.0,20.0,21.0,19.0,21.0,-1.0
Hyderabad,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,9134.0,8946.0,9527.0,11004.0,10640.0,10479.0,10445.0,11005.0,10453.0,10202.0,10460.0,10058.0,122353.0
Hyderabad,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,7241.0,7305.0,4474.0,2247.0,1763.0,1036.0,514.0,372.0,196.0,271.0,173.0,187.0,25779.0
Hyderabad,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,6791.0,6914.0,6781.0,4170.0,2855.0,1367.0,622.0,468.0,196.0,339.0,171.0,197.0,30871.0
Hyderabad,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,6828.0,6862.0,6687.0,6681.0,4175.0,1981.0,889.0,542.0,255.0,407.0,204.0,200.0,35711.0
Hyderabad,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,818.0,4873.0,6654.0,5884.0,5941.0,7158.0,7161.0,7347.0,7135.0,7183.0,7322.0,67476.0
Hyderabad,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,123.0,3609.0,5029.0,5489.0,6658.0,6591.0,7036.0,6732.0,6835.0,7012.0,55114.0
Hyderabad,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,92.0,475.0,3365.0,5044.0,6358.0,6390.0,6918.0,6681.0,6797.0,6946.0,49066.0
Hyderabad,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,6961.0,6880.0,7348.0,8954.0,9800.0,9699.0,9280.0,9600.0,9365.0,9225.0,9349.0,8963.0,105424.0
Hyderabad,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,7230.0,7161.0,6496.0,6529.0,7027.0,6751.0,6794.0,6938.0,7028.0,7302.0,7258.0,7345.0,83859.0
Hyderabad,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,6804.0,6816.0,6771.0,6860.0,6975.0,6600.0,6593.0,6745.0,6936.0,6786.0,6917.0,7038.0,81841.0
Hyderabad,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,6829.0,6763.0,6689.0,6635.0,6623.0,6599.0,6476.0,6628.0,6848.0,6868.0,6902.0,6875.0,80735.0
Hyderabad,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,3082.0,3498.0,4880.0,6741.0,4940.0,5609.0,6207.0,5799.0,6351.0,5840.0,5824.0,5756.0,64527.0
Hyderabad,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,7191.0,7084.0,4576.0,1969.0,1825.0,1320.0,384.0,219.0,14.0,141.0,140.0,199.0,25062.0
Hyderabad,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,6723.0,6830.0,6722.0,4365.0,2827.0,1470.0,498.0,284.0,39.0,207.0,140.0,67.0,30172.0
Hyderabad,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,6798.0,6780.0,6818.0,6341.0,4265.0,2084.0,753.0,390.0,85.0,256.0,155.0,76.0,34801.0
Hyderabad,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,6596.0,6674.0,6777.0,6524.0,6805.0,6810.0,7075.0,6977.0,6941.0,6990.0,6918.0,7052.0,82139.0
Hyderabad,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,4243.0,4300.0,4304.0,4833.0,4269.0,4115.0,4781.0,4768.0,4746.0,4835.0,4670.0,4808.0,54672.0
Hyderabad,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,20.0,117.0,304.0,253.0,121.0,131.0,78.0,150.0,360.0,0.0,79.0,68.0,1681.0
Hyderabad,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,3305.0,3169.0,3513.0,2773.0,3064.0,3171.0,3382.0,3461.0,3525.0,3220.0,3029.0,3581.0,39193.0
Hyderabad,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,3173.0,2971.0,3133.0,2641.0,2853.0,3252.0,3251.0,3397.0,3356.0,3102.0,2948.0,3390.0,37467.0
Hyderabad,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,6478.0,6140.0,6646.0,5414.0,5917.0,6423.0,6633.0,6858.0,6881.0,6322.0,5977.0,6971.0,76660.0
Hyderabad,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,5961.0,6222.0,5875.0,5972.0,6342.0,6195.0,6639.0,6464.0,6569.0,6490.0,6378.0,6386.0,75493.0
Hyderabad,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,5941.0,6145.0,6120.0,6057.0,6384.0,6107.0,6639.0,6472.0,6569.0,6483.0,6361.0,6390.0,75668.0
Hyderabad,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,3755.0,4167.0,2926.0,4242.0,4359.0,4387.0,3606.0,4012.0,3696.0,4295.0,4254.0,4138.0,47837.0
Hyderabad,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2852.0,2811.0,2997.0,2389.0,3256.0,4138.0,3028.0,4046.0,4195.0,2202.0,2227.0,1943.0,36084.0
Hyderabad,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2700.0,2753.0,3034.0,2337.0,3035.0,4011.0,3109.0,4202.0,3733.0,2104.0,2111.0,1864.0,34993.0
Hyderabad,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,5552.0,5564.0,6031.0,4726.0,6291.0,8149.0,6137.0,8248.0,7928.0,4306.0,4338.0,3807.0,71077.0
Hyderabad,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,2334.0,2284.0,3987.0,4862.0,5051.0,4707.0,4909.0,5066.0,5057.0,5342.0,4913.0,5404.0,53916.0
Hyderabad,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,5216.0,5406.0,5009.0,5074.0,5339.0,5237.0,5472.0,5381.0,5361.0,5284.0,5125.0,5132.0,63036.0
Hyderabad,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,5173.0,5437.0,4993.0,4919.0,5577.0,5189.0,5449.0,5345.0,5249.0,5236.0,5120.0,5135.0,62822.0
Hyderabad,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hyderabad,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hyderabad,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,2.0,2.0,2.0,2.0,4.0,3.0,2.0,3.0,2.0,5.0,6.0,5.0,38.0
Hyderabad,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1349.0,1258.0,1223.0,1284.0,1181.0,1218.0,1322.0,1439.0,1429.0,1392.0,1371.0,1330.0,15796.0
Hyderabad,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1308.0,1227.0,1180.0,1197.0,1156.0,1166.0,1288.0,1397.0,1403.0,1318.0,1327.0,1285.0,15252.0
Hyderabad,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1079.0,1087.0,991.0,1116.0,992.0,1005.0,1101.0,1189.0,1206.0,1124.0,1137.0,1155.0,13182.0
Hyderabad,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hyderabad,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,5550.0,5854.0,6253.0,5774.0,6303.0,6867.0,6713.0,6309.0,6798.0,6165.0,6351.0,6562.0,75499.0
Hyderabad,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,4258.0,4321.0,4194.0,4320.0,4745.0,4750.0,5066.0,4745.0,5661.0,5269.0,4809.0,5175.0,57313.0
Hyderabad,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,3030.0,2965.0,2733.0,4213.0,3111.0,3404.0,3282.0,3288.0,3927.0,3556.0,3894.0,3600.0,41003.0
Hyderabad,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hyderabad,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hyderabad,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hyderabad,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hyderabad,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hyderabad,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,4.0,0.0,42.0,7.0,0.0,0.0,2.0,33.0,35.0,13.0,136.0
Hyderabad,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,142.0,120.0,884.0,308.0,503.0,842.0,828.0,884.0,1138.0,822.0,710.0,718.0,7899.0
Hyderabad,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hyderabad,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,13.0,10.0,12.0,16.0,9.0,15.0,15.0,16.0,15.0,14.0,17.0,15.0,167.0
Hyderabad,13.1,Number of Patients operated for cataract,TOTAL,37.0,146.0,189.0,436.0,667.0,206.0,14.0,32.0,683.0,38.0,35.0,49.0,2532.0
Hyderabad,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,37.0,21.0,38.0,29.0,29.0,36.0,14.0,32.0,43.0,38.0,35.0,49.0,401.0
Hyderabad,13.3,Number of School children detected with Refractive errors,TOTAL,6.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0,20.0,25.0,24.0,81.0
Hyderabad,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hyderabad,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hyderabad,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hyderabad,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,9.0,9.0,9.0,9.0,10.0,8.0,7.0,7.0,5.0,6.0,6.0,5.0,-1.0
Hyderabad,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,39.0,39.0,32.0,27.0,29.0,15.0,23.0,17.0,17.0,17.0,17.0,16.0,-1.0
Hyderabad,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,,,,,,,,,,,,,-1.0
Hyderabad,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,9.0,8.0,8.0,8.0,8.0,9.0,7.0,4.0,2.0,3.0,5.0,3.0,-1.0
Hyderabad,14.05,Number of RKS meetings held during the month,TOTAL,0.0,0.0,3.0,4.0,13.0,2.0,2.0,2.0,18.0,2.0,14.0,6.0,66.0
Hyderabad,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,31.0,33.0,36.0,32.0,36.0,22.0,28.0,24.0,22.0,23.0,22.0,21.0,-1.0
Hyderabad,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,28.0,52.0,36.0,50.0,57.0,83.0,45.0,70.0,51.0,52.0,54.0,56.0,634.0
Hyderabad,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,2.0,2.0,2.0,2.0,3.0,5.0,2.0,6.0,4.0,5.0,5.0,4.0,-1.0
Hyderabad,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,1.0,4.0,3.0,3.0,4.0,1.0,-1.0
Hyderabad,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,,,,,,,,,,,,,
Hyderabad,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,,,,,,,,,,,,,
Hyderabad,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,,,,,,,,,,,,,
Hyderabad,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,344.0,550.0,619.0,734.0,717.0,869.0,3352.0,3086.0,3284.0,2731.0,2287.0,2997.0,21570.0
Hyderabad,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,2908.0,3338.0,3780.0,3599.0,3243.0,3741.0,3919.0,3508.0,3529.0,3684.0,3427.0,3474.0,42150.0
Hyderabad,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,284.0,414.0,572.0,669.0,655.0,1142.0,3233.0,2884.0,2328.0,2119.0,3094.0,2128.0,19522.0
Hyderabad,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,4773.0,4902.0,5918.0,5209.0,5482.0,5471.0,4130.0,5958.0,5462.0,6259.0,6131.0,6026.0,65721.0
Hyderabad,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,628.0,964.0,1191.0,1403.0,1372.0,2011.0,6585.0,5970.0,5612.0,4850.0,5381.0,5125.0,41092.0
Hyderabad,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,7681.0,8240.0,9698.0,8808.0,8725.0,9212.0,8049.0,9466.0,8991.0,9943.0,9558.0,9500.0,107871.0
Hyderabad,14.10.2.a,Number of death cases of Inpatient males,TOTAL,298.0,727.0,687.0,596.0,542.0,678.0,504.0,440.0,417.0,490.0,470.0,455.0,6304.0
Hyderabad,14.10.2.b,Number of death cases of Inpatient females,TOTAL,173.0,210.0,285.0,204.0,230.0,186.0,414.0,382.0,327.0,374.0,327.0,345.0,3457.0
Hyderabad,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,471.0,937.0,972.0,800.0,772.0,864.0,918.0,822.0,744.0,864.0,797.0,800.0,9761.0
Hyderabad,14.11,In-Patient Head Count at midnight,TOTAL,37551.0,38781.0,36917.0,35656.0,43073.0,34867.0,36065.0,37323.0,38589.0,35618.0,33660.0,41866.0,449966.0
Hyderabad,14.12.1,OPD attendance (All),TOTAL,292573.0,330197.0,311764.0,352586.0,351155.0,422060.0,402588.0,402381.0,397163.0,381295.0,383538.0,375247.0,4402547.0
Hyderabad,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,1939.0,2412.0,2114.0,2117.0,2301.0,1888.0,1493.0,1429.0,1407.0,1550.0,1632.0,1695.0,21977.0
Hyderabad,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,1.0,104.0,37.0,109.0,279.0,310.0,0.0,255.0,13.0,268.0,279.0,18.0,1673.0
Hyderabad,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,,,,,,,,,,,,,
Hyderabad,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,5046.0,3993.0,5269.0,5107.0,3976.0,4510.0,4678.0,4697.0,4504.0,4561.0,4541.0,4613.0,55495.0
Hyderabad,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,,,,,,,,,,,,,
Hyderabad,14.14.a,Number of patients given AYUSH treatment,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,180.0,0.0,180.0,207.0,27.0,594.0
Hyderabad,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,538.0,745.0,545.0,864.0,1154.0,770.0,939.0,1032.0,458.0,581.0,623.0,743.0,8992.0
Hyderabad,14.14.c,Number of Adolescents counselled,TOTAL,170.0,0.0,0.0,6.0,4.0,8.0,52.0,267.0,242.0,271.0,320.0,626.0,1966.0
Hyderabad,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,,,,,,,,,,,,,
Hyderabad,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,6092.0,12432.0,12214.0,14191.0,12437.0,13673.0,11867.0,12409.0,12053.0,11367.0,11770.0,12549.0,143054.0
Hyderabad,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,147.0,1797.0,1888.0,1815.0,1710.0,1964.0,1912.0,1854.0,1765.0,1879.0,1970.0,1814.0,20515.0
Hyderabad,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,2282.0,2096.0,1985.0,1483.0,1537.0,3429.0,1805.0,2230.0,2102.0,1994.0,1792.0,1617.0,24352.0
Hyderabad,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,13.0,16.0,26.0,20.0,16.0,36.0,16.0,16.0,17.0,22.0,29.0,16.0,243.0
Hyderabad,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,1929.0,1974.0,2594.0,1788.0,1896.0,2354.0,1982.0,2733.0,2972.0,2339.0,2136.0,1803.0,26500.0
Hyderabad,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,15.0,7.0,19.0,11.0,16.0,16.0,12.0,17.0,21.0,17.0,15.0,15.0,181.0
Hyderabad,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,2020.0,2028.0,2388.0,1964.0,2724.0,2919.0,1793.0,3070.0,3228.0,2972.0,3502.0,3165.0,31773.0
Hyderabad,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,3.0,2.0,0.0,131.0,77.0,78.0,76.0,109.0,2.0,4.0,3.0,3.0,488.0
Hyderabad,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,6231.0,6098.0,6967.0,5235.0,6157.0,8702.0,5580.0,8033.0,8302.0,7305.0,7430.0,6585.0,82625.0
Hyderabad,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,31.0,25.0,45.0,162.0,109.0,130.0,104.0,142.0,40.0,43.0,47.0,34.0,912.0
Hyderabad,15.2,Number of Widal tests conducted,Number tested,2171.0,2814.0,2803.0,2773.0,5462.0,4318.0,2179.0,4532.0,4644.0,3656.0,4028.0,4376.0,43756.0
Hyderabad,15.3.a,Number of VDRL tests conducted on males,Number tested,162.0,152.0,40.0,148.0,112.0,49.0,145.0,179.0,144.0,175.0,126.0,137.0,1569.0
Hyderabad,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,279.0,218.0,84.0,349.0,824.0,146.0,963.0,605.0,883.0,415.0,362.0,264.0,5392.0
Hyderabad,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,1615.0,3258.0,3619.0,3536.0,4324.0,4892.0,1495.0,3730.0,4247.0,3961.0,3275.0,4317.0,42269.0
Hyderabad,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,2056.0,3628.0,3743.0,4033.0,5260.0,5087.0,2603.0,4514.0,5274.0,4551.0,3763.0,4718.0,49230.0
Hyderabad,15.4.1,Number of blood smears examined for Malaria,TOTAL,732.0,881.0,879.0,1074.0,998.0,829.0,1040.0,1070.0,694.0,553.0,924.0,767.0,10441.0
Hyderabad,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,1.0,0.0,0.0,0.0,0.0,1.0,1.0,1.0,0.0,0.0,0.0,0.0,4.0
Hyderabad,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hyderabad,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Hyderabad,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,,,,,,,,,,
Hyderabad,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Hyderabad,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Hyderabad,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hyderabad,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Hyderabad,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Hyderabad,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Hyderabad,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Hyderabad,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hyderabad,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Hyderabad,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,,,,,,,,,
Hyderabad,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Hyderabad,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,,,,,,,,,
Hyderabad,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hyderabad,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Hyderabad,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,,,,,,,,,
Hyderabad,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Hyderabad,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Hyderabad,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hyderabad,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Hyderabad,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Hyderabad,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Hyderabad,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Hyderabad,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hyderabad,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Hyderabad,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,,,,,,,,,
Hyderabad,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Hyderabad,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,,,,,,,,,
Hyderabad,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hyderabad,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Hyderabad,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,,,,,,,,,
Hyderabad,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Hyderabad,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,,,,,,,,,
Hyderabad,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hyderabad,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Hyderabad,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Hyderabad,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Hyderabad,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Hyderabad,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hyderabad,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Hyderabad,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,,,,,,
Hyderabad,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Hyderabad,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,,,,,,
Hyderabad,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hyderabad,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Hyderabad,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Hyderabad,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Hyderabad,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Hyderabad,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hyderabad,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Hyderabad,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Hyderabad,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Hyderabad,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Hyderabad,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hyderabad,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Hyderabad,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Hyderabad,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Hyderabad,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Hyderabad,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hyderabad,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Hyderabad,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Hyderabad,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Hyderabad,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Hyderabad,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hyderabad,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Hyderabad,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Hyderabad,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Hyderabad,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Hyderabad,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hyderabad,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Hyderabad,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Hyderabad,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Hyderabad,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Hyderabad,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hyderabad,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Hyderabad,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Hyderabad,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Hyderabad,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Hyderabad,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hyderabad,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Hyderabad,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Hyderabad,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Hyderabad,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Hyderabad,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hyderabad,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Hyderabad,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Hyderabad,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Hyderabad,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Hyderabad,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hyderabad,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Hyderabad,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Hyderabad,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Hyderabad,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Hyderabad,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hyderabad,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Hyderabad,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Hyderabad,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Hyderabad,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Hyderabad,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hyderabad,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Hyderabad,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Hyderabad,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Hyderabad,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Hyderabad,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hyderabad,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Hyderabad,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Hyderabad,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Hyderabad,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Hyderabad,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hyderabad,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Hyderabad,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Hyderabad,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Hyderabad,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Hyderabad,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hyderabad,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Hyderabad,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Hyderabad,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Hyderabad,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Hyderabad,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hyderabad,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Hyderabad,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Hyderabad,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Hyderabad,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Hyderabad,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hyderabad,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Hyderabad,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Hyderabad,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Hyderabad,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Hyderabad,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hyderabad,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Hyderabad,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Hyderabad,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Hyderabad,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Hyderabad,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hyderabad,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,,,,,,,
Hyderabad,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,,,,,,,
Hyderabad,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Hyderabad,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,,,,,,,
Hyderabad,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hyderabad,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Hyderabad,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Hyderabad,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Hyderabad,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Hyderabad,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Hyderabad,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Hyderabad,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Hyderabad,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Hyderabad,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Hyderabad,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
Hyderabad,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Hyderabad,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Hyderabad,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
Hyderabad,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Hyderabad,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Hyderabad,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Hyderabad,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Hyderabad,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Hyderabad,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Hyderabad,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Hyderabad,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Hyderabad,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Hyderabad,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Hyderabad,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Hyderabad,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Hyderabad,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
Hyderabad,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
Hyderabad,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
Hyderabad,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Hyderabad,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Hyderabad,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Hyderabad,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Hyderabad,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Hyderabad,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
Hyderabad,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Hyderabad,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
Hyderabad,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Hyderabad,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
Hyderabad,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
Hyderabad,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
Hyderabad,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Hyderabad,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Hyderabad,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Hyderabad,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Hyderabad,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Hyderabad,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
Hyderabad,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Hyderabad,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
Hyderabad,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Hyderabad,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Hyderabad,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Hyderabad,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Hyderabad,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Hyderabad,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
Hyderabad,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
Hyderabad,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
Hyderabad,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Hyderabad,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Hyderabad,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Hyderabad,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
Hyderabad,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Hyderabad,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Hyderabad,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Hyderabad,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Hyderabad,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Hyderabad,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Hyderabad,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Hyderabad,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Hyderabad,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Hyderabad,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Hyderabad,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Hyderabad,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Hyderabad,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Hyderabad,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Hyderabad,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Hyderabad,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Hyderabad,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Hyderabad,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Hyderabad,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Hyderabad,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Hyderabad,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Hyderabad,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
Hyderabad,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Hyderabad,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
Hyderabad,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Hyderabad,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
Hyderabad,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
Hyderabad,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
Hyderabad,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Hyderabad,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
Hyderabad,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Hyderabad,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
Hyderabad,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Hyderabad,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Hyderabad,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Hyderabad,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Hyderabad,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Hyderabad,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
Hyderabad,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
Hyderabad,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
Hyderabad,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Hyderabad,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
Hyderabad,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
Hyderabad,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
Hyderabad,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Hyderabad,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
Hyderabad,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
Hyderabad,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
JAGITIAL,1.1,Total number of pregnant women Registered for ANC,TOTAL,,,,,,,,,,,,,
JAGITIAL,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,,,,,,,,,,,,,
JAGITIAL,1.2,Number of Pregnant women registered under JSY,TOTAL,,,,,,,,,,,,,
JAGITIAL,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,,,,,,,,,,,,,
JAGITIAL,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,,,,,,,,,,,,,
JAGITIAL,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,,,,,,,,,,,,,
JAGITIAL,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,,,,,,,,,,,,,
JAGITIAL,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,,,,,,,,,,,,,
JAGITIAL,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,,,,,,,,,,,,,
JAGITIAL,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,,,,,,,,,,,,,
JAGITIAL,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,,,,,,,,,,,,,
JAGITIAL,1.8,Number of pregnancy test kits used at SC level,TOTAL,,,,,,,,,,,,,
JAGITIAL,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,,,,,,,,,,,,,
JAGITIAL,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,,,,,,,,,,,,,
JAGITIAL,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,,,,,,,,,,,,,
JAGITIAL,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,,,,,,,,,,,,,
JAGITIAL,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,,,,,,,,,,,,,
JAGITIAL,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
JAGITIAL,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,,,,,,,,,,,,,
JAGITIAL,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,,,,,,,,,,,,,
JAGITIAL,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,,,,,,,,,,,,,
JAGITIAL,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
JAGITIAL,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
JAGITIAL,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
JAGITIAL,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
JAGITIAL,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
JAGITIAL,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,,,,,,,,,,,,,
JAGITIAL,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,,,,,,,,,,,,,
JAGITIAL,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,,,,,,,,,,,,,
JAGITIAL,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
JAGITIAL,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,,,,,,,,,,,,,
JAGITIAL,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
JAGITIAL,4.1.1.a,Number of male live births,TOTAL,,,,,,,,,,,,,
JAGITIAL,4.1.1.b,Number of female live births,TOTAL,,,,,,,,,,,,,
JAGITIAL,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,,,,,,,,,,,,,
JAGITIAL,4.1.2,Number of still births,TOTAL,,,,,,,,,,,,,
JAGITIAL,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,,,,,,,,,,,,,
JAGITIAL,4.2.1,Number of Newborns weighed at birth,TOTAL,,,,,,,,,,,,,
JAGITIAL,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,,,,,,,,,,,,,
JAGITIAL,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,,,,,,,,,,,,,
JAGITIAL,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,,,,,,,,,,,,,
JAGITIAL,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,,,,,,,,,,,,,
JAGITIAL,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,,,,,,,,,,,,,
JAGITIAL,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
JAGITIAL,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,,,,,,,,,,,,,
JAGITIAL,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
JAGITIAL,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,,,,,,,,,,,,,
JAGITIAL,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,,,,,,,,,,,,,
JAGITIAL,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,,,,,,,,,,,,,
JAGITIAL,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,,,,,,,,,,,,,
JAGITIAL,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,,,,,,,,,,,,,
JAGITIAL,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,,,,,,,,,,,,,
JAGITIAL,6.3,PNC maternal complications attended,TOTAL,,,,,,,,,,,,,
JAGITIAL,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,,,,,,,,,,,,,
JAGITIAL,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,,,,,,,,,,,,,
JAGITIAL,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,,,,,,,,,,,,,
JAGITIAL,7.2,Number of MTPs conducted at Private Facilities,TOTAL,,,,,,,,,,,,,
JAGITIAL,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,,,,,,,,,,,,,
JAGITIAL,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,,,,,,,,,,,,,
JAGITIAL,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,,,,,,,,,,,,,
JAGITIAL,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,,,,,,,,,,,,,
JAGITIAL,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,,,,,,,,,,,,,
JAGITIAL,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,,,,,,,,,,,,,
JAGITIAL,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
JAGITIAL,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
JAGITIAL,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,,,,,,,,,,,,,
JAGITIAL,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
JAGITIAL,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
JAGITIAL,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
JAGITIAL,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
JAGITIAL,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
JAGITIAL,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,,,,,,,,,,,,,
JAGITIAL,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
JAGITIAL,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
JAGITIAL,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
JAGITIAL,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
JAGITIAL,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
JAGITIAL,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,,,,,,,,,,,,,
JAGITIAL,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
JAGITIAL,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
JAGITIAL,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
JAGITIAL,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
JAGITIAL,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
JAGITIAL,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,,,,,,,,,,,,,
JAGITIAL,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
JAGITIAL,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,,,,,,,,,,,,,
JAGITIAL,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,,,,,,,,,,,,,
JAGITIAL,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,,,,,,,,,,,,,
JAGITIAL,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
JAGITIAL,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
JAGITIAL,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,,,,,,,,,,,,,
JAGITIAL,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,,,,,,,,,,,,,
JAGITIAL,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
JAGITIAL,9.06,Number of IUCD removals,TOTAL,,,,,,,,,,,,,
JAGITIAL,9.07,Number of Oral Pills cycles distributed,TOTAL,,,,,,,,,,,,,
JAGITIAL,9.08,Number of Condom pieces distributed,TOTAL,,,,,,,,,,,,,
JAGITIAL,9.09,Number of Centchroman (weekly) pills given,TOTAL,,,,,,,,,,,,,
JAGITIAL,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,,,,,,,,,,,,,
JAGITIAL,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,,,,,,,,,,,,,
JAGITIAL,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,,,,,,,,,,,,,
JAGITIAL,9.11.2.a,Number of failures following male sterilization,TOTAL,,,,,,,,,,,,,
JAGITIAL,9.11.2.b,Number of failures following female sterilization,TOTAL,,,,,,,,,,,,,
JAGITIAL,9.11.3.a,Number of deaths following male sterilization,TOTAL,,,,,,,,,,,,,
JAGITIAL,9.11.3.b,Number of deaths following female sterilization,TOTAL,,,,,,,,,,,,,
JAGITIAL,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,,,,,,,,,,,-1.0
JAGITIAL,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,,,,,,,,,,,,,
JAGITIAL,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,,,,,,,,,,,,,
JAGITIAL,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,,,,,,,,,,,,,
JAGITIAL,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,,,,,,,,,,,,,
JAGITIAL,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,,,,,,,,,,,,,
JAGITIAL,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,,,,,,,,,,,,,
JAGITIAL,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,,,,,,,,,,,,,
JAGITIAL,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,,,,,,,,,,,,,
JAGITIAL,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,,,,,,,,,,,,,
JAGITIAL,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,,,,,,,,,,,,,
JAGITIAL,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,,,,,,,,,,,,,
JAGITIAL,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,,,,,,,,,,,,,
JAGITIAL,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,,,,,,,,,,,,,
JAGITIAL,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,,,,,,,,,,,,,
JAGITIAL,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,,,,,,,,,,,,,
JAGITIAL,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,,,,,,,,,,,,,
JAGITIAL,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,,,,,,,,,,,,,
JAGITIAL,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,,,,,,,,,,,,,
JAGITIAL,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
JAGITIAL,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
JAGITIAL,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,,,,,,,,,,,,,
JAGITIAL,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,,,,,,,,,,,,,
JAGITIAL,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,,,,,,,,,,,,,
JAGITIAL,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,,,,,,,,,,,,,
JAGITIAL,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
JAGITIAL,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
JAGITIAL,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,,,,,,,,,,,,,
JAGITIAL,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,,,,,,,,,,,,,
JAGITIAL,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,,,,,,,,,,,,,
JAGITIAL,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,,,,,,,,,,,,,
JAGITIAL,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
JAGITIAL,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
JAGITIAL,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
JAGITIAL,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,,,,,,,,,,,,,
JAGITIAL,10.4.2,Number of Immunisation sessions held during the month,TOTAL,,,,,,,,,,,,,
JAGITIAL,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,,,,,,,,,,,,,
JAGITIAL,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,,,,,,,,,,,,,
JAGITIAL,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,,,,,,,,,,,,,
JAGITIAL,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,,,,,,,,,,,,,
JAGITIAL,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,,,,,,,,,,,,,
JAGITIAL,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
JAGITIAL,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
JAGITIAL,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
JAGITIAL,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
JAGITIAL,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
JAGITIAL,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
JAGITIAL,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
JAGITIAL,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
JAGITIAL,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,,,,,,,,,,,,,
JAGITIAL,13.1,Number of Patients operated for cataract,TOTAL,,,,,,,,,,,,,
JAGITIAL,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,,,,,,,,,,,,,
JAGITIAL,13.3,Number of School children detected with Refractive errors,TOTAL,,,,,,,,,,,,,
JAGITIAL,13.4,Number of children provided free glasses,TOTAL,,,,,,,,,,,,,
JAGITIAL,13.5,Number of eyes collected through eye donation,TOTAL,,,,,,,,,,,,,
JAGITIAL,13.6,Number of eyes utilised for corneal transplant,TOTAL,,,,,,,,,,,,,
JAGITIAL,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,,,,,,,,,,,,-1.0
JAGITIAL,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,,,,,,,,,,-1.0
JAGITIAL,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,,,,,,,,,,,,,-1.0
JAGITIAL,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,,,,,,,,,,,,,-1.0
JAGITIAL,14.05,Number of RKS meetings held during the month,TOTAL,,,,,,,,,,,,,
JAGITIAL,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,,,,,,,,,,,,,-1.0
JAGITIAL,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,,,,,,,,,,,,,
JAGITIAL,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,,,,,,,,,-1.0
JAGITIAL,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,,,,,,,,,,,,,-1.0
JAGITIAL,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,,,,,,,,,,,,,
JAGITIAL,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,,,,,,,,,,,,,
JAGITIAL,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,,,,,,,,,,,,,
JAGITIAL,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,,,,,,,,,,,,,
JAGITIAL,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,,,,,,,,,,,,,
JAGITIAL,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,,,,,,,,,,,,,
JAGITIAL,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,,,,,,,,,,,,,
JAGITIAL,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,,,,,,,,,,,,,
JAGITIAL,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,,,,,,,,,,,,,
JAGITIAL,14.10.2.a,Number of death cases of Inpatient males,TOTAL,,,,,,,,,,,,,
JAGITIAL,14.10.2.b,Number of death cases of Inpatient females,TOTAL,,,,,,,,,,,,,
JAGITIAL,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,,,,,,,,,,,,,
JAGITIAL,14.11,In-Patient Head Count at midnight,TOTAL,,,,,,,,,,,,,
JAGITIAL,14.12.1,OPD attendance (All),TOTAL,,,,,,,,,,,,,
JAGITIAL,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,,,,,,,,,,,,,
JAGITIAL,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,,,,,,,,,,,,,
JAGITIAL,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,,,,,,,,,,,,,
JAGITIAL,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,,,,,,,,,,,,,
JAGITIAL,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,,,,,,,,,,,,,
JAGITIAL,14.14.a,Number of patients given AYUSH treatment,TOTAL,,,,,,,,,,,,,
JAGITIAL,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,,,,,,,,,,,,,
JAGITIAL,14.14.c,Number of Adolescents counselled,TOTAL,,,,,,,,,,,,,
JAGITIAL,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,,,,,,,,,,,,,
JAGITIAL,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,,,,,,,,,,,,,
JAGITIAL,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,,,,,,,,,,,,,
JAGITIAL,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,,,,,,,,,,,,,
JAGITIAL,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,,,,,,,,,,,,,
JAGITIAL,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,,,,,,,,,,,,,
JAGITIAL,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,,,,,,,,,,,,,
JAGITIAL,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,,,,,,,,,,,,,
JAGITIAL,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,,,,,,,,,,,,,
JAGITIAL,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,,,,,,,,,,,,,
JAGITIAL,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,,,,,,,,,,,,,
JAGITIAL,15.2,Number of Widal tests conducted,Number tested,,,,,,,,,,,,,
JAGITIAL,15.3.a,Number of VDRL tests conducted on males,Number tested,,,,,,,,,,,,,
JAGITIAL,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,,,,,,,,,,,,,
JAGITIAL,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,,,,,,,,,,,,,
JAGITIAL,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,,,,,,,,,,,,,
JAGITIAL,15.4.1,Number of blood smears examined for Malaria,TOTAL,,,,,,,,,,,,,
JAGITIAL,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,,,,,,,,,,,,,
JAGITIAL,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,,,,,,,,,,,,,
JAGITIAL,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
JAGITIAL,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,,,,,,,,,,
JAGITIAL,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
JAGITIAL,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,,,,,,,,,
JAGITIAL,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JAGITIAL,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
JAGITIAL,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
JAGITIAL,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
JAGITIAL,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
JAGITIAL,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JAGITIAL,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
JAGITIAL,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,,,,,,,,,
JAGITIAL,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
JAGITIAL,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,,,,,,,,,
JAGITIAL,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JAGITIAL,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
JAGITIAL,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,,,,,,,,,
JAGITIAL,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
JAGITIAL,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,,,,,,,,,
JAGITIAL,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JAGITIAL,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
JAGITIAL,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
JAGITIAL,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
JAGITIAL,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
JAGITIAL,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JAGITIAL,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
JAGITIAL,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,,,,,,,,,
JAGITIAL,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
JAGITIAL,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,,,,,,,,,
JAGITIAL,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JAGITIAL,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
JAGITIAL,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,,,,,,,,,
JAGITIAL,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
JAGITIAL,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,,,,,,,,,
JAGITIAL,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JAGITIAL,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
JAGITIAL,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
JAGITIAL,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
JAGITIAL,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
JAGITIAL,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JAGITIAL,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
JAGITIAL,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,,,,,,
JAGITIAL,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
JAGITIAL,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,,,,,,
JAGITIAL,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JAGITIAL,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
JAGITIAL,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
JAGITIAL,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
JAGITIAL,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
JAGITIAL,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JAGITIAL,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
JAGITIAL,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
JAGITIAL,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
JAGITIAL,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
JAGITIAL,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JAGITIAL,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
JAGITIAL,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
JAGITIAL,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
JAGITIAL,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
JAGITIAL,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JAGITIAL,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
JAGITIAL,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
JAGITIAL,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
JAGITIAL,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
JAGITIAL,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JAGITIAL,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
JAGITIAL,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
JAGITIAL,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
JAGITIAL,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
JAGITIAL,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JAGITIAL,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
JAGITIAL,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
JAGITIAL,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
JAGITIAL,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
JAGITIAL,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JAGITIAL,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
JAGITIAL,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
JAGITIAL,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
JAGITIAL,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
JAGITIAL,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JAGITIAL,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
JAGITIAL,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
JAGITIAL,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
JAGITIAL,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
JAGITIAL,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JAGITIAL,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
JAGITIAL,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
JAGITIAL,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
JAGITIAL,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
JAGITIAL,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JAGITIAL,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
JAGITIAL,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
JAGITIAL,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
JAGITIAL,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
JAGITIAL,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JAGITIAL,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
JAGITIAL,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
JAGITIAL,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
JAGITIAL,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
JAGITIAL,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JAGITIAL,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
JAGITIAL,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
JAGITIAL,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
JAGITIAL,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
JAGITIAL,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JAGITIAL,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
JAGITIAL,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
JAGITIAL,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
JAGITIAL,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
JAGITIAL,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JAGITIAL,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
JAGITIAL,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
JAGITIAL,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
JAGITIAL,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
JAGITIAL,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JAGITIAL,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
JAGITIAL,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
JAGITIAL,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
JAGITIAL,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
JAGITIAL,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JAGITIAL,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
JAGITIAL,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
JAGITIAL,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
JAGITIAL,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
JAGITIAL,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JAGITIAL,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
JAGITIAL,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
JAGITIAL,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
JAGITIAL,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
JAGITIAL,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JAGITIAL,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
JAGITIAL,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
JAGITIAL,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
JAGITIAL,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
JAGITIAL,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JAGITIAL,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,,,,,,,
JAGITIAL,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,,,,,,,
JAGITIAL,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
JAGITIAL,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,,,,,,,
JAGITIAL,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JAGITIAL,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
JAGITIAL,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
JAGITIAL,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
JAGITIAL,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
JAGITIAL,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
JAGITIAL,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
JAGITIAL,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
JAGITIAL,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
JAGITIAL,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
JAGITIAL,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
JAGITIAL,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
JAGITIAL,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
JAGITIAL,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
JAGITIAL,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
JAGITIAL,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
JAGITIAL,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
JAGITIAL,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
JAGITIAL,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
JAGITIAL,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
JAGITIAL,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
JAGITIAL,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
JAGITIAL,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
JAGITIAL,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
JAGITIAL,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
JAGITIAL,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
JAGITIAL,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
JAGITIAL,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
JAGITIAL,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
JAGITIAL,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
JAGITIAL,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
JAGITIAL,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
JAGITIAL,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
JAGITIAL,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
JAGITIAL,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
JAGITIAL,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
JAGITIAL,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
JAGITIAL,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
JAGITIAL,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
JAGITIAL,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
JAGITIAL,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
JAGITIAL,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
JAGITIAL,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
JAGITIAL,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
JAGITIAL,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
JAGITIAL,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
JAGITIAL,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
JAGITIAL,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
JAGITIAL,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
JAGITIAL,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
JAGITIAL,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
JAGITIAL,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
JAGITIAL,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
JAGITIAL,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
JAGITIAL,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
JAGITIAL,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
JAGITIAL,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
JAGITIAL,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
JAGITIAL,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
JAGITIAL,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
JAGITIAL,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
JAGITIAL,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
JAGITIAL,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
JAGITIAL,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
JAGITIAL,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
JAGITIAL,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
JAGITIAL,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
JAGITIAL,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
JAGITIAL,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
JAGITIAL,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
JAGITIAL,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
JAGITIAL,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
JAGITIAL,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
JAGITIAL,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
JAGITIAL,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
JAGITIAL,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
JAGITIAL,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
JAGITIAL,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
JAGITIAL,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
JAGITIAL,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
JAGITIAL,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
JAGITIAL,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
JAGITIAL,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
JAGITIAL,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
JAGITIAL,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
JAGITIAL,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
JAGITIAL,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
JAGITIAL,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
JAGITIAL,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
JAGITIAL,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
JAGITIAL,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
JAGITIAL,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
JAGITIAL,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
JAGITIAL,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
JAGITIAL,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
JAGITIAL,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
JAGITIAL,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
JAGITIAL,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
JAGITIAL,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
JAGITIAL,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
JAGITIAL,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
JAGITIAL,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
JAGITIAL,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
JAGITIAL,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
JAGITIAL,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
JAGITIAL,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
JAGITIAL,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
JAGITIAL,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
JAGITIAL,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
JANGOAN,1.1,Total number of pregnant women Registered for ANC,TOTAL,,,,,,,,,,,,,
JANGOAN,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,,,,,,,,,,,,,
JANGOAN,1.2,Number of Pregnant women registered under JSY,TOTAL,,,,,,,,,,,,,
JANGOAN,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,,,,,,,,,,,,,
JANGOAN,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,,,,,,,,,,,,,
JANGOAN,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,,,,,,,,,,,,,
JANGOAN,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,,,,,,,,,,,,,
JANGOAN,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,,,,,,,,,,,,,
JANGOAN,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,,,,,,,,,,,,,
JANGOAN,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,,,,,,,,,,,,,
JANGOAN,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,,,,,,,,,,,,,
JANGOAN,1.8,Number of pregnancy test kits used at SC level,TOTAL,,,,,,,,,,,,,
JANGOAN,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,,,,,,,,,,,,,
JANGOAN,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,,,,,,,,,,,,,
JANGOAN,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,,,,,,,,,,,,,
JANGOAN,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,,,,,,,,,,,,,
JANGOAN,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,,,,,,,,,,,,,
JANGOAN,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
JANGOAN,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,,,,,,,,,,,,,
JANGOAN,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,,,,,,,,,,,,,
JANGOAN,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,,,,,,,,,,,,,
JANGOAN,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
JANGOAN,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
JANGOAN,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
JANGOAN,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
JANGOAN,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
JANGOAN,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,,,,,,,,,,,,,
JANGOAN,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,,,,,,,,,,,,,
JANGOAN,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,,,,,,,,,,,,,
JANGOAN,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
JANGOAN,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,,,,,,,,,,,,,
JANGOAN,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
JANGOAN,4.1.1.a,Number of male live births,TOTAL,,,,,,,,,,,,,
JANGOAN,4.1.1.b,Number of female live births,TOTAL,,,,,,,,,,,,,
JANGOAN,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,,,,,,,,,,,,,
JANGOAN,4.1.2,Number of still births,TOTAL,,,,,,,,,,,,,
JANGOAN,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,,,,,,,,,,,,,
JANGOAN,4.2.1,Number of Newborns weighed at birth,TOTAL,,,,,,,,,,,,,
JANGOAN,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,,,,,,,,,,,,,
JANGOAN,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,,,,,,,,,,,,,
JANGOAN,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,,,,,,,,,,,,,
JANGOAN,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,,,,,,,,,,,,,
JANGOAN,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,,,,,,,,,,,,,
JANGOAN,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
JANGOAN,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,,,,,,,,,,,,,
JANGOAN,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
JANGOAN,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,,,,,,,,,,,,,
JANGOAN,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,,,,,,,,,,,,,
JANGOAN,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,,,,,,,,,,,,,
JANGOAN,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,,,,,,,,,,,,,
JANGOAN,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,,,,,,,,,,,,,
JANGOAN,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,,,,,,,,,,,,,
JANGOAN,6.3,PNC maternal complications attended,TOTAL,,,,,,,,,,,,,
JANGOAN,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,,,,,,,,,,,,,
JANGOAN,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,,,,,,,,,,,,,
JANGOAN,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,,,,,,,,,,,,,
JANGOAN,7.2,Number of MTPs conducted at Private Facilities,TOTAL,,,,,,,,,,,,,
JANGOAN,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,,,,,,,,,,,,,
JANGOAN,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,,,,,,,,,,,,,
JANGOAN,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,,,,,,,,,,,,,
JANGOAN,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,,,,,,,,,,,,,
JANGOAN,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,,,,,,,,,,,,,
JANGOAN,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,,,,,,,,,,,,,
JANGOAN,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
JANGOAN,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
JANGOAN,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,,,,,,,,,,,,,
JANGOAN,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
JANGOAN,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
JANGOAN,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
JANGOAN,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
JANGOAN,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
JANGOAN,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,,,,,,,,,,,,,
JANGOAN,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
JANGOAN,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
JANGOAN,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
JANGOAN,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
JANGOAN,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
JANGOAN,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,,,,,,,,,,,,,
JANGOAN,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
JANGOAN,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
JANGOAN,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
JANGOAN,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
JANGOAN,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
JANGOAN,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,,,,,,,,,,,,,
JANGOAN,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
JANGOAN,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,,,,,,,,,,,,,
JANGOAN,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,,,,,,,,,,,,,
JANGOAN,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,,,,,,,,,,,,,
JANGOAN,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
JANGOAN,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
JANGOAN,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,,,,,,,,,,,,,
JANGOAN,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,,,,,,,,,,,,,
JANGOAN,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
JANGOAN,9.06,Number of IUCD removals,TOTAL,,,,,,,,,,,,,
JANGOAN,9.07,Number of Oral Pills cycles distributed,TOTAL,,,,,,,,,,,,,
JANGOAN,9.08,Number of Condom pieces distributed,TOTAL,,,,,,,,,,,,,
JANGOAN,9.09,Number of Centchroman (weekly) pills given,TOTAL,,,,,,,,,,,,,
JANGOAN,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,,,,,,,,,,,,,
JANGOAN,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,,,,,,,,,,,,,
JANGOAN,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,,,,,,,,,,,,,
JANGOAN,9.11.2.a,Number of failures following male sterilization,TOTAL,,,,,,,,,,,,,
JANGOAN,9.11.2.b,Number of failures following female sterilization,TOTAL,,,,,,,,,,,,,
JANGOAN,9.11.3.a,Number of deaths following male sterilization,TOTAL,,,,,,,,,,,,,
JANGOAN,9.11.3.b,Number of deaths following female sterilization,TOTAL,,,,,,,,,,,,,
JANGOAN,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,,,,,,,,,,,-1.0
JANGOAN,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,,,,,,,,,,,,,
JANGOAN,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,,,,,,,,,,,,,
JANGOAN,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,,,,,,,,,,,,,
JANGOAN,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,,,,,,,,,,,,,
JANGOAN,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,,,,,,,,,,,,,
JANGOAN,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,,,,,,,,,,,,,
JANGOAN,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,,,,,,,,,,,,,
JANGOAN,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,,,,,,,,,,,,,
JANGOAN,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,,,,,,,,,,,,,
JANGOAN,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,,,,,,,,,,,,,
JANGOAN,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,,,,,,,,,,,,,
JANGOAN,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,,,,,,,,,,,,,
JANGOAN,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,,,,,,,,,,,,,
JANGOAN,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,,,,,,,,,,,,,
JANGOAN,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,,,,,,,,,,,,,
JANGOAN,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,,,,,,,,,,,,,
JANGOAN,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,,,,,,,,,,,,,
JANGOAN,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,,,,,,,,,,,,,
JANGOAN,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
JANGOAN,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
JANGOAN,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,,,,,,,,,,,,,
JANGOAN,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,,,,,,,,,,,,,
JANGOAN,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,,,,,,,,,,,,,
JANGOAN,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,,,,,,,,,,,,,
JANGOAN,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
JANGOAN,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
JANGOAN,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,,,,,,,,,,,,,
JANGOAN,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,,,,,,,,,,,,,
JANGOAN,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,,,,,,,,,,,,,
JANGOAN,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,,,,,,,,,,,,,
JANGOAN,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
JANGOAN,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
JANGOAN,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
JANGOAN,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,,,,,,,,,,,,,
JANGOAN,10.4.2,Number of Immunisation sessions held during the month,TOTAL,,,,,,,,,,,,,
JANGOAN,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,,,,,,,,,,,,,
JANGOAN,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,,,,,,,,,,,,,
JANGOAN,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,,,,,,,,,,,,,
JANGOAN,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,,,,,,,,,,,,,
JANGOAN,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,,,,,,,,,,,,,
JANGOAN,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
JANGOAN,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
JANGOAN,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
JANGOAN,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
JANGOAN,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
JANGOAN,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
JANGOAN,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
JANGOAN,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
JANGOAN,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,,,,,,,,,,,,,
JANGOAN,13.1,Number of Patients operated for cataract,TOTAL,,,,,,,,,,,,,
JANGOAN,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,,,,,,,,,,,,,
JANGOAN,13.3,Number of School children detected with Refractive errors,TOTAL,,,,,,,,,,,,,
JANGOAN,13.4,Number of children provided free glasses,TOTAL,,,,,,,,,,,,,
JANGOAN,13.5,Number of eyes collected through eye donation,TOTAL,,,,,,,,,,,,,
JANGOAN,13.6,Number of eyes utilised for corneal transplant,TOTAL,,,,,,,,,,,,,
JANGOAN,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,,,,,,,,,,,,-1.0
JANGOAN,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,,,,,,,,,,-1.0
JANGOAN,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,,,,,,,,,,,,,-1.0
JANGOAN,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,,,,,,,,,,,,,-1.0
JANGOAN,14.05,Number of RKS meetings held during the month,TOTAL,,,,,,,,,,,,,
JANGOAN,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,,,,,,,,,,,,,-1.0
JANGOAN,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,,,,,,,,,,,,,
JANGOAN,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,,,,,,,,,-1.0
JANGOAN,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,,,,,,,,,,,,,-1.0
JANGOAN,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,,,,,,,,,,,,,
JANGOAN,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,,,,,,,,,,,,,
JANGOAN,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,,,,,,,,,,,,,
JANGOAN,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,,,,,,,,,,,,,
JANGOAN,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,,,,,,,,,,,,,
JANGOAN,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,,,,,,,,,,,,,
JANGOAN,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,,,,,,,,,,,,,
JANGOAN,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,,,,,,,,,,,,,
JANGOAN,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,,,,,,,,,,,,,
JANGOAN,14.10.2.a,Number of death cases of Inpatient males,TOTAL,,,,,,,,,,,,,
JANGOAN,14.10.2.b,Number of death cases of Inpatient females,TOTAL,,,,,,,,,,,,,
JANGOAN,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,,,,,,,,,,,,,
JANGOAN,14.11,In-Patient Head Count at midnight,TOTAL,,,,,,,,,,,,,
JANGOAN,14.12.1,OPD attendance (All),TOTAL,,,,,,,,,,,,,
JANGOAN,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,,,,,,,,,,,,,
JANGOAN,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,,,,,,,,,,,,,
JANGOAN,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,,,,,,,,,,,,,
JANGOAN,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,,,,,,,,,,,,,
JANGOAN,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,,,,,,,,,,,,,
JANGOAN,14.14.a,Number of patients given AYUSH treatment,TOTAL,,,,,,,,,,,,,
JANGOAN,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,,,,,,,,,,,,,
JANGOAN,14.14.c,Number of Adolescents counselled,TOTAL,,,,,,,,,,,,,
JANGOAN,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,,,,,,,,,,,,,
JANGOAN,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,,,,,,,,,,,,,
JANGOAN,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,,,,,,,,,,,,,
JANGOAN,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,,,,,,,,,,,,,
JANGOAN,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,,,,,,,,,,,,,
JANGOAN,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,,,,,,,,,,,,,
JANGOAN,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,,,,,,,,,,,,,
JANGOAN,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,,,,,,,,,,,,,
JANGOAN,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,,,,,,,,,,,,,
JANGOAN,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,,,,,,,,,,,,,
JANGOAN,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,,,,,,,,,,,,,
JANGOAN,15.2,Number of Widal tests conducted,Number tested,,,,,,,,,,,,,
JANGOAN,15.3.a,Number of VDRL tests conducted on males,Number tested,,,,,,,,,,,,,
JANGOAN,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,,,,,,,,,,,,,
JANGOAN,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,,,,,,,,,,,,,
JANGOAN,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,,,,,,,,,,,,,
JANGOAN,15.4.1,Number of blood smears examined for Malaria,TOTAL,,,,,,,,,,,,,
JANGOAN,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,,,,,,,,,,,,,
JANGOAN,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,,,,,,,,,,,,,
JANGOAN,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
JANGOAN,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,,,,,,,,,,
JANGOAN,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
JANGOAN,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,,,,,,,,,
JANGOAN,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JANGOAN,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
JANGOAN,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
JANGOAN,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
JANGOAN,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
JANGOAN,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JANGOAN,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
JANGOAN,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,,,,,,,,,
JANGOAN,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
JANGOAN,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,,,,,,,,,
JANGOAN,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JANGOAN,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
JANGOAN,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,,,,,,,,,
JANGOAN,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
JANGOAN,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,,,,,,,,,
JANGOAN,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JANGOAN,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
JANGOAN,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
JANGOAN,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
JANGOAN,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
JANGOAN,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JANGOAN,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
JANGOAN,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,,,,,,,,,
JANGOAN,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
JANGOAN,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,,,,,,,,,
JANGOAN,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JANGOAN,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
JANGOAN,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,,,,,,,,,
JANGOAN,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
JANGOAN,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,,,,,,,,,
JANGOAN,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JANGOAN,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
JANGOAN,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
JANGOAN,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
JANGOAN,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
JANGOAN,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JANGOAN,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
JANGOAN,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,,,,,,
JANGOAN,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
JANGOAN,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,,,,,,
JANGOAN,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JANGOAN,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
JANGOAN,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
JANGOAN,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
JANGOAN,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
JANGOAN,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JANGOAN,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
JANGOAN,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
JANGOAN,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
JANGOAN,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
JANGOAN,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JANGOAN,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
JANGOAN,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
JANGOAN,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
JANGOAN,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
JANGOAN,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JANGOAN,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
JANGOAN,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
JANGOAN,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
JANGOAN,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
JANGOAN,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JANGOAN,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
JANGOAN,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
JANGOAN,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
JANGOAN,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
JANGOAN,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JANGOAN,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
JANGOAN,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
JANGOAN,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
JANGOAN,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
JANGOAN,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JANGOAN,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
JANGOAN,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
JANGOAN,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
JANGOAN,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
JANGOAN,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JANGOAN,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
JANGOAN,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
JANGOAN,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
JANGOAN,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
JANGOAN,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JANGOAN,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
JANGOAN,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
JANGOAN,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
JANGOAN,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
JANGOAN,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JANGOAN,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
JANGOAN,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
JANGOAN,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
JANGOAN,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
JANGOAN,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JANGOAN,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
JANGOAN,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
JANGOAN,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
JANGOAN,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
JANGOAN,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JANGOAN,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
JANGOAN,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
JANGOAN,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
JANGOAN,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
JANGOAN,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JANGOAN,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
JANGOAN,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
JANGOAN,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
JANGOAN,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
JANGOAN,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JANGOAN,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
JANGOAN,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
JANGOAN,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
JANGOAN,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
JANGOAN,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JANGOAN,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
JANGOAN,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
JANGOAN,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
JANGOAN,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
JANGOAN,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JANGOAN,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
JANGOAN,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
JANGOAN,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
JANGOAN,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
JANGOAN,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JANGOAN,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
JANGOAN,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
JANGOAN,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
JANGOAN,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
JANGOAN,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JANGOAN,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
JANGOAN,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
JANGOAN,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
JANGOAN,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
JANGOAN,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JANGOAN,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,,,,,,,
JANGOAN,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,,,,,,,
JANGOAN,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
JANGOAN,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,,,,,,,
JANGOAN,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JANGOAN,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
JANGOAN,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
JANGOAN,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
JANGOAN,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
JANGOAN,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
JANGOAN,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
JANGOAN,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
JANGOAN,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
JANGOAN,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
JANGOAN,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
JANGOAN,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
JANGOAN,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
JANGOAN,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
JANGOAN,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
JANGOAN,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
JANGOAN,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
JANGOAN,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
JANGOAN,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
JANGOAN,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
JANGOAN,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
JANGOAN,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
JANGOAN,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
JANGOAN,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
JANGOAN,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
JANGOAN,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
JANGOAN,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
JANGOAN,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
JANGOAN,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
JANGOAN,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
JANGOAN,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
JANGOAN,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
JANGOAN,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
JANGOAN,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
JANGOAN,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
JANGOAN,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
JANGOAN,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
JANGOAN,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
JANGOAN,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
JANGOAN,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
JANGOAN,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
JANGOAN,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
JANGOAN,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
JANGOAN,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
JANGOAN,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
JANGOAN,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
JANGOAN,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
JANGOAN,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
JANGOAN,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
JANGOAN,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
JANGOAN,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
JANGOAN,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
JANGOAN,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
JANGOAN,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
JANGOAN,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
JANGOAN,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
JANGOAN,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
JANGOAN,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
JANGOAN,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
JANGOAN,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
JANGOAN,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
JANGOAN,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
JANGOAN,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
JANGOAN,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
JANGOAN,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
JANGOAN,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
JANGOAN,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
JANGOAN,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
JANGOAN,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
JANGOAN,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
JANGOAN,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
JANGOAN,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
JANGOAN,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
JANGOAN,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
JANGOAN,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
JANGOAN,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
JANGOAN,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
JANGOAN,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
JANGOAN,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
JANGOAN,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
JANGOAN,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
JANGOAN,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
JANGOAN,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
JANGOAN,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
JANGOAN,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
JANGOAN,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
JANGOAN,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
JANGOAN,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
JANGOAN,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
JANGOAN,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
JANGOAN,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
JANGOAN,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
JANGOAN,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
JANGOAN,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
JANGOAN,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
JANGOAN,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
JANGOAN,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
JANGOAN,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
JANGOAN,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
JANGOAN,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
JANGOAN,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
JANGOAN,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
JANGOAN,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
JANGOAN,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
JANGOAN,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
JANGOAN,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
JANGOAN,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
JANGOAN,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
JANGOAN,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,1.1,Total number of pregnant women Registered for ANC,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,1.2,Number of Pregnant women registered under JSY,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,1.8,Number of pregnancy test kits used at SC level,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,4.1.1.a,Number of male live births,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,4.1.1.b,Number of female live births,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,4.1.2,Number of still births,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,4.2.1,Number of Newborns weighed at birth,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,6.3,PNC maternal complications attended,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,7.2,Number of MTPs conducted at Private Facilities,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,9.06,Number of IUCD removals,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,9.07,Number of Oral Pills cycles distributed,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,9.08,Number of Condom pieces distributed,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,9.09,Number of Centchroman (weekly) pills given,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,9.11.2.a,Number of failures following male sterilization,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,9.11.2.b,Number of failures following female sterilization,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,9.11.3.a,Number of deaths following male sterilization,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,9.11.3.b,Number of deaths following female sterilization,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,,,,,,,,,,,-1.0
JAYASHANKAR BHUPALPALLY,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,10.4.2,Number of Immunisation sessions held during the month,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,13.1,Number of Patients operated for cataract,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,13.3,Number of School children detected with Refractive errors,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,13.4,Number of children provided free glasses,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,13.5,Number of eyes collected through eye donation,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,13.6,Number of eyes utilised for corneal transplant,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,,,,,,,,,,,,-1.0
JAYASHANKAR BHUPALPALLY,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,,,,,,,,,,-1.0
JAYASHANKAR BHUPALPALLY,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,,,,,,,,,,,,,-1.0
JAYASHANKAR BHUPALPALLY,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,,,,,,,,,,,,,-1.0
JAYASHANKAR BHUPALPALLY,14.05,Number of RKS meetings held during the month,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,,,,,,,,,,,,,-1.0
JAYASHANKAR BHUPALPALLY,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,,,,,,,,,-1.0
JAYASHANKAR BHUPALPALLY,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,,,,,,,,,,,,,-1.0
JAYASHANKAR BHUPALPALLY,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,14.10.2.a,Number of death cases of Inpatient males,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,14.10.2.b,Number of death cases of Inpatient females,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,14.11,In-Patient Head Count at midnight,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,14.12.1,OPD attendance (All),TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,14.14.a,Number of patients given AYUSH treatment,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,14.14.c,Number of Adolescents counselled,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,15.2,Number of Widal tests conducted,Number tested,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,15.3.a,Number of VDRL tests conducted on males,Number tested,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,15.4.1,Number of blood smears examined for Malaria,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JAYASHANKAR BHUPALPALLY,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JAYASHANKAR BHUPALPALLY,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JAYASHANKAR BHUPALPALLY,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JAYASHANKAR BHUPALPALLY,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JAYASHANKAR BHUPALPALLY,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JAYASHANKAR BHUPALPALLY,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JAYASHANKAR BHUPALPALLY,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JAYASHANKAR BHUPALPALLY,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JAYASHANKAR BHUPALPALLY,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JAYASHANKAR BHUPALPALLY,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JAYASHANKAR BHUPALPALLY,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JAYASHANKAR BHUPALPALLY,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JAYASHANKAR BHUPALPALLY,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JAYASHANKAR BHUPALPALLY,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JAYASHANKAR BHUPALPALLY,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JAYASHANKAR BHUPALPALLY,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JAYASHANKAR BHUPALPALLY,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JAYASHANKAR BHUPALPALLY,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JAYASHANKAR BHUPALPALLY,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JAYASHANKAR BHUPALPALLY,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JAYASHANKAR BHUPALPALLY,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JAYASHANKAR BHUPALPALLY,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JAYASHANKAR BHUPALPALLY,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JAYASHANKAR BHUPALPALLY,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JAYASHANKAR BHUPALPALLY,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JAYASHANKAR BHUPALPALLY,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JAYASHANKAR BHUPALPALLY,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JAYASHANKAR BHUPALPALLY,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
JAYASHANKAR BHUPALPALLY,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
JOGULAMBA GADWAL,1.1,Total number of pregnant women Registered for ANC,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,1.2,Number of Pregnant women registered under JSY,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,1.8,Number of pregnancy test kits used at SC level,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,4.1.1.a,Number of male live births,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,4.1.1.b,Number of female live births,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,4.1.2,Number of still births,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,4.2.1,Number of Newborns weighed at birth,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,6.3,PNC maternal complications attended,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,7.2,Number of MTPs conducted at Private Facilities,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,9.06,Number of IUCD removals,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,9.07,Number of Oral Pills cycles distributed,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,9.08,Number of Condom pieces distributed,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,9.09,Number of Centchroman (weekly) pills given,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,9.11.2.a,Number of failures following male sterilization,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,9.11.2.b,Number of failures following female sterilization,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,9.11.3.a,Number of deaths following male sterilization,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,9.11.3.b,Number of deaths following female sterilization,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,,,,,,,,,,,-1.0
JOGULAMBA GADWAL,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,10.4.2,Number of Immunisation sessions held during the month,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,13.1,Number of Patients operated for cataract,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,13.3,Number of School children detected with Refractive errors,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,13.4,Number of children provided free glasses,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,13.5,Number of eyes collected through eye donation,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,13.6,Number of eyes utilised for corneal transplant,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,,,,,,,,,,,,-1.0
JOGULAMBA GADWAL,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,,,,,,,,,,-1.0
JOGULAMBA GADWAL,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,,,,,,,,,,,,,-1.0
JOGULAMBA GADWAL,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,,,,,,,,,,,,,-1.0
JOGULAMBA GADWAL,14.05,Number of RKS meetings held during the month,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,,,,,,,,,,,,,-1.0
JOGULAMBA GADWAL,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,,,,,,,,,-1.0
JOGULAMBA GADWAL,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,,,,,,,,,,,,,-1.0
JOGULAMBA GADWAL,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,,,,,,,,,,,,,
JOGULAMBA GADWAL,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,,,,,,,,,,,,,
JOGULAMBA GADWAL,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,,,,,,,,,,,,,
JOGULAMBA GADWAL,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,,,,,,,,,,,,,
JOGULAMBA GADWAL,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,,,,,,,,,,,,,
JOGULAMBA GADWAL,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,,,,,,,,,,,,,
JOGULAMBA GADWAL,14.10.2.a,Number of death cases of Inpatient males,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,14.10.2.b,Number of death cases of Inpatient females,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,14.11,In-Patient Head Count at midnight,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,14.12.1,OPD attendance (All),TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,14.14.a,Number of patients given AYUSH treatment,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,14.14.c,Number of Adolescents counselled,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,,,,,,,,,,,,,
JOGULAMBA GADWAL,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,,,,,,,,,,,,,
JOGULAMBA GADWAL,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,,,,,,,,,,,,,
JOGULAMBA GADWAL,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,,,,,,,,,,,,,
JOGULAMBA GADWAL,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,,,,,,,,,,,,,
JOGULAMBA GADWAL,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,,,,,,,,,,,,,
JOGULAMBA GADWAL,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,,,,,,,,,,,,,
JOGULAMBA GADWAL,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,,,,,,,,,,,,,
JOGULAMBA GADWAL,15.2,Number of Widal tests conducted,Number tested,,,,,,,,,,,,,
JOGULAMBA GADWAL,15.3.a,Number of VDRL tests conducted on males,Number tested,,,,,,,,,,,,,
JOGULAMBA GADWAL,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,,,,,,,,,,,,,
JOGULAMBA GADWAL,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,,,,,,,,,,,,,
JOGULAMBA GADWAL,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,,,,,,,,,,,,,
JOGULAMBA GADWAL,15.4.1,Number of blood smears examined for Malaria,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JOGULAMBA GADWAL,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JOGULAMBA GADWAL,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JOGULAMBA GADWAL,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JOGULAMBA GADWAL,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JOGULAMBA GADWAL,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JOGULAMBA GADWAL,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JOGULAMBA GADWAL,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JOGULAMBA GADWAL,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JOGULAMBA GADWAL,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JOGULAMBA GADWAL,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JOGULAMBA GADWAL,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JOGULAMBA GADWAL,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JOGULAMBA GADWAL,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JOGULAMBA GADWAL,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JOGULAMBA GADWAL,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JOGULAMBA GADWAL,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JOGULAMBA GADWAL,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JOGULAMBA GADWAL,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JOGULAMBA GADWAL,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JOGULAMBA GADWAL,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JOGULAMBA GADWAL,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JOGULAMBA GADWAL,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JOGULAMBA GADWAL,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JOGULAMBA GADWAL,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JOGULAMBA GADWAL,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JOGULAMBA GADWAL,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JOGULAMBA GADWAL,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,,,,,,,
JOGULAMBA GADWAL,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
JOGULAMBA GADWAL,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
JOGULAMBA GADWAL,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
KAMAREDDY,1.1,Total number of pregnant women Registered for ANC,TOTAL,,,,,,,,,,,,,
KAMAREDDY,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,,,,,,,,,,,,,
KAMAREDDY,1.2,Number of Pregnant women registered under JSY,TOTAL,,,,,,,,,,,,,
KAMAREDDY,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,,,,,,,,,,,,,
KAMAREDDY,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,,,,,,,,,,,,,
KAMAREDDY,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,,,,,,,,,,,,,
KAMAREDDY,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,,,,,,,,,,,,,
KAMAREDDY,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,,,,,,,,,,,,,
KAMAREDDY,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,,,,,,,,,,,,,
KAMAREDDY,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,,,,,,,,,,,,,
KAMAREDDY,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,,,,,,,,,,,,,
KAMAREDDY,1.8,Number of pregnancy test kits used at SC level,TOTAL,,,,,,,,,,,,,
KAMAREDDY,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,,,,,,,,,,,,,
KAMAREDDY,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,,,,,,,,,,,,,
KAMAREDDY,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,,,,,,,,,,,,,
KAMAREDDY,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,,,,,,,,,,,,,
KAMAREDDY,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,,,,,,,,,,,,,
KAMAREDDY,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
KAMAREDDY,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,,,,,,,,,,,,,
KAMAREDDY,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,,,,,,,,,,,,,
KAMAREDDY,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,,,,,,,,,,,,,
KAMAREDDY,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
KAMAREDDY,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
KAMAREDDY,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
KAMAREDDY,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
KAMAREDDY,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
KAMAREDDY,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,,,,,,,,,,,,,
KAMAREDDY,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,,,,,,,,,,,,,
KAMAREDDY,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,,,,,,,,,,,,,
KAMAREDDY,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
KAMAREDDY,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,,,,,,,,,,,,,
KAMAREDDY,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
KAMAREDDY,4.1.1.a,Number of male live births,TOTAL,,,,,,,,,,,,,
KAMAREDDY,4.1.1.b,Number of female live births,TOTAL,,,,,,,,,,,,,
KAMAREDDY,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,,,,,,,,,,,,,
KAMAREDDY,4.1.2,Number of still births,TOTAL,,,,,,,,,,,,,
KAMAREDDY,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,,,,,,,,,,,,,
KAMAREDDY,4.2.1,Number of Newborns weighed at birth,TOTAL,,,,,,,,,,,,,
KAMAREDDY,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,,,,,,,,,,,,,
KAMAREDDY,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,,,,,,,,,,,,,
KAMAREDDY,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,,,,,,,,,,,,,
KAMAREDDY,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,,,,,,,,,,,,,
KAMAREDDY,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,,,,,,,,,,,,,
KAMAREDDY,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
KAMAREDDY,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,,,,,,,,,,,,,
KAMAREDDY,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
KAMAREDDY,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,,,,,,,,,,,,,
KAMAREDDY,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,,,,,,,,,,,,,
KAMAREDDY,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,,,,,,,,,,,,,
KAMAREDDY,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,,,,,,,,,,,,,
KAMAREDDY,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,,,,,,,,,,,,,
KAMAREDDY,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,,,,,,,,,,,,,
KAMAREDDY,6.3,PNC maternal complications attended,TOTAL,,,,,,,,,,,,,
KAMAREDDY,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,,,,,,,,,,,,,
KAMAREDDY,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,,,,,,,,,,,,,
KAMAREDDY,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,,,,,,,,,,,,,
KAMAREDDY,7.2,Number of MTPs conducted at Private Facilities,TOTAL,,,,,,,,,,,,,
KAMAREDDY,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,,,,,,,,,,,,,
KAMAREDDY,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,,,,,,,,,,,,,
KAMAREDDY,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,,,,,,,,,,,,,
KAMAREDDY,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,,,,,,,,,,,,,
KAMAREDDY,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,,,,,,,,,,,,,
KAMAREDDY,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,,,,,,,,,,,,,
KAMAREDDY,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
KAMAREDDY,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
KAMAREDDY,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,,,,,,,,,,,,,
KAMAREDDY,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
KAMAREDDY,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
KAMAREDDY,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
KAMAREDDY,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
KAMAREDDY,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
KAMAREDDY,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,,,,,,,,,,,,,
KAMAREDDY,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
KAMAREDDY,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
KAMAREDDY,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
KAMAREDDY,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
KAMAREDDY,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
KAMAREDDY,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,,,,,,,,,,,,,
KAMAREDDY,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
KAMAREDDY,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
KAMAREDDY,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
KAMAREDDY,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
KAMAREDDY,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
KAMAREDDY,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,,,,,,,,,,,,,
KAMAREDDY,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
KAMAREDDY,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,,,,,,,,,,,,,
KAMAREDDY,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,,,,,,,,,,,,,
KAMAREDDY,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,,,,,,,,,,,,,
KAMAREDDY,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
KAMAREDDY,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
KAMAREDDY,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,,,,,,,,,,,,,
KAMAREDDY,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,,,,,,,,,,,,,
KAMAREDDY,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
KAMAREDDY,9.06,Number of IUCD removals,TOTAL,,,,,,,,,,,,,
KAMAREDDY,9.07,Number of Oral Pills cycles distributed,TOTAL,,,,,,,,,,,,,
KAMAREDDY,9.08,Number of Condom pieces distributed,TOTAL,,,,,,,,,,,,,
KAMAREDDY,9.09,Number of Centchroman (weekly) pills given,TOTAL,,,,,,,,,,,,,
KAMAREDDY,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,,,,,,,,,,,,,
KAMAREDDY,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,,,,,,,,,,,,,
KAMAREDDY,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,,,,,,,,,,,,,
KAMAREDDY,9.11.2.a,Number of failures following male sterilization,TOTAL,,,,,,,,,,,,,
KAMAREDDY,9.11.2.b,Number of failures following female sterilization,TOTAL,,,,,,,,,,,,,
KAMAREDDY,9.11.3.a,Number of deaths following male sterilization,TOTAL,,,,,,,,,,,,,
KAMAREDDY,9.11.3.b,Number of deaths following female sterilization,TOTAL,,,,,,,,,,,,,
KAMAREDDY,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,,,,,,,,,,,-1.0
KAMAREDDY,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,,,,,,,,,,,,,
KAMAREDDY,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,,,,,,,,,,,,,
KAMAREDDY,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,,,,,,,,,,,,,
KAMAREDDY,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,,,,,,,,,,,,,
KAMAREDDY,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,,,,,,,,,,,,,
KAMAREDDY,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,,,,,,,,,,,,,
KAMAREDDY,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,,,,,,,,,,,,,
KAMAREDDY,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,,,,,,,,,,,,,
KAMAREDDY,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,,,,,,,,,,,,,
KAMAREDDY,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,,,,,,,,,,,,,
KAMAREDDY,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,,,,,,,,,,,,,
KAMAREDDY,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,,,,,,,,,,,,,
KAMAREDDY,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,,,,,,,,,,,,,
KAMAREDDY,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,,,,,,,,,,,,,
KAMAREDDY,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,,,,,,,,,,,,,
KAMAREDDY,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,,,,,,,,,,,,,
KAMAREDDY,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,,,,,,,,,,,,,
KAMAREDDY,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,,,,,,,,,,,,,
KAMAREDDY,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
KAMAREDDY,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
KAMAREDDY,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,,,,,,,,,,,,,
KAMAREDDY,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,,,,,,,,,,,,,
KAMAREDDY,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,,,,,,,,,,,,,
KAMAREDDY,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,,,,,,,,,,,,,
KAMAREDDY,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
KAMAREDDY,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
KAMAREDDY,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,,,,,,,,,,,,,
KAMAREDDY,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,,,,,,,,,,,,,
KAMAREDDY,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,,,,,,,,,,,,,
KAMAREDDY,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,,,,,,,,,,,,,
KAMAREDDY,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
KAMAREDDY,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
KAMAREDDY,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
KAMAREDDY,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,,,,,,,,,,,,,
KAMAREDDY,10.4.2,Number of Immunisation sessions held during the month,TOTAL,,,,,,,,,,,,,
KAMAREDDY,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,,,,,,,,,,,,,
KAMAREDDY,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,,,,,,,,,,,,,
KAMAREDDY,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,,,,,,,,,,,,,
KAMAREDDY,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,,,,,,,,,,,,,
KAMAREDDY,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,,,,,,,,,,,,,
KAMAREDDY,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
KAMAREDDY,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
KAMAREDDY,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
KAMAREDDY,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
KAMAREDDY,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
KAMAREDDY,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
KAMAREDDY,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
KAMAREDDY,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
KAMAREDDY,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,,,,,,,,,,,,,
KAMAREDDY,13.1,Number of Patients operated for cataract,TOTAL,,,,,,,,,,,,,
KAMAREDDY,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,,,,,,,,,,,,,
KAMAREDDY,13.3,Number of School children detected with Refractive errors,TOTAL,,,,,,,,,,,,,
KAMAREDDY,13.4,Number of children provided free glasses,TOTAL,,,,,,,,,,,,,
KAMAREDDY,13.5,Number of eyes collected through eye donation,TOTAL,,,,,,,,,,,,,
KAMAREDDY,13.6,Number of eyes utilised for corneal transplant,TOTAL,,,,,,,,,,,,,
KAMAREDDY,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,,,,,,,,,,,,-1.0
KAMAREDDY,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,,,,,,,,,,-1.0
KAMAREDDY,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,,,,,,,,,,,,,-1.0
KAMAREDDY,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,,,,,,,,,,,,,-1.0
KAMAREDDY,14.05,Number of RKS meetings held during the month,TOTAL,,,,,,,,,,,,,
KAMAREDDY,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,,,,,,,,,,,,,-1.0
KAMAREDDY,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,,,,,,,,,,,,,
KAMAREDDY,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,,,,,,,,,-1.0
KAMAREDDY,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,,,,,,,,,,,,,-1.0
KAMAREDDY,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,,,,,,,,,,,,,
KAMAREDDY,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,,,,,,,,,,,,,
KAMAREDDY,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,,,,,,,,,,,,,
KAMAREDDY,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,,,,,,,,,,,,,
KAMAREDDY,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,,,,,,,,,,,,,
KAMAREDDY,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,,,,,,,,,,,,,
KAMAREDDY,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,,,,,,,,,,,,,
KAMAREDDY,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,,,,,,,,,,,,,
KAMAREDDY,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,,,,,,,,,,,,,
KAMAREDDY,14.10.2.a,Number of death cases of Inpatient males,TOTAL,,,,,,,,,,,,,
KAMAREDDY,14.10.2.b,Number of death cases of Inpatient females,TOTAL,,,,,,,,,,,,,
KAMAREDDY,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,,,,,,,,,,,,,
KAMAREDDY,14.11,In-Patient Head Count at midnight,TOTAL,,,,,,,,,,,,,
KAMAREDDY,14.12.1,OPD attendance (All),TOTAL,,,,,,,,,,,,,
KAMAREDDY,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,,,,,,,,,,,,,
KAMAREDDY,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,,,,,,,,,,,,,
KAMAREDDY,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,,,,,,,,,,,,,
KAMAREDDY,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,,,,,,,,,,,,,
KAMAREDDY,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,,,,,,,,,,,,,
KAMAREDDY,14.14.a,Number of patients given AYUSH treatment,TOTAL,,,,,,,,,,,,,
KAMAREDDY,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,,,,,,,,,,,,,
KAMAREDDY,14.14.c,Number of Adolescents counselled,TOTAL,,,,,,,,,,,,,
KAMAREDDY,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,,,,,,,,,,,,,
KAMAREDDY,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,,,,,,,,,,,,,
KAMAREDDY,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,,,,,,,,,,,,,
KAMAREDDY,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,,,,,,,,,,,,,
KAMAREDDY,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,,,,,,,,,,,,,
KAMAREDDY,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,,,,,,,,,,,,,
KAMAREDDY,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,,,,,,,,,,,,,
KAMAREDDY,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,,,,,,,,,,,,,
KAMAREDDY,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,,,,,,,,,,,,,
KAMAREDDY,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,,,,,,,,,,,,,
KAMAREDDY,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,,,,,,,,,,,,,
KAMAREDDY,15.2,Number of Widal tests conducted,Number tested,,,,,,,,,,,,,
KAMAREDDY,15.3.a,Number of VDRL tests conducted on males,Number tested,,,,,,,,,,,,,
KAMAREDDY,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,,,,,,,,,,,,,
KAMAREDDY,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,,,,,,,,,,,,,
KAMAREDDY,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,,,,,,,,,,,,,
KAMAREDDY,15.4.1,Number of blood smears examined for Malaria,TOTAL,,,,,,,,,,,,,
KAMAREDDY,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,,,,,,,,,,,,,
KAMAREDDY,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,,,,,,,,,,,,,
KAMAREDDY,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
KAMAREDDY,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,,,,,,,,,,
KAMAREDDY,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
KAMAREDDY,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,,,,,,,,,
KAMAREDDY,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
KAMAREDDY,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
KAMAREDDY,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
KAMAREDDY,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
KAMAREDDY,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
KAMAREDDY,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
KAMAREDDY,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
KAMAREDDY,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,,,,,,,,,
KAMAREDDY,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
KAMAREDDY,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,,,,,,,,,
KAMAREDDY,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
KAMAREDDY,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
KAMAREDDY,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,,,,,,,,,
KAMAREDDY,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
KAMAREDDY,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,,,,,,,,,
KAMAREDDY,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
KAMAREDDY,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
KAMAREDDY,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
KAMAREDDY,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
KAMAREDDY,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
KAMAREDDY,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
KAMAREDDY,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
KAMAREDDY,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,,,,,,,,,
KAMAREDDY,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
KAMAREDDY,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,,,,,,,,,
KAMAREDDY,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
KAMAREDDY,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
KAMAREDDY,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,,,,,,,,,
KAMAREDDY,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
KAMAREDDY,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,,,,,,,,,
KAMAREDDY,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
KAMAREDDY,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
KAMAREDDY,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
KAMAREDDY,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
KAMAREDDY,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
KAMAREDDY,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
KAMAREDDY,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
KAMAREDDY,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,,,,,,
KAMAREDDY,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
KAMAREDDY,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,,,,,,
KAMAREDDY,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
KAMAREDDY,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
KAMAREDDY,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
KAMAREDDY,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
KAMAREDDY,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
KAMAREDDY,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
KAMAREDDY,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
KAMAREDDY,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
KAMAREDDY,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
KAMAREDDY,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
KAMAREDDY,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
KAMAREDDY,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
KAMAREDDY,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
KAMAREDDY,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
KAMAREDDY,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
KAMAREDDY,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
KAMAREDDY,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
KAMAREDDY,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
KAMAREDDY,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
KAMAREDDY,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
KAMAREDDY,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
KAMAREDDY,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
KAMAREDDY,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
KAMAREDDY,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
KAMAREDDY,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
KAMAREDDY,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
KAMAREDDY,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
KAMAREDDY,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
KAMAREDDY,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
KAMAREDDY,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
KAMAREDDY,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
KAMAREDDY,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
KAMAREDDY,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
KAMAREDDY,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
KAMAREDDY,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
KAMAREDDY,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
KAMAREDDY,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
KAMAREDDY,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
KAMAREDDY,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
KAMAREDDY,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
KAMAREDDY,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
KAMAREDDY,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
KAMAREDDY,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
KAMAREDDY,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
KAMAREDDY,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
KAMAREDDY,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
KAMAREDDY,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
KAMAREDDY,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
KAMAREDDY,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
KAMAREDDY,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
KAMAREDDY,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
KAMAREDDY,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
KAMAREDDY,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
KAMAREDDY,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
KAMAREDDY,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
KAMAREDDY,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
KAMAREDDY,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
KAMAREDDY,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
KAMAREDDY,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
KAMAREDDY,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
KAMAREDDY,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
KAMAREDDY,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
KAMAREDDY,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
KAMAREDDY,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
KAMAREDDY,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
KAMAREDDY,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
KAMAREDDY,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
KAMAREDDY,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
KAMAREDDY,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
KAMAREDDY,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
KAMAREDDY,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
KAMAREDDY,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
KAMAREDDY,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
KAMAREDDY,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
KAMAREDDY,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
KAMAREDDY,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
KAMAREDDY,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
KAMAREDDY,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
KAMAREDDY,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
KAMAREDDY,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
KAMAREDDY,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
KAMAREDDY,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
KAMAREDDY,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
KAMAREDDY,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
KAMAREDDY,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
KAMAREDDY,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
KAMAREDDY,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
KAMAREDDY,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
KAMAREDDY,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
KAMAREDDY,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
KAMAREDDY,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
KAMAREDDY,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,,,,,,,
KAMAREDDY,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,,,,,,,
KAMAREDDY,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
KAMAREDDY,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,,,,,,,
KAMAREDDY,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
KAMAREDDY,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
KAMAREDDY,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
KAMAREDDY,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
KAMAREDDY,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
KAMAREDDY,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
KAMAREDDY,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
KAMAREDDY,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
KAMAREDDY,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
KAMAREDDY,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
KAMAREDDY,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
KAMAREDDY,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
KAMAREDDY,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
KAMAREDDY,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
KAMAREDDY,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
KAMAREDDY,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
KAMAREDDY,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
KAMAREDDY,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
KAMAREDDY,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
KAMAREDDY,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
KAMAREDDY,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
KAMAREDDY,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
KAMAREDDY,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
KAMAREDDY,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
KAMAREDDY,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
KAMAREDDY,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
KAMAREDDY,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
KAMAREDDY,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
KAMAREDDY,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
KAMAREDDY,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
KAMAREDDY,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
KAMAREDDY,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
KAMAREDDY,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
KAMAREDDY,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
KAMAREDDY,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
KAMAREDDY,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
KAMAREDDY,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
KAMAREDDY,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
KAMAREDDY,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
KAMAREDDY,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
KAMAREDDY,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
KAMAREDDY,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
KAMAREDDY,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
KAMAREDDY,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
KAMAREDDY,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
KAMAREDDY,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
KAMAREDDY,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
KAMAREDDY,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
KAMAREDDY,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
KAMAREDDY,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
KAMAREDDY,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
KAMAREDDY,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
KAMAREDDY,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
KAMAREDDY,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
KAMAREDDY,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
KAMAREDDY,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
KAMAREDDY,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
KAMAREDDY,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
KAMAREDDY,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
KAMAREDDY,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
KAMAREDDY,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
KAMAREDDY,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
KAMAREDDY,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
KAMAREDDY,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
KAMAREDDY,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
KAMAREDDY,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
KAMAREDDY,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
KAMAREDDY,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
KAMAREDDY,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
KAMAREDDY,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
KAMAREDDY,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
KAMAREDDY,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
KAMAREDDY,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
KAMAREDDY,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
KAMAREDDY,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
KAMAREDDY,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
KAMAREDDY,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
KAMAREDDY,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
KAMAREDDY,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
KAMAREDDY,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
KAMAREDDY,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
KAMAREDDY,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
KAMAREDDY,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
KAMAREDDY,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
KAMAREDDY,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
KAMAREDDY,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
KAMAREDDY,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
KAMAREDDY,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
KAMAREDDY,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
KAMAREDDY,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
KAMAREDDY,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
KAMAREDDY,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
KAMAREDDY,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
KAMAREDDY,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
KAMAREDDY,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
KAMAREDDY,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
KAMAREDDY,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
KAMAREDDY,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
KAMAREDDY,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
KAMAREDDY,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
KAMAREDDY,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
KAMAREDDY,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
KAMAREDDY,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
KAMAREDDY,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
KAMAREDDY,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
KAMAREDDY,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
KAMAREDDY,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
KAMAREDDY,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
KAMAREDDY,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
KOMARAM BHEEM,1.1,Total number of pregnant women Registered for ANC,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,1.2,Number of Pregnant women registered under JSY,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,1.8,Number of pregnancy test kits used at SC level,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,4.1.1.a,Number of male live births,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,4.1.1.b,Number of female live births,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,4.1.2,Number of still births,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,4.2.1,Number of Newborns weighed at birth,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,6.3,PNC maternal complications attended,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,7.2,Number of MTPs conducted at Private Facilities,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,9.06,Number of IUCD removals,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,9.07,Number of Oral Pills cycles distributed,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,9.08,Number of Condom pieces distributed,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,9.09,Number of Centchroman (weekly) pills given,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,9.11.2.a,Number of failures following male sterilization,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,9.11.2.b,Number of failures following female sterilization,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,9.11.3.a,Number of deaths following male sterilization,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,9.11.3.b,Number of deaths following female sterilization,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,,,,,,,,,,,-1.0
KOMARAM BHEEM,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,10.4.2,Number of Immunisation sessions held during the month,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,13.1,Number of Patients operated for cataract,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,13.3,Number of School children detected with Refractive errors,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,13.4,Number of children provided free glasses,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,13.5,Number of eyes collected through eye donation,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,13.6,Number of eyes utilised for corneal transplant,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,,,,,,,,,,,,-1.0
KOMARAM BHEEM,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,,,,,,,,,,-1.0
KOMARAM BHEEM,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,,,,,,,,,,,,,-1.0
KOMARAM BHEEM,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,,,,,,,,,,,,,-1.0
KOMARAM BHEEM,14.05,Number of RKS meetings held during the month,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,,,,,,,,,,,,,-1.0
KOMARAM BHEEM,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,,,,,,,,,-1.0
KOMARAM BHEEM,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,,,,,,,,,,,,,-1.0
KOMARAM BHEEM,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,,,,,,,,,,,,,
KOMARAM BHEEM,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,,,,,,,,,,,,,
KOMARAM BHEEM,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,,,,,,,,,,,,,
KOMARAM BHEEM,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,,,,,,,,,,,,,
KOMARAM BHEEM,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,,,,,,,,,,,,,
KOMARAM BHEEM,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,,,,,,,,,,,,,
KOMARAM BHEEM,14.10.2.a,Number of death cases of Inpatient males,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,14.10.2.b,Number of death cases of Inpatient females,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,14.11,In-Patient Head Count at midnight,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,14.12.1,OPD attendance (All),TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,14.14.a,Number of patients given AYUSH treatment,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,14.14.c,Number of Adolescents counselled,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,,,,,,,,,,,,,
KOMARAM BHEEM,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,,,,,,,,,,,,,
KOMARAM BHEEM,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,,,,,,,,,,,,,
KOMARAM BHEEM,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,,,,,,,,,,,,,
KOMARAM BHEEM,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,,,,,,,,,,,,,
KOMARAM BHEEM,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,,,,,,,,,,,,,
KOMARAM BHEEM,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,,,,,,,,,,,,,
KOMARAM BHEEM,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,,,,,,,,,,,,,
KOMARAM BHEEM,15.2,Number of Widal tests conducted,Number tested,,,,,,,,,,,,,
KOMARAM BHEEM,15.3.a,Number of VDRL tests conducted on males,Number tested,,,,,,,,,,,,,
KOMARAM BHEEM,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,,,,,,,,,,,,,
KOMARAM BHEEM,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,,,,,,,,,,,,,
KOMARAM BHEEM,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,,,,,,,,,,,,,
KOMARAM BHEEM,15.4.1,Number of blood smears examined for Malaria,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
KOMARAM BHEEM,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,,,,,,,,,,
KOMARAM BHEEM,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
KOMARAM BHEEM,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,,,,,,,,,
KOMARAM BHEEM,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
KOMARAM BHEEM,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
KOMARAM BHEEM,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
KOMARAM BHEEM,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
KOMARAM BHEEM,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
KOMARAM BHEEM,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
KOMARAM BHEEM,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
KOMARAM BHEEM,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,,,,,,,,,
KOMARAM BHEEM,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
KOMARAM BHEEM,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,,,,,,,,,
KOMARAM BHEEM,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
KOMARAM BHEEM,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
KOMARAM BHEEM,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,,,,,,,,,
KOMARAM BHEEM,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
KOMARAM BHEEM,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,,,,,,,,,
KOMARAM BHEEM,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
KOMARAM BHEEM,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
KOMARAM BHEEM,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
KOMARAM BHEEM,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
KOMARAM BHEEM,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
KOMARAM BHEEM,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
KOMARAM BHEEM,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
KOMARAM BHEEM,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,,,,,,,,,
KOMARAM BHEEM,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
KOMARAM BHEEM,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,,,,,,,,,
KOMARAM BHEEM,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
KOMARAM BHEEM,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
KOMARAM BHEEM,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,,,,,,,,,
KOMARAM BHEEM,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
KOMARAM BHEEM,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,,,,,,,,,
KOMARAM BHEEM,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
KOMARAM BHEEM,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
KOMARAM BHEEM,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
KOMARAM BHEEM,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
KOMARAM BHEEM,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
KOMARAM BHEEM,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
KOMARAM BHEEM,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
KOMARAM BHEEM,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,,,,,,
KOMARAM BHEEM,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
KOMARAM BHEEM,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,,,,,,
KOMARAM BHEEM,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
KOMARAM BHEEM,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
KOMARAM BHEEM,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
KOMARAM BHEEM,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
KOMARAM BHEEM,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
KOMARAM BHEEM,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
KOMARAM BHEEM,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
KOMARAM BHEEM,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
KOMARAM BHEEM,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
KOMARAM BHEEM,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
KOMARAM BHEEM,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
KOMARAM BHEEM,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
KOMARAM BHEEM,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
KOMARAM BHEEM,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
KOMARAM BHEEM,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
KOMARAM BHEEM,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
KOMARAM BHEEM,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
KOMARAM BHEEM,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
KOMARAM BHEEM,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
KOMARAM BHEEM,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
KOMARAM BHEEM,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
KOMARAM BHEEM,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
KOMARAM BHEEM,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
KOMARAM BHEEM,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
KOMARAM BHEEM,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
KOMARAM BHEEM,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
KOMARAM BHEEM,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
KOMARAM BHEEM,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
KOMARAM BHEEM,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
KOMARAM BHEEM,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
KOMARAM BHEEM,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
KOMARAM BHEEM,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
KOMARAM BHEEM,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
KOMARAM BHEEM,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
KOMARAM BHEEM,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
KOMARAM BHEEM,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
KOMARAM BHEEM,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
KOMARAM BHEEM,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
KOMARAM BHEEM,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
KOMARAM BHEEM,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
KOMARAM BHEEM,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
KOMARAM BHEEM,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
KOMARAM BHEEM,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
KOMARAM BHEEM,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
KOMARAM BHEEM,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
KOMARAM BHEEM,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
KOMARAM BHEEM,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
KOMARAM BHEEM,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
KOMARAM BHEEM,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
KOMARAM BHEEM,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
KOMARAM BHEEM,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
KOMARAM BHEEM,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
KOMARAM BHEEM,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
KOMARAM BHEEM,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
KOMARAM BHEEM,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
KOMARAM BHEEM,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
KOMARAM BHEEM,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
KOMARAM BHEEM,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
KOMARAM BHEEM,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
KOMARAM BHEEM,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
KOMARAM BHEEM,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
KOMARAM BHEEM,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
KOMARAM BHEEM,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
KOMARAM BHEEM,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
KOMARAM BHEEM,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
KOMARAM BHEEM,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
KOMARAM BHEEM,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
KOMARAM BHEEM,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
KOMARAM BHEEM,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
KOMARAM BHEEM,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
KOMARAM BHEEM,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
KOMARAM BHEEM,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
KOMARAM BHEEM,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
KOMARAM BHEEM,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
KOMARAM BHEEM,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
KOMARAM BHEEM,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
KOMARAM BHEEM,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
KOMARAM BHEEM,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
KOMARAM BHEEM,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
KOMARAM BHEEM,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
KOMARAM BHEEM,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
KOMARAM BHEEM,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
KOMARAM BHEEM,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
KOMARAM BHEEM,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
KOMARAM BHEEM,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
KOMARAM BHEEM,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
KOMARAM BHEEM,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
KOMARAM BHEEM,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
KOMARAM BHEEM,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
KOMARAM BHEEM,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
KOMARAM BHEEM,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
KOMARAM BHEEM,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,,,,,,,
KOMARAM BHEEM,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,,,,,,,
KOMARAM BHEEM,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
KOMARAM BHEEM,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,,,,,,,
KOMARAM BHEEM,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
KOMARAM BHEEM,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
KOMARAM BHEEM,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
KOMARAM BHEEM,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
KOMARAM BHEEM,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
KOMARAM BHEEM,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
KOMARAM BHEEM,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
KOMARAM BHEEM,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
KOMARAM BHEEM,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
KOMARAM BHEEM,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
KOMARAM BHEEM,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
KOMARAM BHEEM,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
KOMARAM BHEEM,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
KOMARAM BHEEM,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
KOMARAM BHEEM,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
KOMARAM BHEEM,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
KOMARAM BHEEM,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
KOMARAM BHEEM,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
KOMARAM BHEEM,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
KOMARAM BHEEM,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
KOMARAM BHEEM,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
KOMARAM BHEEM,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
KOMARAM BHEEM,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
KOMARAM BHEEM,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
KOMARAM BHEEM,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
KOMARAM BHEEM,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
KOMARAM BHEEM,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
KOMARAM BHEEM,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
KOMARAM BHEEM,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
KOMARAM BHEEM,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
KOMARAM BHEEM,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
KOMARAM BHEEM,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
KOMARAM BHEEM,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
KOMARAM BHEEM,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
KOMARAM BHEEM,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
KOMARAM BHEEM,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
KOMARAM BHEEM,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
KOMARAM BHEEM,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
KOMARAM BHEEM,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
KOMARAM BHEEM,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
KOMARAM BHEEM,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
KOMARAM BHEEM,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
KOMARAM BHEEM,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
KOMARAM BHEEM,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
KOMARAM BHEEM,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
KOMARAM BHEEM,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
KOMARAM BHEEM,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
KOMARAM BHEEM,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
KOMARAM BHEEM,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
KOMARAM BHEEM,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
KOMARAM BHEEM,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
KOMARAM BHEEM,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
KOMARAM BHEEM,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
KOMARAM BHEEM,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
KOMARAM BHEEM,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
KOMARAM BHEEM,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
KOMARAM BHEEM,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
KOMARAM BHEEM,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
KOMARAM BHEEM,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
KOMARAM BHEEM,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
KOMARAM BHEEM,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
KOMARAM BHEEM,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
KOMARAM BHEEM,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
KOMARAM BHEEM,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
KOMARAM BHEEM,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
KOMARAM BHEEM,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
KOMARAM BHEEM,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
KOMARAM BHEEM,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
KOMARAM BHEEM,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
KOMARAM BHEEM,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
KOMARAM BHEEM,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
KOMARAM BHEEM,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
KOMARAM BHEEM,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
KOMARAM BHEEM,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
KOMARAM BHEEM,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
KOMARAM BHEEM,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
KOMARAM BHEEM,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
KOMARAM BHEEM,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
KOMARAM BHEEM,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
KOMARAM BHEEM,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
KOMARAM BHEEM,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
KOMARAM BHEEM,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
KOMARAM BHEEM,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
KOMARAM BHEEM,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
KOMARAM BHEEM,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
KOMARAM BHEEM,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
KOMARAM BHEEM,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
KOMARAM BHEEM,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
KOMARAM BHEEM,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
KOMARAM BHEEM,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
KOMARAM BHEEM,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
KOMARAM BHEEM,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
KOMARAM BHEEM,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
KOMARAM BHEEM,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
KOMARAM BHEEM,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
KOMARAM BHEEM,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
KOMARAM BHEEM,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
KOMARAM BHEEM,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
KOMARAM BHEEM,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
KOMARAM BHEEM,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
KOMARAM BHEEM,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
KOMARAM BHEEM,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
KOMARAM BHEEM,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
KOMARAM BHEEM,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
KOMARAM BHEEM,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
KOMARAM BHEEM,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
KOMARAM BHEEM,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
KOMARAM BHEEM,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
KOMARAM BHEEM,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
Karim Nagar,1.1,Total number of pregnant women Registered for ANC,TOTAL,7682.0,7275.0,7977.0,8168.0,7443.0,6240.0,6525.0,7488.0,6891.0,7681.0,7505.0,7767.0,88642.0
Karim Nagar,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,5309.0,4973.0,5240.0,4867.0,5199.0,4337.0,4234.0,5022.0,4514.0,5372.0,5254.0,5166.0,59487.0
Karim Nagar,1.2,Number of Pregnant women registered under JSY,TOTAL,5670.0,4854.0,5405.0,5244.0,5452.0,4154.0,4316.0,4895.0,4841.0,5102.0,4773.0,5303.0,60009.0
Karim Nagar,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,4223.0,4297.0,4627.0,4741.0,5917.0,4831.0,5063.0,4676.0,4012.0,4418.0,4950.0,5448.0,57203.0
Karim Nagar,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,6586.0,5957.0,6071.0,6341.0,6216.0,5191.0,5064.0,6277.0,5595.0,6139.0,6403.0,5755.0,71595.0
Karim Nagar,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,5325.0,5918.0,5851.0,5925.0,5874.0,6061.0,5386.0,5311.0,5519.0,5286.0,6022.0,6027.0,68505.0
Karim Nagar,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,6664.0,6288.0,6378.0,7372.0,7495.0,6078.0,6141.0,6820.0,6280.0,6082.0,6852.0,7014.0,79464.0
Karim Nagar,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,96.0,173.0,93.0,169.0,67.0,173.0,53.0,93.0,225.0,84.0,89.0,85.0,1400.0
Karim Nagar,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,2.0,0.0,0.0,0.0,0.0,1.0,11.0,0.0,0.0,2.0,1.0,3.0,20.0
Karim Nagar,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1496.0,1347.0,1876.0,1695.0,1597.0,1654.0,2474.0,1969.0,1734.0,1683.0,1781.0,2403.0,21709.0
Karim Nagar,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,48.0,39.0,91.0,47.0,84.0,35.0,134.0,136.0,85.0,37.0,56.0,166.0,958.0
Karim Nagar,1.8,Number of pregnancy test kits used at SC level,TOTAL,1049.0,948.0,1054.0,1192.0,888.0,808.0,749.0,864.0,862.0,908.0,846.0,893.0,11061.0
Karim Nagar,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karim Nagar,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karim Nagar,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karim Nagar,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karim Nagar,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karim Nagar,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1169.0,1140.0,1063.0,1113.0,1364.0,1220.0,1065.0,1173.0,1167.0,1137.0,1105.0,1254.0,13970.0
Karim Nagar,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,426.0,280.0,362.0,375.0,606.0,404.0,494.0,463.0,453.0,441.0,494.0,421.0,5219.0
Karim Nagar,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,537.0,411.0,481.0,507.0,593.0,760.0,1094.0,921.0,968.0,831.0,876.0,939.0,8918.0
Karim Nagar,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,20.0,35.0,18.0,24.0,21.0,15.0,3.0,0.0,20.0,24.0,5.0,20.0,205.0
Karim Nagar,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,2.0,0.0,3.0,0.0,1.0,3.0,0.0,0.0,0.0,1.0,0.0,10.0
Karim Nagar,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,3331.0,3730.0,3734.0,3836.0,3307.0,3471.0,3738.0,3841.0,3915.0,3904.0,3532.0,3955.0,44294.0
Karim Nagar,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Karim Nagar,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Karim Nagar,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Karim Nagar,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,45.0,41.0,47.0,36.0,41.0,51.0,57.0,71.0,76.0,50.0,44.0,69.0,628.0
Karim Nagar,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,116.0,129.0,79.0,123.0,125.0,111.0,78.0,111.0,101.0,116.0,135.0,163.0,1387.0
Karim Nagar,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,466.0,447.0,475.0,503.0,484.0,517.0,470.0,473.0,493.0,422.0,314.0,492.0,5556.0
Karim Nagar,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Karim Nagar,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,627.0,617.0,601.0,662.0,650.0,679.0,605.0,655.0,670.0,588.0,493.0,724.0,7571.0
Karim Nagar,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,2929.0,3211.0,3078.0,3495.0,3026.0,3139.0,3387.0,3426.0,3507.0,3509.0,3185.0,3411.0,39303.0
Karim Nagar,4.1.1.a,Number of male live births,TOTAL,2225.0,2421.0,2393.0,2444.0,2246.0,2173.0,2245.0,2170.0,2218.0,2135.0,2120.0,2579.0,27369.0
Karim Nagar,4.1.1.b,Number of female live births,TOTAL,2310.0,2581.0,2498.0,2581.0,2424.0,2580.0,2772.0,2931.0,2870.0,2919.0,2536.0,2657.0,31659.0
Karim Nagar,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,4535.0,5002.0,4891.0,5025.0,4670.0,4753.0,5017.0,5101.0,5088.0,5054.0,4656.0,5236.0,59028.0
Karim Nagar,4.1.2,Number of still births,TOTAL,13.0,7.0,18.0,6.0,6.0,13.0,15.0,3.0,4.0,2.0,5.0,9.0,101.0
Karim Nagar,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,14.0,17.0,8.0,10.0,14.0,6.0,9.0,3.0,14.0,5.0,11.0,14.0,125.0
Karim Nagar,4.2.1,Number of Newborns weighed at birth,TOTAL,968.0,910.0,994.0,957.0,1098.0,1092.0,1001.0,1008.0,1002.0,955.0,928.0,1126.0,12039.0
Karim Nagar,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,26.0,35.0,49.0,49.0,107.0,71.0,111.0,46.0,90.0,38.0,48.0,103.0,773.0
Karim Nagar,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1010.0,961.0,981.0,928.0,1115.0,997.0,981.0,941.0,753.0,801.0,769.0,1091.0,11328.0
Karim Nagar,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,8.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8.0
Karim Nagar,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,5.0,0.0,1.0,0.0,13.0,7.0,5.0,0.0,8.0,6.0,1.0,5.0,51.0
Karim Nagar,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,14.0,8.0,23.0,29.0,33.0,3.0,17.0,8.0,25.0,5.0,9.0,20.0,194.0
Karim Nagar,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Karim Nagar,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,19.0,8.0,24.0,29.0,54.0,10.0,22.0,8.0,33.0,11.0,10.0,25.0,253.0
Karim Nagar,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karim Nagar,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,6.0,8.0,23.0,29.0,51.0,7.0,21.0,4.0,21.0,7.0,2.0,22.0,201.0
Karim Nagar,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,5.0,0.0,0.0,1.0,0.0,0.0,6.0
Karim Nagar,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,5.0,4.0,0.0,13.0,25.0,7.0,15.0,4.0,0.0,7.0,2.0,0.0,82.0
Karim Nagar,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,14.0,5.0,14.0,13.0,11.0,0.0,0.0,8.0,1.0,4.0,10.0,0.0,80.0
Karim Nagar,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,559.0,584.0,485.0,366.0,591.0,580.0,646.0,381.0,552.0,503.0,549.0,623.0,6419.0
Karim Nagar,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1386.0,1677.0,1901.0,1538.0,1907.0,1906.0,1840.0,1946.0,2329.0,2124.0,1910.0,2196.0,22660.0
Karim Nagar,6.3,PNC maternal complications attended,TOTAL,6.0,1.0,1.0,6.0,4.0,4.0,0.0,0.0,10.0,5.0,5.0,5.0,47.0
Karim Nagar,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,3.0,2.0,3.0,3.0,4.0,0.0,3.0,0.0,1.0,1.0,0.0,0.0,20.0
Karim Nagar,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,2.0,0.0,0.0,3.0,6.0,0.0,5.0,0.0,1.0,2.0,0.0,2.0,21.0
Karim Nagar,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,5.0,2.0,3.0,6.0,10.0,0.0,8.0,0.0,2.0,3.0,0.0,2.0,41.0
Karim Nagar,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,1.0,0.0,0.0,0.0,1.0,0.0,1.0,2.0,3.0,0.0,0.0,8.0
Karim Nagar,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,513.0,428.0,240.0,424.0,323.0,405.0,694.0,640.0,674.0,605.0,598.0,694.0,6238.0
Karim Nagar,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,536.0,588.0,409.0,604.0,561.0,569.0,817.0,933.0,961.0,844.0,757.0,879.0,8458.0
Karim Nagar,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,1049.0,1016.0,649.0,1028.0,884.0,974.0,1511.0,1573.0,1635.0,1449.0,1355.0,1573.0,14696.0
Karim Nagar,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,15.0,12.0,18.0,0.0,0.0,14.0,1.0,1.0,21.0,0.0,82.0
Karim Nagar,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,142.0,62.0,94.0,112.0,152.0,149.0,41.0,82.0,95.0,147.0,141.0,209.0,1426.0
Karim Nagar,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,57.0,18.0,25.0,15.0,63.0,62.0,0.0,41.0,71.0,104.0,169.0,93.0,718.0
Karim Nagar,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,51.0,45.0,39.0,27.0,60.0,62.0,34.0,52.0,43.0,42.0,73.0,94.0,622.0
Karim Nagar,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Karim Nagar,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,250.0,125.0,158.0,154.0,275.0,273.0,75.0,175.0,209.0,293.0,383.0,396.0,2766.0
Karim Nagar,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,2.0,0.0,2.0,2.0,2.0,0.0,0.0,2.0,2.0,0.0,2.0,2.0,16.0
Karim Nagar,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,24.0,22.0,7.0,38.0,128.0,47.0,89.0,61.0,80.0,11.0,126.0,73.0,706.0
Karim Nagar,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,6.0,5.0,16.0,2.0,5.0,60.0,3.0,73.0,104.0,121.0,80.0,159.0,634.0
Karim Nagar,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,33.0,52.0,0.0,0.0,69.0,52.0,36.0,132.0,40.0,88.0,170.0,243.0,915.0
Karim Nagar,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Karim Nagar,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,63.0,79.0,23.0,40.0,202.0,159.0,128.0,266.0,224.0,220.0,376.0,475.0,2255.0
Karim Nagar,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karim Nagar,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,20.0,50.0,26.0,31.0,40.0,113.0,44.0,23.0,41.0,47.0,49.0,48.0,532.0
Karim Nagar,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,51.0,29.0,15.0,19.0,21.0,53.0,9.0,20.0,29.0,0.0,107.0,32.0,385.0
Karim Nagar,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,51.0,35.0,87.0,84.0,106.0,51.0,75.0,60.0,107.0,0.0,0.0,0.0,656.0
Karim Nagar,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Karim Nagar,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,122.0,114.0,128.0,134.0,167.0,217.0,128.0,103.0,177.0,47.0,156.0,80.0,1573.0
Karim Nagar,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,182.0,203.0,257.0,267.0,278.0,264.0,285.0,258.0,275.0,289.0,322.0,303.0,3183.0
Karim Nagar,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,67.0,33.0,36.0,36.0,66.0,29.0,42.0,68.0,70.0,60.0,66.0,82.0,655.0
Karim Nagar,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,15.0,20.0,11.0,19.0,21.0,17.0,0.0,5.0,17.0,19.0,13.0,19.0,176.0
Karim Nagar,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,51.0,4.0,60.0,41.0,50.0,53.0,56.0,44.0,40.0,94.0,73.0,99.0,665.0
Karim Nagar,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Karim Nagar,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,133.0,57.0,107.0,96.0,137.0,99.0,98.0,117.0,127.0,173.0,152.0,200.0,1496.0
Karim Nagar,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,531.0,545.0,705.0,705.0,838.0,743.0,835.0,796.0,825.0,846.0,974.0,820.0,9163.0
Karim Nagar,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,104.0,107.0,90.0,86.0,96.0,133.0,96.0,86.0,80.0,96.0,109.0,101.0,1184.0
Karim Nagar,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,82.0,107.0,57.0,74.0,67.0,67.0,64.0,27.0,25.0,40.0,48.0,36.0,694.0
Karim Nagar,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,12.0,9.0,10.0,9.0,8.0,8.0,9.0,7.0,8.0,9.0,9.0,8.0,106.0
Karim Nagar,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,9.0,8.0,8.0,9.0,10.0,11.0,11.0,10.0,10.0,11.0,10.0,10.0,117.0
Karim Nagar,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Karim Nagar,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,207.0,231.0,165.0,178.0,181.0,219.0,180.0,130.0,123.0,156.0,176.0,155.0,2101.0
Karim Nagar,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,28.0,36.0,3.0,7.0,8.0,11.0,6.0,6.0,4.0,9.0,7.0,23.0,148.0
Karim Nagar,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karim Nagar,9.06,Number of IUCD removals,TOTAL,218.0,184.0,115.0,126.0,193.0,171.0,147.0,121.0,113.0,114.0,112.0,124.0,1738.0
Karim Nagar,9.07,Number of Oral Pills cycles distributed,TOTAL,1671.0,1726.0,1650.0,1638.0,1894.0,1904.0,1959.0,1376.0,1399.0,1583.0,1779.0,1559.0,20138.0
Karim Nagar,9.08,Number of Condom pieces distributed,TOTAL,4929.0,4619.0,4479.0,4179.0,5988.0,6023.0,3109.0,6211.0,3818.0,6834.0,13596.0,15601.0,79386.0
Karim Nagar,9.09,Number of Centchroman (weekly) pills given,TOTAL,31.0,43.0,25.0,41.0,115.0,60.0,69.0,137.0,115.0,27.0,164.0,18.0,845.0
Karim Nagar,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,66.0,111.0,112.0,137.0,101.0,55.0,28.0,51.0,30.0,65.0,59.0,35.0,850.0
Karim Nagar,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karim Nagar,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0
Karim Nagar,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karim Nagar,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karim Nagar,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karim Nagar,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karim Nagar,9.12,Number of Institutions having NSV trained doctors,TOTAL,58.0,59.0,61.0,60.0,57.0,62.0,59.0,61.0,60.0,58.0,59.0,59.0,-1.0
Karim Nagar,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,4338.0,4753.0,4632.0,4845.0,4425.0,4507.0,4798.0,4960.0,5086.0,4897.0,4583.0,4999.0,56823.0
Karim Nagar,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,4370.0,4659.0,4257.0,1598.0,1065.0,520.0,263.0,228.0,197.0,174.0,221.0,139.0,17691.0
Karim Nagar,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,4440.0,4475.0,4542.0,3835.0,1413.0,560.0,270.0,226.0,226.0,168.0,229.0,127.0,20511.0
Karim Nagar,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,4937.0,4640.0,4606.0,4535.0,3059.0,788.0,346.0,268.0,218.0,195.0,227.0,154.0,23973.0
Karim Nagar,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,114.0,53.0,941.0,3154.0,3487.0,4177.0,4616.0,5016.0,5072.0,5318.0,5009.0,5182.0,42139.0
Karim Nagar,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,105.0,3.0,128.0,1256.0,3438.0,4178.0,4285.0,5054.0,5022.0,5103.0,5120.0,5555.0,39247.0
Karim Nagar,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,108.0,3.0,128.0,325.0,1832.0,4157.0,4301.0,4528.0,5074.0,5214.0,4947.0,5952.0,36569.0
Karim Nagar,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,4338.0,4753.0,4634.0,4860.0,4426.0,4508.0,4798.0,4965.0,5086.0,4897.0,4583.0,4999.0,56847.0
Karim Nagar,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,4513.0,4455.0,4682.0,3879.0,4005.0,4392.0,4684.0,5111.0,5308.0,5656.0,5331.0,5440.0,57456.0
Karim Nagar,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,4545.0,4421.0,4646.0,4601.0,4230.0,4423.0,4365.0,5150.0,5259.0,5466.0,5453.0,5805.0,58364.0
Karim Nagar,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,5056.0,4602.0,4725.0,4675.0,4602.0,4586.0,4462.0,4721.0,5286.0,5575.0,5280.0,6267.0,59837.0
Karim Nagar,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,4206.0,4905.0,5034.0,5060.0,4701.0,4667.0,4945.0,5308.0,5466.0,4999.0,4649.0,5178.0,59118.0
Karim Nagar,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,4126.0,4261.0,4095.0,1686.0,1023.0,651.0,351.0,227.0,222.0,181.0,213.0,322.0,17358.0
Karim Nagar,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,4453.0,4472.0,4554.0,3800.0,1502.0,749.0,477.0,236.0,230.0,200.0,237.0,335.0,21245.0
Karim Nagar,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,4974.0,4649.0,4615.0,4469.0,3096.0,1077.0,543.0,245.0,228.0,310.0,340.0,539.0,25085.0
Karim Nagar,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,4955.0,4924.0,5437.0,5227.0,5250.0,4941.0,5216.0,5805.0,5040.0,5034.0,4860.0,5483.0,62172.0
Karim Nagar,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,2727.0,2554.0,3004.0,2719.0,2653.0,2545.0,2857.0,4360.0,3962.0,3154.0,2953.0,3096.0,36584.0
Karim Nagar,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,80.0,147.0,114.0,29.0,86.0,39.0,112.0,6.0,0.0,46.0,81.0,23.0,763.0
Karim Nagar,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2078.0,2090.0,2213.0,2667.0,2224.0,1969.0,2066.0,2366.0,2302.0,2353.0,2362.0,2517.0,27207.0
Karim Nagar,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1947.0,2016.0,2148.0,2276.0,2032.0,1873.0,1759.0,2175.0,2176.0,2143.0,2185.0,2258.0,24988.0
Karim Nagar,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,4025.0,4106.0,4361.0,4943.0,4256.0,3842.0,3825.0,4541.0,4478.0,4496.0,4547.0,4775.0,52195.0
Karim Nagar,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,4657.0,5011.0,5422.0,5155.0,4277.0,4068.0,4881.0,7259.0,6337.0,5155.0,4710.0,5090.0,62022.0
Karim Nagar,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,4556.0,4568.0,4987.0,4598.0,4267.0,4060.0,4879.0,7250.0,6395.0,5152.0,4700.0,5081.0,60493.0
Karim Nagar,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,560.0,378.0,502.0,573.0,513.0,425.0,1157.0,1479.0,1630.0,1251.0,1186.0,1296.0,10950.0
Karim Nagar,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1277.0,1366.0,1270.0,1702.0,1244.0,1168.0,1508.0,1741.0,1895.0,1400.0,1393.0,1595.0,17559.0
Karim Nagar,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1155.0,1234.0,1262.0,1341.0,1148.0,1126.0,1290.0,1615.0,1740.0,1330.0,1229.0,1434.0,15904.0
Karim Nagar,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,2432.0,2600.0,2532.0,3043.0,2392.0,2294.0,2798.0,3356.0,3635.0,2730.0,2622.0,3029.0,33463.0
Karim Nagar,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,3205.0,3537.0,3864.0,3708.0,3464.0,3521.0,3525.0,3935.0,4121.0,4128.0,3946.0,3877.0,44831.0
Karim Nagar,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,2720.0,3103.0,3315.0,3326.0,2966.0,3000.0,2986.0,3190.0,3398.0,3449.0,3268.0,3736.0,38457.0
Karim Nagar,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,2350.0,2698.0,2687.0,2837.0,2695.0,2688.0,2549.0,2517.0,3611.0,2947.0,2918.0,3401.0,33898.0
Karim Nagar,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,4.0,0.0,0.0,0.0,0.0,3.0,0.0,0.0,0.0,5.0,0.0,7.0,19.0
Karim Nagar,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0
Karim Nagar,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karim Nagar,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,2655.0,2757.0,2686.0,2685.0,2662.0,2720.0,2702.0,2691.0,2850.0,2720.0,2709.0,2662.0,32499.0
Karim Nagar,10.4.2,Number of Immunisation sessions held during the month,TOTAL,2636.0,2731.0,2671.0,2638.0,2649.0,2697.0,2685.0,2676.0,2822.0,2699.0,2713.0,2649.0,32266.0
Karim Nagar,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,2555.0,2617.0,2594.0,2632.0,2600.0,1170.0,551.0,291.0,853.0,2550.0,2651.0,2539.0,23603.0
Karim Nagar,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karim Nagar,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,4075.0,3970.0,4404.0,4201.0,4276.0,4124.0,4474.0,4599.0,3844.0,3874.0,3797.0,3767.0,49405.0
Karim Nagar,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,1335.0,1389.0,1464.0,1576.0,1413.0,1430.0,1404.0,1974.0,2043.0,1482.0,1437.0,1451.0,18398.0
Karim Nagar,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,1222.0,1230.0,1552.0,1509.0,1345.0,1290.0,1306.0,1370.0,1902.0,1299.0,1328.0,1327.0,16680.0
Karim Nagar,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karim Nagar,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karim Nagar,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karim Nagar,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karim Nagar,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karim Nagar,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,32.0,29.0,9.0,57.0,9.0,57.0,35.0,31.0,16.0,9.0,11.0,6.0,301.0
Karim Nagar,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,106.0,109.0,214.0,140.0,132.0,72.0,72.0,63.0,68.0,33.0,32.0,56.0,1097.0
Karim Nagar,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,34.0,44.0,88.0,139.0,62.0,33.0,72.0,48.0,81.0,100.0,95.0,60.0,856.0
Karim Nagar,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,42.0,45.0,59.0,30.0,62.0,24.0,53.0,73.0,81.0,48.0,84.0,14.0,615.0
Karim Nagar,13.1,Number of Patients operated for cataract,TOTAL,113.0,126.0,211.0,224.0,221.0,305.0,223.0,168.0,191.0,242.0,280.0,215.0,2519.0
Karim Nagar,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,113.0,121.0,197.0,215.0,179.0,295.0,149.0,152.0,169.0,236.0,259.0,213.0,2298.0
Karim Nagar,13.3,Number of School children detected with Refractive errors,TOTAL,67.0,18.0,6.0,6.0,38.0,184.0,51.0,85.0,76.0,71.0,21.0,0.0,623.0
Karim Nagar,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,6.0,0.0,8.0,4.0,6.0,0.0,22.0,12.0,0.0,0.0,58.0
Karim Nagar,13.5,Number of eyes collected through eye donation,TOTAL,0.0,1.0,0.0,0.0,1.0,1.0,1.0,1.0,0.0,0.0,2.0,2.0,9.0
Karim Nagar,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,1.0,0.0,0.0,1.0,1.0,0.0,1.0,0.0,0.0,2.0,0.0,6.0
Karim Nagar,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,6.0,6.0,7.0,6.0,5.0,5.0,5.0,5.0,5.0,8.0,7.0,8.0,-1.0
Karim Nagar,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,52.0,51.0,49.0,54.0,52.0,55.0,55.0,55.0,56.0,55.0,54.0,53.0,-1.0
Karim Nagar,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,2365.0,2511.0,2578.0,2434.0,2505.0,2269.0,2581.0,2325.0,2502.0,3056.0,2472.0,2656.0,-1.0
Karim Nagar,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,5.0,5.0,6.0,5.0,5.0,5.0,5.0,5.0,4.0,7.0,7.0,7.0,-1.0
Karim Nagar,14.05,Number of RKS meetings held during the month,TOTAL,11.0,11.0,9.0,11.0,6.0,21.0,8.0,8.0,17.0,5.0,6.0,13.0,126.0
Karim Nagar,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,49.0,49.0,50.0,49.0,48.0,47.0,51.0,50.0,47.0,52.0,54.0,54.0,-1.0
Karim Nagar,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,10.0,4.0,6.0,15.0,14.0,12.0,7.0,7.0,2.0,5.0,4.0,60.0,146.0
Karim Nagar,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,7.0,6.0,7.0,6.0,6.0,5.0,5.0,6.0,7.0,7.0,8.0,8.0,-1.0
Karim Nagar,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,1.0,1.0,0.0,1.0,1.0,1.0,1.0,1.0,0.0,1.0,1.0,1.0,-1.0
Karim Nagar,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,,,,,,,,,,,,,
Karim Nagar,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,,,,,,,,,,,,,
Karim Nagar,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,,,,,,,,,,,,,
Karim Nagar,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,469.0,541.0,405.0,681.0,1030.0,2093.0,1830.0,778.0,862.0,1097.0,924.0,1050.0,11760.0
Karim Nagar,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,3105.0,3441.0,3677.0,3609.0,3902.0,3268.0,3039.0,2192.0,3423.0,3972.0,3706.0,2368.0,39702.0
Karim Nagar,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,532.0,628.0,448.0,735.0,910.0,2321.0,1932.0,1751.0,952.0,1001.0,1052.0,1083.0,13345.0
Karim Nagar,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,4084.0,4575.0,4449.0,5069.0,4904.0,4688.0,4254.0,4222.0,4590.0,4601.0,4749.0,4313.0,54498.0
Karim Nagar,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,1001.0,1169.0,853.0,1416.0,1940.0,4414.0,3762.0,2529.0,1814.0,2098.0,1976.0,2133.0,25105.0
Karim Nagar,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,7189.0,8016.0,8126.0,8678.0,8806.0,7956.0,7293.0,6414.0,8013.0,8573.0,8455.0,6681.0,94200.0
Karim Nagar,14.10.2.a,Number of death cases of Inpatient males,TOTAL,34.0,81.0,62.0,62.0,81.0,74.0,63.0,85.0,78.0,59.0,62.0,59.0,800.0
Karim Nagar,14.10.2.b,Number of death cases of Inpatient females,TOTAL,43.0,48.0,53.0,47.0,44.0,60.0,47.0,54.0,38.0,51.0,51.0,44.0,580.0
Karim Nagar,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,77.0,129.0,115.0,109.0,125.0,134.0,110.0,139.0,116.0,110.0,113.0,103.0,1380.0
Karim Nagar,14.11,In-Patient Head Count at midnight,TOTAL,5347.0,4847.0,1395.0,5423.0,2272.0,7042.0,6233.0,5248.0,9605.0,7624.0,7971.0,9924.0,72931.0
Karim Nagar,14.12.1,OPD attendance (All),TOTAL,249469.0,247491.0,258070.0,271743.0,299735.0,306921.0,301974.0,275503.0,297663.0,286089.0,288702.0,276524.0,3359884.0
Karim Nagar,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,1799.0,404.0,2591.0,585.0,1840.0,705.0,648.0,665.0,659.0,668.0,1018.0,2600.0,14182.0
Karim Nagar,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,1.0,5.0,0.0,76.0,38.0,57.0,55.0,37.0,39.0,24.0,0.0,944.0,1276.0
Karim Nagar,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,,,,,,,,,,,,,
Karim Nagar,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,1052.0,1321.0,564.0,1542.0,1442.0,1570.0,1580.0,1482.0,1390.0,1126.0,1373.0,2119.0,16561.0
Karim Nagar,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,,,,,,,,,,,,,
Karim Nagar,14.14.a,Number of patients given AYUSH treatment,TOTAL,15188.0,16430.0,13849.0,16827.0,15535.0,15343.0,14491.0,15432.0,16053.0,15200.0,13341.0,12455.0,180144.0
Karim Nagar,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,888.0,1104.0,752.0,577.0,854.0,1202.0,909.0,1005.0,1036.0,803.0,1288.0,1207.0,11625.0
Karim Nagar,14.14.c,Number of Adolescents counselled,TOTAL,10.0,126.0,37.0,22.0,20.0,119.0,5.0,24.0,70.0,494.0,48.0,52.0,1027.0
Karim Nagar,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,,,,,,,,,,,,,
Karim Nagar,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,14418.0,14418.0,14972.0,15758.0,15909.0,17843.0,11270.0,10830.0,16593.0,18955.0,18452.0,13575.0,182993.0
Karim Nagar,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,264.0,421.0,282.0,422.0,353.0,502.0,437.0,500.0,1406.0,675.0,719.0,1410.0,7391.0
Karim Nagar,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,2672.0,2414.0,2175.0,2663.0,2618.0,2683.0,2548.0,2415.0,2698.0,3054.0,3169.0,3380.0,32489.0
Karim Nagar,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,56.0,119.0,132.0,50.0,53.0,52.0,38.0,30.0,54.0,38.0,66.0,71.0,759.0
Karim Nagar,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,1759.0,1977.0,1568.0,1948.0,2063.0,2100.0,1832.0,1755.0,2085.0,2365.0,1979.0,2241.0,23672.0
Karim Nagar,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,30.0,83.0,75.0,39.0,44.0,62.0,41.0,30.0,45.0,41.0,35.0,42.0,567.0
Karim Nagar,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,3708.0,3328.0,3472.0,3829.0,3329.0,3971.0,3553.0,2992.0,3664.0,4324.0,3906.0,3919.0,43995.0
Karim Nagar,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,14.0,121.0,230.0,16.0,80.0,63.0,90.0,73.0,105.0,19.0,88.0,91.0,990.0
Karim Nagar,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,8139.0,7719.0,7215.0,8440.0,8010.0,8754.0,7933.0,7162.0,8447.0,9743.0,9054.0,9540.0,100156.0
Karim Nagar,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,100.0,323.0,437.0,105.0,177.0,177.0,169.0,133.0,204.0,98.0,189.0,204.0,2316.0
Karim Nagar,15.2,Number of Widal tests conducted,Number tested,1712.0,1625.0,1777.0,2884.0,4125.0,5058.0,4696.0,3724.0,2292.0,1627.0,1939.0,1770.0,33229.0
Karim Nagar,15.3.a,Number of VDRL tests conducted on males,Number tested,42.0,13.0,13.0,46.0,388.0,34.0,45.0,58.0,46.0,81.0,27.0,40.0,833.0
Karim Nagar,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,127.0,60.0,45.0,79.0,177.0,88.0,79.0,84.0,66.0,132.0,190.0,153.0,1280.0
Karim Nagar,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,724.0,837.0,928.0,768.0,923.0,965.0,1021.0,846.0,966.0,663.0,529.0,984.0,10154.0
Karim Nagar,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,893.0,910.0,986.0,893.0,1488.0,1087.0,1145.0,988.0,1078.0,876.0,746.0,1177.0,12267.0
Karim Nagar,15.4.1,Number of blood smears examined for Malaria,TOTAL,14150.0,15364.0,16805.0,17207.0,17914.0,18743.0,19516.0,17483.0,16697.0,14946.0,15310.0,14880.0,199015.0
Karim Nagar,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,2.0,2.0,19.0,0.0,6.0,13.0,1.0,15.0,0.0,1.0,2.0,2.0,63.0
Karim Nagar,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,1.0,1.0,0.0,5.0,109.0,13.0,0.0,17.0,1.0,1.0,4.0,1.0,153.0
Karim Nagar,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Karim Nagar,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,,,,,,,,,,
Karim Nagar,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Karim Nagar,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Karim Nagar,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karim Nagar,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Karim Nagar,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Karim Nagar,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Karim Nagar,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Karim Nagar,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karim Nagar,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Karim Nagar,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,,,,,,,,,
Karim Nagar,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Karim Nagar,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,,,,,,,,,
Karim Nagar,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karim Nagar,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Karim Nagar,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,,,,,,,,,
Karim Nagar,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Karim Nagar,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Karim Nagar,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karim Nagar,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Karim Nagar,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Karim Nagar,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Karim Nagar,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Karim Nagar,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karim Nagar,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Karim Nagar,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,,,,,,,,,
Karim Nagar,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Karim Nagar,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,,,,,,,,,
Karim Nagar,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karim Nagar,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Karim Nagar,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,,,,,,,,,
Karim Nagar,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Karim Nagar,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,,,,,,,,,
Karim Nagar,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karim Nagar,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Karim Nagar,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Karim Nagar,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Karim Nagar,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Karim Nagar,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karim Nagar,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Karim Nagar,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,,,,,,
Karim Nagar,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Karim Nagar,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,,,,,,
Karim Nagar,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karim Nagar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Karim Nagar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Karim Nagar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Karim Nagar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Karim Nagar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karim Nagar,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Karim Nagar,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Karim Nagar,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Karim Nagar,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Karim Nagar,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karim Nagar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Karim Nagar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Karim Nagar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Karim Nagar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Karim Nagar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karim Nagar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Karim Nagar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Karim Nagar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Karim Nagar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Karim Nagar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karim Nagar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Karim Nagar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Karim Nagar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Karim Nagar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Karim Nagar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karim Nagar,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Karim Nagar,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Karim Nagar,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Karim Nagar,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Karim Nagar,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karim Nagar,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Karim Nagar,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Karim Nagar,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Karim Nagar,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Karim Nagar,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karim Nagar,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Karim Nagar,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Karim Nagar,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Karim Nagar,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Karim Nagar,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karim Nagar,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Karim Nagar,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Karim Nagar,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Karim Nagar,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Karim Nagar,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karim Nagar,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Karim Nagar,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Karim Nagar,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Karim Nagar,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Karim Nagar,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karim Nagar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Karim Nagar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Karim Nagar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Karim Nagar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Karim Nagar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karim Nagar,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Karim Nagar,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Karim Nagar,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Karim Nagar,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Karim Nagar,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karim Nagar,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Karim Nagar,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Karim Nagar,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Karim Nagar,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Karim Nagar,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karim Nagar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Karim Nagar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Karim Nagar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Karim Nagar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Karim Nagar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karim Nagar,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Karim Nagar,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Karim Nagar,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Karim Nagar,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Karim Nagar,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karim Nagar,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Karim Nagar,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Karim Nagar,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Karim Nagar,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Karim Nagar,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karim Nagar,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Karim Nagar,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Karim Nagar,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Karim Nagar,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Karim Nagar,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karim Nagar,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Karim Nagar,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Karim Nagar,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Karim Nagar,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Karim Nagar,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karim Nagar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,,,,,,,
Karim Nagar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,,,,,,,
Karim Nagar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Karim Nagar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,,,,,,,
Karim Nagar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karim Nagar,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,1.0,,,,,,,,,,,1.0
Karim Nagar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Karim Nagar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Karim Nagar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Karim Nagar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,1.0,,1.0,,,1.0,,,,,,3.0
Karim Nagar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Karim Nagar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,1.0,,1.0,,,1.0,,,,,,3.0
Karim Nagar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,1.0,,2.0,1.0,,,1.0,2.0,,,,,7.0
Karim Nagar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Karim Nagar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,1.0,,2.0,1.0,,,1.0,2.0,,,,,7.0
Karim Nagar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,1.0,,1.0,,,2.0,1.0,1.0,,1.0,,1.0,8.0
Karim Nagar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Karim Nagar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,1.0,,1.0,,,2.0,1.0,1.0,,1.0,,1.0,8.0
Karim Nagar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Karim Nagar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Karim Nagar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Karim Nagar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Karim Nagar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Karim Nagar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Karim Nagar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Karim Nagar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,1.0,,,,,,,,1.0
Karim Nagar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,1.0,,,,,,,,1.0
Karim Nagar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Karim Nagar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Karim Nagar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Karim Nagar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,1.0,,1.0,1.0,,1.0,,,2.0,,6.0
Karim Nagar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,2.0,1.0,,1.0,1.0,1.0,,,1.0,,,7.0
Karim Nagar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,2.0,2.0,,2.0,2.0,1.0,1.0,,1.0,2.0,,13.0
Karim Nagar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Karim Nagar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,1.0,,,,,,,,,1.0
Karim Nagar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,1.0,,,,,,,,,,1.0
Karim Nagar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,1.0,1.0,,,,,,,,,2.0
Karim Nagar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Karim Nagar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,1.0,3.0,4.0,1.0,6.0,2.0,2.0,1.0,,4.0,2.0,1.0,27.0
Karim Nagar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,1.0,1.0,2.0,4.0,1.0,2.0,2.0,1.0,5.0,1.0,5.0,3.0,28.0
Karim Nagar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,2.0,4.0,6.0,5.0,7.0,4.0,4.0,2.0,5.0,5.0,7.0,4.0,55.0
Karim Nagar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,1.0,,,1.0
Karim Nagar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,1.0,1.0,4.0,3.0,,,,,,9.0
Karim Nagar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,2.0,2.0,,1.0,2.0,2.0,1.0,2.0,1.0,3.0,,4.0,20.0
Karim Nagar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,2.0,2.0,,2.0,3.0,6.0,4.0,2.0,1.0,4.0,,4.0,30.0
Karim Nagar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Karim Nagar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,1.0,,1.0,,,,,,2.0
Karim Nagar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Karim Nagar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,1.0,,1.0,,,,,,2.0
Karim Nagar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,1.0,,,,,1.0
Karim Nagar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,1.0,,2.0,3.0,1.0,2.0,,1.0,,,,10.0
Karim Nagar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,1.0,,,,1.0,1.0,,,,,,3.0
Karim Nagar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,2.0,,2.0,3.0,2.0,3.0,1.0,1.0,,,,14.0
Karim Nagar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,1.0,,,,,,1.0,,2.0
Karim Nagar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,4.0,5.0,3.0,2.0,6.0,5.0,3.0,,,3.0,1.0,,32.0
Karim Nagar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,2.0,1.0,,,,1.0,1.0,,,,1.0,,6.0
Karim Nagar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,6.0,6.0,3.0,2.0,7.0,6.0,4.0,,,3.0,3.0,,40.0
Karim Nagar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Karim Nagar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,7.0,9.0,11.0,14.0,14.0,12.0,13.0,10.0,14.0,10.0,12.0,9.0,135.0
Karim Nagar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,14.0,9.0,14.0,7.0,12.0,20.0,12.0,21.0,16.0,9.0,22.0,10.0,166.0
Karim Nagar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,21.0,18.0,25.0,21.0,26.0,32.0,25.0,31.0,30.0,19.0,34.0,19.0,301.0
Karim Nagar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,1.0,,1.0,,,,,,,,2.0
Karim Nagar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,4.0,1.0,2.0,3.0,1.0,2.0,,4.0,4.0,1.0,2.0,24.0
Karim Nagar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,5.0,2.0,5.0,6.0,5.0,13.0,7.0,6.0,7.0,9.0,8.0,9.0,82.0
Karim Nagar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,5.0,6.0,7.0,8.0,9.0,14.0,9.0,6.0,11.0,13.0,9.0,11.0,108.0
Karim Nagar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Karim Nagar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Karim Nagar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Karim Nagar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Karim Nagar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Karim Nagar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Karim Nagar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Karim Nagar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Karim Nagar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Karim Nagar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Karim Nagar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Karim Nagar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Karim Nagar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Karim Nagar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Karim Nagar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Karim Nagar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Karim Nagar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Karim Nagar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Karim Nagar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Karim Nagar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Karim Nagar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Karim Nagar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,1.0,2.0,1.0,3.0,,1.0,1.0,,,9.0
Karim Nagar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Karim Nagar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,1.0,2.0,1.0,3.0,,1.0,1.0,,,9.0
Karim Nagar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,1.0,2.0,,,,,,,,,,3.0
Karim Nagar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,4.0,11.0,5.0,3.0,10.0,8.0,8.0,4.0,15.0,3.0,7.0,7.0,85.0
Karim Nagar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,7.0,2.0,8.0,,3.0,3.0,2.0,2.0,3.0,,5.0,2.0,37.0
Karim Nagar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,11.0,14.0,15.0,3.0,13.0,11.0,10.0,6.0,18.0,3.0,12.0,9.0,125.0
Karim Nagar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Karim Nagar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,9.0,13.0,7.0,12.0,18.0,27.0,15.0,10.0,9.0,7.0,9.0,12.0,148.0
Karim Nagar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,3.0,1.0,3.0,2.0,1.0,1.0,,3.0,3.0,5.0,4.0,5.0,31.0
Karim Nagar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,12.0,14.0,10.0,14.0,19.0,28.0,15.0,13.0,12.0,12.0,13.0,17.0,179.0
Karim Nagar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Karim Nagar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,1.0,,1.0,,,,,,,,2.0
Karim Nagar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,1.0,1.0,2.0,2.0,2.0,,,,1.0,9.0
Karim Nagar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,1.0,1.0,2.0,2.0,2.0,2.0,,,,1.0,11.0
Karim Nagar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,1.0,,,,,1.0,,,,,,,2.0
Karim Nagar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,8.0,1.0,9.0,2.0,3.0,5.0,5.0,1.0,5.0,3.0,,1.0,43.0
Karim Nagar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,3.0,1.0,5.0,4.0,6.0,9.0,9.0,2.0,3.0,4.0,3.0,4.0,53.0
Karim Nagar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,12.0,2.0,14.0,6.0,9.0,15.0,14.0,3.0,8.0,7.0,3.0,5.0,98.0
Karim Nagar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,1.0,1.0,,,,,,,,,2.0
Karim Nagar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,3.0,9.0,12.0,8.0,5.0,8.0,5.0,5.0,3.0,7.0,2.0,12.0,79.0
Karim Nagar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,11.0,12.0,13.0,2.0,15.0,14.0,16.0,14.0,15.0,10.0,13.0,10.0,145.0
Karim Nagar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,14.0,21.0,26.0,11.0,20.0,22.0,21.0,19.0,18.0,17.0,15.0,22.0,226.0
Karim Nagar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,4.0,4.0,1.0,3.0,4.0,2.0,,,,,,18.0
Karim Nagar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,46.0,74.0,52.0,48.0,62.0,57.0,69.0,60.0,50.0,53.0,61.0,60.0,692.0
Karim Nagar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,155.0,213.0,241.0,179.0,237.0,248.0,206.0,160.0,166.0,213.0,228.0,170.0,2416.0
Karim Nagar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,201.0,291.0,297.0,228.0,302.0,309.0,277.0,220.0,216.0,266.0,289.0,230.0,3126.0
Khammam,1.1,Total number of pregnant women Registered for ANC,TOTAL,4071.0,3525.0,3824.0,3509.0,3377.0,3231.0,3534.0,4062.0,3690.0,3863.0,3817.0,4124.0,44627.0
Khammam,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,3673.0,3162.0,3412.0,3103.0,2905.0,2877.0,3113.0,3311.0,3150.0,3375.0,3282.0,3449.0,38812.0
Khammam,1.2,Number of Pregnant women registered under JSY,TOTAL,3396.0,3134.0,3389.0,3177.0,2978.0,2816.0,3032.0,3104.0,3242.0,3288.0,3309.0,3665.0,38530.0
Khammam,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,3449.0,3012.0,3091.0,3154.0,3368.0,3316.0,3268.0,3348.0,3317.0,3377.0,3304.0,3720.0,39724.0
Khammam,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,3768.0,3366.0,3711.0,3384.0,3229.0,3151.0,3386.0,3601.0,3504.0,3593.0,3610.0,3691.0,41994.0
Khammam,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,3523.0,3485.0,3500.0,3643.0,3448.0,3233.0,3199.0,3428.0,3806.0,3512.0,3476.0,3880.0,42133.0
Khammam,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,3420.0,3239.0,3268.0,3307.0,3444.0,3270.0,3726.0,4652.0,5135.0,5088.0,3891.0,5612.0,48052.0
Khammam,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,15.0,42.0,21.0,33.0,30.0,29.0,32.0,10.0,26.0,39.0,18.0,17.0,312.0
Khammam,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,5.0,8.0,11.0,0.0,7.0,2.0,5.0,0.0,0.0,0.0,2.0,0.0,40.0
Khammam,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1531.0,1677.0,2090.0,1996.0,3343.0,2140.0,1884.0,1860.0,2724.0,2301.0,1290.0,1568.0,24404.0
Khammam,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,167.0,192.0,234.0,278.0,378.0,267.0,232.0,202.0,250.0,251.0,308.0,272.0,3031.0
Khammam,1.8,Number of pregnancy test kits used at SC level,TOTAL,1940.0,1782.0,2054.0,1869.0,1614.0,1655.0,1809.0,1799.0,1763.0,1731.0,1753.0,1883.0,21652.0
Khammam,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,16.0,10.0,7.0,8.0,11.0,10.0,9.0,12.0,10.0,15.0,7.0,7.0,122.0
Khammam,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,6.0,8.0,11.0,3.0,19.0,8.0,11.0,9.0,13.0,15.0,11.0,10.0,124.0
Khammam,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,22.0,18.0,18.0,11.0,30.0,18.0,20.0,21.0,23.0,30.0,18.0,17.0,246.0
Khammam,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,21.0,18.0,18.0,11.0,29.0,15.0,20.0,18.0,20.0,25.0,18.0,16.0,229.0
Khammam,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,7.0,6.0,8.0,3.0,14.0,10.0,9.0,0.0,11.0,19.0,5.0,2.0,94.0
Khammam,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1134.0,1306.0,1180.0,1189.0,1502.0,1569.0,1512.0,1557.0,1517.0,1186.0,1029.0,1048.0,15729.0
Khammam,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,605.0,748.0,668.0,692.0,867.0,902.0,903.0,914.0,795.0,720.0,656.0,572.0,9042.0
Khammam,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1107.0,1300.0,1166.0,1177.0,1501.0,1582.0,1505.0,1546.0,1500.0,1169.0,986.0,1028.0,15567.0
Khammam,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,0.0,1.0,4.0,0.0,0.0,3.0,0.0,16.0,14.0,49.0,52.0,38.0,177.0
Khammam,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,3.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Khammam,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,2520.0,2682.0,2842.0,2823.0,2472.0,2424.0,2487.0,2447.0,2416.0,2574.0,2279.0,2617.0,30583.0
Khammam,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khammam,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khammam,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khammam,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,5.0,6.0,6.0,5.0,0.0,0.0,23.0
Khammam,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khammam,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,489.0,540.0,471.0,474.0,610.0,641.0,588.0,614.0,660.0,433.0,368.0,436.0,6324.0
Khammam,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Khammam,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,489.0,541.0,471.0,474.0,610.0,641.0,593.0,620.0,666.0,438.0,368.0,436.0,6347.0
Khammam,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,1436.0,1842.0,2082.0,2004.0,1786.0,1769.0,1700.0,1566.0,1739.0,1935.0,1632.0,2054.0,21545.0
Khammam,4.1.1.a,Number of male live births,TOTAL,1842.0,2044.0,1996.0,2124.0,2039.0,1970.0,2063.0,2046.0,1956.0,1916.0,1708.0,1860.0,23564.0
Khammam,4.1.1.b,Number of female live births,TOTAL,1854.0,2001.0,2043.0,1895.0,1953.0,2027.0,1948.0,1966.0,2004.0,1870.0,1606.0,1813.0,22980.0
Khammam,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,3696.0,4045.0,4039.0,4019.0,3992.0,3997.0,4011.0,4012.0,3960.0,3786.0,3314.0,3673.0,46544.0
Khammam,4.1.2,Number of still births,TOTAL,9.0,23.0,15.0,18.0,12.0,17.0,8.0,23.0,17.0,12.0,21.0,18.0,193.0
Khammam,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,9.0,17.0,13.0,35.0,19.0,7.0,27.0,18.0,9.0,13.0,21.0,27.0,215.0
Khammam,4.2.1,Number of Newborns weighed at birth,TOTAL,3656.0,4030.0,4035.0,4019.0,3986.0,3997.0,4004.0,4011.0,3954.0,3745.0,3296.0,3670.0,46403.0
Khammam,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,107.0,153.0,117.0,102.0,125.0,98.0,120.0,130.0,130.0,126.0,106.0,81.0,1395.0
Khammam,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,3226.0,3677.0,3458.0,3925.0,3735.0,3920.0,3643.0,3321.0,3579.0,3343.0,2935.0,3447.0,42209.0
Khammam,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,1.0,0.0,0.0,2.0,0.0,0.0,1.0,0.0,2.0,0.0,4.0,0.0,10.0
Khammam,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khammam,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,168.0,137.0,129.0,134.0,126.0,131.0,105.0,121.0,161.0,168.0,127.0,129.0,1636.0
Khammam,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Khammam,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,169.0,137.0,129.0,136.0,126.0,131.0,106.0,121.0,163.0,168.0,131.0,129.0,1646.0
Khammam,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,261.0,120.0,99.0,194.0,115.0,46.0,56.0,57.0,76.0,89.0,130.0,94.0,1337.0
Khammam,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,429.0,254.0,224.0,328.0,241.0,176.0,161.0,178.0,237.0,257.0,255.0,223.0,2963.0
Khammam,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,57.0,66.0,70.0,29.0,100.0,65.0,39.0,75.0,74.0,57.0,61.0,59.0,752.0
Khammam,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,175.0,108.0,133.0,104.0,143.0,140.0,124.0,141.0,154.0,131.0,107.0,102.0,1562.0
Khammam,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,264.0,203.0,188.0,169.0,159.0,140.0,103.0,129.0,155.0,183.0,153.0,114.0,1960.0
Khammam,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,3633.0,3984.0,3986.0,3961.0,4018.0,3984.0,3938.0,3995.0,3921.0,3705.0,3243.0,3620.0,45988.0
Khammam,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,99.0,71.0,107.0,82.0,129.0,88.0,91.0,109.0,104.0,165.0,57.0,53.0,1155.0
Khammam,6.3,PNC maternal complications attended,TOTAL,0.0,0.0,3.0,0.0,0.0,0.0,0.0,2.0,1.0,0.0,0.0,0.0,6.0
Khammam,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,7.0,7.0,10.0,6.0,5.0,3.0,5.0,7.0,3.0,0.0,12.0,6.0,71.0
Khammam,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,3.0,1.0,0.0,5.0,2.0,0.0,12.0
Khammam,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,7.0,7.0,10.0,6.0,5.0,4.0,8.0,8.0,3.0,5.0,14.0,6.0,83.0
Khammam,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,14.0,0.0,0.0,11.0,0.0,0.0,7.0,10.0,10.0,52.0
Khammam,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,1051.0,1113.0,1158.0,1378.0,1115.0,1146.0,1118.0,1191.0,1451.0,1188.0,1037.0,1133.0,14079.0
Khammam,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,1332.0,1201.0,1525.0,1573.0,1250.0,1287.0,1206.0,1577.0,1724.0,1510.0,1260.0,1488.0,16933.0
Khammam,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,2383.0,2314.0,2683.0,2951.0,2365.0,2433.0,2324.0,2768.0,3175.0,2698.0,2297.0,2621.0,31012.0
Khammam,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,24.0,0.0,0.0,24.0
Khammam,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,4.0,2.0,1.0,0.0,2.0,2.0,0.0,3.0,0.0,0.0,2.0,2.0,18.0
Khammam,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,1.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Khammam,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,1.0,0.0,0.0,0.0,0.0,1.0,3.0,1.0,3.0,2.0,1.0,4.0,16.0
Khammam,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Khammam,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,6.0,2.0,1.0,0.0,2.0,5.0,3.0,4.0,3.0,2.0,3.0,6.0,37.0
Khammam,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khammam,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khammam,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khammam,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khammam,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Khammam,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khammam,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khammam,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,160.0,256.0,227.0,217.0,324.0,438.0,353.0,260.0,235.0,167.0,273.0,465.0,3375.0
Khammam,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,12.0,0.0,0.0,0.0,0.0,33.0,0.0,0.0,0.0,4.0,4.0,4.0,57.0
Khammam,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,142.0,0.0,82.0,60.0,45.0,155.0,220.0,199.0,270.0,199.0,366.0,245.0,1983.0
Khammam,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Khammam,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,314.0,256.0,309.0,277.0,369.0,626.0,573.0,459.0,505.0,370.0,643.0,714.0,5415.0
Khammam,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,175.0,186.0,143.0,146.0,299.0,169.0,166.0,127.0,67.0,97.0,159.0,177.0,1911.0
Khammam,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,255.0,92.0,110.0,305.0,175.0,91.0,119.0,147.0,104.0,70.0,74.0,0.0,1542.0
Khammam,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khammam,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,104.0,0.0,26.0,20.0,19.0,362.0,281.0,374.0,191.0,191.0,224.0,143.0,1935.0
Khammam,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Khammam,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,359.0,92.0,136.0,325.0,194.0,453.0,400.0,521.0,295.0,261.0,298.0,143.0,3477.0
Khammam,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,412.0,543.0,499.0,316.0,547.0,397.0,508.0,464.0,534.0,537.0,341.0,493.0,5591.0
Khammam,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,22.0,30.0,23.0,23.0,22.0,18.0,6.0,7.0,10.0,10.0,4.0,0.0,175.0
Khammam,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,119.0,107.0,47.0,118.0,113.0,109.0,86.0,30.0,55.0,86.0,60.0,55.0,985.0
Khammam,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,4.0,6.0,14.0
Khammam,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,13.0,0.0,0.0,26.0,44.0,61.0,63.0,83.0,54.0,63.0,51.0,64.0,522.0
Khammam,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Khammam,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,154.0,137.0,70.0,167.0,179.0,188.0,155.0,120.0,119.0,163.0,119.0,125.0,1696.0
Khammam,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,34.0,32.0,55.0,42.0,53.0,41.0,68.0,83.0,60.0,58.0,50.0,64.0,640.0
Khammam,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,8.0,0.0,0.0,0.0,0.0,0.0,8.0
Khammam,9.06,Number of IUCD removals,TOTAL,50.0,47.0,36.0,98.0,108.0,95.0,32.0,29.0,44.0,39.0,64.0,99.0,741.0
Khammam,9.07,Number of Oral Pills cycles distributed,TOTAL,5342.0,5139.0,9171.0,7464.0,6963.0,6697.0,7040.0,8742.0,5710.0,5670.0,5834.0,6354.0,80126.0
Khammam,9.08,Number of Condom pieces distributed,TOTAL,14323.0,31911.0,46357.0,41910.0,44991.0,38901.0,37702.0,39724.0,31626.0,36732.0,38867.0,41795.0,444839.0
Khammam,9.09,Number of Centchroman (weekly) pills given,TOTAL,8.0,322.0,298.0,14.0,12.0,365.0,24.0,700.0,12.0,87.0,72.0,76.0,1990.0
Khammam,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,2.0,18.0,6.0,51.0,192.0,206.0,192.0,10.0,0.0,18.0,12.0,35.0,742.0
Khammam,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khammam,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khammam,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khammam,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,3.0
Khammam,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khammam,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0
Khammam,9.12,Number of Institutions having NSV trained doctors,TOTAL,24.0,27.0,33.0,26.0,22.0,29.0,34.0,37.0,30.0,31.0,28.0,36.0,-1.0
Khammam,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,3224.0,2473.0,3502.0,3181.0,3715.0,3746.0,3975.0,3935.0,3700.0,3363.0,3021.0,3895.0,41730.0
Khammam,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,2859.0,2100.0,2016.0,278.0,161.0,24.0,6.0,14.0,7.0,0.0,3.0,322.0,7790.0
Khammam,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,3015.0,2184.0,2794.0,1707.0,330.0,42.0,25.0,22.0,13.0,0.0,4.0,316.0,10452.0
Khammam,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,3592.0,2429.0,3080.0,2962.0,1488.0,163.0,89.0,23.0,34.0,1.0,2.0,313.0,14176.0
Khammam,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,571.0,1389.0,3283.0,3083.0,3254.0,3551.0,3785.0,3748.0,3868.0,3200.0,3286.0,33018.0
Khammam,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,496.0,14.0,1663.0,3365.0,3262.0,3244.0,3559.0,4110.0,3773.0,3541.0,3548.0,30575.0
Khammam,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,543.0,3.0,86.0,1827.0,3576.0,3376.0,3395.0,3899.0,4238.0,3699.0,4144.0,28786.0
Khammam,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,2211.0,1177.0,1321.0,2112.0,1371.0,2359.0,2717.0,2637.0,2512.0,2044.0,1898.0,2945.0,25304.0
Khammam,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,2844.0,2684.0,3082.0,3168.0,3151.0,3219.0,3295.0,3783.0,3725.0,3863.0,3200.0,3733.0,39747.0
Khammam,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,3037.0,2692.0,2810.0,3168.0,3518.0,3257.0,3027.0,3573.0,4110.0,3777.0,3541.0,3964.0,40474.0
Khammam,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,3577.0,2967.0,3085.0,3025.0,3208.0,3668.0,3170.0,3407.0,3894.0,4249.0,3704.0,4533.0,42487.0
Khammam,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,1940.0,705.0,1994.0,1803.0,818.0,1980.0,2265.0,2175.0,1734.0,1396.0,1319.0,2681.0,20810.0
Khammam,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,2863.0,2102.0,2078.0,412.0,230.0,42.0,20.0,0.0,4.0,11.0,11.0,333.0,8106.0
Khammam,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,3026.0,2173.0,2800.0,1777.0,418.0,74.0,39.0,11.0,5.0,10.0,10.0,326.0,10669.0
Khammam,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,3579.0,2448.0,3085.0,2897.0,1555.0,200.0,97.0,28.0,13.0,19.0,11.0,327.0,14259.0
Khammam,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,3506.0,2953.0,3915.0,3836.0,3907.0,3644.0,3658.0,3544.0,3203.0,3206.0,3342.0,4114.0,42828.0
Khammam,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,3530.0,2918.0,3435.0,3134.0,2923.0,2809.0,3386.0,3868.0,3862.0,3478.0,3092.0,3657.0,40092.0
Khammam,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,3291.0,2767.0,3587.0,3567.0,3619.0,3411.0,3487.0,3377.0,3034.0,3064.0,3183.0,3894.0,40281.0
Khammam,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1793.0,1498.0,1990.0,1956.0,1986.0,1921.0,1868.0,1871.0,1675.0,1571.0,1706.0,2086.0,21921.0
Khammam,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1610.0,1419.0,1903.0,1803.0,1860.0,1679.0,1726.0,1670.0,1523.0,1360.0,1554.0,1989.0,20096.0
Khammam,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,3403.0,2917.0,3893.0,3759.0,3846.0,3600.0,3594.0,3541.0,3198.0,2931.0,3260.0,4075.0,42017.0
Khammam,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,3614.0,3045.0,3488.0,3386.0,3114.0,2999.0,3396.0,3958.0,4098.0,3817.0,3389.0,3916.0,42220.0
Khammam,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,3625.0,3046.0,3486.0,3387.0,3117.0,3000.0,3391.0,3959.0,4097.0,3817.0,3391.0,3914.0,42230.0
Khammam,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,54.0,6.0,23.0,21.0,69.0,29.0,18.0,22.0,3.0,67.0,45.0,52.0,409.0
Khammam,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,223.0,194.0,126.0,201.0,269.0,231.0,265.0,213.0,312.0,346.0,286.0,215.0,2881.0
Khammam,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,204.0,190.0,124.0,197.0,220.0,185.0,235.0,178.0,317.0,301.0,217.0,187.0,2555.0
Khammam,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,427.0,384.0,250.0,398.0,489.0,416.0,500.0,391.0,629.0,647.0,503.0,402.0,5436.0
Khammam,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,2143.0,2061.0,2566.0,3371.0,3979.0,4230.0,3052.0,3323.0,3576.0,3374.0,3423.0,3923.0,39021.0
Khammam,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,2058.0,2104.0,2515.0,3843.0,4941.0,5114.0,3143.0,3717.0,4078.0,3706.0,3643.0,4480.0,43342.0
Khammam,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,2021.0,2088.0,2492.0,3978.0,5024.0,5482.0,3138.0,3887.0,4273.0,3797.0,3958.0,4933.0,45071.0
Khammam,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khammam,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khammam,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khammam,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,2410.0,2409.0,2406.0,2464.0,2481.0,2468.0,2493.0,2444.0,2475.0,2461.0,2441.0,2444.0,29396.0
Khammam,10.4.2,Number of Immunisation sessions held during the month,TOTAL,2404.0,2403.0,2399.0,2463.0,2478.0,2458.0,2481.0,2416.0,2471.0,2446.0,2432.0,2431.0,29282.0
Khammam,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,2258.0,2305.0,2329.0,2388.0,2338.0,955.0,531.0,167.0,259.0,2186.0,2227.0,2242.0,20185.0
Khammam,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,3305.0,2722.0,3133.0,2922.0,2709.0,2773.0,2999.0,3579.0,3676.0,3367.0,3107.0,3198.0,37490.0
Khammam,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,2718.0,2329.0,3307.0,3218.0,3039.0,2904.0,2874.0,2802.0,2660.0,2640.0,2751.0,3451.0,34693.0
Khammam,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,439.0,794.0,366.0,395.0,504.0,418.0,606.0,595.0,855.0,833.0,806.0,1002.0,7613.0
Khammam,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,242.0,155.0,284.0,149.0,267.0,192.0,167.0,182.0,452.0,300.0,733.0,496.0,3619.0
Khammam,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khammam,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khammam,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khammam,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khammam,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khammam,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,10.0,19.0,0.0,0.0,0.0,10.0,4.0,6.0,1.0,4.0,10.0,7.0,71.0
Khammam,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,309.0,229.0,236.0,294.0,391.0,263.0,187.0,311.0,173.0,260.0,321.0,249.0,3223.0
Khammam,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,7.0,0.0,0.0,0.0,4.0,0.0,0.0,0.0,0.0,0.0,0.0,11.0
Khammam,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,73.0,47.0,5.0,82.0,59.0,47.0,55.0,48.0,43.0,140.0,105.0,42.0,746.0
Khammam,13.1,Number of Patients operated for cataract,TOTAL,202.0,0.0,378.0,480.0,374.0,315.0,336.0,291.0,268.0,305.0,288.0,314.0,3551.0
Khammam,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,202.0,0.0,376.0,478.0,374.0,313.0,333.0,291.0,268.0,260.0,288.0,275.0,3458.0
Khammam,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,3.0,3.0,10.0,0.0,0.0,0.0,0.0,0.0,152.0,166.0,334.0
Khammam,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khammam,13.5,Number of eyes collected through eye donation,TOTAL,80.0,68.0,68.0,76.0,80.0,80.0,70.0,60.0,64.0,78.0,74.0,70.0,868.0
Khammam,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khammam,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,14.0,14.0,14.0,14.0,13.0,14.0,14.0,14.0,12.0,14.0,13.0,14.0,-1.0
Khammam,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,40.0,36.0,30.0,33.0,30.0,39.0,35.0,37.0,29.0,37.0,33.0,33.0,-1.0
Khammam,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,2419.0,2496.0,2563.0,2646.0,2725.0,2552.0,2667.0,2722.0,2670.0,2741.0,2839.0,2821.0,-1.0
Khammam,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,10.0,10.0,10.0,11.0,10.0,10.0,11.0,11.0,9.0,10.0,9.0,10.0,-1.0
Khammam,14.05,Number of RKS meetings held during the month,TOTAL,14.0,26.0,16.0,17.0,20.0,14.0,12.0,12.0,10.0,12.0,14.0,8.0,175.0
Khammam,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,42.0,41.0,41.0,44.0,44.0,52.0,45.0,43.0,30.0,39.0,31.0,40.0,-1.0
Khammam,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,284.0,220.0,181.0,316.0,194.0,249.0,292.0,261.0,278.0,176.0,148.0,221.0,2820.0
Khammam,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,7.0,5.0,7.0,7.0,7.0,7.0,6.0,7.0,8.0,9.0,9.0,8.0,-1.0
Khammam,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,5.0,4.0,4.0,4.0,4.0,4.0,4.0,5.0,7.0,5.0,5.0,7.0,-1.0
Khammam,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,,,,,,,,,,,,,
Khammam,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,,,,,,,,,,,,,
Khammam,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,,,,,,,,,,,,,
Khammam,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,1913.0,2309.0,1607.0,1791.0,1852.0,1959.0,1982.0,1641.0,1420.0,1503.0,1426.0,1753.0,21156.0
Khammam,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,7524.0,8847.0,7269.0,8373.0,9161.0,9254.0,10537.0,7551.0,7065.0,7334.0,5822.0,6449.0,95186.0
Khammam,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,1904.0,2544.0,1525.0,1861.0,2017.0,1869.0,2066.0,1744.0,1581.0,1485.0,2248.0,1686.0,22530.0
Khammam,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,11757.0,13476.0,11974.0,14638.0,16355.0,16093.0,16874.0,13621.0,13291.0,11351.0,11551.0,12349.0,163330.0
Khammam,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,3817.0,4853.0,3132.0,3652.0,3869.0,3828.0,4048.0,3385.0,3001.0,2988.0,3674.0,3439.0,43686.0
Khammam,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,19281.0,22323.0,19243.0,23011.0,25516.0,25347.0,27411.0,21172.0,20356.0,18685.0,17373.0,18798.0,258516.0
Khammam,14.10.2.a,Number of death cases of Inpatient males,TOTAL,111.0,120.0,83.0,91.0,118.0,108.0,95.0,108.0,98.0,105.0,97.0,92.0,1226.0
Khammam,14.10.2.b,Number of death cases of Inpatient females,TOTAL,56.0,99.0,62.0,65.0,80.0,69.0,73.0,55.0,61.0,84.0,79.0,69.0,852.0
Khammam,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,167.0,219.0,145.0,156.0,198.0,177.0,168.0,163.0,159.0,189.0,176.0,161.0,2078.0
Khammam,14.11,In-Patient Head Count at midnight,TOTAL,15234.0,16429.0,16636.0,17304.0,19470.0,20510.0,25688.0,18816.0,28356.0,16676.0,16623.0,17704.0,229446.0
Khammam,14.12.1,OPD attendance (All),TOTAL,404725.0,408304.0,418404.0,465033.0,456453.0,506361.0,529378.0,468336.0,431755.0,438158.0,427824.0,388410.0,5343141.0
Khammam,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,3305.0,5352.0,5512.0,8378.0,8519.0,9943.0,3249.0,3863.0,3129.0,6587.0,12958.0,7675.0,78470.0
Khammam,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,7.0,16.0,17.0,3.0,16.0,6.0,14.0,12.0,24.0,5.0,21.0,10.0,151.0
Khammam,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,,,,,,,,,,,,,
Khammam,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,4538.0,4584.0,4862.0,4512.0,5231.0,4673.0,5079.0,4168.0,3306.0,2941.0,3204.0,3081.0,50179.0
Khammam,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,,,,,,,,,,,,,
Khammam,14.14.a,Number of patients given AYUSH treatment,TOTAL,15411.0,15109.0,15583.0,15231.0,13672.0,15679.0,13247.0,12829.0,10210.0,11912.0,11739.0,11246.0,161868.0
Khammam,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,5546.0,6259.0,5856.0,6013.0,6916.0,4491.0,3985.0,3181.0,3328.0,1594.0,1646.0,2302.0,51117.0
Khammam,14.14.c,Number of Adolescents counselled,TOTAL,729.0,314.0,805.0,256.0,701.0,702.0,459.0,558.0,646.0,194.0,315.0,370.0,6049.0
Khammam,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,,,,,,,,,,,,,
Khammam,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,9128.0,9879.0,11040.0,12688.0,15875.0,18046.0,21525.0,15099.0,14003.0,16282.0,15460.0,14459.0,173484.0
Khammam,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,1104.0,880.0,1134.0,1515.0,1615.0,1623.0,3057.0,1669.0,1215.0,1455.0,1116.0,1637.0,18020.0
Khammam,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,3609.0,3697.0,2868.0,1534.0,2331.0,3535.0,2904.0,3976.0,3271.0,2894.0,3181.0,3157.0,36957.0
Khammam,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,68.0,55.0,68.0,38.0,46.0,39.0,76.0,47.0,68.0,56.0,55.0,63.0,679.0
Khammam,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,2884.0,2794.0,2420.0,1230.0,2262.0,3061.0,2701.0,3100.0,2814.0,2418.0,2708.0,2915.0,31307.0
Khammam,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,44.0,50.0,69.0,32.0,41.0,53.0,95.0,48.0,51.0,59.0,52.0,50.0,644.0
Khammam,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,4082.0,3407.0,3816.0,2255.0,2842.0,3217.0,3463.0,3076.0,3581.0,3445.0,3781.0,3985.0,40950.0
Khammam,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,12.0,6.0,20.0,1.0,4.0,5.0,11.0,1.0,5.0,5.0,4.0,7.0,81.0
Khammam,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,10575.0,9898.0,9104.0,5019.0,7435.0,9813.0,9068.0,10152.0,9666.0,8757.0,9670.0,10057.0,109214.0
Khammam,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,124.0,111.0,157.0,71.0,91.0,97.0,182.0,96.0,124.0,120.0,111.0,120.0,1404.0
Khammam,15.2,Number of Widal tests conducted,Number tested,2959.0,2708.0,3647.0,5003.0,10237.0,10787.0,11461.0,7079.0,4830.0,3384.0,4097.0,3330.0,69522.0
Khammam,15.3.a,Number of VDRL tests conducted on males,Number tested,641.0,649.0,547.0,680.0,596.0,409.0,320.0,348.0,508.0,354.0,564.0,731.0,6347.0
Khammam,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,418.0,285.0,433.0,411.0,400.0,502.0,358.0,809.0,476.0,645.0,711.0,531.0,5979.0
Khammam,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,2521.0,1974.0,1443.0,3338.0,2684.0,1603.0,1027.0,1401.0,1723.0,1940.0,2557.0,2325.0,24536.0
Khammam,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,3580.0,2908.0,2423.0,4429.0,3680.0,2514.0,1705.0,2558.0,2707.0,2939.0,3832.0,3587.0,36862.0
Khammam,15.4.1,Number of blood smears examined for Malaria,TOTAL,13237.0,14828.0,16035.0,30700.0,43107.0,47323.0,46100.0,27406.0,23091.0,19442.0,19213.0,19140.0,319622.0
Khammam,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,5.0,415.0,357.0,490.0,137.0,389.0,9.0,74.0,79.0,80.0,20.0,17.0,2072.0
Khammam,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,80.0,63.0,66.0,591.0,607.0,222.0,102.0,166.0,174.0,199.0,52.0,42.0,2364.0
Khammam,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Khammam,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,,,,,,,,,,
Khammam,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Khammam,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Khammam,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khammam,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Khammam,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Khammam,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Khammam,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Khammam,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khammam,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Khammam,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,,,,,,,,,
Khammam,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Khammam,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,,,,,,,,,
Khammam,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khammam,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Khammam,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,,,,,,,,,
Khammam,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Khammam,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Khammam,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khammam,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Khammam,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Khammam,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Khammam,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Khammam,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khammam,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Khammam,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,,,,,,,,,
Khammam,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Khammam,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,,,,,,,,,
Khammam,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khammam,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Khammam,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,,,,,,,,,
Khammam,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Khammam,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,,,,,,,,,
Khammam,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khammam,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Khammam,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Khammam,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Khammam,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Khammam,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khammam,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Khammam,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,,,,,,
Khammam,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Khammam,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,,,,,,
Khammam,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khammam,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Khammam,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Khammam,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Khammam,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Khammam,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khammam,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Khammam,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Khammam,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Khammam,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Khammam,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khammam,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Khammam,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Khammam,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Khammam,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Khammam,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khammam,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Khammam,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Khammam,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Khammam,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Khammam,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khammam,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Khammam,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Khammam,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Khammam,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Khammam,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khammam,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Khammam,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Khammam,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Khammam,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Khammam,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khammam,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Khammam,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Khammam,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Khammam,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Khammam,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khammam,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Khammam,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Khammam,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Khammam,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Khammam,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khammam,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Khammam,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Khammam,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Khammam,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Khammam,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khammam,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Khammam,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Khammam,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Khammam,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Khammam,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khammam,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Khammam,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Khammam,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Khammam,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Khammam,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khammam,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Khammam,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Khammam,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Khammam,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Khammam,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khammam,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Khammam,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Khammam,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Khammam,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Khammam,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khammam,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Khammam,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Khammam,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Khammam,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Khammam,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khammam,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Khammam,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Khammam,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Khammam,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Khammam,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khammam,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Khammam,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Khammam,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Khammam,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Khammam,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khammam,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Khammam,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Khammam,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Khammam,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Khammam,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khammam,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Khammam,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Khammam,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Khammam,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Khammam,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khammam,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,,,,,,,
Khammam,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,,,,,,,
Khammam,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Khammam,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,,,,,,,
Khammam,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khammam,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Khammam,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,4.0,1.0,,1.0,2.0,,,,,1.0,,9.0
Khammam,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Khammam,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,4.0,1.0,,1.0,2.0,,,,,1.0,,9.0
Khammam,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,3.0,3.0,3.0,2.0,4.0,,,2.0,,,1.0,18.0
Khammam,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Khammam,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,3.0,3.0,3.0,2.0,4.0,,,2.0,,,1.0,18.0
Khammam,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,3.0,8.0,7.0,3.0,6.0,3.0,1.0,4.0,3.0,,,,38.0
Khammam,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Khammam,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,3.0,8.0,7.0,3.0,6.0,3.0,1.0,4.0,3.0,,,,38.0
Khammam,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,7.0,2.0,3.0,3.0,2.0,3.0,6.0,6.0,3.0,,3.0,1.0,39.0
Khammam,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Khammam,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,7.0,2.0,3.0,3.0,2.0,3.0,6.0,6.0,3.0,,3.0,1.0,39.0
Khammam,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,3.0,,1.0,,2.0,1.0,2.0,1.0,4.0,,2.0,,16.0
Khammam,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Khammam,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,3.0,,1.0,,2.0,1.0,2.0,1.0,4.0,,2.0,,16.0
Khammam,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Khammam,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Khammam,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Khammam,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Khammam,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,1.0,,,,,,1.0
Khammam,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,1.0,,,,,,1.0
Khammam,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Khammam,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Khammam,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Khammam,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,2.0,2.0,2.0,5.0,3.0,1.0,1.0,6.0,8.0,6.0,1.0,7.0,44.0
Khammam,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,4.0,2.0,1.0,,1.0,1.0,,1.0,2.0,2.0,3.0,4.0,21.0
Khammam,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,6.0,4.0,3.0,5.0,4.0,2.0,1.0,7.0,10.0,8.0,4.0,11.0,65.0
Khammam,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Khammam,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Khammam,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Khammam,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Khammam,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,1.0,,,1.0
Khammam,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,7.0,7.0,10.0,5.0,6.0,4.0,7.0,6.0,3.0,7.0,5.0,3.0,70.0
Khammam,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,3.0,1.0,4.0,2.0,6.0,1.0,5.0,3.0,4.0,5.0,4.0,,38.0
Khammam,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,10.0,8.0,14.0,7.0,12.0,5.0,12.0,9.0,7.0,13.0,9.0,3.0,109.0
Khammam,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,1.0,,,,,1.0,,,,,2.0
Khammam,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,8.0,3.0,5.0,4.0,6.0,8.0,7.0,11.0,3.0,6.0,4.0,11.0,76.0
Khammam,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,12.0,7.0,16.0,2.0,15.0,1.0,17.0,16.0,,4.0,5.0,8.0,103.0
Khammam,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,20.0,10.0,22.0,6.0,21.0,9.0,24.0,28.0,3.0,10.0,9.0,19.0,181.0
Khammam,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,1.0,1.0,1.0,,,,,,,3.0
Khammam,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,1.0,,,,,,,,1.0
Khammam,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,1.0,,,,,,,,1.0
Khammam,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,1.0,3.0,1.0,,,,,,,5.0
Khammam,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,1.0,1.0,1.0,,,,,,3.0
Khammam,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,1.0,1.0,2.0,1.0,,,1.0,,,6.0
Khammam,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,1.0,2.0,1.0,,1.0,,,,1.0,6.0
Khammam,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,2.0,4.0,4.0,2.0,1.0,,1.0,,1.0,15.0
Khammam,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Khammam,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,9.0,7.0,5.0,3.0,3.0,4.0,5.0,2.0,2.0,6.0,6.0,3.0,55.0
Khammam,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,1.0,,1.0,,,,,2.0
Khammam,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,9.0,7.0,5.0,3.0,3.0,5.0,5.0,3.0,2.0,6.0,6.0,3.0,57.0
Khammam,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,1.0,,2.0,,1.0,,,,1.0,1.0,6.0
Khammam,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,36.0,23.0,31.0,31.0,36.0,37.0,38.0,28.0,21.0,24.0,29.0,24.0,358.0
Khammam,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,29.0,21.0,31.0,20.0,24.0,22.0,23.0,29.0,21.0,33.0,18.0,33.0,304.0
Khammam,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,65.0,44.0,63.0,51.0,62.0,59.0,62.0,57.0,42.0,57.0,48.0,58.0,668.0
Khammam,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,1.0,,,1.0,1.0,,,,,3.0
Khammam,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,5.0,4.0,9.0,10.0,11.0,6.0,5.0,4.0,1.0,1.0,5.0,4.0,65.0
Khammam,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,5.0,4.0,5.0,6.0,6.0,3.0,11.0,6.0,2.0,2.0,8.0,5.0,63.0
Khammam,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,10.0,8.0,14.0,17.0,17.0,9.0,17.0,11.0,3.0,3.0,13.0,9.0,131.0
Khammam,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Khammam,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Khammam,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Khammam,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Khammam,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Khammam,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,2.0,,1.0,,,,2.0,2.0,,,,1.0,8.0
Khammam,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Khammam,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,2.0,,1.0,,,,2.0,2.0,,,,1.0,8.0
Khammam,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Khammam,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,1.0,,,,1.0,,,1.0,,,,,3.0
Khammam,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Khammam,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,1.0,,,,1.0,,,1.0,,,,,3.0
Khammam,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Khammam,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,1.0,,,,,,1.0,,,2.0
Khammam,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Khammam,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,1.0,,,,,,1.0,,,2.0
Khammam,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Khammam,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Khammam,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Khammam,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Khammam,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Khammam,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,4.0,1.0,,,2.0,,2.0,,9.0
Khammam,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Khammam,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,4.0,1.0,,,2.0,,2.0,,9.0
Khammam,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,2.0,1.0,4.0,,2.0,1.0,2.0,,1.0,3.0,1.0,,17.0
Khammam,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,21.0,28.0,30.0,21.0,17.0,32.0,24.0,17.0,17.0,20.0,27.0,24.0,278.0
Khammam,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,5.0,4.0,9.0,8.0,5.0,5.0,11.0,2.0,5.0,9.0,8.0,7.0,78.0
Khammam,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,28.0,33.0,43.0,29.0,24.0,38.0,37.0,19.0,23.0,32.0,36.0,31.0,373.0
Khammam,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,1.0,,,1.0,4.0,,3.0,,,,1.0,1.0,11.0
Khammam,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,44.0,33.0,40.0,32.0,40.0,42.0,42.0,34.0,29.0,43.0,35.0,33.0,447.0
Khammam,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,8.0,3.0,4.0,4.0,7.0,5.0,7.0,3.0,2.0,1.0,7.0,1.0,52.0
Khammam,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,53.0,36.0,44.0,37.0,51.0,47.0,52.0,37.0,31.0,44.0,43.0,35.0,510.0
Khammam,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,1.0,,,2.0,,,,1.0,,4.0
Khammam,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,3.0,4.0,6.0,3.0,8.0,2.0,9.0,6.0,2.0,2.0,2.0,4.0,51.0
Khammam,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,2.0,1.0,2.0,6.0,3.0,4.0,3.0,4.0,1.0,1.0,8.0,2.0,37.0
Khammam,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,5.0,5.0,8.0,10.0,11.0,6.0,14.0,10.0,3.0,3.0,11.0,6.0,92.0
Khammam,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,1.0,,,,,,,,,,1.0
Khammam,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,1.0,4.0,6.0,3.0,6.0,7.0,3.0,8.0,2.0,3.0,4.0,7.0,54.0
Khammam,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,8.0,5.0,7.0,1.0,,5.0,10.0,,7.0,2.0,1.0,1.0,47.0
Khammam,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,9.0,9.0,14.0,4.0,6.0,12.0,13.0,8.0,9.0,5.0,5.0,8.0,102.0
Khammam,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,3.0,1.0,,,,,,1.0,,5.0
Khammam,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,30.0,14.0,47.0,40.0,33.0,37.0,20.0,41.0,24.0,23.0,21.0,16.0,346.0
Khammam,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,60.0,15.0,82.0,41.0,62.0,61.0,53.0,62.0,38.0,24.0,44.0,34.0,576.0
Khammam,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,90.0,29.0,129.0,84.0,96.0,98.0,73.0,103.0,62.0,47.0,66.0,50.0,927.0
Khammam,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,4.0,2.0,2.0,3.0,3.0,4.0,4.0,4.0,1.0,1.0,5.0,1.0,34.0
Khammam,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,73.0,66.0,111.0,94.0,95.0,106.0,82.0,60.0,73.0,57.0,59.0,36.0,912.0
Khammam,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,210.0,171.0,267.0,206.0,269.0,208.0,162.0,201.0,210.0,211.0,182.0,142.0,2439.0
Khammam,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,287.0,239.0,380.0,303.0,367.0,318.0,248.0,265.0,284.0,269.0,246.0,179.0,3385.0
MAHABUBABAD,1.1,Total number of pregnant women Registered for ANC,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,,,,,,,,,,,,,
MAHABUBABAD,1.2,Number of Pregnant women registered under JSY,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,,,,,,,,,,,,,
MAHABUBABAD,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,1.8,Number of pregnancy test kits used at SC level,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,,,,,,,,,,,,,
MAHABUBABAD,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,,,,,,,,,,,,,
MAHABUBABAD,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,,,,,,,,,,,,,
MAHABUBABAD,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
MAHABUBABAD,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,,,,,,,,,,,,,
MAHABUBABAD,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
MAHABUBABAD,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
MAHABUBABAD,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
MAHABUBABAD,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,,,,,,,,,,,,,
MAHABUBABAD,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,,,,,,,,,,,,,
MAHABUBABAD,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,,,,,,,,,,,,,
MAHABUBABAD,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,,,,,,,,,,,,,
MAHABUBABAD,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,4.1.1.a,Number of male live births,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,4.1.1.b,Number of female live births,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,,,,,,,,,,,,,
MAHABUBABAD,4.1.2,Number of still births,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,,,,,,,,,,,,,
MAHABUBABAD,4.2.1,Number of Newborns weighed at birth,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,,,,,,,,,,,,,
MAHABUBABAD,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,6.3,PNC maternal complications attended,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,,,,,,,,,,,,,
MAHABUBABAD,7.2,Number of MTPs conducted at Private Facilities,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,,,,,,,,,,,,,
MAHABUBABAD,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,,,,,,,,,,,,,
MAHABUBABAD,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,,,,,,,,,,,,,
MAHABUBABAD,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,,,,,,,,,,,,,
MAHABUBABAD,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,,,,,,,,,,,,,
MAHABUBABAD,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,,,,,,,,,,,,,
MAHABUBABAD,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,,,,,,,,,,,,,
MAHABUBABAD,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,9.06,Number of IUCD removals,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,9.07,Number of Oral Pills cycles distributed,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,9.08,Number of Condom pieces distributed,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,9.09,Number of Centchroman (weekly) pills given,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,9.11.2.a,Number of failures following male sterilization,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,9.11.2.b,Number of failures following female sterilization,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,9.11.3.a,Number of deaths following male sterilization,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,9.11.3.b,Number of deaths following female sterilization,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,,,,,,,,,,,-1.0
MAHABUBABAD,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,,,,,,,,,,,,,
MAHABUBABAD,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,,,,,,,,,,,,,
MAHABUBABAD,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,,,,,,,,,,,,,
MAHABUBABAD,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,,,,,,,,,,,,,
MAHABUBABAD,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,,,,,,,,,,,,,
MAHABUBABAD,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,,,,,,,,,,,,,
MAHABUBABAD,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,,,,,,,,,,,,,
MAHABUBABAD,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,,,,,,,,,,,,,
MAHABUBABAD,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,,,,,,,,,,,,,
MAHABUBABAD,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
MAHABUBABAD,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
MAHABUBABAD,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
MAHABUBABAD,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,10.4.2,Number of Immunisation sessions held during the month,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,,,,,,,,,,,,,
MAHABUBABAD,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,,,,,,,,,,,,,
MAHABUBABAD,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,,,,,,,,,,,,,
MAHABUBABAD,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,13.1,Number of Patients operated for cataract,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,13.3,Number of School children detected with Refractive errors,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,13.4,Number of children provided free glasses,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,13.5,Number of eyes collected through eye donation,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,13.6,Number of eyes utilised for corneal transplant,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,,,,,,,,,,,,-1.0
MAHABUBABAD,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,,,,,,,,,,-1.0
MAHABUBABAD,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,,,,,,,,,,,,,-1.0
MAHABUBABAD,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,,,,,,,,,,,,,-1.0
MAHABUBABAD,14.05,Number of RKS meetings held during the month,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,,,,,,,,,,,,,-1.0
MAHABUBABAD,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,,,,,,,,,-1.0
MAHABUBABAD,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,,,,,,,,,,,,,-1.0
MAHABUBABAD,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,,,,,,,,,,,,,
MAHABUBABAD,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,,,,,,,,,,,,,
MAHABUBABAD,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,,,,,,,,,,,,,
MAHABUBABAD,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,,,,,,,,,,,,,
MAHABUBABAD,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,,,,,,,,,,,,,
MAHABUBABAD,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,,,,,,,,,,,,,
MAHABUBABAD,14.10.2.a,Number of death cases of Inpatient males,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,14.10.2.b,Number of death cases of Inpatient females,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,,,,,,,,,,,,,
MAHABUBABAD,14.11,In-Patient Head Count at midnight,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,14.12.1,OPD attendance (All),TOTAL,,,,,,,,,,,,,
MAHABUBABAD,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,,,,,,,,,,,,,
MAHABUBABAD,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,,,,,,,,,,,,,
MAHABUBABAD,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,14.14.a,Number of patients given AYUSH treatment,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,14.14.c,Number of Adolescents counselled,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,,,,,,,,,,,,,
MAHABUBABAD,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,,,,,,,,,,,,,
MAHABUBABAD,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,,,,,,,,,,,,,
MAHABUBABAD,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,,,,,,,,,,,,,
MAHABUBABAD,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,,,,,,,,,,,,,
MAHABUBABAD,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,,,,,,,,,,,,,
MAHABUBABAD,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,,,,,,,,,,,,,
MAHABUBABAD,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,,,,,,,,,,,,,
MAHABUBABAD,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,,,,,,,,,,,,,
MAHABUBABAD,15.2,Number of Widal tests conducted,Number tested,,,,,,,,,,,,,
MAHABUBABAD,15.3.a,Number of VDRL tests conducted on males,Number tested,,,,,,,,,,,,,
MAHABUBABAD,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,,,,,,,,,,,,,
MAHABUBABAD,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,,,,,,,,,,,,,
MAHABUBABAD,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,,,,,,,,,,,,,
MAHABUBABAD,15.4.1,Number of blood smears examined for Malaria,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,,,,,,,,,,,,,
MAHABUBABAD,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,,,,,,,,,,,,,
MAHABUBABAD,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
MAHABUBABAD,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,,,,,,,,,,
MAHABUBABAD,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
MAHABUBABAD,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,,,,,,,,,
MAHABUBABAD,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MAHABUBABAD,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
MAHABUBABAD,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
MAHABUBABAD,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
MAHABUBABAD,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
MAHABUBABAD,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MAHABUBABAD,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
MAHABUBABAD,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,,,,,,,,,
MAHABUBABAD,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
MAHABUBABAD,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,,,,,,,,,
MAHABUBABAD,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MAHABUBABAD,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
MAHABUBABAD,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,,,,,,,,,
MAHABUBABAD,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
MAHABUBABAD,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,,,,,,,,,
MAHABUBABAD,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MAHABUBABAD,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
MAHABUBABAD,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
MAHABUBABAD,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
MAHABUBABAD,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
MAHABUBABAD,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MAHABUBABAD,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
MAHABUBABAD,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,,,,,,,,,
MAHABUBABAD,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
MAHABUBABAD,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,,,,,,,,,
MAHABUBABAD,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MAHABUBABAD,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
MAHABUBABAD,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,,,,,,,,,
MAHABUBABAD,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
MAHABUBABAD,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,,,,,,,,,
MAHABUBABAD,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MAHABUBABAD,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
MAHABUBABAD,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
MAHABUBABAD,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
MAHABUBABAD,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
MAHABUBABAD,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MAHABUBABAD,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
MAHABUBABAD,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,,,,,,
MAHABUBABAD,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
MAHABUBABAD,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,,,,,,
MAHABUBABAD,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MAHABUBABAD,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
MAHABUBABAD,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
MAHABUBABAD,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
MAHABUBABAD,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
MAHABUBABAD,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MAHABUBABAD,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
MAHABUBABAD,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
MAHABUBABAD,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
MAHABUBABAD,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
MAHABUBABAD,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MAHABUBABAD,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
MAHABUBABAD,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
MAHABUBABAD,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
MAHABUBABAD,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
MAHABUBABAD,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MAHABUBABAD,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
MAHABUBABAD,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
MAHABUBABAD,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
MAHABUBABAD,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
MAHABUBABAD,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MAHABUBABAD,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
MAHABUBABAD,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
MAHABUBABAD,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
MAHABUBABAD,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
MAHABUBABAD,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MAHABUBABAD,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
MAHABUBABAD,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
MAHABUBABAD,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
MAHABUBABAD,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
MAHABUBABAD,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MAHABUBABAD,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
MAHABUBABAD,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
MAHABUBABAD,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
MAHABUBABAD,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
MAHABUBABAD,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MAHABUBABAD,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
MAHABUBABAD,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
MAHABUBABAD,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
MAHABUBABAD,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
MAHABUBABAD,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MAHABUBABAD,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
MAHABUBABAD,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
MAHABUBABAD,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
MAHABUBABAD,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
MAHABUBABAD,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MAHABUBABAD,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
MAHABUBABAD,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
MAHABUBABAD,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
MAHABUBABAD,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
MAHABUBABAD,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MAHABUBABAD,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
MAHABUBABAD,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
MAHABUBABAD,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
MAHABUBABAD,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
MAHABUBABAD,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MAHABUBABAD,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
MAHABUBABAD,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
MAHABUBABAD,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
MAHABUBABAD,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
MAHABUBABAD,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MAHABUBABAD,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
MAHABUBABAD,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
MAHABUBABAD,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
MAHABUBABAD,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
MAHABUBABAD,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MAHABUBABAD,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
MAHABUBABAD,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
MAHABUBABAD,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
MAHABUBABAD,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
MAHABUBABAD,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MAHABUBABAD,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
MAHABUBABAD,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
MAHABUBABAD,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
MAHABUBABAD,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
MAHABUBABAD,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MAHABUBABAD,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
MAHABUBABAD,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
MAHABUBABAD,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
MAHABUBABAD,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
MAHABUBABAD,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MAHABUBABAD,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
MAHABUBABAD,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
MAHABUBABAD,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
MAHABUBABAD,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
MAHABUBABAD,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MAHABUBABAD,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
MAHABUBABAD,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
MAHABUBABAD,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
MAHABUBABAD,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
MAHABUBABAD,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MAHABUBABAD,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,,,,,,,
MAHABUBABAD,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,,,,,,,
MAHABUBABAD,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
MAHABUBABAD,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,,,,,,,
MAHABUBABAD,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MAHABUBABAD,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
MAHABUBABAD,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
MAHABUBABAD,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
MAHABUBABAD,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
MAHABUBABAD,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
MAHABUBABAD,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
MAHABUBABAD,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
MAHABUBABAD,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
MAHABUBABAD,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
MAHABUBABAD,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
MAHABUBABAD,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
MAHABUBABAD,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
MAHABUBABAD,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
MAHABUBABAD,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
MAHABUBABAD,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
MAHABUBABAD,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
MAHABUBABAD,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
MAHABUBABAD,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
MAHABUBABAD,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
MAHABUBABAD,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
MAHABUBABAD,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
MAHABUBABAD,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
MAHABUBABAD,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
MAHABUBABAD,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
MAHABUBABAD,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
MAHABUBABAD,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
MAHABUBABAD,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
MAHABUBABAD,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
MAHABUBABAD,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
MAHABUBABAD,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
MAHABUBABAD,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
MAHABUBABAD,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
MAHABUBABAD,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
MAHABUBABAD,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
MAHABUBABAD,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
MAHABUBABAD,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
MAHABUBABAD,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
MAHABUBABAD,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
MAHABUBABAD,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
MAHABUBABAD,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
MAHABUBABAD,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
MAHABUBABAD,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
MAHABUBABAD,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
MAHABUBABAD,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
MAHABUBABAD,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
MAHABUBABAD,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
MAHABUBABAD,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
MAHABUBABAD,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
MAHABUBABAD,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
MAHABUBABAD,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
MAHABUBABAD,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
MAHABUBABAD,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
MAHABUBABAD,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
MAHABUBABAD,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
MAHABUBABAD,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
MAHABUBABAD,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
MAHABUBABAD,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
MAHABUBABAD,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
MAHABUBABAD,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
MAHABUBABAD,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
MAHABUBABAD,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
MAHABUBABAD,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
MAHABUBABAD,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
MAHABUBABAD,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
MAHABUBABAD,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
MAHABUBABAD,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
MAHABUBABAD,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
MAHABUBABAD,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
MAHABUBABAD,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
MAHABUBABAD,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
MAHABUBABAD,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
MAHABUBABAD,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
MAHABUBABAD,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
MAHABUBABAD,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
MAHABUBABAD,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
MAHABUBABAD,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
MAHABUBABAD,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
MAHABUBABAD,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
MAHABUBABAD,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
MAHABUBABAD,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
MAHABUBABAD,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
MAHABUBABAD,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
MAHABUBABAD,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
MAHABUBABAD,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
MAHABUBABAD,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
MAHABUBABAD,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
MAHABUBABAD,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
MAHABUBABAD,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
MAHABUBABAD,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
MAHABUBABAD,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
MAHABUBABAD,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
MAHABUBABAD,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
MAHABUBABAD,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
MAHABUBABAD,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
MAHABUBABAD,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
MAHABUBABAD,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
MAHABUBABAD,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
MAHABUBABAD,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
MAHABUBABAD,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
MAHABUBABAD,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
MAHABUBABAD,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
MAHABUBABAD,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
MAHABUBABAD,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
MAHABUBABAD,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
MAHABUBABAD,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
MAHABUBABAD,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
MAHABUBABAD,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
MAHABUBABAD,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
MANCHERIAL,1.1,Total number of pregnant women Registered for ANC,TOTAL,,,,,,,,,,,,,
MANCHERIAL,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,,,,,,,,,,,,,
MANCHERIAL,1.2,Number of Pregnant women registered under JSY,TOTAL,,,,,,,,,,,,,
MANCHERIAL,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,,,,,,,,,,,,,
MANCHERIAL,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,,,,,,,,,,,,,
MANCHERIAL,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,,,,,,,,,,,,,
MANCHERIAL,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,,,,,,,,,,,,,
MANCHERIAL,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,,,,,,,,,,,,,
MANCHERIAL,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,,,,,,,,,,,,,
MANCHERIAL,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,,,,,,,,,,,,,
MANCHERIAL,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,,,,,,,,,,,,,
MANCHERIAL,1.8,Number of pregnancy test kits used at SC level,TOTAL,,,,,,,,,,,,,
MANCHERIAL,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,,,,,,,,,,,,,
MANCHERIAL,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,,,,,,,,,,,,,
MANCHERIAL,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,,,,,,,,,,,,,
MANCHERIAL,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,,,,,,,,,,,,,
MANCHERIAL,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,,,,,,,,,,,,,
MANCHERIAL,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
MANCHERIAL,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,,,,,,,,,,,,,
MANCHERIAL,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,,,,,,,,,,,,,
MANCHERIAL,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,,,,,,,,,,,,,
MANCHERIAL,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
MANCHERIAL,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
MANCHERIAL,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
MANCHERIAL,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
MANCHERIAL,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
MANCHERIAL,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,,,,,,,,,,,,,
MANCHERIAL,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,,,,,,,,,,,,,
MANCHERIAL,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,,,,,,,,,,,,,
MANCHERIAL,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
MANCHERIAL,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,,,,,,,,,,,,,
MANCHERIAL,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
MANCHERIAL,4.1.1.a,Number of male live births,TOTAL,,,,,,,,,,,,,
MANCHERIAL,4.1.1.b,Number of female live births,TOTAL,,,,,,,,,,,,,
MANCHERIAL,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,,,,,,,,,,,,,
MANCHERIAL,4.1.2,Number of still births,TOTAL,,,,,,,,,,,,,
MANCHERIAL,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,,,,,,,,,,,,,
MANCHERIAL,4.2.1,Number of Newborns weighed at birth,TOTAL,,,,,,,,,,,,,
MANCHERIAL,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,,,,,,,,,,,,,
MANCHERIAL,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,,,,,,,,,,,,,
MANCHERIAL,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,,,,,,,,,,,,,
MANCHERIAL,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,,,,,,,,,,,,,
MANCHERIAL,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,,,,,,,,,,,,,
MANCHERIAL,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
MANCHERIAL,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,,,,,,,,,,,,,
MANCHERIAL,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
MANCHERIAL,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,,,,,,,,,,,,,
MANCHERIAL,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,,,,,,,,,,,,,
MANCHERIAL,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,,,,,,,,,,,,,
MANCHERIAL,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,,,,,,,,,,,,,
MANCHERIAL,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,,,,,,,,,,,,,
MANCHERIAL,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,,,,,,,,,,,,,
MANCHERIAL,6.3,PNC maternal complications attended,TOTAL,,,,,,,,,,,,,
MANCHERIAL,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,,,,,,,,,,,,,
MANCHERIAL,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,,,,,,,,,,,,,
MANCHERIAL,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,,,,,,,,,,,,,
MANCHERIAL,7.2,Number of MTPs conducted at Private Facilities,TOTAL,,,,,,,,,,,,,
MANCHERIAL,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,,,,,,,,,,,,,
MANCHERIAL,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,,,,,,,,,,,,,
MANCHERIAL,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,,,,,,,,,,,,,
MANCHERIAL,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,,,,,,,,,,,,,
MANCHERIAL,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,,,,,,,,,,,,,
MANCHERIAL,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,,,,,,,,,,,,,
MANCHERIAL,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
MANCHERIAL,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
MANCHERIAL,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,,,,,,,,,,,,,
MANCHERIAL,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
MANCHERIAL,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
MANCHERIAL,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
MANCHERIAL,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
MANCHERIAL,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
MANCHERIAL,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,,,,,,,,,,,,,
MANCHERIAL,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
MANCHERIAL,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
MANCHERIAL,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
MANCHERIAL,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
MANCHERIAL,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
MANCHERIAL,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,,,,,,,,,,,,,
MANCHERIAL,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
MANCHERIAL,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
MANCHERIAL,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
MANCHERIAL,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
MANCHERIAL,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
MANCHERIAL,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,,,,,,,,,,,,,
MANCHERIAL,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
MANCHERIAL,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,,,,,,,,,,,,,
MANCHERIAL,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,,,,,,,,,,,,,
MANCHERIAL,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,,,,,,,,,,,,,
MANCHERIAL,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
MANCHERIAL,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
MANCHERIAL,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,,,,,,,,,,,,,
MANCHERIAL,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,,,,,,,,,,,,,
MANCHERIAL,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
MANCHERIAL,9.06,Number of IUCD removals,TOTAL,,,,,,,,,,,,,
MANCHERIAL,9.07,Number of Oral Pills cycles distributed,TOTAL,,,,,,,,,,,,,
MANCHERIAL,9.08,Number of Condom pieces distributed,TOTAL,,,,,,,,,,,,,
MANCHERIAL,9.09,Number of Centchroman (weekly) pills given,TOTAL,,,,,,,,,,,,,
MANCHERIAL,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,,,,,,,,,,,,,
MANCHERIAL,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,,,,,,,,,,,,,
MANCHERIAL,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,,,,,,,,,,,,,
MANCHERIAL,9.11.2.a,Number of failures following male sterilization,TOTAL,,,,,,,,,,,,,
MANCHERIAL,9.11.2.b,Number of failures following female sterilization,TOTAL,,,,,,,,,,,,,
MANCHERIAL,9.11.3.a,Number of deaths following male sterilization,TOTAL,,,,,,,,,,,,,
MANCHERIAL,9.11.3.b,Number of deaths following female sterilization,TOTAL,,,,,,,,,,,,,
MANCHERIAL,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,,,,,,,,,,,-1.0
MANCHERIAL,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,,,,,,,,,,,,,
MANCHERIAL,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,,,,,,,,,,,,,
MANCHERIAL,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,,,,,,,,,,,,,
MANCHERIAL,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,,,,,,,,,,,,,
MANCHERIAL,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,,,,,,,,,,,,,
MANCHERIAL,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,,,,,,,,,,,,,
MANCHERIAL,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,,,,,,,,,,,,,
MANCHERIAL,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,,,,,,,,,,,,,
MANCHERIAL,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,,,,,,,,,,,,,
MANCHERIAL,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,,,,,,,,,,,,,
MANCHERIAL,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,,,,,,,,,,,,,
MANCHERIAL,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,,,,,,,,,,,,,
MANCHERIAL,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,,,,,,,,,,,,,
MANCHERIAL,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,,,,,,,,,,,,,
MANCHERIAL,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,,,,,,,,,,,,,
MANCHERIAL,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,,,,,,,,,,,,,
MANCHERIAL,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,,,,,,,,,,,,,
MANCHERIAL,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,,,,,,,,,,,,,
MANCHERIAL,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
MANCHERIAL,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
MANCHERIAL,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,,,,,,,,,,,,,
MANCHERIAL,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,,,,,,,,,,,,,
MANCHERIAL,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,,,,,,,,,,,,,
MANCHERIAL,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,,,,,,,,,,,,,
MANCHERIAL,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
MANCHERIAL,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
MANCHERIAL,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,,,,,,,,,,,,,
MANCHERIAL,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,,,,,,,,,,,,,
MANCHERIAL,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,,,,,,,,,,,,,
MANCHERIAL,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,,,,,,,,,,,,,
MANCHERIAL,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
MANCHERIAL,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
MANCHERIAL,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
MANCHERIAL,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,,,,,,,,,,,,,
MANCHERIAL,10.4.2,Number of Immunisation sessions held during the month,TOTAL,,,,,,,,,,,,,
MANCHERIAL,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,,,,,,,,,,,,,
MANCHERIAL,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,,,,,,,,,,,,,
MANCHERIAL,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,,,,,,,,,,,,,
MANCHERIAL,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,,,,,,,,,,,,,
MANCHERIAL,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,,,,,,,,,,,,,
MANCHERIAL,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
MANCHERIAL,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
MANCHERIAL,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
MANCHERIAL,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
MANCHERIAL,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
MANCHERIAL,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
MANCHERIAL,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
MANCHERIAL,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
MANCHERIAL,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,,,,,,,,,,,,,
MANCHERIAL,13.1,Number of Patients operated for cataract,TOTAL,,,,,,,,,,,,,
MANCHERIAL,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,,,,,,,,,,,,,
MANCHERIAL,13.3,Number of School children detected with Refractive errors,TOTAL,,,,,,,,,,,,,
MANCHERIAL,13.4,Number of children provided free glasses,TOTAL,,,,,,,,,,,,,
MANCHERIAL,13.5,Number of eyes collected through eye donation,TOTAL,,,,,,,,,,,,,
MANCHERIAL,13.6,Number of eyes utilised for corneal transplant,TOTAL,,,,,,,,,,,,,
MANCHERIAL,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,,,,,,,,,,,,-1.0
MANCHERIAL,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,,,,,,,,,,-1.0
MANCHERIAL,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,,,,,,,,,,,,,-1.0
MANCHERIAL,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,,,,,,,,,,,,,-1.0
MANCHERIAL,14.05,Number of RKS meetings held during the month,TOTAL,,,,,,,,,,,,,
MANCHERIAL,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,,,,,,,,,,,,,-1.0
MANCHERIAL,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,,,,,,,,,,,,,
MANCHERIAL,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,,,,,,,,,-1.0
MANCHERIAL,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,,,,,,,,,,,,,-1.0
MANCHERIAL,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,,,,,,,,,,,,,
MANCHERIAL,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,,,,,,,,,,,,,
MANCHERIAL,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,,,,,,,,,,,,,
MANCHERIAL,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,,,,,,,,,,,,,
MANCHERIAL,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,,,,,,,,,,,,,
MANCHERIAL,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,,,,,,,,,,,,,
MANCHERIAL,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,,,,,,,,,,,,,
MANCHERIAL,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,,,,,,,,,,,,,
MANCHERIAL,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,,,,,,,,,,,,,
MANCHERIAL,14.10.2.a,Number of death cases of Inpatient males,TOTAL,,,,,,,,,,,,,
MANCHERIAL,14.10.2.b,Number of death cases of Inpatient females,TOTAL,,,,,,,,,,,,,
MANCHERIAL,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,,,,,,,,,,,,,
MANCHERIAL,14.11,In-Patient Head Count at midnight,TOTAL,,,,,,,,,,,,,
MANCHERIAL,14.12.1,OPD attendance (All),TOTAL,,,,,,,,,,,,,
MANCHERIAL,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,,,,,,,,,,,,,
MANCHERIAL,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,,,,,,,,,,,,,
MANCHERIAL,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,,,,,,,,,,,,,
MANCHERIAL,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,,,,,,,,,,,,,
MANCHERIAL,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,,,,,,,,,,,,,
MANCHERIAL,14.14.a,Number of patients given AYUSH treatment,TOTAL,,,,,,,,,,,,,
MANCHERIAL,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,,,,,,,,,,,,,
MANCHERIAL,14.14.c,Number of Adolescents counselled,TOTAL,,,,,,,,,,,,,
MANCHERIAL,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,,,,,,,,,,,,,
MANCHERIAL,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,,,,,,,,,,,,,
MANCHERIAL,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,,,,,,,,,,,,,
MANCHERIAL,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,,,,,,,,,,,,,
MANCHERIAL,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,,,,,,,,,,,,,
MANCHERIAL,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,,,,,,,,,,,,,
MANCHERIAL,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,,,,,,,,,,,,,
MANCHERIAL,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,,,,,,,,,,,,,
MANCHERIAL,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,,,,,,,,,,,,,
MANCHERIAL,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,,,,,,,,,,,,,
MANCHERIAL,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,,,,,,,,,,,,,
MANCHERIAL,15.2,Number of Widal tests conducted,Number tested,,,,,,,,,,,,,
MANCHERIAL,15.3.a,Number of VDRL tests conducted on males,Number tested,,,,,,,,,,,,,
MANCHERIAL,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,,,,,,,,,,,,,
MANCHERIAL,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,,,,,,,,,,,,,
MANCHERIAL,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,,,,,,,,,,,,,
MANCHERIAL,15.4.1,Number of blood smears examined for Malaria,TOTAL,,,,,,,,,,,,,
MANCHERIAL,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,,,,,,,,,,,,,
MANCHERIAL,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,,,,,,,,,,,,,
MANCHERIAL,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
MANCHERIAL,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,,,,,,,,,,
MANCHERIAL,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
MANCHERIAL,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,,,,,,,,,
MANCHERIAL,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MANCHERIAL,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
MANCHERIAL,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
MANCHERIAL,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
MANCHERIAL,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
MANCHERIAL,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MANCHERIAL,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
MANCHERIAL,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,,,,,,,,,
MANCHERIAL,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
MANCHERIAL,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,,,,,,,,,
MANCHERIAL,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MANCHERIAL,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
MANCHERIAL,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,,,,,,,,,
MANCHERIAL,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
MANCHERIAL,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,,,,,,,,,
MANCHERIAL,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MANCHERIAL,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
MANCHERIAL,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
MANCHERIAL,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
MANCHERIAL,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
MANCHERIAL,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MANCHERIAL,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
MANCHERIAL,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,,,,,,,,,
MANCHERIAL,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
MANCHERIAL,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,,,,,,,,,
MANCHERIAL,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MANCHERIAL,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
MANCHERIAL,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,,,,,,,,,
MANCHERIAL,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
MANCHERIAL,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,,,,,,,,,
MANCHERIAL,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MANCHERIAL,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
MANCHERIAL,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
MANCHERIAL,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
MANCHERIAL,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
MANCHERIAL,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MANCHERIAL,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
MANCHERIAL,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,,,,,,
MANCHERIAL,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
MANCHERIAL,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,,,,,,
MANCHERIAL,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MANCHERIAL,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
MANCHERIAL,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
MANCHERIAL,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
MANCHERIAL,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
MANCHERIAL,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MANCHERIAL,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
MANCHERIAL,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
MANCHERIAL,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
MANCHERIAL,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
MANCHERIAL,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MANCHERIAL,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
MANCHERIAL,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
MANCHERIAL,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
MANCHERIAL,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
MANCHERIAL,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MANCHERIAL,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
MANCHERIAL,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
MANCHERIAL,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
MANCHERIAL,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
MANCHERIAL,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MANCHERIAL,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
MANCHERIAL,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
MANCHERIAL,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
MANCHERIAL,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
MANCHERIAL,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MANCHERIAL,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
MANCHERIAL,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
MANCHERIAL,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
MANCHERIAL,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
MANCHERIAL,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MANCHERIAL,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
MANCHERIAL,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
MANCHERIAL,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
MANCHERIAL,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
MANCHERIAL,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MANCHERIAL,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
MANCHERIAL,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
MANCHERIAL,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
MANCHERIAL,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
MANCHERIAL,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MANCHERIAL,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
MANCHERIAL,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
MANCHERIAL,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
MANCHERIAL,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
MANCHERIAL,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MANCHERIAL,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
MANCHERIAL,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
MANCHERIAL,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
MANCHERIAL,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
MANCHERIAL,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MANCHERIAL,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
MANCHERIAL,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
MANCHERIAL,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
MANCHERIAL,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
MANCHERIAL,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MANCHERIAL,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
MANCHERIAL,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
MANCHERIAL,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
MANCHERIAL,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
MANCHERIAL,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MANCHERIAL,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
MANCHERIAL,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
MANCHERIAL,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
MANCHERIAL,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
MANCHERIAL,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MANCHERIAL,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
MANCHERIAL,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
MANCHERIAL,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
MANCHERIAL,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
MANCHERIAL,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MANCHERIAL,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
MANCHERIAL,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
MANCHERIAL,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
MANCHERIAL,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
MANCHERIAL,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MANCHERIAL,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
MANCHERIAL,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
MANCHERIAL,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
MANCHERIAL,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
MANCHERIAL,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MANCHERIAL,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
MANCHERIAL,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
MANCHERIAL,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
MANCHERIAL,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
MANCHERIAL,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MANCHERIAL,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
MANCHERIAL,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
MANCHERIAL,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
MANCHERIAL,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
MANCHERIAL,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MANCHERIAL,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,,,,,,,
MANCHERIAL,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,,,,,,,
MANCHERIAL,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
MANCHERIAL,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,,,,,,,
MANCHERIAL,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MANCHERIAL,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
MANCHERIAL,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
MANCHERIAL,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
MANCHERIAL,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
MANCHERIAL,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
MANCHERIAL,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
MANCHERIAL,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
MANCHERIAL,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
MANCHERIAL,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
MANCHERIAL,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
MANCHERIAL,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
MANCHERIAL,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
MANCHERIAL,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
MANCHERIAL,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
MANCHERIAL,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
MANCHERIAL,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
MANCHERIAL,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
MANCHERIAL,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
MANCHERIAL,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
MANCHERIAL,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
MANCHERIAL,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
MANCHERIAL,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
MANCHERIAL,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
MANCHERIAL,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
MANCHERIAL,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
MANCHERIAL,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
MANCHERIAL,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
MANCHERIAL,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
MANCHERIAL,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
MANCHERIAL,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
MANCHERIAL,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
MANCHERIAL,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
MANCHERIAL,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
MANCHERIAL,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
MANCHERIAL,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
MANCHERIAL,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
MANCHERIAL,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
MANCHERIAL,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
MANCHERIAL,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
MANCHERIAL,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
MANCHERIAL,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
MANCHERIAL,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
MANCHERIAL,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
MANCHERIAL,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
MANCHERIAL,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
MANCHERIAL,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
MANCHERIAL,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
MANCHERIAL,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
MANCHERIAL,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
MANCHERIAL,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
MANCHERIAL,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
MANCHERIAL,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
MANCHERIAL,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
MANCHERIAL,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
MANCHERIAL,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
MANCHERIAL,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
MANCHERIAL,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
MANCHERIAL,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
MANCHERIAL,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
MANCHERIAL,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
MANCHERIAL,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
MANCHERIAL,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
MANCHERIAL,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
MANCHERIAL,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
MANCHERIAL,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
MANCHERIAL,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
MANCHERIAL,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
MANCHERIAL,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
MANCHERIAL,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
MANCHERIAL,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
MANCHERIAL,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
MANCHERIAL,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
MANCHERIAL,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
MANCHERIAL,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
MANCHERIAL,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
MANCHERIAL,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
MANCHERIAL,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
MANCHERIAL,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
MANCHERIAL,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
MANCHERIAL,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
MANCHERIAL,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
MANCHERIAL,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
MANCHERIAL,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
MANCHERIAL,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
MANCHERIAL,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
MANCHERIAL,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
MANCHERIAL,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
MANCHERIAL,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
MANCHERIAL,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
MANCHERIAL,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
MANCHERIAL,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
MANCHERIAL,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
MANCHERIAL,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
MANCHERIAL,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
MANCHERIAL,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
MANCHERIAL,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
MANCHERIAL,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
MANCHERIAL,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
MANCHERIAL,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
MANCHERIAL,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
MANCHERIAL,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
MANCHERIAL,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
MANCHERIAL,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
MANCHERIAL,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
MANCHERIAL,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
MANCHERIAL,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
MANCHERIAL,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
MANCHERIAL,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,1.1,Total number of pregnant women Registered for ANC,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,1.2,Number of Pregnant women registered under JSY,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,1.8,Number of pregnancy test kits used at SC level,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,4.1.1.a,Number of male live births,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,4.1.1.b,Number of female live births,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,4.1.2,Number of still births,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,4.2.1,Number of Newborns weighed at birth,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,6.3,PNC maternal complications attended,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,7.2,Number of MTPs conducted at Private Facilities,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,9.06,Number of IUCD removals,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,9.07,Number of Oral Pills cycles distributed,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,9.08,Number of Condom pieces distributed,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,9.09,Number of Centchroman (weekly) pills given,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,9.11.2.a,Number of failures following male sterilization,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,9.11.2.b,Number of failures following female sterilization,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,9.11.3.a,Number of deaths following male sterilization,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,9.11.3.b,Number of deaths following female sterilization,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,,,,,,,,,,,-1.0
MEDCHAL MALKAJGIRI,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,10.4.2,Number of Immunisation sessions held during the month,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,13.1,Number of Patients operated for cataract,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,13.3,Number of School children detected with Refractive errors,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,13.4,Number of children provided free glasses,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,13.5,Number of eyes collected through eye donation,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,13.6,Number of eyes utilised for corneal transplant,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,,,,,,,,,,,,-1.0
MEDCHAL MALKAJGIRI,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,,,,,,,,,,-1.0
MEDCHAL MALKAJGIRI,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,,,,,,,,,,,,,-1.0
MEDCHAL MALKAJGIRI,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,,,,,,,,,,,,,-1.0
MEDCHAL MALKAJGIRI,14.05,Number of RKS meetings held during the month,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,,,,,,,,,,,,,-1.0
MEDCHAL MALKAJGIRI,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,,,,,,,,,-1.0
MEDCHAL MALKAJGIRI,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,,,,,,,,,,,,,-1.0
MEDCHAL MALKAJGIRI,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,14.10.2.a,Number of death cases of Inpatient males,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,14.10.2.b,Number of death cases of Inpatient females,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,14.11,In-Patient Head Count at midnight,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,14.12.1,OPD attendance (All),TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,14.14.a,Number of patients given AYUSH treatment,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,14.14.c,Number of Adolescents counselled,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,15.2,Number of Widal tests conducted,Number tested,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,15.3.a,Number of VDRL tests conducted on males,Number tested,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,15.4.1,Number of blood smears examined for Malaria,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MEDCHAL MALKAJGIRI,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MEDCHAL MALKAJGIRI,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MEDCHAL MALKAJGIRI,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MEDCHAL MALKAJGIRI,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MEDCHAL MALKAJGIRI,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MEDCHAL MALKAJGIRI,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MEDCHAL MALKAJGIRI,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MEDCHAL MALKAJGIRI,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MEDCHAL MALKAJGIRI,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MEDCHAL MALKAJGIRI,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MEDCHAL MALKAJGIRI,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MEDCHAL MALKAJGIRI,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MEDCHAL MALKAJGIRI,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MEDCHAL MALKAJGIRI,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MEDCHAL MALKAJGIRI,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MEDCHAL MALKAJGIRI,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MEDCHAL MALKAJGIRI,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MEDCHAL MALKAJGIRI,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MEDCHAL MALKAJGIRI,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MEDCHAL MALKAJGIRI,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MEDCHAL MALKAJGIRI,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MEDCHAL MALKAJGIRI,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MEDCHAL MALKAJGIRI,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MEDCHAL MALKAJGIRI,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MEDCHAL MALKAJGIRI,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MEDCHAL MALKAJGIRI,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MEDCHAL MALKAJGIRI,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MEDCHAL MALKAJGIRI,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
MEDCHAL MALKAJGIRI,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
Mahbubnagar,1.1,Total number of pregnant women Registered for ANC,TOTAL,9116.0,6846.0,8078.0,8301.0,7832.0,7069.0,7598.0,8130.0,7892.0,8618.0,9020.0,9315.0,97815.0
Mahbubnagar,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,5667.0,4705.0,5323.0,5200.0,5151.0,4469.0,4505.0,4895.0,4867.0,5117.0,5493.0,5298.0,60690.0
Mahbubnagar,1.2,Number of Pregnant women registered under JSY,TOTAL,6745.0,5803.0,6734.0,6745.0,6464.0,5639.0,5890.0,6737.0,6299.0,7091.0,6875.0,6416.0,77438.0
Mahbubnagar,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,6557.0,7121.0,7725.0,6642.0,7272.0,7030.0,6763.0,6593.0,6865.0,6739.0,7315.0,7671.0,84293.0
Mahbubnagar,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,8043.0,6846.0,7896.0,8063.0,7432.0,6433.0,6696.0,7363.0,7108.0,7581.0,7548.0,7638.0,88647.0
Mahbubnagar,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,6730.0,7181.0,6832.0,7056.0,6930.0,6724.0,6448.0,6435.0,6831.0,6703.0,7030.0,7166.0,82066.0
Mahbubnagar,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,7907.0,6936.0,7040.0,6788.0,7380.0,6908.0,7063.0,6650.0,6927.0,6947.0,7555.0,7549.0,85650.0
Mahbubnagar,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,166.0,189.0,225.0,197.0,170.0,146.0,112.0,215.0,123.0,190.0,182.0,118.0,2033.0
Mahbubnagar,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,5.0,6.0,6.0,4.0,6.0,25.0,4.0,3.0,4.0,12.0,6.0,12.0,93.0
Mahbubnagar,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,2728.0,2795.0,2953.0,3016.0,2674.0,2644.0,2528.0,3052.0,2605.0,3019.0,2781.0,3137.0,33932.0
Mahbubnagar,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,55.0,46.0,33.0,19.0,28.0,35.0,33.0,47.0,36.0,16.0,32.0,33.0,413.0
Mahbubnagar,1.8,Number of pregnancy test kits used at SC level,TOTAL,1040.0,1086.0,1206.0,1543.0,2157.0,1975.0,1864.0,1947.0,1873.0,1950.0,2020.0,2003.0,20664.0
Mahbubnagar,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,53.0,61.0,56.0,94.0,96.0,31.0,54.0,64.0,86.0,98.0,96.0,75.0,864.0
Mahbubnagar,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,195.0,192.0,174.0,168.0,159.0,129.0,92.0,79.0,69.0,91.0,101.0,75.0,1524.0
Mahbubnagar,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,248.0,253.0,230.0,262.0,255.0,160.0,146.0,143.0,155.0,189.0,197.0,150.0,2388.0
Mahbubnagar,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,177.0,170.0,158.0,160.0,188.0,133.0,97.0,92.0,71.0,110.0,108.0,83.0,1547.0
Mahbubnagar,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,1.0,0.0,0.0,5.0,1.0,1.0,2.0,0.0,6.0,60.0,60.0,60.0,196.0
Mahbubnagar,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1493.0,1370.0,1372.0,1591.0,1492.0,1561.0,1567.0,1443.0,1625.0,1627.0,1573.0,1658.0,18372.0
Mahbubnagar,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,1108.0,969.0,888.0,1025.0,1002.0,1044.0,1069.0,936.0,963.0,899.0,930.0,1068.0,11901.0
Mahbubnagar,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,563.0,439.0,635.0,784.0,521.0,627.0,560.0,671.0,825.0,390.0,615.0,464.0,7094.0
Mahbubnagar,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,0.0,17.0,0.0,13.0,21.0,16.0,0.0,2.0,0.0,2.0,17.0,6.0,94.0
Mahbubnagar,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0,0.0,6.0
Mahbubnagar,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,3997.0,4395.0,4533.0,4134.0,4475.0,3846.0,4031.0,4964.0,4047.0,4323.0,3807.0,4141.0,50693.0
Mahbubnagar,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Mahbubnagar,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Mahbubnagar,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Mahbubnagar,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,29.0,50.0,40.0,50.0,43.0,68.0,64.0,66.0,81.0,46.0,35.0,34.0,606.0
Mahbubnagar,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,6.0,5.0,6.0,7.0,14.0,16.0,15.0,19.0,43.0,69.0,91.0,112.0,403.0
Mahbubnagar,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,156.0,136.0,171.0,167.0,131.0,175.0,146.0,110.0,157.0,191.0,147.0,153.0,1840.0
Mahbubnagar,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mahbubnagar,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,191.0,191.0,217.0,224.0,188.0,259.0,225.0,195.0,281.0,306.0,273.0,299.0,2849.0
Mahbubnagar,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,2358.0,2461.0,2488.0,2274.0,2372.0,2231.0,2338.0,2432.0,2145.0,2248.0,1980.0,2153.0,27480.0
Mahbubnagar,4.1.1.a,Number of male live births,TOTAL,2925.0,3102.0,3163.0,3032.0,3157.0,2927.0,2948.0,3438.0,2972.0,3148.0,2894.0,3084.0,36790.0
Mahbubnagar,4.1.1.b,Number of female live births,TOTAL,2762.0,2849.0,2939.0,2840.0,3008.0,2676.0,2730.0,3156.0,2795.0,2955.0,2668.0,2841.0,34219.0
Mahbubnagar,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,5687.0,5951.0,6102.0,5872.0,6165.0,5603.0,5678.0,6594.0,5767.0,6103.0,5562.0,5925.0,71009.0
Mahbubnagar,4.1.2,Number of still births,TOTAL,92.0,112.0,80.0,127.0,59.0,68.0,68.0,110.0,62.0,70.0,62.0,114.0,1024.0
Mahbubnagar,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,32.0,40.0,60.0,56.0,38.0,40.0,32.0,78.0,35.0,35.0,22.0,83.0,551.0
Mahbubnagar,4.2.1,Number of Newborns weighed at birth,TOTAL,1496.0,1500.0,1498.0,1676.0,1537.0,1607.0,1564.0,1455.0,1654.0,1727.0,1692.0,1434.0,18840.0
Mahbubnagar,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,103.0,101.0,78.0,114.0,87.0,86.0,119.0,85.0,210.0,252.0,109.0,100.0,1444.0
Mahbubnagar,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1450.0,1563.0,1593.0,1619.0,1557.0,1656.0,1599.0,1502.0,1736.0,1511.0,1560.0,1748.0,19094.0
Mahbubnagar,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,10.0,10.0,5.0,12.0,10.0,8.0,12.0,6.0,6.0,9.0,14.0,6.0,108.0
Mahbubnagar,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,1.0,33.0,13.0,3.0,21.0,15.0,3.0,17.0,11.0,5.0,10.0,132.0
Mahbubnagar,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,238.0,199.0,153.0,108.0,152.0,53.0,64.0,107.0,143.0,52.0,75.0,77.0,1421.0
Mahbubnagar,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mahbubnagar,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,248.0,210.0,191.0,133.0,165.0,82.0,91.0,116.0,166.0,72.0,94.0,93.0,1661.0
Mahbubnagar,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Mahbubnagar,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,149.0,126.0,49.0,72.0,101.0,55.0,49.0,114.0,139.0,45.0,56.0,86.0,1041.0
Mahbubnagar,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,19.0,15.0,2.0,4.0,3.0,14.0,14.0,5.0,4.0,11.0,6.0,11.0,108.0
Mahbubnagar,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,90.0,82.0,144.0,107.0,152.0,63.0,66.0,51.0,50.0,41.0,44.0,85.0,975.0
Mahbubnagar,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,3.0,2.0,3.0,5.0,6.0,26.0,29.0,5.0,19.0,14.0,23.0,6.0,141.0
Mahbubnagar,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,2376.0,1929.0,2572.0,2819.0,2381.0,2741.0,2584.0,2689.0,2468.0,2468.0,2284.0,2491.0,29802.0
Mahbubnagar,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,3108.0,2641.0,2887.0,3235.0,3179.0,2932.0,3109.0,3392.0,3199.0,3261.0,2930.0,3055.0,36928.0
Mahbubnagar,6.3,PNC maternal complications attended,TOTAL,0.0,0.0,4.0,7.0,14.0,2.0,12.0,20.0,12.0,16.0,15.0,2.0,104.0
Mahbubnagar,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,5.0,3.0,4.0,0.0,0.0,1.0,3.0,16.0
Mahbubnagar,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,3.0,5.0,3.0,0.0,0.0,0.0,17.0,0.0,0.0,3.0,3.0,34.0
Mahbubnagar,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,0.0,3.0,5.0,3.0,0.0,5.0,3.0,21.0,0.0,0.0,4.0,6.0,50.0
Mahbubnagar,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahbubnagar,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,972.0,1000.0,1155.0,992.0,951.0,1101.0,1148.0,1204.0,1172.0,1059.0,1046.0,1043.0,12843.0
Mahbubnagar,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,1714.0,1585.0,1769.0,1738.0,1616.0,1754.0,1816.0,1647.0,1691.0,1670.0,1515.0,1563.0,20078.0
Mahbubnagar,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,2686.0,2585.0,2924.0,2730.0,2567.0,2855.0,2964.0,2851.0,2863.0,2729.0,2561.0,2606.0,32921.0
Mahbubnagar,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,11.0,232.0,0.0,0.0,58.0,459.0,0.0,77.0,0.0,0.0,837.0
Mahbubnagar,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,1.0,0.0,0.0,0.0,12.0,0.0,0.0,0.0,0.0,1.0,1.0,2.0,17.0
Mahbubnagar,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahbubnagar,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,1.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,1.0,1.0,0.0,5.0
Mahbubnagar,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mahbubnagar,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,2.0,0.0,0.0,0.0,12.0,2.0,0.0,0.0,0.0,2.0,2.0,2.0,22.0
Mahbubnagar,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Mahbubnagar,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,763.0,1752.0,0.0,0.0,189.0,1276.0,1304.0,1309.0,1519.0,8112.0
Mahbubnagar,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,225.0,1162.0,0.0,0.0,8.0,1032.0,461.0,588.0,545.0,4021.0
Mahbubnagar,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,142.0,0.0,0.0,0.0,128.0,243.0,68.0,78.0,659.0
Mahbubnagar,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mahbubnagar,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,988.0,3056.0,0.0,0.0,197.0,2436.0,2008.0,1965.0,2142.0,12792.0
Mahbubnagar,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Mahbubnagar,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,231.0,157.0,117.0,590.0,353.0,182.0,173.0,180.0,180.0,124.0,145.0,204.0,2636.0
Mahbubnagar,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,12.0,9.0,9.0,148.0,18.0,31.0,26.0,253.0
Mahbubnagar,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,38.0,0.0,28.0,36.0,17.0,21.0,24.0,164.0
Mahbubnagar,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mahbubnagar,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,231.0,157.0,117.0,590.0,353.0,232.0,182.0,217.0,364.0,159.0,197.0,254.0,3053.0
Mahbubnagar,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,149.0,200.0,208.0,173.0,150.0,240.0,181.0,194.0,220.0,226.0,302.0,,2243.0
Mahbubnagar,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,91.0,85.0,119.0,109.0,124.0,107.0,76.0,123.0,70.0,24.0,46.0,48.0,1022.0
Mahbubnagar,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,29.0,0.0,15.0,36.0,27.0,27.0,21.0,30.0,39.0,29.0,32.0,46.0,331.0
Mahbubnagar,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,58.0,96.0,102.0,105.0,81.0,74.0,79.0,45.0,52.0,71.0,24.0,63.0,850.0
Mahbubnagar,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mahbubnagar,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,178.0,181.0,236.0,250.0,232.0,208.0,176.0,198.0,161.0,124.0,102.0,157.0,2203.0
Mahbubnagar,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,121.0,275.0,252.0,192.0,175.0,345.0,271.0,281.0,315.0,299.0,250.0,,2776.0
Mahbubnagar,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,11.0,7.0,6.0,15.0,8.0,2.0,0.0,7.0,0.0,6.0,5.0,9.0,76.0
Mahbubnagar,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,62.0,66.0,55.0,61.0,69.0,71.0,63.0,56.0,48.0,41.0,53.0,53.0,698.0
Mahbubnagar,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,8.0,0.0,0.0,4.0,1.0,3.0,3.0,3.0,2.0,3.0,6.0,7.0,40.0
Mahbubnagar,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,7.0,41.0,7.0,7.0,7.0,7.0,12.0,0.0,0.0,8.0,8.0,0.0,104.0
Mahbubnagar,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mahbubnagar,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,88.0,114.0,68.0,87.0,85.0,83.0,78.0,66.0,50.0,58.0,72.0,69.0,918.0
Mahbubnagar,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,0.0,0.0,24.0,1.0,2.0,0.0,0.0,1.0,0.0,8.0,9.0,0.0,45.0
Mahbubnagar,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,506.0,511.0,249.0,348.0,355.0,359.0,378.0,348.0,290.0,315.0,336.0,,3995.0
Mahbubnagar,9.06,Number of IUCD removals,TOTAL,198.0,101.0,114.0,126.0,135.0,197.0,112.0,125.0,79.0,140.0,106.0,7.0,1440.0
Mahbubnagar,9.07,Number of Oral Pills cycles distributed,TOTAL,7672.0,7713.0,7651.0,6046.0,5574.0,5276.0,5239.0,4908.0,4836.0,4818.0,9886.0,5281.0,74900.0
Mahbubnagar,9.08,Number of Condom pieces distributed,TOTAL,91835.0,89825.0,91872.0,77025.0,67998.0,65560.0,63891.0,53720.0,62758.0,58463.0,124870.0,73468.0,921285.0
Mahbubnagar,9.09,Number of Centchroman (weekly) pills given,TOTAL,768.0,703.0,796.0,685.0,575.0,250.0,613.0,239.0,267.0,384.0,221.0,270.0,5771.0
Mahbubnagar,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,17.0,663.0,39.0,36.0,98.0,84.0,84.0,30.0,21.0,32.0,30.0,20.0,1154.0
Mahbubnagar,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahbubnagar,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,2.0
Mahbubnagar,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahbubnagar,9.11.2.b,Number of failures following female sterilization,TOTAL,3.0,0.0,0.0,3.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,8.0
Mahbubnagar,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahbubnagar,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahbubnagar,9.12,Number of Institutions having NSV trained doctors,TOTAL,88.0,80.0,86.0,87.0,78.0,79.0,73.0,77.0,74.0,75.0,75.0,78.0,-1.0
Mahbubnagar,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,5683.0,5934.0,6085.0,5854.0,5972.0,5502.0,5624.0,6594.0,5759.0,5897.0,5553.0,5885.0,70342.0
Mahbubnagar,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,6315.0,6862.0,6381.0,2631.0,526.0,318.0,39.0,65.0,31.0,16.0,62.0,93.0,23339.0
Mahbubnagar,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,6139.0,6633.0,6620.0,6238.0,1348.0,525.0,53.0,62.0,70.0,16.0,58.0,102.0,27864.0
Mahbubnagar,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,6548.0,6662.0,6692.0,6359.0,5428.0,1307.0,274.0,135.0,280.0,31.0,94.0,141.0,33951.0
Mahbubnagar,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,124.0,3767.0,5152.0,5923.0,5742.0,6176.0,5946.0,6018.0,6031.0,6227.0,51106.0
Mahbubnagar,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,233.0,4697.0,5452.0,5456.0,5981.0,5900.0,5684.0,6161.0,6318.0,45882.0
Mahbubnagar,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,13.0,57.0,890.0,4762.0,5408.0,5774.0,5654.0,5896.0,6048.0,6501.0,41003.0
Mahbubnagar,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,3684.0,3774.0,3517.0,3680.0,4121.0,3696.0,3527.0,4103.0,3841.0,3851.0,3809.0,4010.0,45613.0
Mahbubnagar,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,6314.0,6853.0,6402.0,5858.0,5684.0,6311.0,6119.0,6209.0,6461.0,6515.0,6477.0,6784.0,75987.0
Mahbubnagar,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,6117.0,6615.0,6655.0,6316.0,6085.0,6031.0,5865.0,6018.0,6434.0,6101.0,6610.0,6813.0,75660.0
Mahbubnagar,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,6572.0,6665.0,6697.0,6328.0,5703.0,5893.0,5863.0,6127.0,6388.0,6323.0,6443.0,6999.0,76001.0
Mahbubnagar,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,1556.0,1793.0,1426.0,1605.0,1901.0,1740.0,1581.0,1550.0,1782.0,1673.0,1607.0,1732.0,19946.0
Mahbubnagar,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,6306.0,6526.0,6404.0,2716.0,825.0,486.0,90.0,166.0,180.0,113.0,116.0,51.0,23979.0
Mahbubnagar,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,6123.0,6629.0,6619.0,6183.0,1650.0,628.0,110.0,159.0,198.0,89.0,102.0,54.0,28544.0
Mahbubnagar,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,6530.0,6643.0,6696.0,6403.0,5352.0,1334.0,263.0,152.0,382.0,117.0,90.0,61.0,34023.0
Mahbubnagar,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,7652.0,7059.0,7156.0,6790.0,6065.0,5780.0,5969.0,6040.0,6113.0,5879.0,6697.0,6935.0,78135.0
Mahbubnagar,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,6201.0,5528.0,5370.0,4890.0,4587.0,4244.0,4623.0,4748.0,5092.0,4999.0,5448.0,5639.0,61369.0
Mahbubnagar,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,4433.0,4325.0,4389.0,4461.0,3890.0,4075.0,4425.0,4640.0,4607.0,4299.0,5357.0,5232.0,54133.0
Mahbubnagar,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,3616.0,3345.0,3353.0,3224.0,2972.0,2819.0,2959.0,2888.0,3035.0,2898.0,3307.0,3312.0,37728.0
Mahbubnagar,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,3379.0,3149.0,3085.0,2909.0,2587.0,2549.0,2620.0,2675.0,2750.0,2608.0,2866.0,2968.0,34145.0
Mahbubnagar,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,6995.0,6494.0,6438.0,6133.0,5559.0,5368.0,5579.0,5563.0,5785.0,5506.0,6173.0,6280.0,71873.0
Mahbubnagar,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,7599.0,6415.0,6496.0,5905.0,5302.0,4980.0,5432.0,5594.0,5820.0,5768.0,6076.0,6272.0,71659.0
Mahbubnagar,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,7576.0,6385.0,6488.0,5890.0,5302.0,4999.0,5431.0,5566.0,5812.0,5749.0,6076.0,6256.0,71530.0
Mahbubnagar,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,462.0,560.0,412.0,454.0,421.0,346.0,350.0,544.0,406.0,358.0,532.0,587.0,5432.0
Mahbubnagar,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1224.0,880.0,675.0,681.0,652.0,507.0,616.0,652.0,685.0,707.0,782.0,806.0,8867.0
Mahbubnagar,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1121.0,787.0,621.0,627.0,569.0,454.0,533.0,590.0,634.0,613.0,680.0,771.0,8000.0
Mahbubnagar,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,2345.0,1667.0,1296.0,1308.0,1221.0,961.0,1149.0,1242.0,1319.0,1320.0,1462.0,1577.0,16867.0
Mahbubnagar,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,2847.0,2839.0,2986.0,3536.0,4555.0,3378.0,3257.0,3920.0,4226.0,3401.0,3756.0,3454.0,42155.0
Mahbubnagar,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,2747.0,2644.0,2663.0,3907.0,5116.0,3801.0,3122.0,5180.0,4914.0,3320.0,3667.0,3179.0,44260.0
Mahbubnagar,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,2330.0,2365.0,2560.0,3154.0,3586.0,3276.0,2864.0,4727.0,3673.0,3198.0,3091.0,3013.0,37837.0
Mahbubnagar,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,3.0,6.0,0.0,5.0,5.0,9.0,0.0,0.0,0.0,0.0,0.0,1.0,29.0
Mahbubnagar,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,2.0,0.0,4.0
Mahbubnagar,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,4.0,17.0,0.0,0.0,10.0,18.0,6.0,7.0,0.0,2.0,0.0,0.0,64.0
Mahbubnagar,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,5250.0,5164.0,4993.0,4998.0,4867.0,4988.0,4913.0,4974.0,4965.0,4962.0,4981.0,5119.0,60174.0
Mahbubnagar,10.4.2,Number of Immunisation sessions held during the month,TOTAL,5173.0,5017.0,4875.0,4881.0,4722.0,4829.0,4732.0,4797.0,4833.0,4716.0,4696.0,4837.0,58108.0
Mahbubnagar,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,4680.0,4649.0,4546.0,4396.0,4333.0,515.0,190.0,234.0,656.0,3712.0,4273.0,4331.0,36515.0
Mahbubnagar,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,7231.0,4962.0,5041.0,4776.0,3992.0,3555.0,3830.0,3947.0,4002.0,3744.0,4112.0,4473.0,53665.0
Mahbubnagar,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,7395.0,6835.0,7061.0,7314.0,5704.0,5441.0,5503.0,5564.0,7471.0,5903.0,6690.0,6787.0,77668.0
Mahbubnagar,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,3728.0,3600.0,3813.0,3720.0,3447.0,3479.0,3879.0,3428.0,15413.0,3653.0,3704.0,3781.0,55645.0
Mahbubnagar,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,3522.0,3606.0,3543.0,3450.0,3405.0,3431.0,3541.0,3215.0,17975.0,3599.0,3508.0,3494.0,56289.0
Mahbubnagar,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,286.0,0.0,286.0
Mahbubnagar,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Mahbubnagar,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahbubnagar,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,132.0,0.0,133.0
Mahbubnagar,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahbubnagar,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,44.0,51.0,21.0,12.0,15.0,21.0,8.0,27.0,30.0,29.0,25.0,13.0,296.0
Mahbubnagar,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,916.0,818.0,866.0,1005.0,812.0,730.0,704.0,622.0,579.0,605.0,550.0,632.0,8839.0
Mahbubnagar,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,3.0,3.0,164.0,0.0,59.0,6.0,12.0,0.0,7.0,30.0,51.0,0.0,335.0
Mahbubnagar,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,311.0,47.0,14.0,41.0,1.0,48.0,111.0,22.0,74.0,50.0,22.0,7.0,748.0
Mahbubnagar,13.1,Number of Patients operated for cataract,TOTAL,1564.0,1450.0,1829.0,1838.0,1717.0,1378.0,299.0,271.0,196.0,316.0,342.0,1272.0,12472.0
Mahbubnagar,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,1502.0,1419.0,1725.0,1778.0,1645.0,1319.0,209.0,198.0,131.0,263.0,296.0,1206.0,11691.0
Mahbubnagar,13.3,Number of School children detected with Refractive errors,TOTAL,436.0,0.0,864.0,1270.0,2377.0,1017.0,425.0,2322.0,356.0,373.0,454.0,674.0,10568.0
Mahbubnagar,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,6.0,21.0,32.0,47.0,1284.0,42.0,369.0,454.0,669.0,2924.0
Mahbubnagar,13.5,Number of eyes collected through eye donation,TOTAL,0.0,2.0,4.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0
Mahbubnagar,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahbubnagar,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,15.0,14.0,14.0,14.0,14.0,15.0,15.0,13.0,15.0,14.0,14.0,14.0,-1.0
Mahbubnagar,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,91.0,90.0,87.0,90.0,86.0,81.0,75.0,72.0,75.0,76.0,75.0,78.0,-1.0
Mahbubnagar,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,3112.0,3078.0,3231.0,3112.0,3257.0,3095.0,3150.0,3028.0,3019.0,3436.0,3213.0,3311.0,-1.0
Mahbubnagar,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,14.0,13.0,13.0,13.0,13.0,13.0,12.0,11.0,12.0,12.0,13.0,12.0,-1.0
Mahbubnagar,14.05,Number of RKS meetings held during the month,TOTAL,17.0,18.0,16.0,14.0,16.0,15.0,12.0,16.0,16.0,13.0,14.0,25.0,192.0
Mahbubnagar,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,67.0,63.0,58.0,62.0,60.0,50.0,51.0,46.0,47.0,49.0,51.0,51.0,-1.0
Mahbubnagar,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,16.0,24.0,234.0,23.0,37.0,42.0,113.0,70.0,71.0,34.0,41.0,93.0,798.0
Mahbubnagar,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,12.0,12.0,14.0,13.0,13.0,13.0,11.0,11.0,12.0,12.0,12.0,13.0,-1.0
Mahbubnagar,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,-1.0
Mahbubnagar,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,,,,,,,,,,,,,
Mahbubnagar,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,,,,,,,,,,,,,
Mahbubnagar,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,,,,,,,,,,,,,
Mahbubnagar,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,795.0,708.0,497.0,643.0,569.0,642.0,867.0,637.0,698.0,1047.0,946.0,820.0,8869.0
Mahbubnagar,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,6173.0,10956.0,11573.0,12161.0,10661.0,7846.0,8727.0,6886.0,6827.0,8507.0,6326.0,10730.0,107373.0
Mahbubnagar,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,741.0,776.0,531.0,685.0,643.0,643.0,770.0,707.0,662.0,822.0,739.0,870.0,8589.0
Mahbubnagar,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,6750.0,10861.0,10101.0,12312.0,10142.0,9415.0,9972.0,8509.0,7806.0,9799.0,8274.0,12866.0,116807.0
Mahbubnagar,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,1536.0,1484.0,1028.0,1328.0,1212.0,1285.0,1637.0,1344.0,1360.0,1869.0,1685.0,1690.0,17458.0
Mahbubnagar,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,12923.0,21817.0,21674.0,24473.0,20803.0,17261.0,18699.0,15395.0,14633.0,18306.0,14600.0,23596.0,224180.0
Mahbubnagar,14.10.2.a,Number of death cases of Inpatient males,TOTAL,101.0,114.0,93.0,71.0,85.0,85.0,22.0,20.0,35.0,74.0,77.0,87.0,864.0
Mahbubnagar,14.10.2.b,Number of death cases of Inpatient females,TOTAL,58.0,94.0,72.0,59.0,72.0,70.0,15.0,4.0,15.0,37.0,55.0,82.0,633.0
Mahbubnagar,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,159.0,208.0,165.0,130.0,157.0,155.0,37.0,24.0,50.0,111.0,132.0,169.0,1497.0
Mahbubnagar,14.11,In-Patient Head Count at midnight,TOTAL,8873.0,18066.0,17194.0,19022.0,23063.0,12834.0,15004.0,14215.0,14960.0,14948.0,13098.0,17653.0,188930.0
Mahbubnagar,14.12.1,OPD attendance (All),TOTAL,347376.0,339377.0,329395.0,352950.0,351644.0,359995.0,351337.0,342340.0,333836.0,321032.0,329779.0,363643.0,4122704.0
Mahbubnagar,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,969.0,2871.0,243.0,258.0,242.0,2636.0,112.0,1902.0,162.0,134.0,324.0,104.0,9957.0
Mahbubnagar,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,0.0,0.0,0.0,10.0,0.0,0.0,1.0,17.0,29.0,3.0,60.0
Mahbubnagar,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,,,,,,,,,,,,,
Mahbubnagar,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,2675.0,2591.0,3245.0,3270.0,3048.0,2784.0,2644.0,2089.0,2663.0,2088.0,2220.0,2753.0,32070.0
Mahbubnagar,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,,,,,,,,,,,,,
Mahbubnagar,14.14.a,Number of patients given AYUSH treatment,TOTAL,26795.0,24516.0,25455.0,27932.0,26833.0,25311.0,32382.0,25506.0,22322.0,21464.0,22854.0,23859.0,305229.0
Mahbubnagar,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,838.0,718.0,650.0,692.0,550.0,733.0,683.0,517.0,513.0,279.0,434.0,427.0,7034.0
Mahbubnagar,14.14.c,Number of Adolescents counselled,TOTAL,147.0,334.0,82.0,204.0,1047.0,215.0,632.0,675.0,228.0,226.0,109.0,233.0,4132.0
Mahbubnagar,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,,,,,,,,,,,,,
Mahbubnagar,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,13404.0,12489.0,14410.0,16316.0,14962.0,13957.0,11931.0,12841.0,13796.0,14209.0,13627.0,13498.0,165440.0
Mahbubnagar,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,579.0,894.0,799.0,797.0,632.0,729.0,376.0,523.0,537.0,628.0,448.0,563.0,7505.0
Mahbubnagar,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,1035.0,2159.0,952.0,1150.0,1689.0,2312.0,1937.0,2100.0,2080.0,2018.0,2065.0,2117.0,21614.0
Mahbubnagar,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,45.0,61.0,22.0,35.0,56.0,63.0,47.0,93.0,34.0,38.0,33.0,37.0,564.0
Mahbubnagar,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,1113.0,2105.0,1353.0,1184.0,1674.0,1897.0,1596.0,2215.0,2087.0,1568.0,1853.0,2239.0,20884.0
Mahbubnagar,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,58.0,67.0,34.0,27.0,84.0,34.0,42.0,56.0,42.0,39.0,33.0,39.0,555.0
Mahbubnagar,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,3670.0,4743.0,2815.0,3160.0,3772.0,4280.0,3386.0,4029.0,3957.0,4233.0,4570.0,4778.0,47393.0
Mahbubnagar,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,107.0,139.0,21.0,201.0,169.0,111.0,111.0,382.0,76.0,98.0,97.0,3.0,1515.0
Mahbubnagar,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,5818.0,9007.0,5120.0,5494.0,7135.0,8489.0,6919.0,8344.0,8124.0,7819.0,8488.0,9134.0,89891.0
Mahbubnagar,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,210.0,267.0,77.0,263.0,309.0,208.0,200.0,531.0,152.0,175.0,163.0,79.0,2634.0
Mahbubnagar,15.2,Number of Widal tests conducted,Number tested,989.0,878.0,1692.0,2010.0,1467.0,2481.0,2430.0,1943.0,1419.0,1478.0,1271.0,1141.0,19199.0
Mahbubnagar,15.3.a,Number of VDRL tests conducted on males,Number tested,548.0,443.0,68.0,450.0,409.0,225.0,179.0,82.0,380.0,515.0,713.0,405.0,4417.0
Mahbubnagar,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,509.0,230.0,182.0,636.0,134.0,306.0,96.0,317.0,265.0,618.0,531.0,706.0,4530.0
Mahbubnagar,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,726.0,615.0,660.0,1257.0,523.0,620.0,533.0,629.0,596.0,999.0,885.0,1711.0,9754.0
Mahbubnagar,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,1783.0,1288.0,910.0,2343.0,1066.0,1151.0,808.0,1028.0,1241.0,2132.0,2129.0,2822.0,18701.0
Mahbubnagar,15.4.1,Number of blood smears examined for Malaria,TOTAL,29746.0,25981.0,27957.0,29365.0,31365.0,32316.0,33606.0,32744.0,31153.0,29871.0,28582.0,31384.0,364070.0
Mahbubnagar,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,2.0,193.0,3.0,1.0,2.0,10.0,2.0,1.0,0.0,98.0,16.0,0.0,328.0
Mahbubnagar,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,0.0,1.0,1.0,3.0,2.0,2.0,1.0,0.0,2.0,0.0,12.0
Mahbubnagar,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Mahbubnagar,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,,,,,,,,,,
Mahbubnagar,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Mahbubnagar,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Mahbubnagar,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahbubnagar,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Mahbubnagar,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Mahbubnagar,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Mahbubnagar,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Mahbubnagar,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahbubnagar,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Mahbubnagar,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,,,,,,,,,
Mahbubnagar,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Mahbubnagar,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,,,,,,,,,
Mahbubnagar,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahbubnagar,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Mahbubnagar,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,,,,,,,,,
Mahbubnagar,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Mahbubnagar,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Mahbubnagar,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahbubnagar,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Mahbubnagar,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Mahbubnagar,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Mahbubnagar,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Mahbubnagar,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahbubnagar,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Mahbubnagar,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,,,,,,,,,
Mahbubnagar,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Mahbubnagar,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,,,,,,,,,
Mahbubnagar,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahbubnagar,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Mahbubnagar,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,,,,,,,,,
Mahbubnagar,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Mahbubnagar,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,,,,,,,,,
Mahbubnagar,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahbubnagar,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Mahbubnagar,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Mahbubnagar,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Mahbubnagar,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Mahbubnagar,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahbubnagar,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Mahbubnagar,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,,,,,,
Mahbubnagar,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Mahbubnagar,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,,,,,,
Mahbubnagar,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahbubnagar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Mahbubnagar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Mahbubnagar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Mahbubnagar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Mahbubnagar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahbubnagar,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Mahbubnagar,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Mahbubnagar,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Mahbubnagar,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Mahbubnagar,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahbubnagar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Mahbubnagar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Mahbubnagar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Mahbubnagar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Mahbubnagar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahbubnagar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Mahbubnagar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Mahbubnagar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Mahbubnagar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Mahbubnagar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahbubnagar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Mahbubnagar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Mahbubnagar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Mahbubnagar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Mahbubnagar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahbubnagar,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Mahbubnagar,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Mahbubnagar,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Mahbubnagar,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Mahbubnagar,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahbubnagar,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Mahbubnagar,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Mahbubnagar,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Mahbubnagar,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Mahbubnagar,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahbubnagar,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Mahbubnagar,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Mahbubnagar,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Mahbubnagar,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Mahbubnagar,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahbubnagar,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Mahbubnagar,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Mahbubnagar,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Mahbubnagar,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Mahbubnagar,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahbubnagar,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Mahbubnagar,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Mahbubnagar,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Mahbubnagar,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Mahbubnagar,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahbubnagar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Mahbubnagar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Mahbubnagar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Mahbubnagar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Mahbubnagar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahbubnagar,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Mahbubnagar,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Mahbubnagar,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Mahbubnagar,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Mahbubnagar,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahbubnagar,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Mahbubnagar,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Mahbubnagar,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Mahbubnagar,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Mahbubnagar,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahbubnagar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Mahbubnagar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Mahbubnagar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Mahbubnagar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Mahbubnagar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahbubnagar,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Mahbubnagar,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Mahbubnagar,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Mahbubnagar,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Mahbubnagar,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahbubnagar,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Mahbubnagar,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Mahbubnagar,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Mahbubnagar,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Mahbubnagar,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahbubnagar,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Mahbubnagar,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Mahbubnagar,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Mahbubnagar,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Mahbubnagar,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahbubnagar,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Mahbubnagar,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Mahbubnagar,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Mahbubnagar,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Mahbubnagar,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahbubnagar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,,,,,,,
Mahbubnagar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,,,,,,,
Mahbubnagar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Mahbubnagar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,,,,,,,
Mahbubnagar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahbubnagar,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,2.0,,2.0
Mahbubnagar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,1.0,,,,,,1.0,,2.0
Mahbubnagar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Mahbubnagar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,1.0,,,,,,1.0,,2.0
Mahbubnagar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,1.0,,1.0,,2.0,3.0,1.0,,1.0,,,,9.0
Mahbubnagar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Mahbubnagar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,1.0,,1.0,,2.0,3.0,1.0,,1.0,,,,9.0
Mahbubnagar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,2.0,2.0,3.0,2.0,2.0,1.0,2.0,3.0,2.0,1.0,5.0,1.0,26.0
Mahbubnagar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Mahbubnagar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,2.0,2.0,3.0,2.0,2.0,1.0,2.0,3.0,2.0,1.0,5.0,1.0,26.0
Mahbubnagar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,3.0,3.0,3.0,7.0,4.0,3.0,2.0,2.0,1.0,5.0,10.0,2.0,45.0
Mahbubnagar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Mahbubnagar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,3.0,3.0,3.0,7.0,4.0,3.0,2.0,2.0,1.0,5.0,10.0,2.0,45.0
Mahbubnagar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,2.0,,,,,1.0,1.0,,,4.0
Mahbubnagar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,1.0,,,,,,,,,1.0
Mahbubnagar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,3.0,,,,,1.0,1.0,,,5.0
Mahbubnagar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Mahbubnagar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Mahbubnagar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Mahbubnagar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,2.0,,1.0,1.0,,,,4.0
Mahbubnagar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,1.0,,1.0,2.0
Mahbubnagar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,2.0,,1.0,1.0,1.0,,1.0,6.0
Mahbubnagar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Mahbubnagar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Mahbubnagar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Mahbubnagar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,5.0,2.0,4.0,7.0,5.0,8.0,6.0,3.0,3.0,2.0,,2.0,47.0
Mahbubnagar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,1.0,4.0,3.0,1.0,2.0,,2.0,4.0,3.0,,1.0,4.0,25.0
Mahbubnagar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,6.0,6.0,7.0,8.0,7.0,8.0,8.0,7.0,6.0,2.0,1.0,6.0,72.0
Mahbubnagar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Mahbubnagar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,1.0,,3.0,,,,,,,1.0,,,5.0
Mahbubnagar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,1.0,,2.0,,,,,,,,,,3.0
Mahbubnagar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,2.0,,5.0,,,,,,,1.0,,,8.0
Mahbubnagar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,1.0,,,,,,,1.0,2.0
Mahbubnagar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,12.0,11.0,12.0,12.0,8.0,9.0,11.0,12.0,12.0,11.0,5.0,8.0,123.0
Mahbubnagar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,12.0,9.0,10.0,7.0,7.0,5.0,4.0,5.0,3.0,7.0,4.0,2.0,75.0
Mahbubnagar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,24.0,20.0,22.0,19.0,16.0,14.0,15.0,17.0,15.0,18.0,9.0,11.0,200.0
Mahbubnagar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,1.0,1.0,1.0,,,,,,,,,3.0
Mahbubnagar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,3.0,7.0,5.0,1.0,3.0,2.0,9.0,4.0,2.0,5.0,2.0,1.0,44.0
Mahbubnagar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,5.0,1.0,7.0,,2.0,7.0,12.0,1.0,,9.0,,6.0,50.0
Mahbubnagar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,8.0,9.0,13.0,2.0,5.0,9.0,21.0,5.0,2.0,14.0,2.0,7.0,97.0
Mahbubnagar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Mahbubnagar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Mahbubnagar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Mahbubnagar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Mahbubnagar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,2.0,2.0,4.0
Mahbubnagar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,2.0,2.0,2.0,,,2.0,3.0,1.0,,6.0,1.0,2.0,21.0
Mahbubnagar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,1.0,,1.0,1.0,1.0,,3.0,2.0,,,,2.0,11.0
Mahbubnagar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,3.0,2.0,3.0,1.0,1.0,2.0,6.0,3.0,,6.0,3.0,6.0,36.0
Mahbubnagar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Mahbubnagar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,7.0,8.0,9.0,6.0,7.0,13.0,12.0,8.0,4.0,6.0,3.0,13.0,96.0
Mahbubnagar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,2.0,,1.0,1.0,1.0,,1.0,6.0
Mahbubnagar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,7.0,8.0,9.0,6.0,7.0,15.0,12.0,9.0,5.0,7.0,3.0,14.0,102.0
Mahbubnagar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,1.0,,1.0,2.0,,,1.0,,,,1.0,6.0
Mahbubnagar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,33.0,48.0,43.0,32.0,42.0,37.0,24.0,30.0,30.0,28.0,23.0,22.0,392.0
Mahbubnagar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,28.0,15.0,24.0,24.0,24.0,25.0,15.0,17.0,20.0,21.0,21.0,22.0,256.0
Mahbubnagar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,61.0,64.0,67.0,57.0,68.0,62.0,39.0,48.0,50.0,49.0,44.0,45.0,654.0
Mahbubnagar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,2.0,1.0,,1.0,1.0,2.0,,,,1.0,,,8.0
Mahbubnagar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,5.0,4.0,8.0,5.0,6.0,10.0,5.0,6.0,9.0,8.0,5.0,3.0,74.0
Mahbubnagar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,8.0,10.0,4.0,11.0,6.0,4.0,7.0,4.0,3.0,7.0,9.0,3.0,76.0
Mahbubnagar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,15.0,15.0,12.0,17.0,13.0,16.0,12.0,10.0,12.0,16.0,14.0,6.0,158.0
Mahbubnagar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Mahbubnagar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Mahbubnagar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Mahbubnagar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Mahbubnagar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Mahbubnagar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Mahbubnagar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Mahbubnagar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Mahbubnagar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Mahbubnagar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,2.0,,,,,1.0,,1.0,,,,4.0
Mahbubnagar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Mahbubnagar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,2.0,,,,,1.0,,1.0,,,,4.0
Mahbubnagar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Mahbubnagar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,1.0,1.0,,1.0,3.0,,,1.0,,,,7.0
Mahbubnagar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Mahbubnagar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,1.0,1.0,,1.0,3.0,,,1.0,,,,7.0
Mahbubnagar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Mahbubnagar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Mahbubnagar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Mahbubnagar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Mahbubnagar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Mahbubnagar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,1.0,5.0,,2.0,2.0,1.0,,,1.0,,1.0,1.0,14.0
Mahbubnagar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Mahbubnagar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,1.0,5.0,,2.0,2.0,1.0,,,1.0,,1.0,1.0,14.0
Mahbubnagar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,3.0,5.0,4.0,3.0,4.0,6.0,2.0,4.0,1.0,2.0,2.0,3.0,39.0
Mahbubnagar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,52.0,48.0,76.0,60.0,49.0,28.0,56.0,42.0,37.0,36.0,32.0,39.0,555.0
Mahbubnagar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,9.0,13.0,13.0,7.0,14.0,7.0,8.0,5.0,7.0,11.0,2.0,10.0,106.0
Mahbubnagar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,64.0,66.0,93.0,70.0,67.0,41.0,66.0,51.0,45.0,49.0,36.0,52.0,700.0
Mahbubnagar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,2.0,2.0,3.0,1.0,1.0,,1.0,,,1.0,,11.0
Mahbubnagar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,82.0,84.0,100.0,73.0,88.0,94.0,73.0,58.0,67.0,65.0,53.0,78.0,915.0
Mahbubnagar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,12.0,11.0,22.0,20.0,18.0,10.0,9.0,12.0,16.0,14.0,9.0,13.0,166.0
Mahbubnagar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,94.0,97.0,124.0,96.0,107.0,105.0,82.0,71.0,83.0,79.0,63.0,91.0,1092.0
Mahbubnagar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,1.0,2.0,1.0,2.0,4.0,4.0,2.0,,,,,16.0
Mahbubnagar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,4.0,12.0,12.0,7.0,12.0,14.0,16.0,5.0,6.0,3.0,2.0,2.0,95.0
Mahbubnagar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,5.0,2.0,8.0,4.0,2.0,2.0,2.0,4.0,2.0,,2.0,1.0,34.0
Mahbubnagar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,9.0,15.0,22.0,12.0,16.0,20.0,22.0,11.0,8.0,3.0,4.0,3.0,145.0
Mahbubnagar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,1.0,1.0,2.0,4.0,2.0,,,,1.0,11.0
Mahbubnagar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,13.0,20.0,26.0,20.0,9.0,12.0,6.0,12.0,12.0,3.0,11.0,14.0,158.0
Mahbubnagar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,34.0,27.0,27.0,35.0,27.0,23.0,25.0,16.0,15.0,10.0,9.0,15.0,263.0
Mahbubnagar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,47.0,47.0,53.0,56.0,37.0,37.0,35.0,30.0,27.0,13.0,20.0,30.0,432.0
Mahbubnagar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,1.0,1.0,1.0,3.0,1.0,3.0,,1.0,3.0,1.0,,2.0,17.0
Mahbubnagar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,42.0,47.0,43.0,45.0,47.0,37.0,42.0,40.0,27.0,45.0,41.0,39.0,495.0
Mahbubnagar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,50.0,55.0,48.0,30.0,58.0,51.0,41.0,32.0,36.0,32.0,34.0,43.0,510.0
Mahbubnagar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,93.0,103.0,92.0,78.0,106.0,91.0,83.0,73.0,66.0,78.0,75.0,84.0,1022.0
Mahbubnagar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,7.0,14.0,8.0,8.0,3.0,7.0,4.0,7.0,9.0,5.0,2.0,5.0,79.0
Mahbubnagar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,164.0,212.0,191.0,216.0,244.0,201.0,173.0,183.0,142.0,165.0,167.0,162.0,2220.0
Mahbubnagar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,659.0,672.0,695.0,687.0,718.0,691.0,654.0,691.0,592.0,754.0,608.0,604.0,8025.0
Mahbubnagar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,830.0,898.0,894.0,911.0,965.0,899.0,831.0,881.0,743.0,924.0,777.0,771.0,10324.0
Medak,1.1,Total number of pregnant women Registered for ANC,TOTAL,4163.0,3727.0,4639.0,4511.0,4466.0,4055.0,5731.0,4986.0,4285.0,3900.0,4391.0,4085.0,52939.0
Medak,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,2602.0,2427.0,2908.0,2806.0,2864.0,2664.0,2815.0,3125.0,2774.0,2544.0,2864.0,2583.0,32976.0
Medak,1.2,Number of Pregnant women registered under JSY,TOTAL,3586.0,3237.0,3917.0,3831.0,3729.0,3494.0,3334.0,4073.0,3617.0,3321.0,3634.0,3436.0,43209.0
Medak,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,6922.0,6784.0,6732.0,5338.0,5404.0,6780.0,6030.0,5706.0,7704.0,3699.0,3982.0,3745.0,68826.0
Medak,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,3972.0,3611.0,4337.0,4273.0,4182.0,3887.0,3867.0,4606.0,4044.0,3695.0,4140.0,3897.0,48511.0
Medak,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,3760.0,3677.0,3687.0,4190.0,4007.0,3923.0,3923.0,3910.0,4285.0,3830.0,3683.0,3801.0,46676.0
Medak,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,3988.0,3657.0,4063.0,4419.0,4096.0,3898.0,5711.0,4092.0,3996.0,3837.0,4046.0,3946.0,49749.0
Medak,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,59.0,33.0,71.0,47.0,42.0,37.0,45.0,42.0,9.0,11.0,27.0,39.0,462.0
Medak,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,,,,,0.0,0.0,0.0,,0.0,,0.0,,0.0
Medak,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,3127.0,3099.0,3333.0,3531.0,3345.0,3406.0,3406.0,3374.0,3242.0,3205.0,3417.0,3172.0,39657.0
Medak,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,10.0,,,,,,13.0,,,,,,23.0
Medak,1.8,Number of pregnancy test kits used at SC level,TOTAL,254.0,312.0,321.0,264.0,627.0,398.0,729.0,764.0,626.0,423.0,603.0,533.0,5854.0
Medak,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Medak,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Medak,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Medak,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Medak,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Medak,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,2485.0,2365.0,2062.0,2058.0,2287.0,2197.0,2264.0,2432.0,2215.0,2083.0,2173.0,2162.0,26783.0
Medak,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,1110.0,1176.0,1049.0,1054.0,1151.0,1086.0,1059.0,1118.0,1087.0,1065.0,1199.0,1272.0,13426.0
Medak,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,849.0,679.0,1103.0,795.0,1274.0,758.0,1050.0,1131.0,980.0,1090.0,1408.0,912.0,12029.0
Medak,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,66.0,15.0,11.0,42.0,28.0,8.0,11.0,0.0,0.0,41.0,3.0,16.0,241.0
Medak,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,7.0,0.0,0.0,10.0,5.0,3.0,0.0,2.0,4.0,1.0,0.0,0.0,32.0
Medak,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,1692.0,1717.0,1640.0,1606.0,1675.0,1414.0,1372.0,1685.0,1525.0,1587.0,1514.0,1416.0,18843.0
Medak,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Medak,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Medak,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Medak,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,30.0,23.0,,,56.0,13.0,32.0,,27.0,24.0,0.0,,205.0
Medak,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,110.0,101.0,114.0,136.0,146.0,147.0,166.0,182.0,164.0,134.0,127.0,156.0,1683.0
Medak,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,408.0,406.0,328.0,385.0,466.0,446.0,508.0,493.0,498.0,491.0,647.0,487.0,5563.0
Medak,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Medak,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,548.0,530.0,442.0,521.0,668.0,606.0,706.0,675.0,689.0,649.0,774.0,643.0,7451.0
Medak,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,1167.0,1144.0,1015.0,1121.0,891.0,1052.0,956.0,911.0,961.0,813.0,973.0,902.0,11906.0
Medak,4.1.1.a,Number of male live births,TOTAL,2157.0,2109.0,1869.0,1851.0,2010.0,1929.0,1852.0,2078.0,1889.0,1896.0,1908.0,1858.0,23406.0
Medak,4.1.1.b,Number of female live births,TOTAL,2020.0,1939.0,1836.0,1771.0,1917.0,1704.0,1763.0,2035.0,1832.0,1783.0,1774.0,1801.0,22175.0
Medak,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,4177.0,4048.0,3705.0,3622.0,3927.0,3633.0,3615.0,4113.0,3721.0,3679.0,3682.0,3659.0,45581.0
Medak,4.1.2,Number of still births,TOTAL,49.0,69.0,61.0,48.0,51.0,39.0,40.0,43.0,42.0,42.0,38.0,45.0,567.0
Medak,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,33.0,9.0,15.0,18.0,15.0,17.0,10.0,19.0,8.0,16.0,9.0,6.0,175.0
Medak,4.2.1,Number of Newborns weighed at birth,TOTAL,4169.0,3983.0,3459.0,3590.0,3820.0,3478.0,3387.0,4000.0,3643.0,3658.0,3655.0,3512.0,44354.0
Medak,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,299.0,288.0,238.0,209.0,125.0,222.0,162.0,97.0,278.0,222.0,152.0,76.0,2368.0
Medak,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,3758.0,3557.0,3139.0,3348.0,3414.0,3215.0,3012.0,3358.0,3274.0,3271.0,3440.0,2744.0,39530.0
Medak,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,65.0,60.0,51.0,30.0,14.0,20.0,5.0,39.0,13.0,32.0,21.0,26.0,376.0
Medak,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,153.0,141.0,147.0,156.0,149.0,130.0,141.0,164.0,113.0,139.0,155.0,129.0,1717.0
Medak,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,843.0,737.0,771.0,794.0,1016.0,771.0,1096.0,611.0,992.0,782.0,913.0,788.0,10114.0
Medak,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Medak,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,1061.0,938.0,969.0,980.0,1179.0,921.0,1242.0,814.0,1118.0,953.0,1089.0,943.0,12207.0
Medak,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Medak,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,880.0,830.0,730.0,839.0,708.0,660.0,916.0,685.0,733.0,727.0,726.0,634.0,9068.0
Medak,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,57.0,217.0,87.0,65.0,65.0,30.0,299.0,337.0,344.0,77.0,79.0,78.0,1735.0
Medak,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,1001.0,922.0,933.0,946.0,1176.0,921.0,863.0,641.0,747.0,798.0,800.0,748.0,10496.0
Medak,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,101.0,90.0,120.0,87.0,127.0,127.0,211.0,166.0,167.0,138.0,188.0,166.0,1688.0
Medak,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1841.0,1483.0,1203.0,1299.0,1473.0,1397.0,1365.0,1694.0,1648.0,1553.0,1673.0,1736.0,18365.0
Medak,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,210.0,92.0,121.0,220.0,26.0,378.0,178.0,22.0,178.0,118.0,111.0,423.0,2077.0
Medak,6.3,PNC maternal complications attended,TOTAL,,,,,,0.0,,,0.0,,0.0,0.0,0.0
Medak,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,,1.0,2.0,4.0,1.0,13.0,7.0,7.0,5.0,4.0,0.0,3.0,47.0
Medak,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,,,3.0,2.0,1.0,1.0,,,0.0,,0.0,,7.0
Medak,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,,1.0,5.0,6.0,2.0,14.0,7.0,7.0,5.0,4.0,0.0,3.0,54.0
Medak,7.2,Number of MTPs conducted at Private Facilities,TOTAL,3.0,2.0,5.0,3.0,8.0,5.0,0.0,1.0,0.0,1.0,1.0,3.0,32.0
Medak,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,1212.0,1197.0,1260.0,1059.0,1181.0,1169.0,903.0,939.0,827.0,793.0,954.0,978.0,12472.0
Medak,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,1765.0,1709.0,1771.0,1488.0,1489.0,1529.0,1266.0,1425.0,1383.0,1322.0,1762.0,1802.0,18711.0
Medak,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,2977.0,2906.0,3031.0,2547.0,2670.0,2698.0,2169.0,2364.0,2210.0,2115.0,2716.0,2780.0,31183.0
Medak,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,,,,,,0.0,22.0,,0.0,,0.0,,22.0
Medak,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,2.0,2.0,1.0,1.0,3.0,4.0,3.0,,0.0,0.0,1.0,1.0,18.0
Medak,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,,,,,,,,,,,,,
Medak,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Medak,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Medak,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,2.0,2.0,1.0,1.0,3.0,4.0,3.0,,0.0,0.0,1.0,1.0,18.0
Medak,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Medak,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,338.0,,130.0,502.0,447.0,233.0,177.0,356.0,391.0,443.0,425.0,538.0,3980.0
Medak,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,33.0,,84.0,50.0,109.0,39.0,29.0,108.0,48.0,51.0,69.0,71.0,691.0
Medak,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,444.0,,235.0,592.0,479.0,244.0,248.0,318.0,445.0,465.0,416.0,522.0,4408.0
Medak,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Medak,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,815.0,,449.0,1144.0,1035.0,516.0,454.0,782.0,884.0,959.0,910.0,1131.0,9079.0
Medak,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Medak,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,482.0,346.0,18.0,109.0,125.0,20.0,26.0,126.0,19.0,89.0,104.0,25.0,1489.0
Medak,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,37.0,11.0,,5.0,7.0,,,,,6.0,20.0,10.0,96.0
Medak,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,122.0,43.0,,,,,,,13.0,14.0,46.0,23.0,261.0
Medak,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Medak,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,641.0,400.0,18.0,114.0,132.0,20.0,26.0,126.0,32.0,109.0,170.0,58.0,1846.0
Medak,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Medak,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,116.0,132.0,66.0,26.0,9.0,105.0,79.0,22.0,74.0,87.0,0.0,72.0,788.0
Medak,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,12.0,6.0,8.0,,10.0,13.0,8.0,12.0,7.0,,,,76.0
Medak,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,46.0,21.0,25.0,20.0,36.0,23.0,16.0,52.0,18.0,22.0,13.0,15.0,307.0
Medak,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Medak,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,174.0,159.0,99.0,46.0,55.0,141.0,103.0,86.0,99.0,109.0,13.0,87.0,1171.0
Medak,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,284.0,323.0,328.0,286.0,295.0,295.0,224.0,314.0,316.0,302.0,255.0,316.0,3538.0
Medak,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,10.0,6.0,5.0,4.0,8.0,19.0,4.0,0.0,2.0,19.0,0.0,5.0,82.0
Medak,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,70.0,517.0,96.0,129.0,130.0,100.0,77.0,85.0,88.0,92.0,101.0,109.0,1594.0
Medak,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,34.0,8.0,8.0,5.0,5.0,9.0,20.0,17.0,16.0,11.0,9.0,13.0,155.0
Medak,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,20.0,8.0,,10.0,9.0,,8.0,10.0,10.0,8.0,6.0,6.0,95.0
Medak,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Medak,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,134.0,539.0,109.0,148.0,152.0,128.0,109.0,112.0,116.0,130.0,116.0,133.0,1926.0
Medak,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,9.0,0.0,7.0,5.0,4.0,31.0,1.0,0.0,4.0,3.0,0.0,0.0,64.0
Medak,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Medak,9.06,Number of IUCD removals,TOTAL,24.0,45.0,82.0,45.0,178.0,97.0,98.0,51.0,123.0,109.0,97.0,73.0,1022.0
Medak,9.07,Number of Oral Pills cycles distributed,TOTAL,2833.0,2237.0,2052.0,1998.0,2470.0,1860.0,1777.0,1943.0,2137.0,1952.0,1882.0,1775.0,24916.0
Medak,9.08,Number of Condom pieces distributed,TOTAL,13776.0,13006.0,15957.0,15024.0,12491.0,13794.0,13476.0,13106.0,12269.0,14674.0,9560.0,10670.0,157803.0
Medak,9.09,Number of Centchroman (weekly) pills given,TOTAL,11.0,10.0,20.0,5.0,2.0,26.0,7.0,35.0,10.0,44.0,21.0,12.0,203.0
Medak,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,0.0,0.0,12.0,5.0,4.0,13.0,11.0,3.0,5.0,16.0,14.0,0.0,83.0
Medak,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Medak,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Medak,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Medak,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Medak,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Medak,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Medak,9.12,Number of Institutions having NSV trained doctors,TOTAL,4.0,8.0,5.0,3.0,6.0,9.0,9.0,6.0,9.0,7.0,9.0,10.0,-1.0
Medak,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,3400.0,2944.0,3190.0,3263.0,3369.0,3611.0,3606.0,3790.0,3493.0,3213.0,3367.0,3410.0,40656.0
Medak,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,3764.0,4024.0,2752.0,916.0,525.0,314.0,501.0,338.0,436.0,465.0,319.0,395.0,14749.0
Medak,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,3732.0,3728.0,4063.0,2757.0,855.0,360.0,441.0,400.0,383.0,398.0,348.0,385.0,17850.0
Medak,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,4064.0,3635.0,3958.0,3823.0,2421.0,710.0,528.0,425.0,503.0,485.0,372.0,408.0,21332.0
Medak,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,32.0,55.0,1295.0,2760.0,3159.0,4324.0,3942.0,4178.0,3807.0,3763.0,3682.0,3448.0,34445.0
Medak,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,36.0,55.0,80.0,1400.0,2976.0,3529.0,3591.0,4140.0,4029.0,9543.0,3671.0,3584.0,36634.0
Medak,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,37.0,65.0,56.0,288.0,1788.0,3151.0,3385.0,3725.0,3722.0,3751.0,3521.0,3656.0,27145.0
Medak,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,2030.0,1503.0,1806.0,1667.0,1883.0,1769.0,1862.0,2213.0,1914.0,1630.0,1971.0,1759.0,22007.0
Medak,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,3583.0,4051.0,3181.0,3180.0,3289.0,3388.0,4005.0,4340.0,4368.0,3904.0,3811.0,3742.0,44842.0
Medak,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,3635.0,3751.0,4059.0,3680.0,3437.0,3383.0,3619.0,4385.0,4480.0,3683.0,3898.0,4007.0,46017.0
Medak,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,4020.0,3712.0,3950.0,3843.0,3408.0,3392.0,3508.0,4002.0,4316.0,3951.0,3748.0,3995.0,45845.0
Medak,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,1304.0,844.0,1189.0,1312.0,1805.0,1095.0,1084.0,1391.0,1407.0,1277.0,1519.0,1199.0,15426.0
Medak,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,3481.0,3923.0,2759.0,1141.0,295.0,141.0,394.0,180.0,457.0,292.0,201.0,474.0,13738.0
Medak,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,3615.0,3705.0,3988.0,2928.0,771.0,373.0,313.0,273.0,498.0,287.0,171.0,180.0,17102.0
Medak,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,3859.0,3630.0,3982.0,3831.0,2402.0,869.0,392.0,292.0,532.0,355.0,231.0,380.0,20755.0
Medak,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,4088.0,4130.0,4407.0,4168.0,4120.0,3666.0,4009.0,4411.0,4099.0,4198.0,3967.0,4117.0,49380.0
Medak,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,3668.0,2955.0,2523.0,3532.0,2722.0,2447.0,3140.0,4308.0,3499.0,3165.0,3154.0,3473.0,38586.0
Medak,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,511.0,919.0,879.0,1499.0,2192.0,1995.0,2344.0,2895.0,2453.0,2262.0,2388.0,2394.0,22731.0
Medak,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1532.0,1566.0,1541.0,1563.0,1878.0,1216.0,1706.0,1492.0,1834.0,1894.0,1918.0,1649.0,19789.0
Medak,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1483.0,1385.0,1421.0,1525.0,1847.0,1149.0,1645.0,1405.0,1747.0,1732.0,1795.0,1609.0,18743.0
Medak,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,3015.0,2951.0,2962.0,3088.0,3725.0,2365.0,3351.0,2897.0,3581.0,3626.0,3713.0,3258.0,38532.0
Medak,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,3942.0,3753.0,4142.0,3699.0,3546.0,3467.0,4015.0,4708.0,4442.0,3819.0,3768.0,3699.0,47000.0
Medak,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,3833.0,3747.0,4133.0,3668.0,3547.0,3443.0,4023.0,4708.0,4420.0,3799.0,3762.0,3694.0,46777.0
Medak,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,700.0,817.0,810.0,620.0,664.0,652.0,784.0,896.0,948.0,625.0,767.0,667.0,8950.0
Medak,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1742.0,1680.0,1924.0,1620.0,1589.0,1516.0,1684.0,1969.0,1942.0,1628.0,1663.0,1515.0,20472.0
Medak,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1647.0,1591.0,1843.0,1620.0,1548.0,1439.0,1559.0,1882.0,1878.0,1548.0,1586.0,1495.0,19636.0
Medak,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,3389.0,3271.0,3767.0,3240.0,3137.0,2955.0,3243.0,3851.0,3820.0,3176.0,3249.0,3010.0,40108.0
Medak,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,2253.0,2399.0,2730.0,2876.0,3512.0,2973.0,2328.0,2530.0,2720.0,2485.0,2542.0,2485.0,31833.0
Medak,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1814.0,1757.0,1776.0,2568.0,3416.0,2946.0,2004.0,2086.0,2296.0,1947.0,1962.0,2049.0,26621.0
Medak,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1606.0,1581.0,1579.0,2640.0,3504.0,3139.0,1795.0,2440.0,1945.0,1869.0,1880.0,1916.0,25894.0
Medak,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Medak,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Medak,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Medak,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,2651.0,2634.0,2712.0,2766.0,2743.0,2625.0,2695.0,2678.0,2667.0,2614.0,2668.0,2655.0,32108.0
Medak,10.4.2,Number of Immunisation sessions held during the month,TOTAL,2650.0,2634.0,2700.0,2778.0,2715.0,2609.0,2695.0,2689.0,2655.0,2642.0,2654.0,2648.0,32069.0
Medak,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,2133.0,2099.0,2126.0,2145.0,2215.0,874.0,536.0,600.0,575.0,1774.0,1934.0,1990.0,19001.0
Medak,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,461.0,641.0,926.0,1482.0,2310.0,1881.0,2403.0,3325.0,3107.0,2320.0,2531.0,2466.0,23853.0
Medak,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,3735.0,3787.0,3754.0,3806.0,3743.0,3192.0,3340.0,3632.0,3352.0,3598.0,3398.0,3495.0,42832.0
Medak,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,1424.0,718.0,992.0,996.0,964.0,923.0,1141.0,1721.0,1788.0,1010.0,1003.0,1170.0,13850.0
Medak,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,1069.0,536.0,682.0,718.0,828.0,833.0,735.0,1026.0,1342.0,873.0,856.0,1021.0,10519.0
Medak,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,,,0.0,5.0,8.0,0.0,,,0.0,,0.0,,13.0
Medak,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,,,,,,0.0,,,0.0,,0.0,,0.0
Medak,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,,,,,,0.0,,,0.0,,0.0,,0.0
Medak,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,,,,,,0.0,,,0.0,,0.0,,0.0
Medak,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,,,,,,0.0,,,0.0,,0.0,,0.0
Medak,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,2.0,13.0,33.0,18.0,10.0,21.0,20.0,21.0,28.0,,26.0,20.0,212.0
Medak,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,1460.0,1621.0,1624.0,1616.0,1755.0,1410.0,1312.0,1289.0,1438.0,1414.0,1366.0,1540.0,17845.0
Medak,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,7.0,60.0,3.0,4.0,8.0,2.0,47.0,2.0,0.0,,3.0,40.0,176.0
Medak,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,41.0,32.0,65.0,95.0,62.0,80.0,43.0,52.0,36.0,33.0,39.0,49.0,627.0
Medak,13.1,Number of Patients operated for cataract,TOTAL,188.0,124.0,251.0,215.0,208.0,288.0,146.0,165.0,196.0,143.0,183.0,269.0,2376.0
Medak,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,182.0,115.0,131.0,212.0,208.0,273.0,140.0,161.0,196.0,143.0,172.0,261.0,2194.0
Medak,13.3,Number of School children detected with Refractive errors,TOTAL,220.0,74.0,233.0,109.0,204.0,186.0,142.0,265.0,287.0,96.0,48.0,205.0,2069.0
Medak,13.4,Number of children provided free glasses,TOTAL,128.0,,6.0,8.0,63.0,14.0,,114.0,141.0,14.0,12.0,163.0,663.0
Medak,13.5,Number of eyes collected through eye donation,TOTAL,,,,,,,,,,,,,
Medak,13.6,Number of eyes utilised for corneal transplant,TOTAL,,,,,,,,,,,,,
Medak,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,3.0,4.0,5.0,5.0,4.0,5.0,5.0,4.0,4.0,4.0,5.0,3.0,-1.0
Medak,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,25.0,18.0,21.0,18.0,20.0,25.0,22.0,25.0,31.0,23.0,24.0,25.0,-1.0
Medak,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,1856.0,1844.0,1974.0,1908.0,2126.0,2251.0,2375.0,1856.0,2084.0,1846.0,2044.0,2065.0,-1.0
Medak,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,2.0,2.0,3.0,3.0,3.0,3.0,3.0,3.0,2.0,3.0,4.0,2.0,-1.0
Medak,14.05,Number of RKS meetings held during the month,TOTAL,17.0,15.0,8.0,8.0,7.0,8.0,7.0,11.0,22.0,12.0,12.0,12.0,139.0
Medak,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,12.0,12.0,11.0,11.0,9.0,16.0,19.0,20.0,22.0,15.0,18.0,14.0,-1.0
Medak,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,203.0,220.0,151.0,159.0,160.0,139.0,85.0,122.0,135.0,118.0,131.0,267.0,1890.0
Medak,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,4.0,2.0,3.0,3.0,3.0,3.0,2.0,3.0,3.0,3.0,4.0,3.0,-1.0
Medak,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,175.0,,88.0,162.0,88.0,,0.0,67.0,116.0,131.0,95.0,0.0,-1.0
Medak,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,,,,,,,,,,,,,
Medak,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,,,,,,,,,,,,,
Medak,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,,,,,,,,,,,,,
Medak,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,1114.0,904.0,895.0,1088.0,985.0,1499.0,944.0,992.0,1154.0,975.0,974.0,1015.0,12539.0
Medak,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,5765.0,6759.0,6576.0,8312.0,5987.0,7800.0,6591.0,6239.0,5600.0,4773.0,5711.0,5449.0,75562.0
Medak,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,898.0,842.0,894.0,1113.0,994.0,1288.0,926.0,882.0,1027.0,1036.0,857.0,990.0,11747.0
Medak,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,7709.0,9218.0,8500.0,9614.0,8593.0,9580.0,8967.0,6656.0,7792.0,6277.0,7265.0,7578.0,97749.0
Medak,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,2012.0,1746.0,1789.0,2201.0,1979.0,2787.0,1870.0,1874.0,2181.0,2011.0,1831.0,2005.0,24286.0
Medak,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,13474.0,15977.0,15076.0,17926.0,14580.0,17380.0,15558.0,12895.0,13392.0,11050.0,12976.0,13027.0,173311.0
Medak,14.10.2.a,Number of death cases of Inpatient males,TOTAL,127.0,91.0,99.0,71.0,89.0,67.0,47.0,54.0,40.0,22.0,25.0,60.0,792.0
Medak,14.10.2.b,Number of death cases of Inpatient females,TOTAL,52.0,54.0,56.0,36.0,47.0,17.0,24.0,38.0,18.0,16.0,14.0,59.0,431.0
Medak,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,179.0,145.0,155.0,107.0,136.0,84.0,71.0,92.0,58.0,38.0,39.0,119.0,1223.0
Medak,14.11,In-Patient Head Count at midnight,TOTAL,17307.0,17000.0,17904.0,17632.0,17186.0,17670.0,18295.0,16303.0,18278.0,16498.0,16576.0,18086.0,208735.0
Medak,14.12.1,OPD attendance (All),TOTAL,370128.0,348425.0,387817.0,415442.0,395680.0,408814.0,410484.0,375415.0,425712.0,405232.0,420657.0,382012.0,4745818.0
Medak,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,556.0,593.0,757.0,483.0,845.0,812.0,596.0,678.0,474.0,461.0,615.0,825.0,7695.0
Medak,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,,94.0,13.0,,183.0,,99.0,10.0,2.0,,1.0,,402.0
Medak,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,,,,,,,,,,,,,
Medak,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,1479.0,1642.0,2106.0,1595.0,1855.0,1951.0,1777.0,1850.0,1704.0,1318.0,1739.0,1648.0,20664.0
Medak,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,,,,,,,,,,,,,
Medak,14.14.a,Number of patients given AYUSH treatment,TOTAL,19240.0,19938.0,19426.0,18693.0,19538.0,19399.0,17803.0,18435.0,21364.0,19212.0,20041.0,21296.0,234385.0
Medak,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,867.0,1236.0,1451.0,1154.0,1077.0,1004.0,1299.0,1236.0,1125.0,1241.0,1123.0,1173.0,13986.0
Medak,14.14.c,Number of Adolescents counselled,TOTAL,1565.0,1864.0,1801.0,1217.0,1978.0,3228.0,2639.0,2892.0,2972.0,3258.0,3742.0,4655.0,31811.0
Medak,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,,,,,,,,,,,,,
Medak,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,16269.0,14856.0,17462.0,17203.0,16558.0,17117.0,15478.0,15031.0,16359.0,15032.0,17300.0,16135.0,194800.0
Medak,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,214.0,173.0,286.0,303.0,205.0,274.0,257.0,281.0,249.0,258.0,309.0,232.0,3041.0
Medak,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,1445.0,1922.0,1628.0,806.0,1040.0,1861.0,1879.0,2135.0,1447.0,1656.0,1904.0,1890.0,19613.0
Medak,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,36.0,17.0,15.0,40.0,44.0,33.0,71.0,46.0,49.0,25.0,24.0,15.0,415.0
Medak,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,2170.0,1507.0,1313.0,686.0,1013.0,1902.0,1628.0,2198.0,1624.0,1681.0,2295.0,2012.0,20029.0
Medak,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,36.0,17.0,16.0,18.0,35.0,21.0,37.0,39.0,28.0,18.0,21.0,10.0,296.0
Medak,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,4148.0,3598.0,3065.0,2412.0,3168.0,3975.0,3190.0,4362.0,4249.0,3236.0,3691.0,3485.0,42579.0
Medak,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,2.0,5.0,2.0,5.0,4.0,8.0,31.0,10.0,21.0,21.0,15.0,4.0,128.0
Medak,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,7763.0,7027.0,6006.0,3904.0,5221.0,7738.0,6697.0,8695.0,7320.0,6573.0,7890.0,7387.0,82221.0
Medak,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,74.0,39.0,33.0,63.0,83.0,62.0,139.0,95.0,98.0,64.0,60.0,29.0,839.0
Medak,15.2,Number of Widal tests conducted,Number tested,2374.0,2320.0,2499.0,3037.0,3317.0,4143.0,4729.0,3611.0,3083.0,2130.0,2331.0,3198.0,36772.0
Medak,15.3.a,Number of VDRL tests conducted on males,Number tested,365.0,294.0,376.0,368.0,266.0,495.0,474.0,481.0,286.0,404.0,699.0,476.0,4984.0
Medak,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,156.0,548.0,506.0,444.0,568.0,537.0,491.0,500.0,386.0,361.0,360.0,531.0,5388.0
Medak,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,1496.0,1708.0,2350.0,2537.0,2193.0,1775.0,2026.0,1948.0,2213.0,2996.0,3392.0,3191.0,27825.0
Medak,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,2017.0,2550.0,3232.0,3349.0,3027.0,2807.0,2991.0,2929.0,2885.0,3761.0,4451.0,4198.0,38197.0
Medak,15.4.1,Number of blood smears examined for Malaria,TOTAL,20507.0,20826.0,22810.0,21237.0,22173.0,22292.0,23163.0,22051.0,20991.0,21608.0,23804.0,23217.0,264679.0
Medak,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,2.0,4.0,4.0,3.0,2.0,2.0,,2.0,2.0,0.0,1.0,6.0,28.0
Medak,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,5.0,6.0,3.0,4.0,0.0,0.0,,,0.0,0.0,1.0,7.0,26.0
Medak,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,140.0,790.0,190.0,620.0,720.0,5220.0,2100.0,1330.0,0.0,,,,11110.0
Medak,16.1.1,Stock position of DPT vaccines,2. Stocks Received,20000.0,15000.0,12000.0,12000.0,10000.0,2000.0,5000.0,5350.0,10000.0,,,,91350.0
Medak,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Medak,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,19350.0,15600.0,11570.0,11900.0,5500.0,5120.0,5770.0,6680.0,9990.0,,,,91480.0
Medak,16.1.1,Stock position of DPT vaccines,5. Total Stock,790.0,190.0,620.0,720.0,5220.0,2100.0,1330.0,0.0,10.0,0.0,0.0,0.0,10980.0
Medak,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,0.0,40320.0,40320.0,26710.0,15240.0,3050.0,10670.0,13930.0,16520.0,,,,166760.0
Medak,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,40320.0,,,,,17280.0,19300.0,20160.0,20160.0,,,,117220.0
Medak,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Medak,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,0.0,,13610.0,11470.0,12190.0,9660.0,16040.0,17570.0,15730.0,,,,96270.0
Medak,16.1.1A,Stock Position of Pentavalent,5. Total Stock,40320.0,40320.0,26710.0,15240.0,3050.0,10670.0,13930.0,16520.0,20950.0,0.0,0.0,0.0,187710.0
Medak,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,20500.0,6800.0,20810.0,12320.0,10380.0,13480.0,24340.0,19020.0,13120.0,,,,140770.0
Medak,16.1.2,Stock position of OPV vaccines,2. Stocks Received,10000.0,40000.0,30000.0,30000.0,30000.0,30000.0,30000.0,30000.0,30000.0,,,,260000.0
Medak,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Medak,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,23700.0,25990.0,38490.0,31940.0,26900.0,19140.0,35320.0,35900.0,34600.0,,,,271980.0
Medak,16.1.2,Stock position of OPV vaccines,5. Total Stock,6800.0,20810.0,12320.0,10380.0,13480.0,24340.0,19020.0,13120.0,8520.0,0.0,0.0,0.0,128790.0
Medak,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,4680.0,4190.0,9350.0,6250.0,3800.0,2100.0,4600.0,10700.0,11750.0,,,,57420.0
Medak,16.1.3,Stock position of TT vaccines,2. Stocks Received,20000.0,20000.0,12000.0,18000.0,18000.0,20000.0,24000.0,20000.0,15000.0,,,,167000.0
Medak,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Medak,16.1.3,Stock position of TT vaccines,4. Stock Distributed,20490.0,14840.0,15100.0,20450.0,19700.0,17500.0,17900.0,18950.0,16630.0,,,,161560.0
Medak,16.1.3,Stock position of TT vaccines,5. Total Stock,4190.0,9350.0,6250.0,3800.0,2100.0,4600.0,10700.0,11750.0,10120.0,0.0,0.0,0.0,62860.0
Medak,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Medak,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Medak,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Medak,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Medak,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Medak,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,5520.0,4920.0,8320.0,7820.0,8120.0,12770.0,15540.0,19240.0,5990.0,,,,88240.0
Medak,16.1.5,Stock position of BCG vaccines,2. Stocks Received,10000.0,15000.0,10000.0,10000.0,14000.0,10000.0,14000.0,,14000.0,,,,97000.0
Medak,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Medak,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,10600.0,11600.0,10500.0,9700.0,9350.0,7230.0,10300.0,13250.0,13400.0,,,,95930.0
Medak,16.1.5,Stock position of BCG vaccines,5. Total Stock,4920.0,8320.0,7820.0,8120.0,12770.0,15540.0,19240.0,5990.0,6590.0,0.0,0.0,0.0,89310.0
Medak,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,5645.0,2160.0,4460.0,1485.0,5035.0,4210.0,10560.0,6660.0,1510.0,,,,41725.0
Medak,16.1.6,Stock position of Measles vaccines,2. Stocks Received,10000.0,15000.0,10000.0,15000.0,10000.0,15000.0,10000.0,10000.0,20000.0,,,,115000.0
Medak,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Medak,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,13485.0,12700.0,12975.0,11450.0,10825.0,8650.0,13900.0,15150.0,16550.0,,,,115685.0
Medak,16.1.6,Stock position of Measles vaccines,5. Total Stock,2160.0,4460.0,1485.0,5035.0,4210.0,10560.0,6660.0,1510.0,4960.0,0.0,0.0,0.0,41040.0
Medak,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,350.0,450.0,7000.0,4850.0,2700.0,6650.0,9790.0,5500.0,3575.0,,,,40865.0
Medak,16.1.7,Stock position of JE vaccines,2. Stocks Received,15000.0,20000.0,10000.0,10000.0,15000.0,10000.0,10000.0,15000.0,15000.0,,,,120000.0
Medak,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Medak,16.1.7,Stock position of JE vaccines,4. Stock Distributed,14900.0,16250.0,12150.0,12150.0,11050.0,6860.0,14290.0,16925.0,18150.0,,,,122725.0
Medak,16.1.7,Stock position of JE vaccines,5. Total Stock,450.0,4200.0,4850.0,2700.0,6650.0,9790.0,5500.0,3575.0,425.0,0.0,0.0,0.0,38140.0
Medak,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,2610.0,5610.0,2040.0,3900.0,3680.0,3870.0,4320.0,1770.0,2580.0,,,,30380.0
Medak,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,20000.0,10000.0,10000.0,6000.0,4000.0,2000.0,,2000.0,0.0,,,,54000.0
Medak,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Medak,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,17000.0,13570.0,8140.0,6220.0,3810.0,1550.0,2550.0,1190.0,1400.0,,,,55430.0
Medak,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,5610.0,2040.0,3900.0,3680.0,3870.0,4320.0,1770.0,2580.0,1180.0,0.0,0.0,0.0,28950.0
Medak,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,1610.0,1510.0,1360.0,1310.0,1210.0,8710.0,8710.0,7810.0,6210.0,,,,38440.0
Medak,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,7800.0,,,,,,,,7800.0
Medak,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Medak,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,100.0,150.0,50.0,100.0,300.0,,900.0,1600.0,50.0,,,,3250.0
Medak,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,1510.0,1360.0,1310.0,1210.0,8710.0,8710.0,7810.0,6210.0,6160.0,0.0,0.0,0.0,42990.0
Medak,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,156120.0,144160.0,125560.0,102520.0,89080.0,341080.0,335080.0,788680.0,764880.0,,,,2847160.0
Medak,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,264000.0,,453600.0,,,,,,717600.0
Medak,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Medak,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,11960.0,18600.0,23040.0,13440.0,12000.0,6000.0,18000.0,23800.0,73200.0,,,,200040.0
Medak,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,144160.0,125560.0,102520.0,89080.0,341080.0,335080.0,770680.0,764880.0,691680.0,0.0,0.0,0.0,3364720.0
Medak,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,1400.0,1100.0,100.0,100.0,,9000.0,9000.0,8400.0,7900.0,,,,37000.0
Medak,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,9000.0,,,,,,,,9000.0
Medak,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Medak,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,300.0,1000.0,,100.0,,,600.0,500.0,3200.0,,,,5700.0
Medak,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,1100.0,100.0,100.0,0.0,9000.0,9000.0,8400.0,7900.0,4700.0,0.0,0.0,0.0,40300.0
Medak,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,3165.0,2930.0,2630.0,2430.0,1530.0,1330.0,1030.0,530.0,230.0,,,,15805.0
Medak,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Medak,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Medak,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,235.0,300.0,200.0,900.0,200.0,300.0,500.0,300.0,,,,,2935.0
Medak,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,2930.0,2630.0,2430.0,1530.0,1330.0,1030.0,530.0,230.0,230.0,0.0,0.0,0.0,12870.0
Medak,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Medak,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Medak,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Medak,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Medak,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Medak,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Medak,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Medak,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Medak,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Medak,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Medak,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Medak,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Medak,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Medak,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Medak,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Medak,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Medak,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Medak,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Medak,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Medak,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Medak,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Medak,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Medak,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Medak,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Medak,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Medak,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Medak,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Medak,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Medak,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Medak,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Medak,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Medak,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Medak,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Medak,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Medak,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Medak,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,36740.0,18935.0,,,,,,,,,,,55675.0
Medak,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Medak,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Medak,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,36740.0,1800.0,,,,,,,,,,,38540.0
Medak,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,17135.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,17135.0
Medak,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,21035.0,,17135.0,14335.0,11635.0,7835.0,6635.0,6135.0,3935.0,,,,88680.0
Medak,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Medak,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Medak,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,2100.0,,2800.0,2700.0,3800.0,1200.0,500.0,2200.0,1000.0,,,,16300.0
Medak,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,18935.0,0.0,14335.0,11635.0,7835.0,6635.0,6135.0,3935.0,2935.0,0.0,0.0,0.0,72380.0
Medak,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Medak,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Medak,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Medak,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Medak,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Medak,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Medak,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Medak,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Medak,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Medak,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Medak,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,26320.0,18930.0,4730.0,4130.0,,,,,,,,,54110.0
Medak,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Medak,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Medak,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,7390.0,14200.0,600.0,4130.0,,,,,,,,,26320.0
Medak,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,18930.0,4730.0,4130.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,27790.0
Medak,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,1800.0,,2200.0,,4800.0,,10200.0,4400.0,,,,23400.0
Medak,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,7600.0,,9900.0,,9900.0,,13200.0,,,,,,40600.0
Medak,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Medak,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,5800.0,1800.0,7700.0,2200.0,5100.0,4800.0,3000.0,5800.0,4400.0,,,,40600.0
Medak,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,1800.0,0.0,2200.0,0.0,4800.0,0.0,10200.0,4400.0,0.0,0.0,0.0,0.0,23400.0
Medak,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,1500.0,400.0,,24700.0,1700.0,182400.0,283600.0,152600.0,135100.0,,,,782000.0
Medak,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,36000.0,,126000.0,40800.0,238200.0,150000.0,,60000.0,,,,,651000.0
Medak,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Medak,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,37100.0,400.0,101300.0,63800.0,57500.0,48800.0,131000.0,77500.0,98200.0,,,,615600.0
Medak,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,400.0,0.0,24700.0,1700.0,182400.0,283600.0,152600.0,135100.0,36900.0,0.0,0.0,0.0,817400.0
Medak,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,10300.0,9300.0,4300.0,3900.0,1300.0,7200.0,4400.0,8700.0,3700.0,,,,53100.0
Medak,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,4800.0,,11200.0,2400.0,10000.0,,10000.0,,,,,,38400.0
Medak,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Medak,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,5800.0,5000.0,11600.0,5000.0,4100.0,2800.0,5700.0,5000.0,3500.0,,,,48500.0
Medak,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,9300.0,4300.0,3900.0,1300.0,7200.0,4400.0,8700.0,3700.0,200.0,0.0,0.0,0.0,43000.0
Medak,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,1.0,1.0,2.0,1.0,,,1.0,,,,1.0,7.0
Medak,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Medak,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Medak,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Medak,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,2.0,2.0,2.0,2.0,1.0,,2.0,3.0,2.0,1.0,,1.0,18.0
Medak,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,1.0,,,,,1.0,2.0
Medak,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,2.0,2.0,2.0,2.0,1.0,,3.0,3.0,2.0,1.0,,2.0,20.0
Medak,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,3.0,,,,2.0,2.0,,3.0,1.0,4.0,4.0,1.0,20.0
Medak,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Medak,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,3.0,,,,2.0,2.0,,3.0,1.0,4.0,4.0,1.0,20.0
Medak,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,3.0,1.0,,3.0,2.0,4.0,2.0,2.0,5.0,3.0,11.0,1.0,37.0
Medak,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Medak,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,3.0,1.0,,3.0,2.0,4.0,2.0,2.0,5.0,3.0,11.0,1.0,37.0
Medak,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,1.0,,,1.0,,,,2.0,,4.0
Medak,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Medak,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,1.0,,,1.0,,,,2.0,,4.0
Medak,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Medak,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Medak,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Medak,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,1.0,,,,1.0,2.0
Medak,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Medak,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,1.0,,,,1.0,2.0
Medak,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Medak,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Medak,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Medak,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,1.0,1.0,1.0,1.0,1.0,6.0,3.0,1.0,3.0,2.0,3.0,23.0
Medak,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,1.0,,3.0,,1.0,3.0,,1.0,9.0
Medak,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,1.0,1.0,1.0,2.0,1.0,9.0,3.0,2.0,6.0,2.0,4.0,32.0
Medak,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Medak,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,2.0,,2.0
Medak,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Medak,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,2.0,,2.0
Medak,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Medak,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,1.0,,,3.0,2.0,1.0,3.0,2.0,4.0,,3.0,19.0
Medak,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,2.0,1.0,,1.0,2.0,,6.0
Medak,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,1.0,,,3.0,2.0,3.0,4.0,2.0,5.0,2.0,3.0,25.0
Medak,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,1.0,,,,,1.0
Medak,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,1.0,,,1.0,,1.0,,,4.0,,1.0,8.0
Medak,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,1.0,,,3.0,4.0,1.0,1.0,1.0,1.0,,2.0,2.0,16.0
Medak,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,1.0,1.0,,3.0,5.0,1.0,2.0,2.0,1.0,4.0,2.0,3.0,25.0
Medak,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Medak,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,1.0,,,,,1.0,,2.0
Medak,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Medak,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,1.0,,,,,1.0,,2.0
Medak,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,1.0,,,,,,,,1.0
Medak,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,1.0,2.0,,1.0,,,,1.0,5.0
Medak,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,3.0,2.0,,1.0,,1.0,1.0,,8.0
Medak,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,5.0,4.0,,2.0,,1.0,1.0,1.0,14.0
Medak,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Medak,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,3.0,,5.0,6.0,1.0,7.0,6.0,3.0,5.0,1.0,2.0,39.0
Medak,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,1.0,,,,,,1.0
Medak,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,3.0,,5.0,6.0,1.0,8.0,6.0,3.0,5.0,1.0,2.0,40.0
Medak,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,1.0,,,,,1.0
Medak,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,1.0,3.0,,13.0,17.0,15.0,15.0,14.0,18.0,15.0,21.0,12.0,144.0
Medak,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,1.0,1.0,1.0,9.0,16.0,7.0,17.0,20.0,4.0,7.0,22.0,13.0,118.0
Medak,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,2.0,4.0,1.0,22.0,33.0,22.0,32.0,35.0,22.0,22.0,43.0,25.0,263.0
Medak,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,1.0,,,,,,,,1.0
Medak,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,1.0,,5.0,4.0,2.0,6.0,1.0,2.0,2.0,4.0,2.0,29.0
Medak,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,1.0,,2.0,12.0,3.0,3.0,10.0,3.0,1.0,10.0,6.0,51.0
Medak,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,2.0,,7.0,17.0,5.0,9.0,11.0,5.0,3.0,14.0,8.0,81.0
Medak,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Medak,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Medak,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Medak,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Medak,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Medak,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Medak,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Medak,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Medak,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Medak,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,1.0,2.0,,,,,1.0,,,1.0,5.0
Medak,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Medak,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,1.0,2.0,,,,,1.0,,,1.0,5.0
Medak,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Medak,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Medak,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Medak,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Medak,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Medak,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,1.0,,1.0
Medak,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Medak,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,1.0,,1.0
Medak,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Medak,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,1.0,,1.0,1.0,2.0,3.0,3.0,1.0,1.0,,2.0,15.0
Medak,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Medak,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,1.0,,1.0,1.0,2.0,3.0,3.0,1.0,1.0,,2.0,15.0
Medak,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,3.0,,1.0,,,3.0,,,,,,7.0
Medak,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,9.0,2.0,17.0,25.0,17.0,15.0,15.0,7.0,19.0,18.0,13.0,157.0
Medak,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,1.0,1.0,,3.0,7.0,1.0,6.0,10.0,3.0,4.0,2.0,1.0,39.0
Medak,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,1.0,13.0,2.0,21.0,32.0,18.0,24.0,25.0,10.0,23.0,20.0,14.0,203.0
Medak,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,1.0,,2.0,,,1.0,,4.0
Medak,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,4.0,6.0,2.0,12.0,28.0,16.0,30.0,28.0,25.0,12.0,19.0,18.0,200.0
Medak,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,1.0,4.0,3.0,2.0,1.0,,2.0,1.0,4.0,18.0
Medak,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,4.0,6.0,2.0,13.0,32.0,20.0,32.0,31.0,25.0,14.0,21.0,22.0,222.0
Medak,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,1.0,,,,,,,1.0
Medak,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,1.0,2.0,4.0,3.0,4.0,,,,,14.0
Medak,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,1.0,,1.0,,1.0,,3.0
Medak,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,1.0,2.0,5.0,4.0,4.0,1.0,,1.0,,18.0
Medak,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,1.0,,,,,,,1.0
Medak,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,1.0,6.0,5.0,1.0,5.0,6.0,8.0,3.0,2.0,1.0,38.0
Medak,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,1.0,15.0,11.0,10.0,19.0,17.0,17.0,12.0,15.0,117.0
Medak,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,1.0,7.0,20.0,13.0,15.0,25.0,25.0,20.0,14.0,16.0,156.0
Medak,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,1.0,,,,,,,,1.0
Medak,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,1.0,,2.0,5.0,9.0,7.0,10.0,7.0,4.0,14.0,4.0,13.0,76.0
Medak,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,3.0,1.0,9.0,11.0,5.0,10.0,7.0,4.0,9.0,11.0,4.0,74.0
Medak,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,1.0,3.0,3.0,14.0,21.0,12.0,20.0,14.0,8.0,23.0,15.0,17.0,151.0
Medak,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,1.0,,,,2.0,3.0,2.0,2.0,,,1.0,1.0,12.0
Medak,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,1.0,11.0,8.0,32.0,45.0,28.0,55.0,23.0,46.0,52.0,42.0,29.0,372.0
Medak,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,12.0,29.0,31.0,143.0,166.0,107.0,185.0,169.0,150.0,231.0,189.0,144.0,1556.0
Medak,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,14.0,40.0,39.0,175.0,213.0,138.0,242.0,194.0,196.0,283.0,232.0,174.0,1940.0
NAGARKURNOOL,1.1,Total number of pregnant women Registered for ANC,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,1.2,Number of Pregnant women registered under JSY,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,1.8,Number of pregnancy test kits used at SC level,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,4.1.1.a,Number of male live births,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,4.1.1.b,Number of female live births,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,4.1.2,Number of still births,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,4.2.1,Number of Newborns weighed at birth,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,6.3,PNC maternal complications attended,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,7.2,Number of MTPs conducted at Private Facilities,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,9.06,Number of IUCD removals,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,9.07,Number of Oral Pills cycles distributed,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,9.08,Number of Condom pieces distributed,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,9.09,Number of Centchroman (weekly) pills given,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,9.11.2.a,Number of failures following male sterilization,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,9.11.2.b,Number of failures following female sterilization,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,9.11.3.a,Number of deaths following male sterilization,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,9.11.3.b,Number of deaths following female sterilization,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,,,,,,,,,,,-1.0
NAGARKURNOOL,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,10.4.2,Number of Immunisation sessions held during the month,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,13.1,Number of Patients operated for cataract,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,13.3,Number of School children detected with Refractive errors,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,13.4,Number of children provided free glasses,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,13.5,Number of eyes collected through eye donation,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,13.6,Number of eyes utilised for corneal transplant,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,,,,,,,,,,,,-1.0
NAGARKURNOOL,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,,,,,,,,,,-1.0
NAGARKURNOOL,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,,,,,,,,,,,,,-1.0
NAGARKURNOOL,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,,,,,,,,,,,,,-1.0
NAGARKURNOOL,14.05,Number of RKS meetings held during the month,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,,,,,,,,,,,,,-1.0
NAGARKURNOOL,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,,,,,,,,,-1.0
NAGARKURNOOL,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,,,,,,,,,,,,,-1.0
NAGARKURNOOL,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,,,,,,,,,,,,,
NAGARKURNOOL,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,,,,,,,,,,,,,
NAGARKURNOOL,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,,,,,,,,,,,,,
NAGARKURNOOL,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,,,,,,,,,,,,,
NAGARKURNOOL,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,,,,,,,,,,,,,
NAGARKURNOOL,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,,,,,,,,,,,,,
NAGARKURNOOL,14.10.2.a,Number of death cases of Inpatient males,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,14.10.2.b,Number of death cases of Inpatient females,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,14.11,In-Patient Head Count at midnight,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,14.12.1,OPD attendance (All),TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,14.14.a,Number of patients given AYUSH treatment,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,14.14.c,Number of Adolescents counselled,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,,,,,,,,,,,,,
NAGARKURNOOL,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,,,,,,,,,,,,,
NAGARKURNOOL,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,,,,,,,,,,,,,
NAGARKURNOOL,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,,,,,,,,,,,,,
NAGARKURNOOL,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,,,,,,,,,,,,,
NAGARKURNOOL,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,,,,,,,,,,,,,
NAGARKURNOOL,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,,,,,,,,,,,,,
NAGARKURNOOL,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,,,,,,,,,,,,,
NAGARKURNOOL,15.2,Number of Widal tests conducted,Number tested,,,,,,,,,,,,,
NAGARKURNOOL,15.3.a,Number of VDRL tests conducted on males,Number tested,,,,,,,,,,,,,
NAGARKURNOOL,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,,,,,,,,,,,,,
NAGARKURNOOL,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,,,,,,,,,,,,,
NAGARKURNOOL,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,,,,,,,,,,,,,
NAGARKURNOOL,15.4.1,Number of blood smears examined for Malaria,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
NAGARKURNOOL,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,,,,,,,,,,
NAGARKURNOOL,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
NAGARKURNOOL,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,,,,,,,,,
NAGARKURNOOL,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
NAGARKURNOOL,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
NAGARKURNOOL,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
NAGARKURNOOL,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
NAGARKURNOOL,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
NAGARKURNOOL,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
NAGARKURNOOL,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
NAGARKURNOOL,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,,,,,,,,,
NAGARKURNOOL,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
NAGARKURNOOL,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,,,,,,,,,
NAGARKURNOOL,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
NAGARKURNOOL,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
NAGARKURNOOL,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,,,,,,,,,
NAGARKURNOOL,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
NAGARKURNOOL,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,,,,,,,,,
NAGARKURNOOL,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
NAGARKURNOOL,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
NAGARKURNOOL,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
NAGARKURNOOL,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
NAGARKURNOOL,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
NAGARKURNOOL,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
NAGARKURNOOL,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
NAGARKURNOOL,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,,,,,,,,,
NAGARKURNOOL,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
NAGARKURNOOL,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,,,,,,,,,
NAGARKURNOOL,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
NAGARKURNOOL,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
NAGARKURNOOL,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,,,,,,,,,
NAGARKURNOOL,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
NAGARKURNOOL,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,,,,,,,,,
NAGARKURNOOL,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
NAGARKURNOOL,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
NAGARKURNOOL,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
NAGARKURNOOL,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
NAGARKURNOOL,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
NAGARKURNOOL,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
NAGARKURNOOL,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
NAGARKURNOOL,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,,,,,,
NAGARKURNOOL,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
NAGARKURNOOL,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,,,,,,
NAGARKURNOOL,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
NAGARKURNOOL,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
NAGARKURNOOL,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
NAGARKURNOOL,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
NAGARKURNOOL,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
NAGARKURNOOL,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
NAGARKURNOOL,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
NAGARKURNOOL,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
NAGARKURNOOL,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
NAGARKURNOOL,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
NAGARKURNOOL,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
NAGARKURNOOL,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
NAGARKURNOOL,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
NAGARKURNOOL,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
NAGARKURNOOL,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
NAGARKURNOOL,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
NAGARKURNOOL,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
NAGARKURNOOL,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
NAGARKURNOOL,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
NAGARKURNOOL,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
NAGARKURNOOL,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
NAGARKURNOOL,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
NAGARKURNOOL,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
NAGARKURNOOL,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
NAGARKURNOOL,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
NAGARKURNOOL,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
NAGARKURNOOL,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
NAGARKURNOOL,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
NAGARKURNOOL,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
NAGARKURNOOL,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
NAGARKURNOOL,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
NAGARKURNOOL,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
NAGARKURNOOL,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
NAGARKURNOOL,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
NAGARKURNOOL,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
NAGARKURNOOL,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
NAGARKURNOOL,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
NAGARKURNOOL,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
NAGARKURNOOL,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
NAGARKURNOOL,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
NAGARKURNOOL,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
NAGARKURNOOL,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
NAGARKURNOOL,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
NAGARKURNOOL,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
NAGARKURNOOL,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
NAGARKURNOOL,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
NAGARKURNOOL,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
NAGARKURNOOL,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
NAGARKURNOOL,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
NAGARKURNOOL,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
NAGARKURNOOL,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
NAGARKURNOOL,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
NAGARKURNOOL,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
NAGARKURNOOL,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
NAGARKURNOOL,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
NAGARKURNOOL,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
NAGARKURNOOL,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
NAGARKURNOOL,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
NAGARKURNOOL,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
NAGARKURNOOL,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
NAGARKURNOOL,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
NAGARKURNOOL,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
NAGARKURNOOL,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
NAGARKURNOOL,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
NAGARKURNOOL,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
NAGARKURNOOL,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
NAGARKURNOOL,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
NAGARKURNOOL,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
NAGARKURNOOL,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
NAGARKURNOOL,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
NAGARKURNOOL,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
NAGARKURNOOL,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
NAGARKURNOOL,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
NAGARKURNOOL,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
NAGARKURNOOL,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
NAGARKURNOOL,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
NAGARKURNOOL,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
NAGARKURNOOL,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
NAGARKURNOOL,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
NAGARKURNOOL,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
NAGARKURNOOL,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
NAGARKURNOOL,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
NAGARKURNOOL,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
NAGARKURNOOL,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
NAGARKURNOOL,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
NAGARKURNOOL,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
NAGARKURNOOL,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
NAGARKURNOOL,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
NAGARKURNOOL,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
NAGARKURNOOL,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
NAGARKURNOOL,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
NAGARKURNOOL,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,,,,,,,
NAGARKURNOOL,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,,,,,,,
NAGARKURNOOL,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
NAGARKURNOOL,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,,,,,,,
NAGARKURNOOL,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
NAGARKURNOOL,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
NAGARKURNOOL,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
NAGARKURNOOL,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
NAGARKURNOOL,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
NAGARKURNOOL,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
NAGARKURNOOL,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
NAGARKURNOOL,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
NAGARKURNOOL,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
NAGARKURNOOL,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
NAGARKURNOOL,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
NAGARKURNOOL,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
NAGARKURNOOL,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
NAGARKURNOOL,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
NAGARKURNOOL,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
NAGARKURNOOL,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
NAGARKURNOOL,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
NAGARKURNOOL,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
NAGARKURNOOL,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
NAGARKURNOOL,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
NAGARKURNOOL,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
NAGARKURNOOL,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
NAGARKURNOOL,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
NAGARKURNOOL,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
NAGARKURNOOL,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
NAGARKURNOOL,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
NAGARKURNOOL,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
NAGARKURNOOL,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
NAGARKURNOOL,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
NAGARKURNOOL,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
NAGARKURNOOL,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
NAGARKURNOOL,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
NAGARKURNOOL,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
NAGARKURNOOL,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
NAGARKURNOOL,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
NAGARKURNOOL,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
NAGARKURNOOL,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
NAGARKURNOOL,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
NAGARKURNOOL,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
NAGARKURNOOL,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
NAGARKURNOOL,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
NAGARKURNOOL,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
NAGARKURNOOL,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
NAGARKURNOOL,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
NAGARKURNOOL,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
NAGARKURNOOL,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
NAGARKURNOOL,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
NAGARKURNOOL,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
NAGARKURNOOL,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
NAGARKURNOOL,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
NAGARKURNOOL,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
NAGARKURNOOL,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
NAGARKURNOOL,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
NAGARKURNOOL,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
NAGARKURNOOL,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
NAGARKURNOOL,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
NAGARKURNOOL,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
NAGARKURNOOL,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
NAGARKURNOOL,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
NAGARKURNOOL,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
NAGARKURNOOL,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
NAGARKURNOOL,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
NAGARKURNOOL,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
NAGARKURNOOL,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
NAGARKURNOOL,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
NAGARKURNOOL,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
NAGARKURNOOL,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
NAGARKURNOOL,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
NAGARKURNOOL,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
NAGARKURNOOL,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
NAGARKURNOOL,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
NAGARKURNOOL,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
NAGARKURNOOL,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
NAGARKURNOOL,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
NAGARKURNOOL,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
NAGARKURNOOL,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
NAGARKURNOOL,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
NAGARKURNOOL,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
NAGARKURNOOL,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
NAGARKURNOOL,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
NAGARKURNOOL,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
NAGARKURNOOL,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
NAGARKURNOOL,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
NAGARKURNOOL,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
NAGARKURNOOL,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
NAGARKURNOOL,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
NAGARKURNOOL,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
NAGARKURNOOL,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
NAGARKURNOOL,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
NAGARKURNOOL,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
NAGARKURNOOL,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
NAGARKURNOOL,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
NAGARKURNOOL,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
NAGARKURNOOL,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
NAGARKURNOOL,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
NAGARKURNOOL,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
NAGARKURNOOL,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
NAGARKURNOOL,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
NAGARKURNOOL,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
NAGARKURNOOL,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
NAGARKURNOOL,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
NAGARKURNOOL,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
NAGARKURNOOL,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
NAGARKURNOOL,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
NAGARKURNOOL,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
NAGARKURNOOL,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
NAGARKURNOOL,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
NAGARKURNOOL,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
NAGARKURNOOL,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
NIRMAL,1.1,Total number of pregnant women Registered for ANC,TOTAL,,,,,,,,,,,,,
NIRMAL,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,,,,,,,,,,,,,
NIRMAL,1.2,Number of Pregnant women registered under JSY,TOTAL,,,,,,,,,,,,,
NIRMAL,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,,,,,,,,,,,,,
NIRMAL,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,,,,,,,,,,,,,
NIRMAL,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,,,,,,,,,,,,,
NIRMAL,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,,,,,,,,,,,,,
NIRMAL,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,,,,,,,,,,,,,
NIRMAL,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,,,,,,,,,,,,,
NIRMAL,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,,,,,,,,,,,,,
NIRMAL,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,,,,,,,,,,,,,
NIRMAL,1.8,Number of pregnancy test kits used at SC level,TOTAL,,,,,,,,,,,,,
NIRMAL,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,,,,,,,,,,,,,
NIRMAL,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,,,,,,,,,,,,,
NIRMAL,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,,,,,,,,,,,,,
NIRMAL,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,,,,,,,,,,,,,
NIRMAL,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,,,,,,,,,,,,,
NIRMAL,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
NIRMAL,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,,,,,,,,,,,,,
NIRMAL,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,,,,,,,,,,,,,
NIRMAL,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,,,,,,,,,,,,,
NIRMAL,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
NIRMAL,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
NIRMAL,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
NIRMAL,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
NIRMAL,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
NIRMAL,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,,,,,,,,,,,,,
NIRMAL,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,,,,,,,,,,,,,
NIRMAL,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,,,,,,,,,,,,,
NIRMAL,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
NIRMAL,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,,,,,,,,,,,,,
NIRMAL,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
NIRMAL,4.1.1.a,Number of male live births,TOTAL,,,,,,,,,,,,,
NIRMAL,4.1.1.b,Number of female live births,TOTAL,,,,,,,,,,,,,
NIRMAL,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,,,,,,,,,,,,,
NIRMAL,4.1.2,Number of still births,TOTAL,,,,,,,,,,,,,
NIRMAL,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,,,,,,,,,,,,,
NIRMAL,4.2.1,Number of Newborns weighed at birth,TOTAL,,,,,,,,,,,,,
NIRMAL,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,,,,,,,,,,,,,
NIRMAL,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,,,,,,,,,,,,,
NIRMAL,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,,,,,,,,,,,,,
NIRMAL,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,,,,,,,,,,,,,
NIRMAL,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,,,,,,,,,,,,,
NIRMAL,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
NIRMAL,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,,,,,,,,,,,,,
NIRMAL,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
NIRMAL,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,,,,,,,,,,,,,
NIRMAL,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,,,,,,,,,,,,,
NIRMAL,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,,,,,,,,,,,,,
NIRMAL,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,,,,,,,,,,,,,
NIRMAL,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,,,,,,,,,,,,,
NIRMAL,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,,,,,,,,,,,,,
NIRMAL,6.3,PNC maternal complications attended,TOTAL,,,,,,,,,,,,,
NIRMAL,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,,,,,,,,,,,,,
NIRMAL,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,,,,,,,,,,,,,
NIRMAL,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,,,,,,,,,,,,,
NIRMAL,7.2,Number of MTPs conducted at Private Facilities,TOTAL,,,,,,,,,,,,,
NIRMAL,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,,,,,,,,,,,,,
NIRMAL,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,,,,,,,,,,,,,
NIRMAL,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,,,,,,,,,,,,,
NIRMAL,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,,,,,,,,,,,,,
NIRMAL,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,,,,,,,,,,,,,
NIRMAL,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,,,,,,,,,,,,,
NIRMAL,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
NIRMAL,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
NIRMAL,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,,,,,,,,,,,,,
NIRMAL,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
NIRMAL,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
NIRMAL,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
NIRMAL,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
NIRMAL,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
NIRMAL,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,,,,,,,,,,,,,
NIRMAL,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
NIRMAL,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
NIRMAL,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
NIRMAL,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
NIRMAL,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
NIRMAL,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,,,,,,,,,,,,,
NIRMAL,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
NIRMAL,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
NIRMAL,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
NIRMAL,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
NIRMAL,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
NIRMAL,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,,,,,,,,,,,,,
NIRMAL,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
NIRMAL,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,,,,,,,,,,,,,
NIRMAL,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,,,,,,,,,,,,,
NIRMAL,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,,,,,,,,,,,,,
NIRMAL,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
NIRMAL,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
NIRMAL,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,,,,,,,,,,,,,
NIRMAL,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,,,,,,,,,,,,,
NIRMAL,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
NIRMAL,9.06,Number of IUCD removals,TOTAL,,,,,,,,,,,,,
NIRMAL,9.07,Number of Oral Pills cycles distributed,TOTAL,,,,,,,,,,,,,
NIRMAL,9.08,Number of Condom pieces distributed,TOTAL,,,,,,,,,,,,,
NIRMAL,9.09,Number of Centchroman (weekly) pills given,TOTAL,,,,,,,,,,,,,
NIRMAL,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,,,,,,,,,,,,,
NIRMAL,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,,,,,,,,,,,,,
NIRMAL,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,,,,,,,,,,,,,
NIRMAL,9.11.2.a,Number of failures following male sterilization,TOTAL,,,,,,,,,,,,,
NIRMAL,9.11.2.b,Number of failures following female sterilization,TOTAL,,,,,,,,,,,,,
NIRMAL,9.11.3.a,Number of deaths following male sterilization,TOTAL,,,,,,,,,,,,,
NIRMAL,9.11.3.b,Number of deaths following female sterilization,TOTAL,,,,,,,,,,,,,
NIRMAL,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,,,,,,,,,,,-1.0
NIRMAL,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,,,,,,,,,,,,,
NIRMAL,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,,,,,,,,,,,,,
NIRMAL,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,,,,,,,,,,,,,
NIRMAL,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,,,,,,,,,,,,,
NIRMAL,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,,,,,,,,,,,,,
NIRMAL,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,,,,,,,,,,,,,
NIRMAL,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,,,,,,,,,,,,,
NIRMAL,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,,,,,,,,,,,,,
NIRMAL,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,,,,,,,,,,,,,
NIRMAL,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,,,,,,,,,,,,,
NIRMAL,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,,,,,,,,,,,,,
NIRMAL,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,,,,,,,,,,,,,
NIRMAL,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,,,,,,,,,,,,,
NIRMAL,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,,,,,,,,,,,,,
NIRMAL,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,,,,,,,,,,,,,
NIRMAL,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,,,,,,,,,,,,,
NIRMAL,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,,,,,,,,,,,,,
NIRMAL,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,,,,,,,,,,,,,
NIRMAL,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
NIRMAL,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
NIRMAL,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,,,,,,,,,,,,,
NIRMAL,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,,,,,,,,,,,,,
NIRMAL,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,,,,,,,,,,,,,
NIRMAL,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,,,,,,,,,,,,,
NIRMAL,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
NIRMAL,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
NIRMAL,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,,,,,,,,,,,,,
NIRMAL,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,,,,,,,,,,,,,
NIRMAL,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,,,,,,,,,,,,,
NIRMAL,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,,,,,,,,,,,,,
NIRMAL,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
NIRMAL,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
NIRMAL,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
NIRMAL,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,,,,,,,,,,,,,
NIRMAL,10.4.2,Number of Immunisation sessions held during the month,TOTAL,,,,,,,,,,,,,
NIRMAL,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,,,,,,,,,,,,,
NIRMAL,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,,,,,,,,,,,,,
NIRMAL,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,,,,,,,,,,,,,
NIRMAL,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,,,,,,,,,,,,,
NIRMAL,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,,,,,,,,,,,,,
NIRMAL,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
NIRMAL,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
NIRMAL,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
NIRMAL,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
NIRMAL,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
NIRMAL,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
NIRMAL,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
NIRMAL,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
NIRMAL,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,,,,,,,,,,,,,
NIRMAL,13.1,Number of Patients operated for cataract,TOTAL,,,,,,,,,,,,,
NIRMAL,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,,,,,,,,,,,,,
NIRMAL,13.3,Number of School children detected with Refractive errors,TOTAL,,,,,,,,,,,,,
NIRMAL,13.4,Number of children provided free glasses,TOTAL,,,,,,,,,,,,,
NIRMAL,13.5,Number of eyes collected through eye donation,TOTAL,,,,,,,,,,,,,
NIRMAL,13.6,Number of eyes utilised for corneal transplant,TOTAL,,,,,,,,,,,,,
NIRMAL,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,,,,,,,,,,,,-1.0
NIRMAL,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,,,,,,,,,,-1.0
NIRMAL,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,,,,,,,,,,,,,-1.0
NIRMAL,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,,,,,,,,,,,,,-1.0
NIRMAL,14.05,Number of RKS meetings held during the month,TOTAL,,,,,,,,,,,,,
NIRMAL,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,,,,,,,,,,,,,-1.0
NIRMAL,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,,,,,,,,,,,,,
NIRMAL,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,,,,,,,,,-1.0
NIRMAL,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,,,,,,,,,,,,,-1.0
NIRMAL,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,,,,,,,,,,,,,
NIRMAL,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,,,,,,,,,,,,,
NIRMAL,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,,,,,,,,,,,,,
NIRMAL,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,,,,,,,,,,,,,
NIRMAL,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,,,,,,,,,,,,,
NIRMAL,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,,,,,,,,,,,,,
NIRMAL,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,,,,,,,,,,,,,
NIRMAL,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,,,,,,,,,,,,,
NIRMAL,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,,,,,,,,,,,,,
NIRMAL,14.10.2.a,Number of death cases of Inpatient males,TOTAL,,,,,,,,,,,,,
NIRMAL,14.10.2.b,Number of death cases of Inpatient females,TOTAL,,,,,,,,,,,,,
NIRMAL,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,,,,,,,,,,,,,
NIRMAL,14.11,In-Patient Head Count at midnight,TOTAL,,,,,,,,,,,,,
NIRMAL,14.12.1,OPD attendance (All),TOTAL,,,,,,,,,,,,,
NIRMAL,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,,,,,,,,,,,,,
NIRMAL,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,,,,,,,,,,,,,
NIRMAL,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,,,,,,,,,,,,,
NIRMAL,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,,,,,,,,,,,,,
NIRMAL,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,,,,,,,,,,,,,
NIRMAL,14.14.a,Number of patients given AYUSH treatment,TOTAL,,,,,,,,,,,,,
NIRMAL,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,,,,,,,,,,,,,
NIRMAL,14.14.c,Number of Adolescents counselled,TOTAL,,,,,,,,,,,,,
NIRMAL,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,,,,,,,,,,,,,
NIRMAL,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,,,,,,,,,,,,,
NIRMAL,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,,,,,,,,,,,,,
NIRMAL,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,,,,,,,,,,,,,
NIRMAL,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,,,,,,,,,,,,,
NIRMAL,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,,,,,,,,,,,,,
NIRMAL,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,,,,,,,,,,,,,
NIRMAL,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,,,,,,,,,,,,,
NIRMAL,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,,,,,,,,,,,,,
NIRMAL,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,,,,,,,,,,,,,
NIRMAL,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,,,,,,,,,,,,,
NIRMAL,15.2,Number of Widal tests conducted,Number tested,,,,,,,,,,,,,
NIRMAL,15.3.a,Number of VDRL tests conducted on males,Number tested,,,,,,,,,,,,,
NIRMAL,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,,,,,,,,,,,,,
NIRMAL,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,,,,,,,,,,,,,
NIRMAL,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,,,,,,,,,,,,,
NIRMAL,15.4.1,Number of blood smears examined for Malaria,TOTAL,,,,,,,,,,,,,
NIRMAL,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,,,,,,,,,,,,,
NIRMAL,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,,,,,,,,,,,,,
NIRMAL,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
NIRMAL,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,,,,,,,,,,
NIRMAL,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
NIRMAL,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,,,,,,,,,
NIRMAL,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
NIRMAL,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
NIRMAL,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
NIRMAL,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
NIRMAL,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
NIRMAL,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
NIRMAL,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
NIRMAL,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,,,,,,,,,
NIRMAL,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
NIRMAL,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,,,,,,,,,
NIRMAL,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
NIRMAL,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
NIRMAL,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,,,,,,,,,
NIRMAL,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
NIRMAL,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,,,,,,,,,
NIRMAL,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
NIRMAL,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
NIRMAL,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
NIRMAL,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
NIRMAL,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
NIRMAL,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
NIRMAL,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
NIRMAL,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,,,,,,,,,
NIRMAL,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
NIRMAL,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,,,,,,,,,
NIRMAL,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
NIRMAL,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
NIRMAL,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,,,,,,,,,
NIRMAL,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
NIRMAL,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,,,,,,,,,
NIRMAL,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
NIRMAL,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
NIRMAL,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
NIRMAL,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
NIRMAL,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
NIRMAL,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
NIRMAL,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
NIRMAL,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,,,,,,
NIRMAL,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
NIRMAL,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,,,,,,
NIRMAL,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
NIRMAL,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
NIRMAL,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
NIRMAL,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
NIRMAL,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
NIRMAL,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
NIRMAL,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
NIRMAL,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
NIRMAL,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
NIRMAL,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
NIRMAL,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
NIRMAL,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
NIRMAL,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
NIRMAL,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
NIRMAL,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
NIRMAL,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
NIRMAL,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
NIRMAL,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
NIRMAL,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
NIRMAL,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
NIRMAL,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
NIRMAL,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
NIRMAL,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
NIRMAL,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
NIRMAL,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
NIRMAL,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
NIRMAL,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
NIRMAL,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
NIRMAL,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
NIRMAL,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
NIRMAL,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
NIRMAL,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
NIRMAL,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
NIRMAL,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
NIRMAL,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
NIRMAL,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
NIRMAL,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
NIRMAL,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
NIRMAL,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
NIRMAL,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
NIRMAL,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
NIRMAL,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
NIRMAL,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
NIRMAL,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
NIRMAL,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
NIRMAL,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
NIRMAL,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
NIRMAL,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
NIRMAL,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
NIRMAL,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
NIRMAL,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
NIRMAL,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
NIRMAL,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
NIRMAL,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
NIRMAL,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
NIRMAL,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
NIRMAL,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
NIRMAL,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
NIRMAL,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
NIRMAL,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
NIRMAL,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
NIRMAL,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
NIRMAL,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
NIRMAL,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
NIRMAL,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
NIRMAL,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
NIRMAL,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
NIRMAL,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
NIRMAL,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
NIRMAL,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
NIRMAL,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
NIRMAL,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
NIRMAL,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
NIRMAL,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
NIRMAL,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
NIRMAL,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
NIRMAL,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
NIRMAL,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
NIRMAL,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
NIRMAL,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
NIRMAL,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
NIRMAL,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
NIRMAL,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
NIRMAL,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
NIRMAL,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
NIRMAL,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
NIRMAL,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
NIRMAL,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
NIRMAL,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
NIRMAL,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
NIRMAL,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
NIRMAL,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,,,,,,,
NIRMAL,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,,,,,,,
NIRMAL,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
NIRMAL,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,,,,,,,
NIRMAL,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
NIRMAL,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
NIRMAL,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
NIRMAL,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
NIRMAL,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
NIRMAL,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
NIRMAL,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
NIRMAL,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
NIRMAL,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
NIRMAL,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
NIRMAL,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
NIRMAL,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
NIRMAL,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
NIRMAL,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
NIRMAL,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
NIRMAL,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
NIRMAL,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
NIRMAL,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
NIRMAL,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
NIRMAL,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
NIRMAL,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
NIRMAL,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
NIRMAL,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
NIRMAL,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
NIRMAL,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
NIRMAL,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
NIRMAL,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
NIRMAL,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
NIRMAL,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
NIRMAL,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
NIRMAL,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
NIRMAL,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
NIRMAL,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
NIRMAL,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
NIRMAL,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
NIRMAL,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
NIRMAL,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
NIRMAL,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
NIRMAL,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
NIRMAL,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
NIRMAL,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
NIRMAL,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
NIRMAL,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
NIRMAL,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
NIRMAL,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
NIRMAL,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
NIRMAL,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
NIRMAL,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
NIRMAL,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
NIRMAL,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
NIRMAL,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
NIRMAL,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
NIRMAL,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
NIRMAL,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
NIRMAL,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
NIRMAL,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
NIRMAL,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
NIRMAL,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
NIRMAL,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
NIRMAL,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
NIRMAL,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
NIRMAL,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
NIRMAL,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
NIRMAL,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
NIRMAL,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
NIRMAL,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
NIRMAL,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
NIRMAL,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
NIRMAL,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
NIRMAL,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
NIRMAL,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
NIRMAL,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
NIRMAL,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
NIRMAL,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
NIRMAL,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
NIRMAL,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
NIRMAL,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
NIRMAL,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
NIRMAL,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
NIRMAL,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
NIRMAL,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
NIRMAL,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
NIRMAL,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
NIRMAL,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
NIRMAL,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
NIRMAL,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
NIRMAL,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
NIRMAL,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
NIRMAL,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
NIRMAL,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
NIRMAL,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
NIRMAL,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
NIRMAL,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
NIRMAL,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
NIRMAL,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
NIRMAL,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
NIRMAL,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
NIRMAL,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
NIRMAL,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
NIRMAL,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
NIRMAL,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
NIRMAL,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
NIRMAL,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
NIRMAL,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
NIRMAL,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
NIRMAL,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
NIRMAL,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
NIRMAL,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
NIRMAL,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
Nalgonda,1.1,Total number of pregnant women Registered for ANC,TOTAL,5464.0,4581.0,5303.0,5081.0,4650.0,4318.0,4728.0,5171.0,4758.0,4686.0,5611.0,5592.0,59943.0
Nalgonda,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,4103.0,3368.0,3857.0,3694.0,3400.0,3257.0,3492.0,3744.0,3498.0,3627.0,3740.0,3649.0,43429.0
Nalgonda,1.2,Number of Pregnant women registered under JSY,TOTAL,4027.0,3187.0,3875.0,3767.0,3502.0,3213.0,3737.0,4174.0,3714.0,3785.0,3885.0,3801.0,44667.0
Nalgonda,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,5493.0,5080.0,5880.0,5770.0,5758.0,6072.0,4704.0,5056.0,4441.0,4840.0,5631.0,5040.0,63765.0
Nalgonda,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,5424.0,4369.0,5281.0,5059.0,4635.0,4273.0,4663.0,5066.0,4636.0,4624.0,4780.0,5452.0,58262.0
Nalgonda,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,4881.0,5143.0,4721.0,4984.0,4991.0,4751.0,4569.0,4527.0,4914.0,4626.0,4471.0,5006.0,57584.0
Nalgonda,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,4805.0,4789.0,4853.0,5065.0,4897.0,4894.0,4791.0,4743.0,4662.0,4520.0,4442.0,4721.0,57182.0
Nalgonda,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,88.0,66.0,83.0,73.0,55.0,73.0,98.0,98.0,102.0,70.0,101.0,79.0,986.0
Nalgonda,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,7.0,4.0,0.0,0.0,1.0,6.0,4.0,4.0,0.0,2.0,2.0,30.0
Nalgonda,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,747.0,832.0,836.0,757.0,846.0,693.0,776.0,835.0,839.0,754.0,777.0,815.0,9507.0
Nalgonda,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,16.0,9.0,4.0,0.0,8.0,39.0,52.0,16.0,16.0,25.0,23.0,25.0,233.0
Nalgonda,1.8,Number of pregnancy test kits used at SC level,TOTAL,430.0,453.0,923.0,1287.0,1473.0,1326.0,1572.0,1731.0,1568.0,1460.0,1666.0,1619.0,15508.0
Nalgonda,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,51.0,26.0,36.0,21.0,21.0,34.0,27.0,45.0,27.0,26.0,32.0,37.0,383.0
Nalgonda,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,34.0,43.0,37.0,39.0,47.0,50.0,48.0,58.0,36.0,38.0,33.0,28.0,491.0
Nalgonda,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,85.0,69.0,73.0,60.0,68.0,84.0,75.0,103.0,63.0,64.0,65.0,65.0,874.0
Nalgonda,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,84.0,59.0,52.0,56.0,68.0,60.0,69.0,101.0,49.0,52.0,56.0,37.0,743.0
Nalgonda,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,17.0,13.0,12.0,18.0,13.0,12.0,8.0,10.0,5.0,11.0,9.0,13.0,141.0
Nalgonda,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1104.0,1037.0,1194.0,750.0,899.0,1294.0,929.0,971.0,911.0,820.0,641.0,776.0,11326.0
Nalgonda,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,581.0,491.0,330.0,336.0,312.0,360.0,356.0,281.0,440.0,446.0,262.0,235.0,4430.0
Nalgonda,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,410.0,604.0,837.0,554.0,593.0,757.0,706.0,248.0,595.0,235.0,541.0,128.0,6208.0
Nalgonda,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,17.0,25.0,0.0,8.0,15.0,0.0,10.0,3.0,2.0,22.0,41.0,63.0,206.0
Nalgonda,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,21.0,22.0,0.0,0.0,6.0,0.0,2.0,0.0,15.0,7.0,11.0,0.0,84.0
Nalgonda,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,2865.0,3083.0,3035.0,2690.0,2862.0,2939.0,2845.0,3425.0,3055.0,2993.0,2441.0,2465.0,34698.0
Nalgonda,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Nalgonda,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Nalgonda,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Nalgonda,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,5.0,0.0,8.0,9.0,0.0,8.0,0.0,0.0,0.0,14.0,0.0,0.0,44.0
Nalgonda,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,73.0,44.0,44.0,37.0,40.0,50.0,79.0,48.0,67.0,63.0,56.0,54.0,655.0
Nalgonda,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,315.0,329.0,530.0,297.0,352.0,500.0,355.0,379.0,429.0,433.0,344.0,384.0,4647.0
Nalgonda,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Nalgonda,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,393.0,373.0,582.0,343.0,392.0,558.0,434.0,427.0,496.0,510.0,400.0,438.0,5346.0
Nalgonda,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,1654.0,2088.0,1742.0,1737.0,1547.0,1631.0,1747.0,1778.0,1643.0,1576.0,1268.0,1424.0,19835.0
Nalgonda,4.1.1.a,Number of male live births,TOTAL,2105.0,2424.0,2363.0,2171.0,2415.0,2548.0,2254.0,2552.0,2661.0,2399.0,2340.0,1950.0,28182.0
Nalgonda,4.1.1.b,Number of female live births,TOTAL,1987.0,2085.0,2154.0,1914.0,2113.0,2329.0,2055.0,2328.0,2317.0,2129.0,2199.0,1613.0,25223.0
Nalgonda,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,4092.0,4509.0,4517.0,4085.0,4528.0,4877.0,4309.0,4880.0,4978.0,4528.0,4539.0,3563.0,53405.0
Nalgonda,4.1.2,Number of still births,TOTAL,46.0,60.0,48.0,56.0,53.0,58.0,64.0,58.0,57.0,71.0,59.0,63.0,693.0
Nalgonda,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,110.0,93.0,144.0,147.0,159.0,114.0,122.0,180.0,147.0,154.0,140.0,148.0,1658.0
Nalgonda,4.2.1,Number of Newborns weighed at birth,TOTAL,3697.0,3744.0,4219.0,3667.0,4283.0,4338.0,3885.0,4194.0,4776.0,4250.0,3716.0,3398.0,48167.0
Nalgonda,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,304.0,329.0,121.0,117.0,98.0,128.0,105.0,341.0,270.0,208.0,226.0,186.0,2433.0
Nalgonda,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,3668.0,3764.0,4245.0,3741.0,4325.0,4178.0,3621.0,4103.0,4764.0,4213.0,3706.0,2958.0,47286.0
Nalgonda,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,20.0,47.0,86.0,53.0,0.0,69.0,85.0,104.0,109.0,100.0,46.0,57.0,776.0
Nalgonda,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Nalgonda,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,20.0,47.0,86.0,53.0,0.0,69.0,85.0,104.0,109.0,100.0,46.0,57.0,776.0
Nalgonda,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,26.0,32.0,31.0,28.0,31.0,33.0,43.0,25.0,38.0,30.0,23.0,35.0,375.0
Nalgonda,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,6.0,71.0,71.0,40.0,28.0,38.0,78.0,93.0,133.0,32.0,37.0,46.0,673.0
Nalgonda,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,35.0,33.0,20.0,0.0,0.0,12.0,28.0,14.0,64.0,14.0,1.0,0.0,221.0
Nalgonda,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,6.0,56.0,52.0,42.0,28.0,17.0,39.0,89.0,105.0,25.0,35.0,27.0,521.0
Nalgonda,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,8.0,6.0,2.0,0.0,1.0,35.0,39.0,26.0,34.0,34.0,30.0,26.0,241.0
Nalgonda,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1949.0,2189.0,2036.0,1642.0,1813.0,2071.0,1928.0,2112.0,2159.0,1970.0,2020.0,1695.0,23584.0
Nalgonda,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,2662.0,3036.0,3016.0,2455.0,2814.0,2927.0,2481.0,2803.0,2894.0,2643.0,2270.0,2280.0,32281.0
Nalgonda,6.3,PNC maternal complications attended,TOTAL,0.0,0.0,35.0,0.0,0.0,66.0,74.0,82.0,94.0,0.0,18.0,0.0,369.0
Nalgonda,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,7.0,13.0,13.0,14.0,11.0,13.0,13.0,9.0,20.0,11.0,14.0,16.0,154.0
Nalgonda,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,3.0,4.0,10.0,2.0,3.0,5.0,6.0,5.0,2.0,3.0,1.0,4.0,48.0
Nalgonda,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,10.0,17.0,23.0,16.0,14.0,18.0,19.0,14.0,22.0,14.0,15.0,20.0,202.0
Nalgonda,7.2,Number of MTPs conducted at Private Facilities,TOTAL,22.0,10.0,14.0,21.0,19.0,20.0,26.0,39.0,28.0,26.0,17.0,21.0,263.0
Nalgonda,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,585.0,596.0,558.0,646.0,722.0,697.0,629.0,454.0,598.0,492.0,538.0,569.0,7084.0
Nalgonda,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,697.0,674.0,686.0,759.0,789.0,905.0,832.0,666.0,781.0,753.0,726.0,767.0,9035.0
Nalgonda,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,1282.0,1270.0,1244.0,1405.0,1511.0,1602.0,1461.0,1120.0,1379.0,1245.0,1264.0,1336.0,16119.0
Nalgonda,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,3.0
Nalgonda,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,2.0
Nalgonda,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Nalgonda,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,2.0,5.0
Nalgonda,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Nalgonda,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,99.0,118.0,21.0,0.0,0.0,0.0,118.0,3.0,0.0,164.0,3.0,110.0,636.0
Nalgonda,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,181.0,181.0
Nalgonda,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,254.0,331.0,244.0,124.0,391.0,1344.0
Nalgonda,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Nalgonda,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,99.0,118.0,21.0,0.0,0.0,0.0,118.0,257.0,331.0,408.0,127.0,682.0,2161.0
Nalgonda,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Nalgonda,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,61.0,40.0,15.0,68.0,46.0,102.0,64.0,37.0,58.0,25.0,83.0,2319.0,2918.0
Nalgonda,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,11.0,0.0,0.0,9.0,2.0,8.0,4.0,22.0,0.0,0.0,0.0,73.0,129.0
Nalgonda,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,71.0,0.0,23.0,33.0,43.0,61.0,72.0,581.0,884.0
Nalgonda,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Nalgonda,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,72.0,40.0,15.0,77.0,119.0,110.0,91.0,92.0,101.0,86.0,155.0,2973.0,3931.0
Nalgonda,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,289.0,462.0,367.0,497.0,462.0,512.0,472.0,523.0,509.0,565.0,496.0,544.0,5698.0
Nalgonda,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,44.0,1.0,3.0,90.0,22.0,51.0,37.0,12.0,0.0,4.0,4.0,6.0,274.0
Nalgonda,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,21.0,14.0,17.0,9.0,5.0,21.0,16.0,20.0,17.0,13.0,28.0,41.0,222.0
Nalgonda,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,170.0,105.0,0.0,42.0,15.0,51.0,103.0,131.0,41.0,54.0,34.0,170.0,916.0
Nalgonda,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Nalgonda,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,235.0,120.0,20.0,141.0,42.0,123.0,156.0,163.0,58.0,71.0,66.0,217.0,1412.0
Nalgonda,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,413.0,338.0,406.0,411.0,444.0,350.0,432.0,334.0,428.0,469.0,356.0,404.0,4785.0
Nalgonda,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,252.0,265.0,206.0,169.0,123.0,122.0,119.0,131.0,108.0,146.0,169.0,107.0,1917.0
Nalgonda,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,163.0,138.0,151.0,220.0,151.0,83.0,102.0,61.0,60.0,57.0,55.0,42.0,1283.0
Nalgonda,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,7.0,7.0,5.0,0.0,2.0,5.0,11.0,23.0,28.0,29.0,4.0,30.0,151.0
Nalgonda,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Nalgonda,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,422.0,410.0,362.0,389.0,276.0,210.0,232.0,215.0,196.0,232.0,228.0,179.0,3351.0
Nalgonda,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,36.0,52.0,28.0,31.0,63.0,72.0,33.0,23.0,16.0,14.0,89.0,54.0,511.0
Nalgonda,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,425.0,481.0,478.0,515.0,485.0,528.0,507.0,525.0,428.0,502.0,528.0,405.0,5807.0
Nalgonda,9.06,Number of IUCD removals,TOTAL,573.0,690.0,388.0,666.0,275.0,226.0,87.0,141.0,151.0,322.0,218.0,261.0,3998.0
Nalgonda,9.07,Number of Oral Pills cycles distributed,TOTAL,8609.0,8428.0,9855.0,10323.0,11454.0,10047.0,10149.0,11253.0,11005.0,11970.0,10405.0,10614.0,124112.0
Nalgonda,9.08,Number of Condom pieces distributed,TOTAL,26175.0,32322.0,33828.0,39422.0,44700.0,39445.0,42507.0,47989.0,45936.0,44847.0,43725.0,41974.0,482870.0
Nalgonda,9.09,Number of Centchroman (weekly) pills given,TOTAL,3491.0,3884.0,3328.0,592.0,5189.0,661.0,1299.0,690.0,442.0,521.0,637.0,632.0,21366.0
Nalgonda,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,55.0,48.0,129.0,76.0,50.0,58.0,64.0,49.0,48.0,209.0,55.0,106.0,947.0
Nalgonda,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,9.12,Number of Institutions having NSV trained doctors,TOTAL,29.0,34.0,8.0,22.0,31.0,19.0,15.0,21.0,20.0,23.0,23.0,5.0,-1.0
Nalgonda,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,4092.0,4432.0,4480.0,3876.0,4260.0,4435.0,4205.0,4880.0,4273.0,4309.0,3600.0,3561.0,50403.0
Nalgonda,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,3960.0,4058.0,3813.0,1053.0,437.0,489.0,250.0,108.0,118.0,145.0,116.0,128.0,14675.0
Nalgonda,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,4144.0,3923.0,4020.0,3500.0,837.0,559.0,252.0,126.0,110.0,78.0,112.0,123.0,17784.0
Nalgonda,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,4621.0,4196.0,4155.0,3895.0,2969.0,977.0,385.0,161.0,98.0,105.0,128.0,142.0,21832.0
Nalgonda,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,779.0,3953.0,4002.0,3662.0,4093.0,4570.0,4321.0,4315.0,4092.0,3737.0,37524.0
Nalgonda,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,1.0,1156.0,3939.0,3899.0,3783.0,4356.0,4569.0,4279.0,4259.0,4210.0,34451.0
Nalgonda,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,5.0,267.0,1344.0,3882.0,4051.0,4273.0,4321.0,4465.0,4238.0,4410.0,31256.0
Nalgonda,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,4031.0,4183.0,4190.0,3753.0,4094.0,4246.0,4097.0,4758.0,4151.0,4250.0,3427.0,3457.0,48637.0
Nalgonda,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,3925.0,3971.0,4068.0,3765.0,3690.0,3882.0,4201.0,4537.0,4310.0,4325.0,4061.0,3937.0,48672.0
Nalgonda,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,4202.0,3906.0,4016.0,4138.0,4087.0,4108.0,3902.0,4391.0,4564.0,4297.0,4255.0,4412.0,50278.0
Nalgonda,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,4599.0,4193.0,4133.0,4058.0,4061.0,4428.0,4145.0,4159.0,4288.0,4516.0,4186.0,4751.0,51517.0
Nalgonda,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,3267.0,3347.0,3814.0,3314.0,3374.0,3505.0,3446.0,4014.0,3448.0,3589.0,2889.0,2803.0,40810.0
Nalgonda,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,3964.0,3998.0,3777.0,1238.0,857.0,596.0,499.0,220.0,120.0,164.0,169.0,202.0,15804.0
Nalgonda,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,4159.0,3965.0,4005.0,3548.0,1186.0,675.0,479.0,203.0,125.0,164.0,183.0,219.0,18911.0
Nalgonda,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,4617.0,4205.0,4195.0,3958.0,3152.0,1054.0,736.0,246.0,113.0,172.0,200.0,242.0,22890.0
Nalgonda,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,4643.0,4274.0,4942.0,4989.0,4760.0,4440.0,4500.0,4432.0,3981.0,4125.0,4308.0,4508.0,53902.0
Nalgonda,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,3378.0,3133.0,3877.0,4055.0,3779.0,3613.0,4177.0,4735.0,4409.0,4005.0,3986.0,3925.0,47072.0
Nalgonda,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,1276.0,1276.0,3003.0,3647.0,3887.0,3411.0,3837.0,3826.0,3388.0,3437.0,3481.0,3832.0,38301.0
Nalgonda,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2395.0,2199.0,2474.0,2624.0,2437.0,2300.0,2314.0,2342.0,2119.0,2144.0,2265.0,2401.0,28014.0
Nalgonda,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2148.0,1910.0,2362.0,2275.0,2267.0,2138.0,2163.0,2090.0,1855.0,1904.0,2001.0,2070.0,25183.0
Nalgonda,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,4543.0,4109.0,4836.0,4899.0,4704.0,4438.0,4477.0,4432.0,3974.0,4048.0,4266.0,4471.0,53197.0
Nalgonda,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,4471.0,4181.0,4631.0,4642.0,4396.0,4061.0,4655.0,5376.0,4996.0,4593.0,4320.0,4431.0,54753.0
Nalgonda,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,4457.0,4185.0,4630.0,4625.0,4394.0,4072.0,4655.0,5389.0,4960.0,4586.0,4372.0,4434.0,54759.0
Nalgonda,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,112.0,62.0,8.0,40.0,21.0,33.0,91.0,59.0,89.0,65.0,134.0,0.0,714.0
Nalgonda,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,962.0,905.0,824.0,782.0,819.0,765.0,1031.0,1365.0,1225.0,1021.0,959.0,1123.0,11781.0
Nalgonda,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,893.0,815.0,719.0,714.0,819.0,717.0,925.0,1235.0,1113.0,885.0,909.0,1032.0,10776.0
Nalgonda,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,1855.0,1720.0,1543.0,1496.0,1638.0,1482.0,1956.0,2600.0,2338.0,1906.0,1868.0,2155.0,22557.0
Nalgonda,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,3495.0,3539.0,3733.0,3839.0,3949.0,4144.0,3729.0,3848.0,3974.0,3762.0,3758.0,3924.0,45694.0
Nalgonda,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,3584.0,3432.0,3884.0,4179.0,4556.0,4859.0,4211.0,4287.0,4582.0,4309.0,4156.0,4293.0,50332.0
Nalgonda,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,3596.0,3519.0,4000.0,4339.0,4535.0,5048.0,4336.0,4384.0,4612.0,4163.0,4111.0,4466.0,51109.0
Nalgonda,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,4494.0,4517.0,4479.0,4442.0,4549.0,4461.0,4500.0,4660.0,4454.0,4502.0,4422.0,4416.0,53896.0
Nalgonda,10.4.2,Number of Immunisation sessions held during the month,TOTAL,4318.0,4317.0,4393.0,4355.0,4316.0,4363.0,4420.0,4621.0,4420.0,4435.0,4386.0,4378.0,52722.0
Nalgonda,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,3234.0,3257.0,3451.0,3486.0,3561.0,1097.0,406.0,209.0,362.0,3243.0,3349.0,3423.0,29078.0
Nalgonda,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,2311.0,2133.0,2885.0,3012.0,3079.0,2948.0,3691.0,4552.0,4009.0,3763.0,3403.0,3566.0,39352.0
Nalgonda,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,4475.0,4011.0,4586.0,4732.0,4648.0,4211.0,4312.0,4322.0,3953.0,4083.0,4912.0,4378.0,52623.0
Nalgonda,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,3708.0,3576.0,3649.0,4387.0,4831.0,4990.0,4507.0,4501.0,5955.0,4621.0,4561.0,4409.0,53695.0
Nalgonda,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,3712.0,3558.0,3605.0,4397.0,4754.0,4603.0,4696.0,4848.0,6141.0,4885.0,4691.0,4496.0,54386.0
Nalgonda,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,231.0,522.0,332.0,323.0,459.0,364.0,363.0,392.0,349.0,334.0,402.0,528.0,4599.0
Nalgonda,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,2.0,1.0,1.0,1.0,1.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,8.0
Nalgonda,13.1,Number of Patients operated for cataract,TOTAL,219.0,15.0,98.0,208.0,337.0,15.0,32.0,35.0,76.0,251.0,369.0,331.0,1986.0
Nalgonda,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,180.0,11.0,80.0,172.0,312.0,0.0,0.0,0.0,40.0,193.0,310.0,297.0,1595.0
Nalgonda,13.3,Number of School children detected with Refractive errors,TOTAL,2.0,0.0,0.0,0.0,0.0,62.0,190.0,295.0,0.0,11.0,123.0,412.0,1095.0
Nalgonda,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,8.0,6.0,6.0,6.0,6.0,7.0,6.0,7.0,6.0,5.0,5.0,9.0,-1.0
Nalgonda,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,47.0,45.0,39.0,40.0,41.0,39.0,39.0,45.0,37.0,33.0,39.0,39.0,-1.0
Nalgonda,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,2432.0,2737.0,2478.0,2468.0,2682.0,3083.0,2589.0,3014.0,3622.0,3419.0,2640.0,2653.0,-1.0
Nalgonda,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,6.0,5.0,6.0,5.0,5.0,4.0,5.0,6.0,6.0,4.0,5.0,7.0,-1.0
Nalgonda,14.05,Number of RKS meetings held during the month,TOTAL,5.0,7.0,5.0,4.0,4.0,4.0,4.0,7.0,10.0,10.0,5.0,4.0,69.0
Nalgonda,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,30.0,21.0,32.0,30.0,31.0,30.0,24.0,32.0,29.0,27.0,27.0,29.0,-1.0
Nalgonda,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,58.0,12.0,21.0,8.0,9.0,35.0,36.0,29.0,25.0,24.0,15.0,19.0,291.0
Nalgonda,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,7.0,6.0,5.0,5.0,5.0,5.0,5.0,4.0,5.0,5.0,5.0,4.0,-1.0
Nalgonda,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,-1.0
Nalgonda,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,,,,,,,,,,,,,
Nalgonda,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,,,,,,,,,,,,,
Nalgonda,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,,,,,,,,,,,,,
Nalgonda,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,890.0,1227.0,822.0,1325.0,1097.0,650.0,722.0,1487.0,898.0,1087.0,912.0,1545.0,12662.0
Nalgonda,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,3191.0,4520.0,4048.0,5095.0,3857.0,5262.0,6106.0,5761.0,5355.0,5386.0,4566.0,4177.0,57324.0
Nalgonda,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,564.0,1100.0,772.0,1147.0,1197.0,579.0,631.0,1358.0,858.0,993.0,750.0,1309.0,11258.0
Nalgonda,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,4040.0,5494.0,4764.0,6422.0,4821.0,6378.0,5857.0,6303.0,5963.0,6035.0,4876.0,4819.0,65772.0
Nalgonda,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,1454.0,2327.0,1594.0,2472.0,2294.0,1229.0,1353.0,2845.0,1756.0,2080.0,1662.0,2854.0,23920.0
Nalgonda,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,7231.0,10014.0,8812.0,11517.0,8678.0,11640.0,11963.0,12064.0,11318.0,11421.0,9442.0,8996.0,123096.0
Nalgonda,14.10.2.a,Number of death cases of Inpatient males,TOTAL,47.0,63.0,66.0,65.0,39.0,93.0,54.0,85.0,38.0,69.0,49.0,78.0,746.0
Nalgonda,14.10.2.b,Number of death cases of Inpatient females,TOTAL,35.0,55.0,31.0,40.0,37.0,55.0,33.0,48.0,14.0,43.0,43.0,32.0,466.0
Nalgonda,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,82.0,118.0,97.0,105.0,76.0,148.0,87.0,133.0,52.0,112.0,92.0,110.0,1212.0
Nalgonda,14.11,In-Patient Head Count at midnight,TOTAL,6862.0,8026.0,6808.0,8711.0,9753.0,11371.0,9128.0,9287.0,6966.0,7344.0,8545.0,7255.0,100056.0
Nalgonda,14.12.1,OPD attendance (All),TOTAL,243072.0,255529.0,261191.0,282467.0,288878.0,302316.0,318650.0,311463.0,309066.0,302088.0,288118.0,299043.0,3461881.0
Nalgonda,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,248.0,260.0,347.0,309.0,343.0,489.0,376.0,471.0,270.0,243.0,370.0,388.0,4114.0
Nalgonda,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,28.0,0.0,0.0,15.0,63.0,53.0,79.0,22.0,37.0,51.0,0.0,348.0
Nalgonda,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,,,,,,,,,,,,,
Nalgonda,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,942.0,935.0,1201.0,852.0,1427.0,1378.0,1308.0,1215.0,1370.0,1547.0,1463.0,1450.0,15088.0
Nalgonda,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,,,,,,,,,,,,,
Nalgonda,14.14.a,Number of patients given AYUSH treatment,TOTAL,8418.0,8345.0,9080.0,7404.0,8775.0,10773.0,11618.0,10003.0,12992.0,11902.0,9619.0,13034.0,121963.0
Nalgonda,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,696.0,1315.0,825.0,391.0,1380.0,1637.0,2162.0,1043.0,1653.0,1408.0,1474.0,2156.0,16140.0
Nalgonda,14.14.c,Number of Adolescents counselled,TOTAL,80.0,121.0,60.0,89.0,48.0,52.0,59.0,51.0,104.0,64.0,64.0,60.0,852.0
Nalgonda,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,,,,,,,,,,,,,
Nalgonda,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,18524.0,17880.0,20246.0,19226.0,19738.0,12104.0,13471.0,13994.0,11607.0,10619.0,11659.0,11991.0,181059.0
Nalgonda,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,435.0,596.0,678.0,428.0,548.0,869.0,645.0,437.0,597.0,593.0,567.0,516.0,6909.0
Nalgonda,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,1962.0,1908.0,1808.0,1732.0,1560.0,1737.0,1806.0,1888.0,2095.0,1877.0,1885.0,2070.0,22328.0
Nalgonda,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,18.0,15.0,42.0,74.0,53.0,59.0,44.0,55.0,56.0,41.0,38.0,62.0,557.0
Nalgonda,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,1899.0,1730.0,1616.0,1618.0,1671.0,1715.0,1386.0,1755.0,2142.0,1936.0,1968.0,2248.0,21684.0
Nalgonda,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,13.0,13.0,53.0,61.0,51.0,59.0,37.0,73.0,43.0,34.0,46.0,58.0,541.0
Nalgonda,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,3680.0,3087.0,2956.0,2440.0,2663.0,2913.0,1925.0,2343.0,2753.0,2088.0,2311.0,2639.0,31798.0
Nalgonda,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,30.0,6.0,40.0,67.0,59.0,43.0,17.0,5.0,101.0,24.0,115.0,96.0,603.0
Nalgonda,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,7541.0,6725.0,6380.0,5790.0,5894.0,6365.0,5117.0,5986.0,6990.0,5901.0,6164.0,6957.0,75810.0
Nalgonda,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,61.0,34.0,135.0,202.0,163.0,161.0,98.0,133.0,200.0,99.0,199.0,216.0,1701.0
Nalgonda,15.2,Number of Widal tests conducted,Number tested,1053.0,865.0,876.0,719.0,1225.0,1303.0,1676.0,1808.0,1606.0,970.0,1131.0,1026.0,14258.0
Nalgonda,15.3.a,Number of VDRL tests conducted on males,Number tested,194.0,230.0,300.0,153.0,294.0,338.0,351.0,573.0,767.0,482.0,560.0,449.0,4691.0
Nalgonda,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,218.0,276.0,192.0,131.0,205.0,226.0,198.0,444.0,250.0,482.0,381.0,555.0,3558.0
Nalgonda,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,344.0,532.0,424.0,509.0,788.0,1037.0,538.0,717.0,1063.0,701.0,1054.0,722.0,8429.0
Nalgonda,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,756.0,1038.0,916.0,793.0,1287.0,1601.0,1087.0,1734.0,2080.0,1665.0,1995.0,1726.0,16678.0
Nalgonda,15.4.1,Number of blood smears examined for Malaria,TOTAL,13968.0,15957.0,15655.0,17401.0,16391.0,17603.0,16722.0,19390.0,17360.0,15935.0,16465.0,15682.0,198529.0
Nalgonda,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,0.0,0.0,0.0,237.0,0.0,0.0,87.0,84.0,98.0,61.0,61.0,0.0,628.0
Nalgonda,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,13060.0,14160.0,27060.0,29510.0,28210.0,17960.0,14910.0,16000.0,15100.0,11500.0,13800.0,10600.0,211870.0
Nalgonda,16.1.1,Stock position of DPT vaccines,2. Stocks Received,25000.0,25000.0,20000.0,12000.0,0.0,0.0,10000.0,5000.0,10000.0,10000.0,0.0,10000.0,127000.0
Nalgonda,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,23900.0,12100.0,17550.0,13300.0,10250.0,3050.0,8910.0,5900.0,13600.0,7700.0,8500.0,9850.0,134610.0
Nalgonda,16.1.1,Stock position of DPT vaccines,5. Total Stock,14160.0,27060.0,29510.0,28210.0,17960.0,14910.0,16000.0,15100.0,11500.0,13800.0,5300.0,10750.0,204260.0
Nalgonda,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,0.0,,46080.0,35190.0,24700.0,12260.0,24270.0,24210.0,22860.0,22230.0,20040.0,15900.0,247740.0
Nalgonda,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,48160.0,48160.0,0.0,0.0,0.0,28800.0,17280.0,14400.0,17280.0,14400.0,14400.0,17280.0,220160.0
Nalgonda,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,0.0,0.0,10890.0,8670.0,12440.0,16790.0,17340.0,15750.0,17910.0,16590.0,18540.0,18220.0,153140.0
Nalgonda,16.1.1A,Stock Position of Pentavalent,5. Total Stock,48160.0,48160.0,35190.0,26520.0,12260.0,24270.0,24210.0,22860.0,22230.0,20040.0,15900.0,14960.0,314760.0
Nalgonda,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,4900.0,7200.0,12000.0,16340.0,14840.0,15960.0,20060.0,24660.0,22120.0,9520.0,3820.0,8000.0,159420.0
Nalgonda,16.1.2,Stock position of OPV vaccines,2. Stocks Received,40000.0,30000.0,40000.0,30000.0,40000.0,40000.0,40000.0,30000.0,30000.0,30000.0,30000.0,10000.0,390000.0
Nalgonda,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,37700.0,25200.0,35660.0,31500.0,38880.0,35900.0,35400.0,32490.0,42600.0,35700.0,25820.0,18000.0,394850.0
Nalgonda,16.1.2,Stock position of OPV vaccines,5. Total Stock,7200.0,12000.0,16340.0,14840.0,15960.0,20060.0,24660.0,22170.0,9520.0,3820.0,8000.0,0.0,154570.0
Nalgonda,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,25810.0,25410.0,33210.0,17510.0,18310.0,18510.0,14310.0,20460.0,20260.0,19060.0,18210.0,21310.0,252370.0
Nalgonda,16.1.3,Stock position of TT vaccines,2. Stocks Received,20000.0,20000.0,0.0,18000.0,20000.0,20000.0,24800.0,15000.0,20000.0,20000.0,22500.0,20000.0,220300.0
Nalgonda,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,16.1.3,Stock position of TT vaccines,4. Stock Distributed,20400.0,12200.0,15700.0,17200.0,19800.0,24200.0,18650.0,15200.0,21200.0,20850.0,19400.0,20350.0,225150.0
Nalgonda,16.1.3,Stock position of TT vaccines,5. Total Stock,25410.0,33210.0,17510.0,18310.0,18510.0,14310.0,20460.0,20260.0,19060.0,18210.0,21310.0,20960.0,247520.0
Nalgonda,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,15750.0,11600.0,16250.0,16400.0,14900.0,18250.0,8050.0,12150.0,12850.0,13900.0,16450.0,19950.0,176500.0
Nalgonda,16.1.5,Stock position of BCG vaccines,2. Stocks Received,5000.0,10000.0,10000.0,5000.0,14000.0,0.0,14000.0,10000.0,14000.0,14000.0,12000.0,14000.0,122000.0
Nalgonda,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,9150.0,5350.0,9850.0,6500.0,10650.0,10200.0,9900.0,9300.0,12950.0,11450.0,8500.0,9700.0,113500.0
Nalgonda,16.1.5,Stock position of BCG vaccines,5. Total Stock,11600.0,16250.0,16400.0,14900.0,18250.0,8050.0,12150.0,12850.0,13900.0,16450.0,19950.0,24250.0,185000.0
Nalgonda,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,6540.0,9540.0,21090.0,13040.0,8140.0,13165.0,19265.0,20565.0,17815.0,14615.0,14490.0,19165.0,177430.0
Nalgonda,16.1.6,Stock position of Measles vaccines,2. Stocks Received,20000.0,20000.0,5000.0,10000.0,20000.0,20000.0,15000.0,10000.0,15000.0,15000.0,20000.0,15000.0,185000.0
Nalgonda,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,17000.0,8450.0,13050.0,14900.0,14975.0,13900.0,13700.0,12750.0,18200.0,15125.0,15325.0,16500.0,173875.0
Nalgonda,16.1.6,Stock position of Measles vaccines,5. Total Stock,9540.0,21090.0,13040.0,8140.0,13165.0,19265.0,20565.0,17815.0,14615.0,14490.0,19165.0,17665.0,188555.0
Nalgonda,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,900.0,0.0,11300.0,17800.0,17550.0,8280.0,8630.0,9330.0,11230.0,8080.0,2080.0,1930.0,97110.0
Nalgonda,16.1.7,Stock position of JE vaccines,2. Stocks Received,15000.0,20000.0,20000.0,15000.0,5000.0,15000.0,15000.0,15000.0,15000.0,10000.0,15000.0,15000.0,175000.0
Nalgonda,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,16.1.7,Stock position of JE vaccines,4. Stock Distributed,15900.0,8700.0,13500.0,15250.0,14270.0,14650.0,14300.0,13100.0,18150.0,16000.0,15150.0,14980.0,173950.0
Nalgonda,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,11300.0,17800.0,17550.0,8280.0,8630.0,9330.0,11230.0,8080.0,2080.0,1930.0,1950.0,98160.0
Nalgonda,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,15430.0,19630.0,24280.0,11030.0,13830.0,18930.0,16730.0,13980.0,19880.0,17880.0,16580.0,14480.0,202660.0
Nalgonda,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,22500.0,15000.0,0.0,12000.0,12000.0,0.0,0.0,8000.0,0.0,0.0,0.0,0.0,69500.0
Nalgonda,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,18300.0,10350.0,13250.0,9200.0,6900.0,2200.0,2750.0,2100.0,2000.0,1300.0,2100.0,800.0,71250.0
Nalgonda,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,19630.0,24280.0,11030.0,13830.0,18930.0,16730.0,13980.0,19880.0,17880.0,16580.0,14480.0,13680.0,200910.0
Nalgonda,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,300.0,0.0,0.0,,0.0,0.0,14400.0,11250.0,8400.0,15450.0,15450.0,65250.0
Nalgonda,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,10200.0,0.0,0.0,10200.0
Nalgonda,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,300.0,0.0,0.0,,0.0,0.0,4400.0,3000.0,3150.0,1450.0,1800.0,14100.0
Nalgonda,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10000.0,8250.0,15450.0,14000.0,13650.0,61350.0
Nalgonda,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,500000.0,357120.0,256560.0,170000.0,100800.0,200000.0,858720.0,726720.0,507360.0,1269930.0,1269930.0,6217140.0
Nalgonda,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,916650.0,0.0,0.0,916650.0
Nalgonda,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,75600.0,82560.0,155760.0,39200.0,20800.0,10000.0,110400.0,90000.0,154080.0,446400.0,24300.0,1209100.0
Nalgonda,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,424400.0,274560.0,100800.0,130800.0,80000.0,190000.0,748320.0,636720.0,1269930.0,823530.0,1245630.0,5924690.0
Nalgonda,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,8000.0,3300.0,1800.0,,1800.0,0.0,9000.0,5100.0,1500.0,106000.0,106000.0,242500.0
Nalgonda,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,112000.0,0.0,0.0,112000.0
Nalgonda,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,4000.0,1500.0,1800.0,,1800.0,0.0,6000.0,2000.0,7500.0,43200.0,6000.0,73800.0
Nalgonda,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,4000.0,1800.0,0.0,0.0,0.0,0.0,3000.0,3100.0,106000.0,62800.0,100000.0,280700.0
Nalgonda,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,3000.0,2550.0,1050.0,50.0,50.0,50.0,50.0,0.0,0.0,1800.0,1800.0,10400.0
Nalgonda,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,1800.0,0.0,0.0,1800.0
Nalgonda,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,450.0,1500.0,1000.0,50.0,0.0,0.0,0.0,0.0,0.0,200.0,200.0,3400.0
Nalgonda,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,2550.0,1050.0,50.0,0.0,50.0,50.0,50.0,0.0,1800.0,1600.0,1600.0,8800.0
Nalgonda,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,2750.0,2750.0,2750.0,2500.0,2750.0,2500.0,2800.0,1500.0,1000.0,0.0,0.0,21300.0
Nalgonda,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,0.0,0.0,0.0,,0.0,0.0,0.0,1000.0,0.0,1500.0,1500.0,4000.0
Nalgonda,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,0.0,0.0,0.0,,750.0,500.0,2400.0,2000.0,1000.0,1500.0,300.0,8450.0
Nalgonda,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,2750.0,2750.0,2750.0,2500.0,2000.0,2000.0,400.0,500.0,0.0,0.0,1200.0,16850.0
Nalgonda,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,16.3.02,Stock Position of Gloves,2. Stocks Received,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,16.3.02,Stock Position of Gloves,3. Unusable Stock,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,16.3.02,Stock Position of Gloves,4. Stock Distributed,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Nalgonda,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Nalgonda,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Nalgonda,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Nalgonda,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,0.0,2527.0,2527.0,2527.0,2527.0,2527.0,527.0,450.0,340.0,0.0,0.0,0.0,13952.0
Nalgonda,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,2527.0,0.0,0.0,0.0,2000.0,77.0,110.0,340.0,0.0,0.0,0.0,5054.0
Nalgonda,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,2527.0,2527.0,2527.0,527.0,450.0,340.0,0.0,0.0,0.0,0.0,8898.0
Nalgonda,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,12800.0,4200.0,3300.0,12700.0,11000.0,17600.0,11300.0,15700.0,12100.0,6100.0,15400.0,25500.0,147700.0
Nalgonda,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,0.0,9900.0,0.0,9900.0,0.0,13200.0,0.0,0.0,9900.0,13200.0,26400.0,82500.0
Nalgonda,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,8600.0,900.0,500.0,1700.0,3300.0,6300.0,8800.0,3600.0,6000.0,600.0,3100.0,7000.0,50400.0
Nalgonda,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,4200.0,3300.0,12700.0,11000.0,17600.0,11300.0,15700.0,12100.0,6100.0,15400.0,25500.0,44900.0,179800.0
Nalgonda,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,25700.0,2400.0,1400.0,163000.0,80300.0,201500.0,269300.0,102800.0,199400.0,127400.0,127100.0,49100.0,1349400.0
Nalgonda,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,0.0,162000.0,0.0,150000.0,150000.0,0.0,150000.0,0.0,0.0,0.0,150000.0,762000.0
Nalgonda,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,23300.0,1000.0,400.0,82700.0,28800.0,82200.0,166500.0,53400.0,72000.0,300.0,78000.0,76300.0,664900.0
Nalgonda,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,2400.0,1400.0,163000.0,80300.0,201500.0,269300.0,102800.0,199400.0,127400.0,127100.0,49100.0,122800.0,1446500.0
Nalgonda,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,10400.0,6500.0,1300.0,12000.0,7700.0,15300.0,13700.0,14100.0,3800.0,0.0,10000.0,24200.0,119000.0
Nalgonda,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,0.0,12000.0,0.0,10000.0,0.0,10000.0,0.0,0.0,10000.0,16000.0,28000.0,86000.0
Nalgonda,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalgonda,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,3900.0,5200.0,1300.0,4300.0,2400.0,1600.0,9600.0,10300.0,3800.0,0.0,1800.0,10600.0,54800.0
Nalgonda,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,6500.0,1300.0,12000.0,7700.0,15300.0,13700.0,14100.0,3800.0,0.0,10000.0,24200.0,41600.0,150200.0
Nalgonda,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,1.0,1.0,,2.0,1.0,,1.0,3.0,1.0,,,10.0
Nalgonda,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,5.0,,5.0
Nalgonda,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Nalgonda,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,5.0,,5.0
Nalgonda,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,2.0,2.0,1.0,,,,,2.0,4.0,11.0
Nalgonda,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Nalgonda,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,2.0,2.0,1.0,,,,,2.0,4.0,11.0
Nalgonda,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,3.0,1.0,4.0,4.0,4.0,2.0,1.0,2.0,,1.0,2.0,2.0,26.0
Nalgonda,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,1.0,,,,,1.0
Nalgonda,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,3.0,1.0,4.0,4.0,4.0,2.0,1.0,3.0,,1.0,2.0,2.0,27.0
Nalgonda,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,1.0,1.0,4.0,6.0,1.0,9.0,6.0,8.0,2.0,1.0,3.0,7.0,49.0
Nalgonda,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,2.0,,,,,,2.0
Nalgonda,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,1.0,1.0,4.0,6.0,1.0,9.0,8.0,8.0,2.0,1.0,3.0,7.0,51.0
Nalgonda,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,1.0,,,3.0,,1.0,3.0,2.0,2.0,3.0,1.0,1.0,17.0
Nalgonda,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Nalgonda,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,1.0,,,3.0,,1.0,3.0,2.0,2.0,3.0,1.0,1.0,17.0
Nalgonda,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Nalgonda,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Nalgonda,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Nalgonda,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Nalgonda,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,1.0,,,,,,,,,1.0
Nalgonda,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,1.0,,,,,,,,,1.0
Nalgonda,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,1.0,,,,1.0
Nalgonda,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Nalgonda,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,1.0,,,,1.0
Nalgonda,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,5.0,3.0,5.0,2.0,5.0,3.0,5.0,6.0,4.0,13.0,3.0,3.0,57.0
Nalgonda,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,2.0,1.0,2.0,,2.0,1.0,2.0,3.0,2.0,,3.0,5.0,23.0
Nalgonda,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,7.0,4.0,7.0,2.0,7.0,4.0,7.0,9.0,6.0,13.0,6.0,8.0,80.0
Nalgonda,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Nalgonda,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,1.0,,,,,,1.0,,1.0,,,3.0
Nalgonda,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Nalgonda,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,1.0,,,,,,1.0,,1.0,,,3.0
Nalgonda,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,1.0,,,,,1.0
Nalgonda,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,8.0,10.0,9.0,6.0,4.0,5.0,5.0,11.0,4.0,8.0,10.0,5.0,85.0
Nalgonda,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,4.0,3.0,2.0,4.0,5.0,4.0,1.0,2.0,2.0,3.0,2.0,6.0,38.0
Nalgonda,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,12.0,13.0,11.0,10.0,9.0,9.0,6.0,14.0,6.0,11.0,12.0,11.0,124.0
Nalgonda,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Nalgonda,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,2.0,5.0,1.0,2.0,1.0,3.0,4.0,3.0,3.0,2.0,2.0,2.0,30.0
Nalgonda,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,3.0,4.0,,3.0,,3.0,1.0,3.0,3.0,,,20.0
Nalgonda,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,2.0,8.0,5.0,2.0,4.0,3.0,7.0,4.0,6.0,5.0,2.0,2.0,50.0
Nalgonda,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Nalgonda,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,1.0,1.0,,1.0,,,,3.0
Nalgonda,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,1.0,,,,,,,1.0
Nalgonda,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,2.0,1.0,,1.0,,,,4.0
Nalgonda,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,2.0,2.0,,,,,,,4.0
Nalgonda,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,3.0,4.0,4.0,3.0,1.0,5.0,,2.0,,1.0,1.0,24.0
Nalgonda,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,1.0,3.0,5.0,1.0,3.0,,1.0,,1.0,,,,15.0
Nalgonda,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,1.0,6.0,9.0,5.0,8.0,3.0,6.0,,3.0,,1.0,1.0,43.0
Nalgonda,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,1.0,,,,,,,,1.0,,,2.0
Nalgonda,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,7.0,7.0,5.0,9.0,7.0,9.0,5.0,9.0,10.0,3.0,9.0,3.0,83.0
Nalgonda,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,1.0,2.0,1.0,,1.0,,,,,,1.0,,6.0
Nalgonda,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,8.0,10.0,6.0,9.0,8.0,9.0,5.0,9.0,10.0,4.0,10.0,3.0,91.0
Nalgonda,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,3.0,1.0,,2.0,1.0,1.0,,8.0
Nalgonda,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,13.0,12.0,12.0,17.0,25.0,20.0,18.0,21.0,9.0,24.0,20.0,13.0,204.0
Nalgonda,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,15.0,12.0,17.0,10.0,13.0,15.0,21.0,21.0,12.0,13.0,15.0,12.0,176.0
Nalgonda,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,28.0,24.0,29.0,27.0,38.0,38.0,40.0,42.0,23.0,38.0,36.0,25.0,388.0
Nalgonda,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,1.0,,1.0
Nalgonda,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,2.0,2.0,5.0,1.0,3.0,1.0,5.0,2.0,4.0,2.0,4.0,2.0,33.0
Nalgonda,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,1.0,5.0,3.0,1.0,,,3.0,4.0,2.0,1.0,4.0,5.0,29.0
Nalgonda,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,3.0,7.0,8.0,2.0,3.0,1.0,8.0,6.0,6.0,3.0,9.0,7.0,63.0
Nalgonda,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Nalgonda,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Nalgonda,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Nalgonda,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Nalgonda,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Nalgonda,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Nalgonda,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Nalgonda,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Nalgonda,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Nalgonda,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,2.0,,,,1.0,1.0,,,,,,4.0
Nalgonda,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Nalgonda,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,2.0,,,,1.0,1.0,,,,,,4.0
Nalgonda,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Nalgonda,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,1.0,1.0,,,1.0,1.0,,,,4.0
Nalgonda,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Nalgonda,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,1.0,1.0,,,1.0,1.0,,,,4.0
Nalgonda,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Nalgonda,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Nalgonda,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Nalgonda,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Nalgonda,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Nalgonda,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,1.0,,,1.0,,3.0,2.0,2.0,1.0,1.0,1.0,12.0
Nalgonda,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Nalgonda,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,1.0,,,1.0,,3.0,2.0,2.0,1.0,1.0,1.0,12.0
Nalgonda,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,2.0,2.0,2.0,,2.0,1.0,1.0,1.0,1.0,1.0,,13.0
Nalgonda,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,23.0,28.0,26.0,15.0,28.0,25.0,17.0,38.0,28.0,28.0,25.0,32.0,313.0
Nalgonda,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,4.0,8.0,5.0,3.0,2.0,13.0,7.0,6.0,7.0,8.0,9.0,9.0,81.0
Nalgonda,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,27.0,38.0,33.0,20.0,30.0,40.0,25.0,45.0,36.0,37.0,35.0,41.0,407.0
Nalgonda,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,1.0,1.0,,,1.0,,1.0,1.0,,,1.0,,6.0
Nalgonda,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,34.0,38.0,21.0,13.0,30.0,33.0,34.0,46.0,34.0,29.0,42.0,39.0,393.0
Nalgonda,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,1.0,3.0,6.0,4.0,6.0,2.0,4.0,5.0,5.0,3.0,5.0,3.0,47.0
Nalgonda,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,36.0,42.0,27.0,17.0,37.0,35.0,39.0,52.0,39.0,32.0,48.0,42.0,446.0
Nalgonda,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,1.0,1.0,1.0,1.0,,,,,,4.0
Nalgonda,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,1.0,2.0,,,4.0,5.0,1.0,3.0,,1.0,2.0,19.0
Nalgonda,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,2.0,,5.0,1.0,1.0,3.0,1.0,,1.0,1.0,,1.0,16.0
Nalgonda,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,2.0,1.0,7.0,2.0,2.0,8.0,7.0,1.0,4.0,1.0,1.0,3.0,39.0
Nalgonda,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Nalgonda,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,4.0,2.0,7.0,6.0,5.0,4.0,6.0,8.0,2.0,4.0,4.0,10.0,62.0
Nalgonda,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,10.0,8.0,10.0,9.0,9.0,13.0,7.0,11.0,8.0,5.0,2.0,7.0,99.0
Nalgonda,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,14.0,10.0,17.0,15.0,14.0,17.0,13.0,19.0,10.0,9.0,6.0,17.0,161.0
Nalgonda,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,1.0,1.0,1.0,,,,,,,,,1.0,4.0
Nalgonda,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,10.0,14.0,9.0,14.0,13.0,12.0,12.0,20.0,5.0,7.0,10.0,6.0,132.0
Nalgonda,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,16.0,16.0,23.0,15.0,17.0,18.0,14.0,10.0,9.0,10.0,13.0,9.0,170.0
Nalgonda,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,27.0,31.0,33.0,29.0,30.0,30.0,26.0,30.0,14.0,17.0,23.0,16.0,306.0
Nalgonda,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,4.0,3.0,6.0,3.0,7.0,4.0,5.0,12.0,7.0,6.0,7.0,7.0,71.0
Nalgonda,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,172.0,170.0,194.0,122.0,171.0,158.0,119.0,159.0,118.0,129.0,142.0,134.0,1788.0
Nalgonda,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,367.0,369.0,505.0,337.0,443.0,376.0,396.0,429.0,349.0,434.0,384.0,359.0,4748.0
Nalgonda,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,543.0,542.0,705.0,462.0,621.0,538.0,520.0,600.0,474.0,569.0,533.0,500.0,6607.0
Nizamabad,1.1,Total number of pregnant women Registered for ANC,TOTAL,4260.0,3935.0,4226.0,4164.0,3746.0,3869.0,3740.0,3782.0,3850.0,4014.0,4374.0,4135.0,48095.0
Nizamabad,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,3172.0,2944.0,3026.0,3086.0,2782.0,2942.0,2891.0,2748.0,2875.0,3001.0,3438.0,3276.0,36181.0
Nizamabad,1.2,Number of Pregnant women registered under JSY,TOTAL,3118.0,2883.0,2966.0,2948.0,2647.0,2704.0,2535.0,2670.0,2682.0,2833.0,3117.0,3083.0,34186.0
Nizamabad,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,4741.0,4765.0,4736.0,4630.0,4992.0,4647.0,4394.0,5110.0,4605.0,4939.0,5096.0,5696.0,58351.0
Nizamabad,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,4131.0,3804.0,4110.0,4008.0,3620.0,3769.0,3637.0,3667.0,3747.0,3886.0,4228.0,3950.0,46557.0
Nizamabad,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,4187.0,4456.0,4048.0,4168.0,3973.0,3863.0,3681.0,3711.0,3795.0,3849.0,3881.0,4347.0,47959.0
Nizamabad,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,4207.0,3933.0,4136.0,3947.0,4093.0,3913.0,3852.0,3989.0,4039.0,4031.0,4347.0,4237.0,48724.0
Nizamabad,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,39.0,32.0,27.0,22.0,14.0,28.0,42.0,5.0,78.0,15.0,45.0,13.0,360.0
Nizamabad,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,5.0,2.0,0.0,5.0,2.0,0.0,1.0,2.0,5.0,10.0,2.0,34.0
Nizamabad,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,729.0,643.0,653.0,793.0,731.0,675.0,840.0,684.0,814.0,989.0,921.0,735.0,9207.0
Nizamabad,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,2.0,8.0,8.0,8.0,8.0,8.0,11.0,1.0,27.0,70.0,95.0,27.0,273.0
Nizamabad,1.8,Number of pregnancy test kits used at SC level,TOTAL,28.0,62.0,94.0,285.0,288.0,388.0,303.0,466.0,497.0,547.0,674.0,584.0,4216.0
Nizamabad,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,2.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,3.0
Nizamabad,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,3.0
Nizamabad,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,3.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,1.0,6.0
Nizamabad,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Nizamabad,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,2.0
Nizamabad,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1055.0,1041.0,928.0,891.0,1017.0,908.0,1163.0,1002.0,1063.0,1069.0,1016.0,1040.0,12193.0
Nizamabad,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,221.0,172.0,205.0,168.0,222.0,219.0,258.0,268.0,253.0,219.0,231.0,219.0,2655.0
Nizamabad,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,275.0,365.0,123.0,109.0,110.0,130.0,704.0,299.0,565.0,738.0,289.0,325.0,4032.0
Nizamabad,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,18.0,15.0,26.0,21.0,19.0,5.0,56.0,53.0,70.0,83.0,9.0,87.0,462.0
Nizamabad,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,4.0,0.0,7.0,9.0,16.0,11.0,44.0,34.0,19.0,21.0,14.0,27.0,206.0
Nizamabad,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,2321.0,2364.0,2250.0,2960.0,3120.0,2904.0,2731.0,2789.0,2820.0,2639.0,2771.0,2754.0,32423.0
Nizamabad,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Nizamabad,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Nizamabad,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Nizamabad,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,12.0,0.0,12.0,0.0,0.0,0.0,4.0,0.0,0.0,0.0,28.0
Nizamabad,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,4.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,9.0,9.0,0.0,22.0
Nizamabad,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,277.0,265.0,277.0,315.0,295.0,293.0,311.0,307.0,289.0,351.0,299.0,375.0,3654.0
Nizamabad,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Nizamabad,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,281.0,265.0,289.0,315.0,307.0,293.0,311.0,307.0,293.0,360.0,308.0,375.0,3704.0
Nizamabad,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,1859.0,1811.0,1673.0,2462.0,2590.0,2295.0,2308.0,2283.0,2309.0,2009.0,2253.0,1856.0,25708.0
Nizamabad,4.1.1.a,Number of male live births,TOTAL,1683.0,1765.0,1599.0,2002.0,2145.0,1960.0,1955.0,1966.0,2011.0,1988.0,1852.0,1908.0,22834.0
Nizamabad,4.1.1.b,Number of female live births,TOTAL,1636.0,1611.0,1551.0,1891.0,2020.0,1900.0,1933.0,1845.0,1855.0,1735.0,1881.0,1863.0,21721.0
Nizamabad,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,3319.0,3376.0,3150.0,3893.0,4165.0,3860.0,3888.0,3811.0,3866.0,3723.0,3733.0,3771.0,44555.0
Nizamabad,4.1.2,Number of still births,TOTAL,64.0,40.0,62.0,49.0,49.0,48.0,50.0,48.0,52.0,69.0,58.0,36.0,625.0
Nizamabad,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,102.0,87.0,15.0,5.0,18.0,95.0,54.0,16.0,68.0,114.0,111.0,66.0,751.0
Nizamabad,4.2.1,Number of Newborns weighed at birth,TOTAL,2785.0,2340.0,2662.0,3415.0,3610.0,3404.0,3865.0,3773.0,3836.0,3705.0,3717.0,3746.0,40858.0
Nizamabad,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,91.0,96.0,99.0,21.0,18.0,27.0,121.0,62.0,111.0,70.0,88.0,165.0,969.0
Nizamabad,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,2781.0,2346.0,2613.0,3414.0,3606.0,3410.0,3808.0,3790.0,3777.0,3703.0,3720.0,3710.0,40678.0
Nizamabad,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,12.0,0.0,12.0,2.0,12.0,6.0,0.0,3.0,3.0,7.0,57.0
Nizamabad,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nizamabad,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,156.0,99.0,39.0,36.0,25.0,44.0,177.0,159.0,229.0,342.0,189.0,347.0,1842.0
Nizamabad,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Nizamabad,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,156.0,99.0,51.0,36.0,37.0,46.0,189.0,165.0,229.0,345.0,192.0,354.0,1899.0
Nizamabad,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Nizamabad,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,156.0,99.0,39.0,36.0,25.0,46.0,108.0,131.0,85.0,158.0,162.0,275.0,1320.0
Nizamabad,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,1.0,12.0,0.0,0.0,0.0,0.0,21.0,4.0,7.0,13.0,5.0,6.0,69.0
Nizamabad,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,52.0,85.0,39.0,36.0,0.0,46.0,174.0,137.0,143.0,281.0,185.0,216.0,1394.0
Nizamabad,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,2.0,0.0,0.0,0.0,0.0,0.0,0.0,31.0,11.0,8.0,21.0,20.0,93.0
Nizamabad,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,2745.0,2427.0,2680.0,3339.0,3579.0,3264.0,3618.0,3743.0,3763.0,3677.0,3706.0,3757.0,40298.0
Nizamabad,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,2245.0,2454.0,2678.0,3553.0,3516.0,3364.0,3268.0,3227.0,3357.0,3427.0,3607.0,2702.0,37398.0
Nizamabad,6.3,PNC maternal complications attended,TOTAL,3.0,4.0,12.0,5.0,8.0,4.0,0.0,0.0,10.0,10.0,4.0,2.0,62.0
Nizamabad,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nizamabad,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nizamabad,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nizamabad,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nizamabad,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,346.0,559.0,339.0,402.0,390.0,319.0,600.0,484.0,557.0,581.0,859.0,358.0,5794.0
Nizamabad,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,426.0,623.0,455.0,505.0,477.0,410.0,711.0,606.0,760.0,724.0,728.0,468.0,6893.0
Nizamabad,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,772.0,1182.0,794.0,907.0,867.0,729.0,1311.0,1090.0,1317.0,1305.0,1587.0,826.0,12687.0
Nizamabad,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nizamabad,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,2.0,0.0,0.0,0.0,2.0,2.0,2.0,0.0,0.0,4.0,1.0,0.0,13.0
Nizamabad,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,6.0,1.0,3.0,9.0,10.0,7.0,0.0,4.0,0.0,0.0,4.0,0.0,44.0
Nizamabad,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,2.0,2.0,2.0,2.0,0.0,0.0,0.0,0.0,2.0,0.0,10.0
Nizamabad,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Nizamabad,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,8.0,1.0,5.0,11.0,14.0,11.0,2.0,4.0,0.0,4.0,7.0,0.0,67.0
Nizamabad,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Nizamabad,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,49.0,4.0,4.0,37.0,22.0,20.0,12.0,55.0,6.0,66.0,27.0,39.0,341.0
Nizamabad,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,187.0,0.0,85.0,256.0,221.0,126.0,69.0,155.0,59.0,70.0,292.0,65.0,1585.0
Nizamabad,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,72.0,0.0,78.0,114.0,114.0,114.0,115.0,241.0,153.0,148.0,336.0,125.0,1610.0
Nizamabad,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Nizamabad,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,308.0,4.0,167.0,407.0,357.0,260.0,196.0,451.0,218.0,284.0,655.0,229.0,3536.0
Nizamabad,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Nizamabad,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,20.0,0.0,0.0,0.0,0.0,33.0,14.0,25.0,19.0,22.0,23.0,18.0,174.0
Nizamabad,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,71.0,0.0,181.0,63.0,66.0,50.0,48.0,27.0,60.0,109.0,183.0,94.0,952.0
Nizamabad,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,26.0,35.0,0.0,0.0,0.0,0.0,103.0,31.0,97.0,2.0,47.0,88.0,429.0
Nizamabad,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Nizamabad,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,117.0,35.0,181.0,63.0,66.0,83.0,165.0,83.0,176.0,133.0,253.0,200.0,1555.0
Nizamabad,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,400.0,646.0,662.0,870.0,608.0,731.0,981.0,769.0,786.0,765.0,490.0,1571.0,9279.0
Nizamabad,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,6.0,6.0,10.0,9.0,10.0,0.0,0.0,0.0,25.0,0.0,0.0,0.0,66.0
Nizamabad,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nizamabad,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,,0.0,49.0,47.0,47.0,47.0,0.0,27.0,0.0,0.0,7.0,17.0,241.0
Nizamabad,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Nizamabad,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,6.0,6.0,59.0,56.0,57.0,47.0,0.0,27.0,25.0,0.0,7.0,17.0,307.0
Nizamabad,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nizamabad,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,46.0,43.0,30.0,45.0,69.0,59.0,56.0,42.0,45.0,46.0,35.0,42.0,558.0
Nizamabad,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,21.0,45.0,25.0,50.0,80.0,64.0,40.0,30.0,15.0,4.0,10.0,11.0,395.0
Nizamabad,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,12.0,7.0,0.0,3.0,0.0,14.0,3.0,0.0,0.0,0.0,5.0,3.0,47.0
Nizamabad,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,12.0,12.0,28.0,28.0,28.0,28.0,0.0,1.0,0.0,0.0,0.0,0.0,137.0
Nizamabad,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Nizamabad,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,91.0,107.0,83.0,126.0,177.0,165.0,99.0,73.0,60.0,50.0,50.0,56.0,1137.0
Nizamabad,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,5.0,8.0,6.0,2.0,10.0,17.0,15.0,9.0,3.0,6.0,2.0,6.0,89.0
Nizamabad,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Nizamabad,9.06,Number of IUCD removals,TOTAL,155.0,130.0,130.0,210.0,233.0,198.0,223.0,120.0,134.0,154.0,159.0,148.0,1994.0
Nizamabad,9.07,Number of Oral Pills cycles distributed,TOTAL,3225.0,3212.0,3383.0,3439.0,3955.0,3492.0,3361.0,3091.0,3193.0,3200.0,2850.0,2677.0,39078.0
Nizamabad,9.08,Number of Condom pieces distributed,TOTAL,8879.0,10029.0,5713.0,5855.0,7848.0,6983.0,6860.0,8494.0,7485.0,7977.0,7533.0,6804.0,90460.0
Nizamabad,9.09,Number of Centchroman (weekly) pills given,TOTAL,434.0,702.0,3746.0,3162.0,3536.0,3698.0,3332.0,642.0,698.0,844.0,613.0,616.0,22023.0
Nizamabad,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,4.0,0.0,8.0,5.0,9.0,7.0,0.0,8.0,2.0,2.0,4.0,9.0,58.0
Nizamabad,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,4.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0
Nizamabad,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nizamabad,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nizamabad,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nizamabad,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nizamabad,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nizamabad,9.12,Number of Institutions having NSV trained doctors,TOTAL,16.0,18.0,17.0,16.0,20.0,19.0,21.0,17.0,17.0,17.0,18.0,20.0,-1.0
Nizamabad,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,2766.0,2746.0,2441.0,3837.0,4341.0,3460.0,3658.0,3621.0,3679.0,3951.0,3732.0,3934.0,42166.0
Nizamabad,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,3191.0,3564.0,3326.0,1549.0,1139.0,652.0,342.0,128.0,38.0,375.0,376.0,1.0,14681.0
Nizamabad,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,3227.0,3535.0,3559.0,3276.0,1436.0,684.0,362.0,135.0,54.0,369.0,387.0,0.0,17024.0
Nizamabad,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,3545.0,3641.0,3511.0,3459.0,2871.0,1126.0,475.0,215.0,108.0,378.0,374.0,2.0,19705.0
Nizamabad,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,321.0,255.0,261.0,1890.0,1990.0,2694.0,3058.0,3594.0,3905.0,3340.0,3271.0,3689.0,28268.0
Nizamabad,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,303.0,239.0,137.0,556.0,1883.0,2576.0,3060.0,3389.0,3882.0,3467.0,3342.0,3716.0,26550.0
Nizamabad,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,330.0,144.0,126.0,203.0,695.0,2374.0,2921.0,3420.0,3672.0,3572.0,3419.0,3940.0,24816.0
Nizamabad,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1590.0,1628.0,1560.0,2754.0,3394.0,3491.0,4219.0,4092.0,4167.0,4927.0,2707.0,2616.0,37145.0
Nizamabad,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,3493.0,3784.0,3488.0,3072.0,2954.0,3337.0,3438.0,3566.0,3884.0,3666.0,3521.0,3451.0,41654.0
Nizamabad,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,3507.0,3739.0,3666.0,3586.0,3098.0,3386.0,3392.0,3382.0,3820.0,3796.0,3642.0,3580.0,42594.0
Nizamabad,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,3689.0,3746.0,3557.0,3530.0,3217.0,3321.0,3341.0,3417.0,3677.0,3802.0,3698.0,3755.0,42750.0
Nizamabad,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,1162.0,1103.0,1186.0,2037.0,2646.0,2652.0,3564.0,3232.0,3303.0,4107.0,1849.0,1610.0,28451.0
Nizamabad,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,3280.0,3618.0,3349.0,1693.0,1187.0,823.0,816.0,397.0,350.0,743.0,706.0,425.0,17387.0
Nizamabad,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,3316.0,3546.0,3602.0,3267.0,1468.0,916.0,829.0,427.0,381.0,763.0,725.0,452.0,19692.0
Nizamabad,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,3466.0,3651.0,3496.0,3487.0,2705.0,1183.0,935.0,500.0,489.0,973.0,959.0,704.0,22548.0
Nizamabad,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,4036.0,4172.0,4238.0,4151.0,4080.0,3824.0,3836.0,3720.0,3830.0,3680.0,3736.0,3784.0,47087.0
Nizamabad,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,3457.0,3692.0,3629.0,3275.0,3029.0,3026.0,3738.0,4114.0,4205.0,3830.0,3454.0,3709.0,43158.0
Nizamabad,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,345.0,353.0,556.0,1464.0,1611.0,2174.0,2036.0,2479.0,2301.0,2127.0,2381.0,2271.0,20098.0
Nizamabad,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2020.0,2163.0,2151.0,2173.0,2105.0,1930.0,2039.0,1950.0,1962.0,1941.0,1933.0,1954.0,24321.0
Nizamabad,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1963.0,2033.0,2074.0,1980.0,1997.0,1859.0,1802.0,1805.0,1867.0,1777.0,1853.0,1852.0,22862.0
Nizamabad,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,3983.0,4196.0,4225.0,4153.0,4102.0,3789.0,3841.0,3755.0,3829.0,3718.0,3786.0,3806.0,47183.0
Nizamabad,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,3824.0,3725.0,3924.0,3497.0,3292.0,3240.0,3760.0,4180.0,4295.0,4089.0,3665.0,3855.0,45346.0
Nizamabad,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,3822.0,3735.0,3923.0,3483.0,3288.0,3255.0,3759.0,4185.0,4299.0,4085.0,3667.0,3850.0,45351.0
Nizamabad,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,109.0,98.0,91.0,66.0,60.0,212.0,80.0,80.0,191.0,114.0,187.0,70.0,1358.0
Nizamabad,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1873.0,1894.0,1948.0,1802.0,1603.0,1595.0,1952.0,2035.0,2072.0,2058.0,1770.0,1872.0,22474.0
Nizamabad,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1788.0,1734.0,1772.0,1591.0,1470.0,1472.0,1799.0,1916.0,1975.0,1855.0,1635.0,1775.0,20782.0
Nizamabad,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,3661.0,3628.0,3720.0,3393.0,3073.0,3067.0,3751.0,3951.0,4047.0,3913.0,3405.0,3647.0,43256.0
Nizamabad,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,1565.0,1544.0,1590.0,2096.0,2349.0,3703.0,2650.0,3502.0,2725.0,2146.0,2275.0,2253.0,28398.0
Nizamabad,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1290.0,1170.0,1103.0,1588.0,2368.0,3787.0,2090.0,3368.0,2096.0,1591.0,1907.0,1819.0,24177.0
Nizamabad,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1180.0,839.0,924.0,1439.0,2211.0,3862.0,1881.0,3454.0,2010.0,1384.0,2141.0,1877.0,23202.0
Nizamabad,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nizamabad,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nizamabad,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nizamabad,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,2521.0,2571.0,2505.0,2632.0,2493.0,2547.0,2517.0,2417.0,2425.0,2471.0,2427.0,2481.0,30007.0
Nizamabad,10.4.2,Number of Immunisation sessions held during the month,TOTAL,2508.0,2553.0,2482.0,2617.0,2492.0,2507.0,2495.0,2404.0,2414.0,2461.0,2424.0,2455.0,29812.0
Nizamabad,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1978.0,2060.0,1963.0,2068.0,2039.0,690.0,446.0,267.0,1187.0,1897.0,2000.0,2004.0,18599.0
Nizamabad,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,3000.0,2614.0,3191.0,2706.0,2585.0,2564.0,2766.0,3180.0,3423.0,3162.0,2784.0,2947.0,34922.0
Nizamabad,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,3759.0,4016.0,4008.0,3856.0,3901.0,3511.0,3677.0,3460.0,4233.0,3568.0,3414.0,3084.0,44487.0
Nizamabad,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,2507.0,2709.0,2913.0,2569.0,2531.0,2261.0,2708.0,2976.0,3548.0,2691.0,2526.0,2504.0,32443.0
Nizamabad,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,1300.0,1475.0,1675.0,1420.0,1501.0,1848.0,1368.0,1822.0,2167.0,1570.0,1453.0,1547.0,19146.0
Nizamabad,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nizamabad,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nizamabad,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nizamabad,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nizamabad,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nizamabad,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,16.0,17.0,15.0,6.0,27.0,43.0,5.0,0.0,7.0,14.0,0.0,22.0,172.0
Nizamabad,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,173.0,164.0,171.0,205.0,123.0,81.0,97.0,83.0,134.0,170.0,182.0,161.0,1744.0
Nizamabad,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,45.0,136.0,3.0,0.0,41.0,1.0,1.0,1.0,99.0,14.0,202.0,60.0,603.0
Nizamabad,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,9.0,5.0,9.0,14.0,12.0,49.0
Nizamabad,13.1,Number of Patients operated for cataract,TOTAL,17.0,11.0,24.0,35.0,43.0,36.0,112.0,87.0,102.0,83.0,102.0,102.0,754.0
Nizamabad,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,17.0,11.0,24.0,35.0,43.0,36.0,90.0,86.0,100.0,83.0,101.0,102.0,728.0
Nizamabad,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,12.0,38.0,31.0,49.0,70.0,155.0,49.0,69.0,71.0,63.0,607.0
Nizamabad,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nizamabad,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nizamabad,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nizamabad,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,7.0,6.0,7.0,6.0,6.0,6.0,8.0,6.0,9.0,7.0,7.0,7.0,-1.0
Nizamabad,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,14.0,11.0,13.0,13.0,16.0,15.0,14.0,16.0,16.0,16.0,17.0,17.0,-1.0
Nizamabad,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,2424.0,2361.0,2391.0,2407.0,2371.0,2378.0,2410.0,2284.0,2366.0,2327.0,2284.0,2271.0,-1.0
Nizamabad,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,6.0,6.0,6.0,6.0,6.0,6.0,8.0,7.0,8.0,8.0,7.0,7.0,-1.0
Nizamabad,14.05,Number of RKS meetings held during the month,TOTAL,1.0,2.0,2.0,1.0,1.0,1.0,2.0,6.0,4.0,4.0,4.0,3.0,31.0
Nizamabad,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,19.0,18.0,15.0,18.0,18.0,20.0,21.0,22.0,20.0,19.0,18.0,19.0,-1.0
Nizamabad,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,7.0,11.0,36.0,15.0,0.0,0.0,26.0,30.0,32.0,32.0,20.0,23.0,232.0
Nizamabad,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,6.0,5.0,5.0,4.0,4.0,5.0,6.0,6.0,8.0,6.0,6.0,6.0,-1.0
Nizamabad,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,1.0,0.0,1.0,1.0,1.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,-1.0
Nizamabad,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,,,,,,,,,,,,,
Nizamabad,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,,,,,,,,,,,,,
Nizamabad,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,,,,,,,,,,,,,
Nizamabad,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,135.0,194.0,238.0,272.0,248.0,278.0,298.0,403.0,380.0,310.0,318.0,529.0,3603.0
Nizamabad,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,2605.0,3385.0,2961.0,3244.0,2077.0,3071.0,5088.0,5160.0,4605.0,4055.0,4922.0,5317.0,46490.0
Nizamabad,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,286.0,221.0,324.0,307.0,234.0,312.0,345.0,336.0,387.0,369.0,379.0,524.0,4024.0
Nizamabad,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,3728.0,4677.0,3990.0,4780.0,3367.0,4543.0,7105.0,8007.0,5985.0,6042.0,7012.0,7337.0,66573.0
Nizamabad,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,421.0,415.0,562.0,579.0,482.0,590.0,643.0,739.0,767.0,679.0,697.0,1053.0,7627.0
Nizamabad,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,6333.0,8062.0,6951.0,8024.0,5444.0,7614.0,12193.0,13167.0,10590.0,10097.0,11934.0,12654.0,113063.0
Nizamabad,14.10.2.a,Number of death cases of Inpatient males,TOTAL,4.0,0.0,0.0,0.0,0.0,0.0,29.0,36.0,44.0,25.0,30.0,40.0,208.0
Nizamabad,14.10.2.b,Number of death cases of Inpatient females,TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,28.0,50.0,44.0,22.0,23.0,30.0,198.0
Nizamabad,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,5.0,0.0,0.0,0.0,0.0,0.0,57.0,86.0,88.0,47.0,53.0,70.0,406.0
Nizamabad,14.11,In-Patient Head Count at midnight,TOTAL,5032.0,2550.0,5432.0,3733.0,2438.0,5072.0,18274.0,21883.0,18815.0,20480.0,20971.0,19802.0,144482.0
Nizamabad,14.12.1,OPD attendance (All),TOTAL,257810.0,259841.0,247051.0,268737.0,264494.0,272590.0,290552.0,276883.0,277007.0,275485.0,278385.0,291820.0,3260655.0
Nizamabad,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,139.0,118.0,2.0,147.0,2.0,535.0,486.0,520.0,456.0,481.0,465.0,575.0,3926.0
Nizamabad,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,16.0,11.0,19.0,24.0,196.0,220.0,486.0
Nizamabad,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,,,,,,,,,,,,,
Nizamabad,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,418.0,212.0,179.0,30.0,255.0,91.0,1516.0,1422.0,1446.0,1431.0,1438.0,1464.0,9902.0
Nizamabad,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,,,,,,,,,,,,,
Nizamabad,14.14.a,Number of patients given AYUSH treatment,TOTAL,9370.0,7466.0,8559.0,8944.0,8798.0,5581.0,10016.0,7673.0,9340.0,10518.0,8484.0,7469.0,102218.0
Nizamabad,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,530.0,901.0,877.0,877.0,813.0,844.0,709.0,753.0,452.0,406.0,1041.0,658.0,8861.0
Nizamabad,14.14.c,Number of Adolescents counselled,TOTAL,91.0,134.0,302.0,179.0,136.0,320.0,210.0,147.0,101.0,142.0,152.0,119.0,2033.0
Nizamabad,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,,,,,,,,,,,,,
Nizamabad,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,4236.0,4470.0,4413.0,5153.0,5039.0,5622.0,5965.0,6151.0,5639.0,7148.0,7899.0,7357.0,69092.0
Nizamabad,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,86.0,125.0,171.0,179.0,201.0,171.0,249.0,317.0,282.0,296.0,113.0,95.0,2285.0
Nizamabad,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,1140.0,1434.0,1263.0,1687.0,1258.0,1356.0,1817.0,2522.0,1960.0,1890.0,2310.0,2057.0,20694.0
Nizamabad,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,15.0,11.0,21.0,14.0,14.0,16.0,33.0,36.0,30.0,42.0,42.0,37.0,311.0
Nizamabad,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,1222.0,1193.0,1884.0,1776.0,1819.0,1778.0,1435.0,1817.0,1627.0,1556.0,1966.0,1704.0,19777.0
Nizamabad,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,12.0,26.0,41.0,35.0,36.0,38.0,30.0,32.0,27.0,20.0,29.0,28.0,354.0
Nizamabad,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,2437.0,2126.0,2931.0,2983.0,2984.0,2763.0,2381.0,3080.0,2310.0,3055.0,3671.0,3368.0,34089.0
Nizamabad,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,10.0,5.0,33.0,5.0,33.0,5.0,6.0,2.0,7.0,5.0,53.0,4.0,168.0
Nizamabad,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,4799.0,4753.0,6078.0,6446.0,6061.0,5897.0,5633.0,7419.0,5897.0,6501.0,7947.0,7129.0,74560.0
Nizamabad,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,37.0,42.0,95.0,54.0,83.0,59.0,69.0,70.0,64.0,67.0,124.0,69.0,833.0
Nizamabad,15.2,Number of Widal tests conducted,Number tested,0.0,0.0,31.0,0.0,0.0,0.0,1322.0,1387.0,1242.0,1198.0,1462.0,1236.0,7878.0
Nizamabad,15.3.a,Number of VDRL tests conducted on males,Number tested,82.0,0.0,220.0,220.0,220.0,220.0,669.0,695.0,468.0,457.0,457.0,416.0,4124.0
Nizamabad,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,111.0,0.0,219.0,219.0,219.0,219.0,802.0,504.0,573.0,495.0,915.0,848.0,5124.0
Nizamabad,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,334.0,13.0,0.0,0.0,13.0,0.0,797.0,839.0,743.0,408.0,1456.0,1308.0,5911.0
Nizamabad,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,527.0,13.0,439.0,439.0,452.0,439.0,2268.0,2038.0,1784.0,1360.0,2828.0,2572.0,15159.0
Nizamabad,15.4.1,Number of blood smears examined for Malaria,TOTAL,14178.0,13012.0,12627.0,11785.0,12402.0,12403.0,11565.0,12072.0,13463.0,13979.0,12526.0,13610.0,153622.0
Nizamabad,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,1.0,0.0,3.0,0.0,0.0,1.0,34.0,0.0,0.0,0.0,378.0,0.0,417.0
Nizamabad,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,2.0,0.0,1.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,5.0
Nizamabad,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Nizamabad,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,,,,,,,,,,
Nizamabad,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Nizamabad,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Nizamabad,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nizamabad,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Nizamabad,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Nizamabad,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Nizamabad,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Nizamabad,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nizamabad,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Nizamabad,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,,,,,,,,,
Nizamabad,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Nizamabad,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,,,,,,,,,
Nizamabad,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nizamabad,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Nizamabad,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,,,,,,,,,
Nizamabad,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Nizamabad,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Nizamabad,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nizamabad,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Nizamabad,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Nizamabad,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Nizamabad,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Nizamabad,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nizamabad,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Nizamabad,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,,,,,,,,,
Nizamabad,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Nizamabad,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,,,,,,,,,
Nizamabad,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nizamabad,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Nizamabad,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,,,,,,,,,
Nizamabad,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Nizamabad,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,,,,,,,,,
Nizamabad,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nizamabad,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Nizamabad,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Nizamabad,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Nizamabad,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Nizamabad,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nizamabad,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Nizamabad,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,,,,,,
Nizamabad,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Nizamabad,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,,,,,,
Nizamabad,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nizamabad,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Nizamabad,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Nizamabad,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Nizamabad,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Nizamabad,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nizamabad,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Nizamabad,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Nizamabad,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Nizamabad,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Nizamabad,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nizamabad,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Nizamabad,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Nizamabad,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Nizamabad,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Nizamabad,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nizamabad,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Nizamabad,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Nizamabad,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Nizamabad,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Nizamabad,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nizamabad,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Nizamabad,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Nizamabad,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Nizamabad,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Nizamabad,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nizamabad,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Nizamabad,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Nizamabad,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Nizamabad,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Nizamabad,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nizamabad,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Nizamabad,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Nizamabad,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Nizamabad,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Nizamabad,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nizamabad,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Nizamabad,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Nizamabad,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Nizamabad,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Nizamabad,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nizamabad,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Nizamabad,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Nizamabad,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Nizamabad,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Nizamabad,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nizamabad,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Nizamabad,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Nizamabad,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Nizamabad,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Nizamabad,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nizamabad,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Nizamabad,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Nizamabad,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Nizamabad,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Nizamabad,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nizamabad,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Nizamabad,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Nizamabad,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Nizamabad,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Nizamabad,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nizamabad,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Nizamabad,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Nizamabad,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Nizamabad,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Nizamabad,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nizamabad,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Nizamabad,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Nizamabad,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Nizamabad,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Nizamabad,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nizamabad,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Nizamabad,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Nizamabad,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Nizamabad,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Nizamabad,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nizamabad,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Nizamabad,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Nizamabad,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Nizamabad,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Nizamabad,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nizamabad,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Nizamabad,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Nizamabad,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Nizamabad,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Nizamabad,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nizamabad,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Nizamabad,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Nizamabad,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Nizamabad,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Nizamabad,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nizamabad,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,,,,,,,
Nizamabad,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,,,,,,,
Nizamabad,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Nizamabad,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,,,,,,,
Nizamabad,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nizamabad,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,1.0,,,1.0
Nizamabad,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,1.0,,,,,,,1.0
Nizamabad,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Nizamabad,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,1.0,,,,,,,1.0
Nizamabad,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,1.0,3.0,1.0,2.0,2.0,,1.0,,,1.0,1.0,,12.0
Nizamabad,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Nizamabad,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,1.0,3.0,1.0,2.0,2.0,,1.0,,,1.0,1.0,,12.0
Nizamabad,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,2.0,3.0,,3.0,1.0,1.0,,1.0,2.0,1.0,,14.0
Nizamabad,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Nizamabad,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,2.0,3.0,,3.0,1.0,1.0,,1.0,2.0,1.0,,14.0
Nizamabad,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,4.0,,3.0,,5.0,3.0,1.0,2.0,1.0,2.0,21.0
Nizamabad,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Nizamabad,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,4.0,,3.0,,5.0,3.0,1.0,2.0,1.0,2.0,21.0
Nizamabad,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,2.0,,,,,,,1.0,,,,,3.0
Nizamabad,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Nizamabad,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,2.0,,,,,,,1.0,,,,,3.0
Nizamabad,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Nizamabad,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Nizamabad,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Nizamabad,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Nizamabad,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,1.0,,,,,1.0
Nizamabad,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,1.0,,,,,1.0
Nizamabad,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Nizamabad,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Nizamabad,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Nizamabad,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,3.0,2.0,3.0,1.0,2.0,2.0,3.0,4.0,1.0,6.0,,3.0,30.0
Nizamabad,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,2.0,,2.0,1.0,1.0,2.0,,3.0,1.0,1.0,2.0,1.0,16.0
Nizamabad,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,5.0,2.0,5.0,2.0,3.0,4.0,3.0,7.0,2.0,7.0,2.0,4.0,46.0
Nizamabad,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Nizamabad,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,1.0,1.0
Nizamabad,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,1.0,,,1.0,1.0,,1.0,,,,,,4.0
Nizamabad,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,1.0,,,1.0,1.0,,1.0,,,,,1.0,5.0
Nizamabad,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Nizamabad,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,2.0,1.0,4.0,1.0,1.0,,,1.0,1.0,,1.0,3.0,15.0
Nizamabad,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,1.0,,,,,,,,1.0,1.0,,1.0,4.0
Nizamabad,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,3.0,1.0,4.0,1.0,1.0,,,1.0,2.0,1.0,1.0,4.0,19.0
Nizamabad,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Nizamabad,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,1.0,1.0,1.0,3.0,,1.0,,,,1.0,,8.0
Nizamabad,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,1.0,1.0,1.0,,,,,,2.0,,5.0
Nizamabad,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,1.0,2.0,2.0,4.0,,1.0,,,,3.0,,13.0
Nizamabad,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Nizamabad,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Nizamabad,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Nizamabad,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Nizamabad,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Nizamabad,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,1.0,1.0
Nizamabad,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,1.0,5.0,1.0,,,,,,,,,,7.0
Nizamabad,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,1.0,5.0,1.0,,,,,,,,,1.0,8.0
Nizamabad,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Nizamabad,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,2.0,3.0,1.0,5.0,5.0,4.0,3.0,2.0,4.0,4.0,1.0,3.0,37.0
Nizamabad,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,1.0,,,,,,,,1.0,2.0
Nizamabad,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,2.0,3.0,1.0,6.0,5.0,4.0,3.0,2.0,4.0,4.0,1.0,4.0,39.0
Nizamabad,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,1.0,,,,1.0,,,,,2.0
Nizamabad,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,12.0,15.0,11.0,12.0,15.0,9.0,15.0,7.0,13.0,10.0,8.0,12.0,139.0
Nizamabad,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,12.0,6.0,12.0,9.0,7.0,5.0,11.0,11.0,14.0,12.0,6.0,10.0,115.0
Nizamabad,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,24.0,21.0,23.0,22.0,22.0,14.0,26.0,19.0,27.0,22.0,14.0,22.0,256.0
Nizamabad,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,1.0,1.0,1.0,,,3.0
Nizamabad,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,2.0,2.0,2.0,4.0,3.0,2.0,4.0,4.0,4.0,3.0,,1.0,31.0
Nizamabad,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,1.0,2.0,1.0,4.0,1.0,2.0,,1.0,2.0,,3.0,17.0
Nizamabad,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,2.0,3.0,4.0,5.0,7.0,3.0,6.0,5.0,6.0,6.0,,4.0,51.0
Nizamabad,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Nizamabad,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Nizamabad,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Nizamabad,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Nizamabad,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Nizamabad,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Nizamabad,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Nizamabad,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Nizamabad,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Nizamabad,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,1.0,,,1.0,,,,1.0,,,,,3.0
Nizamabad,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Nizamabad,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,1.0,,,1.0,,,,1.0,,,,,3.0
Nizamabad,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Nizamabad,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,1.0,,,,,1.0,,,1.0,1.0,,,4.0
Nizamabad,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Nizamabad,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,1.0,,,,,1.0,,,1.0,1.0,,,4.0
Nizamabad,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Nizamabad,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Nizamabad,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Nizamabad,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Nizamabad,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Nizamabad,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,2.0,1.0,4.0,1.0,2.0,2.0,1.0,,1.0,,,,14.0
Nizamabad,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Nizamabad,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,2.0,1.0,4.0,1.0,2.0,2.0,1.0,,1.0,,,,14.0
Nizamabad,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,1.0,,,,1.0,,,,,,2.0
Nizamabad,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,13.0,13.0,17.0,12.0,11.0,9.0,17.0,11.0,10.0,9.0,8.0,12.0,142.0
Nizamabad,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,7.0,3.0,3.0,4.0,2.0,,,1.0,,3.0,1.0,2.0,26.0
Nizamabad,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,20.0,16.0,21.0,16.0,13.0,9.0,18.0,12.0,10.0,12.0,9.0,14.0,170.0
Nizamabad,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,2.0,,,,,,1.0,,,,3.0
Nizamabad,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,22.0,14.0,11.0,13.0,18.0,8.0,20.0,11.0,14.0,5.0,11.0,9.0,156.0
Nizamabad,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,3.0,3.0,1.0,1.0,1.0,6.0,4.0,1.0,2.0,1.0,3.0,1.0,27.0
Nizamabad,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,25.0,17.0,14.0,14.0,19.0,14.0,24.0,12.0,17.0,6.0,14.0,10.0,186.0
Nizamabad,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,1.0,,,,,,,,,1.0
Nizamabad,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,2.0,1.0,2.0,3.0,2.0,1.0,2.0,,1.0,,,,14.0
Nizamabad,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,1.0,,,1.0,1.0,,,,1.0,1.0,5.0
Nizamabad,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,2.0,1.0,3.0,4.0,2.0,2.0,3.0,,1.0,,1.0,1.0,20.0
Nizamabad,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Nizamabad,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,5.0,3.0,2.0,7.0,2.0,5.0,3.0,6.0,2.0,,1.0,2.0,38.0
Nizamabad,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,17.0,8.0,7.0,18.0,12.0,11.0,14.0,12.0,1.0,1.0,1.0,1.0,103.0
Nizamabad,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,22.0,11.0,9.0,25.0,14.0,16.0,17.0,18.0,3.0,1.0,2.0,3.0,141.0
Nizamabad,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,1.0,,1.0,,2.0
Nizamabad,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,14.0,10.0,8.0,10.0,10.0,8.0,4.0,2.0,1.0,5.0,7.0,4.0,83.0
Nizamabad,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,12.0,5.0,6.0,8.0,6.0,8.0,2.0,6.0,5.0,4.0,6.0,4.0,72.0
Nizamabad,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,26.0,15.0,14.0,18.0,16.0,16.0,6.0,8.0,7.0,9.0,14.0,8.0,157.0
Nizamabad,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,3.0,7.0,1.0,2.0,1.0,,,1.0,1.0,5.0,3.0,2.0,26.0
Nizamabad,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,122.0,117.0,107.0,104.0,101.0,94.0,93.0,87.0,98.0,90.0,77.0,85.0,1175.0
Nizamabad,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,297.0,345.0,280.0,270.0,257.0,255.0,268.0,220.0,277.0,326.0,243.0,233.0,3271.0
Nizamabad,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,422.0,469.0,388.0,376.0,359.0,349.0,361.0,308.0,376.0,421.0,323.0,320.0,4472.0
PEDDAPALLI,1.1,Total number of pregnant women Registered for ANC,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,,,,,,,,,,,,,
PEDDAPALLI,1.2,Number of Pregnant women registered under JSY,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,,,,,,,,,,,,,
PEDDAPALLI,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,1.8,Number of pregnancy test kits used at SC level,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,,,,,,,,,,,,,
PEDDAPALLI,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,,,,,,,,,,,,,
PEDDAPALLI,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,,,,,,,,,,,,,
PEDDAPALLI,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
PEDDAPALLI,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,,,,,,,,,,,,,
PEDDAPALLI,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
PEDDAPALLI,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
PEDDAPALLI,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
PEDDAPALLI,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,,,,,,,,,,,,,
PEDDAPALLI,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,,,,,,,,,,,,,
PEDDAPALLI,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,,,,,,,,,,,,,
PEDDAPALLI,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,,,,,,,,,,,,,
PEDDAPALLI,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,4.1.1.a,Number of male live births,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,4.1.1.b,Number of female live births,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,,,,,,,,,,,,,
PEDDAPALLI,4.1.2,Number of still births,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,,,,,,,,,,,,,
PEDDAPALLI,4.2.1,Number of Newborns weighed at birth,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,,,,,,,,,,,,,
PEDDAPALLI,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,6.3,PNC maternal complications attended,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,,,,,,,,,,,,,
PEDDAPALLI,7.2,Number of MTPs conducted at Private Facilities,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,,,,,,,,,,,,,
PEDDAPALLI,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,,,,,,,,,,,,,
PEDDAPALLI,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,,,,,,,,,,,,,
PEDDAPALLI,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,,,,,,,,,,,,,
PEDDAPALLI,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,,,,,,,,,,,,,
PEDDAPALLI,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,,,,,,,,,,,,,
PEDDAPALLI,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,,,,,,,,,,,,,
PEDDAPALLI,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,9.06,Number of IUCD removals,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,9.07,Number of Oral Pills cycles distributed,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,9.08,Number of Condom pieces distributed,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,9.09,Number of Centchroman (weekly) pills given,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,9.11.2.a,Number of failures following male sterilization,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,9.11.2.b,Number of failures following female sterilization,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,9.11.3.a,Number of deaths following male sterilization,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,9.11.3.b,Number of deaths following female sterilization,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,,,,,,,,,,,-1.0
PEDDAPALLI,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,,,,,,,,,,,,,
PEDDAPALLI,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,,,,,,,,,,,,,
PEDDAPALLI,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,,,,,,,,,,,,,
PEDDAPALLI,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,,,,,,,,,,,,,
PEDDAPALLI,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,,,,,,,,,,,,,
PEDDAPALLI,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,,,,,,,,,,,,,
PEDDAPALLI,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,,,,,,,,,,,,,
PEDDAPALLI,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,,,,,,,,,,,,,
PEDDAPALLI,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,,,,,,,,,,,,,
PEDDAPALLI,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
PEDDAPALLI,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
PEDDAPALLI,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
PEDDAPALLI,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,10.4.2,Number of Immunisation sessions held during the month,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,,,,,,,,,,,,,
PEDDAPALLI,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,,,,,,,,,,,,,
PEDDAPALLI,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,,,,,,,,,,,,,
PEDDAPALLI,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,13.1,Number of Patients operated for cataract,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,13.3,Number of School children detected with Refractive errors,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,13.4,Number of children provided free glasses,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,13.5,Number of eyes collected through eye donation,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,13.6,Number of eyes utilised for corneal transplant,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,,,,,,,,,,,,-1.0
PEDDAPALLI,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,,,,,,,,,,-1.0
PEDDAPALLI,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,,,,,,,,,,,,,-1.0
PEDDAPALLI,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,,,,,,,,,,,,,-1.0
PEDDAPALLI,14.05,Number of RKS meetings held during the month,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,,,,,,,,,,,,,-1.0
PEDDAPALLI,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,,,,,,,,,-1.0
PEDDAPALLI,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,,,,,,,,,,,,,-1.0
PEDDAPALLI,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,,,,,,,,,,,,,
PEDDAPALLI,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,,,,,,,,,,,,,
PEDDAPALLI,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,,,,,,,,,,,,,
PEDDAPALLI,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,,,,,,,,,,,,,
PEDDAPALLI,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,,,,,,,,,,,,,
PEDDAPALLI,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,,,,,,,,,,,,,
PEDDAPALLI,14.10.2.a,Number of death cases of Inpatient males,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,14.10.2.b,Number of death cases of Inpatient females,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,,,,,,,,,,,,,
PEDDAPALLI,14.11,In-Patient Head Count at midnight,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,14.12.1,OPD attendance (All),TOTAL,,,,,,,,,,,,,
PEDDAPALLI,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,,,,,,,,,,,,,
PEDDAPALLI,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,,,,,,,,,,,,,
PEDDAPALLI,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,14.14.a,Number of patients given AYUSH treatment,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,14.14.c,Number of Adolescents counselled,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,,,,,,,,,,,,,
PEDDAPALLI,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,,,,,,,,,,,,,
PEDDAPALLI,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,,,,,,,,,,,,,
PEDDAPALLI,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,,,,,,,,,,,,,
PEDDAPALLI,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,,,,,,,,,,,,,
PEDDAPALLI,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,,,,,,,,,,,,,
PEDDAPALLI,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,,,,,,,,,,,,,
PEDDAPALLI,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,,,,,,,,,,,,,
PEDDAPALLI,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,,,,,,,,,,,,,
PEDDAPALLI,15.2,Number of Widal tests conducted,Number tested,,,,,,,,,,,,,
PEDDAPALLI,15.3.a,Number of VDRL tests conducted on males,Number tested,,,,,,,,,,,,,
PEDDAPALLI,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,,,,,,,,,,,,,
PEDDAPALLI,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,,,,,,,,,,,,,
PEDDAPALLI,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,,,,,,,,,,,,,
PEDDAPALLI,15.4.1,Number of blood smears examined for Malaria,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,,,,,,,,,,,,,
PEDDAPALLI,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,,,,,,,,,,,,,
PEDDAPALLI,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
PEDDAPALLI,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,,,,,,,,,,
PEDDAPALLI,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
PEDDAPALLI,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,,,,,,,,,
PEDDAPALLI,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
PEDDAPALLI,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
PEDDAPALLI,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
PEDDAPALLI,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
PEDDAPALLI,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
PEDDAPALLI,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
PEDDAPALLI,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
PEDDAPALLI,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,,,,,,,,,
PEDDAPALLI,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
PEDDAPALLI,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,,,,,,,,,
PEDDAPALLI,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
PEDDAPALLI,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
PEDDAPALLI,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,,,,,,,,,
PEDDAPALLI,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
PEDDAPALLI,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,,,,,,,,,
PEDDAPALLI,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
PEDDAPALLI,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
PEDDAPALLI,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
PEDDAPALLI,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
PEDDAPALLI,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
PEDDAPALLI,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
PEDDAPALLI,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
PEDDAPALLI,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,,,,,,,,,
PEDDAPALLI,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
PEDDAPALLI,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,,,,,,,,,
PEDDAPALLI,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
PEDDAPALLI,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
PEDDAPALLI,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,,,,,,,,,
PEDDAPALLI,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
PEDDAPALLI,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,,,,,,,,,
PEDDAPALLI,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
PEDDAPALLI,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
PEDDAPALLI,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
PEDDAPALLI,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
PEDDAPALLI,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
PEDDAPALLI,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
PEDDAPALLI,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
PEDDAPALLI,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,,,,,,
PEDDAPALLI,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
PEDDAPALLI,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,,,,,,
PEDDAPALLI,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
PEDDAPALLI,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
PEDDAPALLI,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
PEDDAPALLI,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
PEDDAPALLI,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
PEDDAPALLI,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
PEDDAPALLI,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
PEDDAPALLI,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
PEDDAPALLI,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
PEDDAPALLI,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
PEDDAPALLI,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
PEDDAPALLI,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
PEDDAPALLI,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
PEDDAPALLI,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
PEDDAPALLI,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
PEDDAPALLI,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
PEDDAPALLI,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
PEDDAPALLI,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
PEDDAPALLI,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
PEDDAPALLI,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
PEDDAPALLI,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
PEDDAPALLI,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
PEDDAPALLI,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
PEDDAPALLI,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
PEDDAPALLI,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
PEDDAPALLI,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
PEDDAPALLI,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
PEDDAPALLI,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
PEDDAPALLI,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
PEDDAPALLI,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
PEDDAPALLI,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
PEDDAPALLI,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
PEDDAPALLI,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
PEDDAPALLI,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
PEDDAPALLI,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
PEDDAPALLI,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
PEDDAPALLI,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
PEDDAPALLI,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
PEDDAPALLI,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
PEDDAPALLI,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
PEDDAPALLI,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
PEDDAPALLI,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
PEDDAPALLI,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
PEDDAPALLI,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
PEDDAPALLI,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
PEDDAPALLI,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
PEDDAPALLI,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
PEDDAPALLI,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
PEDDAPALLI,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
PEDDAPALLI,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
PEDDAPALLI,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
PEDDAPALLI,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
PEDDAPALLI,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
PEDDAPALLI,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
PEDDAPALLI,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
PEDDAPALLI,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
PEDDAPALLI,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
PEDDAPALLI,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
PEDDAPALLI,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
PEDDAPALLI,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
PEDDAPALLI,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
PEDDAPALLI,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
PEDDAPALLI,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
PEDDAPALLI,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
PEDDAPALLI,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
PEDDAPALLI,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
PEDDAPALLI,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
PEDDAPALLI,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
PEDDAPALLI,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
PEDDAPALLI,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
PEDDAPALLI,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
PEDDAPALLI,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
PEDDAPALLI,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
PEDDAPALLI,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
PEDDAPALLI,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
PEDDAPALLI,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
PEDDAPALLI,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
PEDDAPALLI,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
PEDDAPALLI,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
PEDDAPALLI,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
PEDDAPALLI,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
PEDDAPALLI,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
PEDDAPALLI,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
PEDDAPALLI,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
PEDDAPALLI,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
PEDDAPALLI,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
PEDDAPALLI,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
PEDDAPALLI,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
PEDDAPALLI,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
PEDDAPALLI,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
PEDDAPALLI,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
PEDDAPALLI,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,,,,,,,
PEDDAPALLI,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,,,,,,,
PEDDAPALLI,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
PEDDAPALLI,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,,,,,,,
PEDDAPALLI,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
PEDDAPALLI,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
PEDDAPALLI,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
PEDDAPALLI,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
PEDDAPALLI,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
PEDDAPALLI,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
PEDDAPALLI,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
PEDDAPALLI,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
PEDDAPALLI,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
PEDDAPALLI,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
PEDDAPALLI,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
PEDDAPALLI,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
PEDDAPALLI,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
PEDDAPALLI,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
PEDDAPALLI,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
PEDDAPALLI,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
PEDDAPALLI,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
PEDDAPALLI,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
PEDDAPALLI,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
PEDDAPALLI,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
PEDDAPALLI,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
PEDDAPALLI,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
PEDDAPALLI,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
PEDDAPALLI,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
PEDDAPALLI,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
PEDDAPALLI,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
PEDDAPALLI,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
PEDDAPALLI,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
PEDDAPALLI,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
PEDDAPALLI,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
PEDDAPALLI,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
PEDDAPALLI,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
PEDDAPALLI,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
PEDDAPALLI,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
PEDDAPALLI,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
PEDDAPALLI,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
PEDDAPALLI,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
PEDDAPALLI,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
PEDDAPALLI,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
PEDDAPALLI,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
PEDDAPALLI,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
PEDDAPALLI,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
PEDDAPALLI,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
PEDDAPALLI,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
PEDDAPALLI,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
PEDDAPALLI,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
PEDDAPALLI,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
PEDDAPALLI,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
PEDDAPALLI,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
PEDDAPALLI,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
PEDDAPALLI,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
PEDDAPALLI,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
PEDDAPALLI,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
PEDDAPALLI,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
PEDDAPALLI,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
PEDDAPALLI,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
PEDDAPALLI,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
PEDDAPALLI,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
PEDDAPALLI,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
PEDDAPALLI,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
PEDDAPALLI,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
PEDDAPALLI,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
PEDDAPALLI,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
PEDDAPALLI,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
PEDDAPALLI,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
PEDDAPALLI,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
PEDDAPALLI,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
PEDDAPALLI,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
PEDDAPALLI,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
PEDDAPALLI,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
PEDDAPALLI,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
PEDDAPALLI,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
PEDDAPALLI,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
PEDDAPALLI,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
PEDDAPALLI,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
PEDDAPALLI,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
PEDDAPALLI,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
PEDDAPALLI,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
PEDDAPALLI,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
PEDDAPALLI,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
PEDDAPALLI,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
PEDDAPALLI,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
PEDDAPALLI,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
PEDDAPALLI,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
PEDDAPALLI,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
PEDDAPALLI,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
PEDDAPALLI,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
PEDDAPALLI,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
PEDDAPALLI,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
PEDDAPALLI,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
PEDDAPALLI,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
PEDDAPALLI,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
PEDDAPALLI,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
PEDDAPALLI,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
PEDDAPALLI,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
PEDDAPALLI,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
PEDDAPALLI,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
PEDDAPALLI,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
PEDDAPALLI,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
PEDDAPALLI,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
PEDDAPALLI,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
PEDDAPALLI,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
PEDDAPALLI,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
PEDDAPALLI,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
PEDDAPALLI,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
PEDDAPALLI,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
PEDDAPALLI,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
PEDDAPALLI,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
PEDDAPALLI,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
RAJANNA SIRCILLA,1.1,Total number of pregnant women Registered for ANC,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,1.2,Number of Pregnant women registered under JSY,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,1.8,Number of pregnancy test kits used at SC level,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,4.1.1.a,Number of male live births,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,4.1.1.b,Number of female live births,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,4.1.2,Number of still births,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,4.2.1,Number of Newborns weighed at birth,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,6.3,PNC maternal complications attended,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,7.2,Number of MTPs conducted at Private Facilities,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,9.06,Number of IUCD removals,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,9.07,Number of Oral Pills cycles distributed,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,9.08,Number of Condom pieces distributed,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,9.09,Number of Centchroman (weekly) pills given,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,9.11.2.a,Number of failures following male sterilization,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,9.11.2.b,Number of failures following female sterilization,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,9.11.3.a,Number of deaths following male sterilization,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,9.11.3.b,Number of deaths following female sterilization,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,,,,,,,,,,,-1.0
RAJANNA SIRCILLA,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,10.4.2,Number of Immunisation sessions held during the month,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,13.1,Number of Patients operated for cataract,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,13.3,Number of School children detected with Refractive errors,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,13.4,Number of children provided free glasses,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,13.5,Number of eyes collected through eye donation,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,13.6,Number of eyes utilised for corneal transplant,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,,,,,,,,,,,,-1.0
RAJANNA SIRCILLA,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,,,,,,,,,,-1.0
RAJANNA SIRCILLA,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,,,,,,,,,,,,,-1.0
RAJANNA SIRCILLA,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,,,,,,,,,,,,,-1.0
RAJANNA SIRCILLA,14.05,Number of RKS meetings held during the month,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,,,,,,,,,,,,,-1.0
RAJANNA SIRCILLA,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,,,,,,,,,-1.0
RAJANNA SIRCILLA,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,,,,,,,,,,,,,-1.0
RAJANNA SIRCILLA,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,,,,,,,,,,,,,
RAJANNA SIRCILLA,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,,,,,,,,,,,,,
RAJANNA SIRCILLA,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,,,,,,,,,,,,,
RAJANNA SIRCILLA,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,,,,,,,,,,,,,
RAJANNA SIRCILLA,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,,,,,,,,,,,,,
RAJANNA SIRCILLA,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,,,,,,,,,,,,,
RAJANNA SIRCILLA,14.10.2.a,Number of death cases of Inpatient males,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,14.10.2.b,Number of death cases of Inpatient females,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,14.11,In-Patient Head Count at midnight,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,14.12.1,OPD attendance (All),TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,14.14.a,Number of patients given AYUSH treatment,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,14.14.c,Number of Adolescents counselled,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,,,,,,,,,,,,,
RAJANNA SIRCILLA,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,,,,,,,,,,,,,
RAJANNA SIRCILLA,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,,,,,,,,,,,,,
RAJANNA SIRCILLA,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,,,,,,,,,,,,,
RAJANNA SIRCILLA,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,,,,,,,,,,,,,
RAJANNA SIRCILLA,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,,,,,,,,,,,,,
RAJANNA SIRCILLA,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,,,,,,,,,,,,,
RAJANNA SIRCILLA,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,,,,,,,,,,,,,
RAJANNA SIRCILLA,15.2,Number of Widal tests conducted,Number tested,,,,,,,,,,,,,
RAJANNA SIRCILLA,15.3.a,Number of VDRL tests conducted on males,Number tested,,,,,,,,,,,,,
RAJANNA SIRCILLA,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,,,,,,,,,,,,,
RAJANNA SIRCILLA,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,,,,,,,,,,,,,
RAJANNA SIRCILLA,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,,,,,,,,,,,,,
RAJANNA SIRCILLA,15.4.1,Number of blood smears examined for Malaria,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
RAJANNA SIRCILLA,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
RAJANNA SIRCILLA,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
RAJANNA SIRCILLA,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
RAJANNA SIRCILLA,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
RAJANNA SIRCILLA,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
RAJANNA SIRCILLA,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
RAJANNA SIRCILLA,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
RAJANNA SIRCILLA,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
RAJANNA SIRCILLA,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
RAJANNA SIRCILLA,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
RAJANNA SIRCILLA,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
RAJANNA SIRCILLA,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
RAJANNA SIRCILLA,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
RAJANNA SIRCILLA,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
RAJANNA SIRCILLA,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
RAJANNA SIRCILLA,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
RAJANNA SIRCILLA,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
RAJANNA SIRCILLA,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
RAJANNA SIRCILLA,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
RAJANNA SIRCILLA,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
RAJANNA SIRCILLA,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
RAJANNA SIRCILLA,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
RAJANNA SIRCILLA,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
RAJANNA SIRCILLA,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
RAJANNA SIRCILLA,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
RAJANNA SIRCILLA,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
RAJANNA SIRCILLA,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,,,,,,,
RAJANNA SIRCILLA,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
RAJANNA SIRCILLA,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
RAJANNA SIRCILLA,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
Ranga Reddy,1.1,Total number of pregnant women Registered for ANC,TOTAL,11457.0,10487.0,11184.0,11515.0,9072.0,9193.0,8985.0,9523.0,9390.0,8996.0,9458.0,9762.0,119022.0
Ranga Reddy,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,5063.0,4879.0,4979.0,5244.0,5063.0,5352.0,5007.0,5348.0,5423.0,4960.0,5337.0,5512.0,62167.0
Ranga Reddy,1.2,Number of Pregnant women registered under JSY,TOTAL,4868.0,4900.0,5293.0,5679.0,5239.0,5324.0,5067.0,5426.0,5441.0,5113.0,5628.0,5720.0,63698.0
Ranga Reddy,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,8035.0,8902.0,9175.0,9670.0,9458.0,9146.0,8896.0,9228.0,9757.0,9967.0,9543.0,10008.0,111785.0
Ranga Reddy,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,9569.0,9235.0,9719.0,10170.0,8998.0,9187.0,8984.0,9511.0,9374.0,8969.0,9444.0,9734.0,112894.0
Ranga Reddy,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,8725.0,9718.0,9588.0,10190.0,9240.0,9838.0,9587.0,9424.0,10049.0,9468.0,9617.0,10205.0,115649.0
Ranga Reddy,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,10791.0,10899.0,11121.0,10993.0,11218.0,9171.0,9241.0,8954.0,9916.0,10165.0,10153.0,10406.0,123028.0
Ranga Reddy,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,293.0,351.0,310.0,273.0,246.0,152.0,268.0,266.0,296.0,257.0,246.0,167.0,3125.0
Ranga Reddy,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,1.0,8.0,10.0,8.0,6.0,7.0,3.0,6.0,5.0,7.0,14.0,1.0,76.0
Ranga Reddy,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,957.0,2544.0,2256.0,2317.0,1316.0,1194.0,1050.0,683.0,1030.0,962.0,888.0,1503.0,16700.0
Ranga Reddy,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,27.0,23.0,40.0,58.0,20.0,17.0,2.0,6.0,31.0,67.0,6.0,40.0,337.0
Ranga Reddy,1.8,Number of pregnancy test kits used at SC level,TOTAL,1329.0,1283.0,1220.0,1327.0,1349.0,1499.0,1223.0,1293.0,1226.0,1232.0,1267.0,1219.0,15467.0
Ranga Reddy,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,4.0,0.0,3.0,3.0,1.0,2.0,8.0,9.0,6.0,9.0,6.0,3.0,54.0
Ranga Reddy,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,6.0,5.0,2.0,8.0,6.0,4.0,7.0,8.0,3.0,5.0,3.0,1.0,58.0
Ranga Reddy,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,10.0,5.0,5.0,11.0,7.0,6.0,15.0,17.0,9.0,14.0,9.0,4.0,112.0
Ranga Reddy,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,2.0,2.0,3.0,7.0,4.0,5.0,11.0,15.0,6.0,12.0,8.0,1.0,76.0
Ranga Reddy,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ranga Reddy,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,969.0,951.0,863.0,915.0,1101.0,1076.0,1168.0,1086.0,1025.0,924.0,903.0,1044.0,12025.0
Ranga Reddy,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,756.0,754.0,710.0,710.0,874.0,857.0,852.0,674.0,459.0,477.0,471.0,507.0,8101.0
Ranga Reddy,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,804.0,863.0,1114.0,1031.0,1110.0,1010.0,1093.0,1134.0,1086.0,992.0,1007.0,1112.0,12356.0
Ranga Reddy,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ranga Reddy,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ranga Reddy,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,4086.0,4468.0,4408.0,4629.0,3669.0,3894.0,4163.0,4392.0,4453.0,4563.0,4258.0,4522.0,51505.0
Ranga Reddy,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Ranga Reddy,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Ranga Reddy,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Ranga Reddy,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ranga Reddy,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,8.0,3.0,1.0,1.0,3.0,4.0,7.0,7.0,4.0,4.0,6.0,8.0,56.0
Ranga Reddy,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,250.0,200.0,191.0,197.0,197.0,204.0,202.0,197.0,226.0,201.0,164.0,217.0,2446.0
Ranga Reddy,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Ranga Reddy,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,258.0,203.0,192.0,198.0,200.0,208.0,209.0,204.0,230.0,205.0,170.0,225.0,2502.0
Ranga Reddy,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,1673.0,1450.0,1782.0,2639.0,1521.0,2139.0,1753.0,1216.0,1750.0,15923.0
Ranga Reddy,4.1.1.a,Number of male live births,TOTAL,2798.0,2808.0,3412.0,3211.0,2576.0,2719.0,2907.0,2975.0,2992.0,3111.0,2937.0,3018.0,35464.0
Ranga Reddy,4.1.1.b,Number of female live births,TOTAL,2531.0,2615.0,2300.0,2427.0,2193.0,2263.0,2437.0,2520.0,2491.0,2388.0,2231.0,2546.0,28942.0
Ranga Reddy,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,5329.0,5423.0,5712.0,5638.0,4769.0,4982.0,5344.0,5495.0,5483.0,5499.0,5168.0,5564.0,64406.0
Ranga Reddy,4.1.2,Number of still births,TOTAL,11.0,1.0,11.0,4.0,12.0,12.0,5.0,5.0,8.0,7.0,6.0,6.0,88.0
Ranga Reddy,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,17.0,51.0,14.0,4.0,5.0,4.0,3.0,4.0,1.0,3.0,4.0,2.0,112.0
Ranga Reddy,4.2.1,Number of Newborns weighed at birth,TOTAL,5317.0,4695.0,5585.0,5521.0,4717.0,4924.0,5342.0,5453.0,5480.0,5493.0,5161.0,5563.0,63251.0
Ranga Reddy,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,219.0,94.0,69.0,68.0,84.0,87.0,83.0,75.0,63.0,117.0,58.0,56.0,1073.0
Ranga Reddy,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,5093.0,4674.0,3733.0,3820.0,3581.0,3131.0,3525.0,3536.0,3229.0,3519.0,3785.0,3603.0,45229.0
Ranga Reddy,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,22.0,22.0,21.0,26.0,32.0,16.0,13.0,45.0,39.0,16.0,33.0,34.0,319.0
Ranga Reddy,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,7.0,18.0,5.0,23.0,6.0,4.0,16.0,19.0,17.0,24.0,32.0,31.0,202.0
Ranga Reddy,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,200.0,267.0,175.0,185.0,193.0,219.0,329.0,166.0,518.0,327.0,269.0,308.0,3156.0
Ranga Reddy,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Ranga Reddy,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,229.0,307.0,201.0,234.0,231.0,239.0,358.0,230.0,574.0,367.0,334.0,373.0,3677.0
Ranga Reddy,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,981.0,1029.0,36.0,,,249.0,106.0,2401.0
Ranga Reddy,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,134.0,152.0,143.0,93.0,92.0,1062.0,1141.0,183.0,91.0,138.0,391.0,289.0,3909.0
Ranga Reddy,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,12.0,10.0,10.0,8.0,26.0,51.0,154.0,51.0,18.0,9.0,249.0,17.0,615.0
Ranga Reddy,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,115.0,126.0,69.0,149.0,124.0,826.0,811.0,159.0,477.0,296.0,491.0,326.0,3969.0
Ranga Reddy,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,25.0,13.0,15.0,22.0,35.0,39.0,44.0,31.0,18.0,26.0,23.0,27.0,318.0
Ranga Reddy,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,2543.0,2166.0,1772.0,1754.0,2544.0,2492.0,3075.0,3462.0,2655.0,2499.0,1720.0,3200.0,29882.0
Ranga Reddy,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,2225.0,2850.0,4582.0,4814.0,1640.0,1953.0,3906.0,2102.0,2386.0,2635.0,3136.0,1972.0,34201.0
Ranga Reddy,6.3,PNC maternal complications attended,TOTAL,0.0,0.0,10.0,0.0,15.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,25.0
Ranga Reddy,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,3.0,3.0,1.0,2.0,4.0,4.0,3.0,1.0,1.0,1.0,1.0,2.0,26.0
Ranga Reddy,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Ranga Reddy,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,3.0,3.0,1.0,3.0,4.0,4.0,3.0,1.0,1.0,1.0,1.0,2.0,27.0
Ranga Reddy,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,3.0,0.0,4.0,3.0,0.0,3.0,2.0,0.0,3.0,2.0,20.0
Ranga Reddy,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,896.0,722.0,699.0,757.0,777.0,852.0,640.0,773.0,822.0,801.0,884.0,918.0,9541.0
Ranga Reddy,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,1047.0,785.0,860.0,831.0,995.0,1042.0,799.0,1013.0,1015.0,1000.0,1035.0,1051.0,11473.0
Ranga Reddy,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,1943.0,1507.0,1559.0,1588.0,1772.0,1894.0,1439.0,1786.0,1837.0,1801.0,1919.0,1969.0,21014.0
Ranga Reddy,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ranga Reddy,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,17.0,4.0,3.0,1.0,0.0,78.0,3.0,0.0,9.0,115.0
Ranga Reddy,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ranga Reddy,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,1.0,1.0,4.0
Ranga Reddy,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Ranga Reddy,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,17.0,4.0,3.0,1.0,0.0,79.0,4.0,1.0,10.0,119.0
Ranga Reddy,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,,,,,0.0,0.0,,0.0
Ranga Reddy,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,663.0,66.0,900.0,1059.0,583.0,382.0,265.0,542.0,420.0,442.0,879.0,849.0,7050.0
Ranga Reddy,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,140.0,104.0,153.0,176.0,37.0,67.0,63.0,87.0,118.0,0.0,99.0,141.0,1185.0
Ranga Reddy,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,166.0,0.0,147.0,271.0,71.0,87.0,20.0,67.0,183.0,254.0,95.0,164.0,1525.0
Ranga Reddy,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Ranga Reddy,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,969.0,170.0,1200.0,1506.0,691.0,536.0,348.0,696.0,721.0,696.0,1073.0,1154.0,9760.0
Ranga Reddy,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,,,,,0.0,0.0,,0.0
Ranga Reddy,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,91.0,66.0,75.0,191.0,180.0,106.0,125.0,103.0,179.0,145.0,80.0,114.0,1455.0
Ranga Reddy,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,12.0,3.0,38.0,45.0,10.0,37.0,29.0,68.0,41.0,26.0,27.0,6.0,342.0
Ranga Reddy,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,63.0,90.0,64.0,18.0,89.0,82.0,93.0,103.0,70.0,42.0,20.0,53.0,787.0
Ranga Reddy,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Ranga Reddy,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,166.0,159.0,177.0,254.0,279.0,225.0,247.0,274.0,290.0,213.0,127.0,173.0,2584.0
Ranga Reddy,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,510.0,916.0,918.0,839.0,669.0,812.0,888.0,821.0,,1034.0,861.0,1549.0,9817.0
Ranga Reddy,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,31.0,9.0,8.0,17.0,16.0,8.0,7.0,22.0,15.0,19.0,10.0,0.0,162.0
Ranga Reddy,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,2.0,0.0,5.0,7.0,1.0,3.0,5.0,8.0,3.0,3.0,3.0,2.0,42.0
Ranga Reddy,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,2.0,1.0,1.0,1.0,13.0,25.0,7.0,3.0,6.0,39.0,48.0,41.0,187.0
Ranga Reddy,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Ranga Reddy,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,35.0,10.0,14.0,25.0,30.0,36.0,19.0,33.0,24.0,61.0,61.0,43.0,391.0
Ranga Reddy,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,91.0,161.0,162.0,148.0,486.0,143.0,156.0,144.0,,183.0,152.0,273.0,2099.0
Ranga Reddy,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,7.0,0.0,1.0,9.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,19.0
Ranga Reddy,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,85.0,100.0,94.0,78.0,74.0,79.0,71.0,87.0,70.0,80.0,81.0,52.0,951.0
Ranga Reddy,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,7.0,15.0,10.0,8.0,3.0,10.0,11.0,2.0,2.0,3.0,5.0,4.0,80.0
Ranga Reddy,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,0.0,1.0,0.0,0.0,2.0,0.0,0.0,0.0,3.0,5.0,0.0,0.0,11.0
Ranga Reddy,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Ranga Reddy,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,99.0,116.0,105.0,95.0,79.0,91.0,82.0,89.0,75.0,88.0,86.0,56.0,1061.0
Ranga Reddy,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,134.0,113.0,122.0,166.0,176.0,39.0,148.0,11.0,3.0,162.0,117.0,0.0,1191.0
Ranga Reddy,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,585.0,618.0,777.0,1075.0,1125.0,1097.0,1120.0,1206.0,,1062.0,769.0,1366.0,10800.0
Ranga Reddy,9.06,Number of IUCD removals,TOTAL,46.0,45.0,65.0,63.0,64.0,73.0,48.0,52.0,28.0,63.0,48.0,76.0,671.0
Ranga Reddy,9.07,Number of Oral Pills cycles distributed,TOTAL,3338.0,3003.0,3262.0,3610.0,2899.0,2991.0,2835.0,2908.0,2957.0,2784.0,3583.0,2733.0,36903.0
Ranga Reddy,9.08,Number of Condom pieces distributed,TOTAL,11250.0,12504.0,12036.0,10329.0,13938.0,11987.0,10386.0,10216.0,9428.0,11790.0,10465.0,10682.0,135011.0
Ranga Reddy,9.09,Number of Centchroman (weekly) pills given,TOTAL,479.0,341.0,357.0,151.0,155.0,149.0,164.0,175.0,120.0,263.0,357.0,279.0,2990.0
Ranga Reddy,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,76.0,59.0,38.0,32.0,24.0,42.0,21.0,45.0,54.0,30.0,22.0,41.0,484.0
Ranga Reddy,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ranga Reddy,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ranga Reddy,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ranga Reddy,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ranga Reddy,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ranga Reddy,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ranga Reddy,9.12,Number of Institutions having NSV trained doctors,TOTAL,19.0,17.0,17.0,17.0,17.0,16.0,16.0,14.0,17.0,15.0,15.0,15.0,-1.0
Ranga Reddy,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,5228.0,5304.0,5511.0,5505.0,4701.0,4895.0,5308.0,5448.0,5415.0,5404.0,5111.0,5457.0,63287.0
Ranga Reddy,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,8229.0,8548.0,6813.0,1516.0,766.0,345.0,114.0,131.0,249.0,317.0,111.0,19.0,27158.0
Ranga Reddy,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,8518.0,8731.0,8666.0,5665.0,2795.0,878.0,336.0,249.0,328.0,371.0,100.0,18.0,36655.0
Ranga Reddy,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,8798.0,8919.0,8859.0,7233.0,5675.0,1886.0,1001.0,552.0,497.0,384.0,126.0,110.0,44040.0
Ranga Reddy,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,15.0,7.0,3117.0,6942.0,7288.0,7653.0,7691.0,8241.0,8420.0,8393.0,8639.0,8741.0,75147.0
Ranga Reddy,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,2.0,3929.0,6698.0,7671.0,7776.0,8232.0,8625.0,8571.0,8815.0,9162.0,69481.0
Ranga Reddy,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,2.0,1678.0,3824.0,7166.0,7919.0,8299.0,8612.0,8699.0,9001.0,9373.0,64573.0
Ranga Reddy,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,5091.0,5408.0,5549.0,5558.0,4704.0,4669.0,5281.0,5263.0,5380.0,5433.0,5078.0,5529.0,62943.0
Ranga Reddy,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,8252.0,8517.0,8005.0,6923.0,6857.0,7643.0,7497.0,8249.0,8418.0,8496.0,8689.0,8769.0,96315.0
Ranga Reddy,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,8507.0,8744.0,8667.0,8564.0,8117.0,7984.0,7740.0,8297.0,8685.0,8781.0,8818.0,9188.0,102092.0
Ranga Reddy,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,8788.0,8916.0,8913.0,8560.0,8137.0,8247.0,8114.0,8491.0,8698.0,8849.0,8949.0,9333.0,103995.0
Ranga Reddy,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,6549.0,6687.0,5864.0,4881.0,5207.0,4672.0,4647.0,4591.0,4463.0,4400.0,4463.0,4781.0,61205.0
Ranga Reddy,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,7955.0,8221.0,6745.0,1623.0,1008.0,669.0,195.0,206.0,258.0,264.0,182.0,4.0,27330.0
Ranga Reddy,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,8531.0,8700.0,8577.0,5781.0,3209.0,1137.0,369.0,280.0,269.0,315.0,118.0,24.0,37310.0
Ranga Reddy,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,8681.0,8962.0,8804.0,7209.0,5742.0,2062.0,844.0,525.0,362.0,258.0,156.0,36.0,43641.0
Ranga Reddy,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,9101.0,9059.0,9163.0,9109.0,8890.0,8568.0,8463.0,8916.0,8891.0,8588.0,9036.0,9328.0,107112.0
Ranga Reddy,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,3841.0,4067.0,4081.0,4788.0,4308.0,3920.0,4063.0,4338.0,4376.0,4258.0,4405.0,4717.0,51162.0
Ranga Reddy,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,97.0,6.0,6.0,111.0,0.0,126.0,1.0,9.0,29.0,69.0,0.0,27.0,481.0
Ranga Reddy,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,3410.0,3388.0,3869.0,4124.0,3515.0,3199.0,3124.0,3582.0,4107.0,4281.0,3387.0,4380.0,44366.0
Ranga Reddy,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,3347.0,3131.0,3702.0,3960.0,3214.0,2971.0,2958.0,3322.0,3612.0,4137.0,3154.0,4170.0,41678.0
Ranga Reddy,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,6757.0,6519.0,7571.0,8084.0,6729.0,6170.0,6082.0,6904.0,7719.0,8418.0,6541.0,8550.0,86044.0
Ranga Reddy,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,8000.0,7935.0,8381.0,8324.0,7797.0,7756.0,7907.0,8341.0,8790.0,8090.0,8250.0,8530.0,98101.0
Ranga Reddy,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,8045.0,7906.0,8357.0,8293.0,7804.0,7779.0,7892.0,8354.0,8707.0,8145.0,8253.0,8543.0,98078.0
Ranga Reddy,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,661.0,392.0,536.0,502.0,346.0,1125.0,1206.0,1199.0,616.0,512.0,570.0,468.0,8133.0
Ranga Reddy,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2656.0,2615.0,2879.0,2870.0,1525.0,1755.0,1650.0,1813.0,2210.0,2194.0,1606.0,2791.0,26564.0
Ranga Reddy,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2588.0,2526.0,2512.0,2542.0,1394.0,1570.0,1475.0,1722.0,2083.0,2170.0,1484.0,2632.0,24698.0
Ranga Reddy,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,5244.0,5141.0,5391.0,5412.0,2919.0,3325.0,3125.0,3535.0,4293.0,4364.0,3090.0,5423.0,51262.0
Ranga Reddy,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,6232.0,6787.0,6981.0,7784.0,8386.0,7666.0,7122.0,6890.0,7152.0,7203.0,6690.0,7108.0,86001.0
Ranga Reddy,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,5998.0,6325.0,6476.0,8003.0,9157.0,8441.0,6958.0,6921.0,6910.0,6992.0,6657.0,7133.0,85971.0
Ranga Reddy,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,5842.0,6275.0,6555.0,7913.0,8577.0,8944.0,6557.0,7272.0,7068.0,7058.0,7218.0,7443.0,86722.0
Ranga Reddy,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ranga Reddy,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Ranga Reddy,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ranga Reddy,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,3531.0,3606.0,3505.0,3586.0,3686.0,3465.0,3447.0,3539.0,3554.0,3682.0,3514.0,3595.0,42710.0
Ranga Reddy,10.4.2,Number of Immunisation sessions held during the month,TOTAL,3317.0,3482.0,3388.0,3472.0,3497.0,3320.0,3281.0,3355.0,3440.0,3460.0,3289.0,3338.0,40639.0
Ranga Reddy,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,2706.0,2731.0,2604.0,2687.0,2801.0,818.0,253.0,113.0,276.0,1469.0,1526.0,1693.0,19677.0
Ranga Reddy,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ranga Reddy,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,7618.0,7979.0,7976.0,7553.0,7690.0,7518.0,7738.0,8579.0,8396.0,7636.0,7724.0,7596.0,94003.0
Ranga Reddy,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,5047.0,5780.0,5452.0,5791.0,5795.0,5704.0,5935.0,6187.0,8479.0,6207.0,5856.0,5434.0,71667.0
Ranga Reddy,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,4751.0,5246.0,5122.0,5331.0,5620.0,5716.0,5490.0,5638.0,7551.0,5913.0,5221.0,4999.0,66598.0
Ranga Reddy,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ranga Reddy,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ranga Reddy,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ranga Reddy,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ranga Reddy,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ranga Reddy,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,4.0,0.0,0.0,0.0,0.0,0.0,0.0,10.0,14.0
Ranga Reddy,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,309.0,403.0,541.0,1234.0,843.0,667.0,566.0,348.0,547.0,499.0,437.0,571.0,6965.0
Ranga Reddy,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,3.0
Ranga Reddy,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,11.0,1.0,3.0,0.0,0.0,6.0,2.0,2.0,27.0,14.0,22.0,14.0,102.0
Ranga Reddy,13.1,Number of Patients operated for cataract,TOTAL,55.0,59.0,3247.0,3417.0,3747.0,4022.0,4221.0,4816.0,4851.0,3324.0,3046.0,2477.0,37282.0
Ranga Reddy,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,49.0,59.0,3247.0,3417.0,3747.0,4022.0,4221.0,4816.0,4851.0,3324.0,3046.0,2477.0,37276.0
Ranga Reddy,13.3,Number of School children detected with Refractive errors,TOTAL,487.0,2.0,2.0,0.0,2.0,2.0,0.0,2.0,217.0,1489.0,14.0,19.0,2236.0
Ranga Reddy,13.4,Number of children provided free glasses,TOTAL,458.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,200.0,0.0,0.0,0.0,658.0
Ranga Reddy,13.5,Number of eyes collected through eye donation,TOTAL,2.0,2.0,2.0,2.0,0.0,2.0,0.0,2.0,1.0,2.0,0.0,1.0,16.0
Ranga Reddy,13.6,Number of eyes utilised for corneal transplant,TOTAL,2.0,2.0,2.0,2.0,0.0,2.0,0.0,2.0,1.0,2.0,0.0,1.0,16.0
Ranga Reddy,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,12.0,13.0,13.0,13.0,12.0,6.0,7.0,8.0,6.0,8.0,6.0,5.0,-1.0
Ranga Reddy,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,28.0,28.0,27.0,29.0,27.0,29.0,28.0,24.0,27.0,26.0,26.0,26.0,-1.0
Ranga Reddy,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,1216.0,1277.0,1311.0,1243.0,1133.0,1154.0,1108.0,1342.0,1449.0,1616.0,1179.0,1281.0,-1.0
Ranga Reddy,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,13.0,13.0,13.0,12.0,12.0,9.0,11.0,12.0,12.0,14.0,13.0,11.0,-1.0
Ranga Reddy,14.05,Number of RKS meetings held during the month,TOTAL,2.0,7.0,1.0,1.0,1.0,2.0,2.0,3.0,4.0,2.0,3.0,1.0,29.0
Ranga Reddy,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,1.0,,2.0,2.0,4.0,2.0,2.0,2.0,3.0,2.0,4.0,2.0,-1.0
Ranga Reddy,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,5.0,6.0,6.0,4.0,4.0,4.0,4.0,4.0,0.0,5.0,5.0,4.0,51.0
Ranga Reddy,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,1.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,2.0,1.0,2.0,1.0,-1.0
Ranga Reddy,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,1.0,1.0,0.0,0.0,-1.0
Ranga Reddy,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,,,,,,,,,,,,,
Ranga Reddy,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,,,,,,,,,,,,,
Ranga Reddy,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,,,,,,,,,,,,,
Ranga Reddy,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,1335.0,1152.0,879.0,1040.0,1063.0,984.0,913.0,802.0,742.0,605.0,721.0,748.0,10984.0
Ranga Reddy,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,4097.0,3343.0,3368.0,3763.0,3485.0,3490.0,3346.0,3199.0,2429.0,2384.0,2572.0,2985.0,38461.0
Ranga Reddy,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,962.0,1012.0,754.0,1063.0,1052.0,953.0,916.0,792.0,734.0,642.0,803.0,727.0,10410.0
Ranga Reddy,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,4638.0,4464.0,4524.0,5668.0,4969.0,5182.0,4886.0,4435.0,3764.0,3164.0,3693.0,4762.0,54149.0
Ranga Reddy,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,2297.0,2164.0,1633.0,2103.0,2115.0,1937.0,1829.0,1594.0,1476.0,1247.0,1524.0,1475.0,21394.0
Ranga Reddy,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,8735.0,7807.0,7892.0,9431.0,8454.0,8672.0,8232.0,7634.0,6193.0,5548.0,6265.0,7747.0,92610.0
Ranga Reddy,14.10.2.a,Number of death cases of Inpatient males,TOTAL,11.0,17.0,23.0,17.0,21.0,16.0,20.0,14.0,13.0,12.0,18.0,11.0,193.0
Ranga Reddy,14.10.2.b,Number of death cases of Inpatient females,TOTAL,11.0,11.0,11.0,10.0,18.0,17.0,8.0,16.0,10.0,11.0,5.0,10.0,138.0
Ranga Reddy,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,22.0,28.0,34.0,27.0,39.0,33.0,28.0,30.0,23.0,23.0,23.0,21.0,331.0
Ranga Reddy,14.11,In-Patient Head Count at midnight,TOTAL,2892.0,2787.0,495.0,807.0,3656.0,418.0,10992.0,26146.0,11583.0,10292.0,9086.0,10895.0,90049.0
Ranga Reddy,14.12.1,OPD attendance (All),TOTAL,295424.0,267971.0,296907.0,314888.0,313736.0,328019.0,302811.0,283123.0,279644.0,273617.0,302644.0,296997.0,3555781.0
Ranga Reddy,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,305.0,152.0,251.0,304.0,192.0,267.0,260.0,340.0,490.0,169.0,200.0,312.0,3242.0
Ranga Reddy,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,29.0,2.0,2.0,2.0,24.0,4.0,4.0,2.0,2.0,2.0,73.0
Ranga Reddy,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,,,,,,,,,,,,,
Ranga Reddy,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,1456.0,1620.0,1430.0,1726.0,1770.0,2283.0,1492.0,2016.0,1038.0,1314.0,1946.0,2092.0,20183.0
Ranga Reddy,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,,,,,,,,,,,,,
Ranga Reddy,14.14.a,Number of patients given AYUSH treatment,TOTAL,21254.0,19281.0,22267.0,21386.0,21525.0,20720.0,23297.0,23569.0,22167.0,20315.0,22728.0,20396.0,258905.0
Ranga Reddy,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,2546.0,2114.0,2157.0,2040.0,1903.0,2121.0,1921.0,1760.0,2045.0,2256.0,1534.0,1370.0,23767.0
Ranga Reddy,14.14.c,Number of Adolescents counselled,TOTAL,110.0,2596.0,2707.0,2181.0,2787.0,3072.0,2920.0,3039.0,3116.0,3173.0,3151.0,2755.0,31607.0
Ranga Reddy,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,,,,,,,,,,,,,
Ranga Reddy,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,12002.0,11588.0,13172.0,13736.0,13212.0,13129.0,12755.0,13054.0,12989.0,12005.0,13606.0,13172.0,154420.0
Ranga Reddy,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,142.0,182.0,243.0,324.0,235.0,275.0,201.0,252.0,253.0,234.0,248.0,289.0,2878.0
Ranga Reddy,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,1990.0,1671.0,1385.0,1281.0,1603.0,1808.0,1661.0,1678.0,1683.0,1671.0,1949.0,1798.0,20178.0
Ranga Reddy,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,51.0,59.0,37.0,32.0,39.0,42.0,35.0,30.0,29.0,34.0,47.0,53.0,488.0
Ranga Reddy,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,1620.0,1638.0,1686.0,1754.0,1818.0,1961.0,1729.0,1585.0,1633.0,1999.0,2156.0,1798.0,21377.0
Ranga Reddy,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,34.0,49.0,32.0,31.0,29.0,26.0,27.0,29.0,27.0,32.0,49.0,32.0,397.0
Ranga Reddy,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,2582.0,2266.0,2011.0,1740.0,2058.0,2213.0,1967.0,2168.0,2313.0,2230.0,2345.0,2780.0,26673.0
Ranga Reddy,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,10.0,15.0,8.0,6.0,3.0,9.0,4.0,1.0,5.0,1.0,9.0,9.0,80.0
Ranga Reddy,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,6192.0,5575.0,5082.0,4775.0,5479.0,5982.0,5357.0,5431.0,5629.0,5900.0,6450.0,6376.0,68228.0
Ranga Reddy,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,95.0,123.0,77.0,69.0,71.0,77.0,66.0,60.0,61.0,67.0,105.0,94.0,965.0
Ranga Reddy,15.2,Number of Widal tests conducted,Number tested,1323.0,866.0,497.0,710.0,1542.0,1268.0,1839.0,1915.0,1459.0,1329.0,1392.0,1806.0,15946.0
Ranga Reddy,15.3.a,Number of VDRL tests conducted on males,Number tested,54.0,69.0,46.0,71.0,36.0,241.0,436.0,178.0,45.0,341.0,96.0,117.0,1730.0
Ranga Reddy,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,129.0,232.0,127.0,139.0,168.0,375.0,207.0,239.0,212.0,379.0,260.0,318.0,2785.0
Ranga Reddy,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,1139.0,779.0,1022.0,977.0,723.0,1052.0,471.0,838.0,731.0,987.0,815.0,832.0,10366.0
Ranga Reddy,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,1322.0,1080.0,1195.0,1187.0,927.0,1668.0,1114.0,1255.0,988.0,1707.0,1171.0,1267.0,14881.0
Ranga Reddy,15.4.1,Number of blood smears examined for Malaria,TOTAL,14665.0,13804.0,15436.0,16322.0,15811.0,16406.0,15410.0,15195.0,14988.0,14715.0,17000.0,14943.0,184695.0
Ranga Reddy,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,0.0,2.0,0.0,5.0,8.0,6.0,2.0,1.0,0.0,1.0,0.0,0.0,25.0
Ranga Reddy,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,0.0,1.0,1.0,6.0,1.0,1.0,0.0,0.0,0.0,0.0,10.0
Ranga Reddy,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,27330.0,20780.0,25130.0,,22960.0,29450.0,15380.0,4620.0,830.0,2190.0,12910.0,,161580.0
Ranga Reddy,16.1.1,Stock position of DPT vaccines,2. Stocks Received,42000.0,30000.0,36000.0,,20000.0,0.0,0.0,7500.0,10000.0,20000.0,0.0,,165500.0
Ranga Reddy,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ranga Reddy,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,48550.0,25650.0,35450.0,,13510.0,14070.0,10760.0,11290.0,8640.0,9280.0,7900.0,,185100.0
Ranga Reddy,16.1.1,Stock position of DPT vaccines,5. Total Stock,20780.0,25130.0,25680.0,0.0,29450.0,15380.0,4620.0,830.0,2190.0,12910.0,5010.0,0.0,141980.0
Ranga Reddy,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,0.0,0.0,0.0,,20570.0,35730.0,7610.0,1620.0,7120.0,22470.0,30820.0,,125940.0
Ranga Reddy,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,0.0,0.0,40320.0,,28800.0,0.0,23040.0,28800.0,34560.0,34560.0,0.0,,190080.0
Ranga Reddy,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ranga Reddy,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,0.0,0.0,19230.0,,13640.0,28120.0,29030.0,23300.0,19210.0,26210.0,21750.0,,180490.0
Ranga Reddy,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,21090.0,0.0,35730.0,7610.0,1620.0,7120.0,22470.0,30820.0,9070.0,0.0,135530.0
Ranga Reddy,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,20340.0,11690.0,16190.0,,34290.0,55290.0,0.0,49990.0,16430.0,21150.0,16490.0,,241860.0
Ranga Reddy,16.1.2,Stock position of OPV vaccines,2. Stocks Received,50000.0,40000.0,80000.0,,50000.0,0.0,50000.0,5000.0,40000.0,30000.0,38000.0,,383000.0
Ranga Reddy,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ranga Reddy,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,58650.0,35500.0,51400.0,,29000.0,55290.0,10.0,38560.0,35280.0,34660.0,38500.0,,376850.0
Ranga Reddy,16.1.2,Stock position of OPV vaccines,5. Total Stock,11690.0,16190.0,44790.0,0.0,55290.0,0.0,49990.0,16430.0,21150.0,16490.0,15990.0,0.0,248010.0
Ranga Reddy,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,25850.0,32400.0,47400.0,,31570.0,47510.0,16430.0,14260.0,25170.0,34850.0,39150.0,,314590.0
Ranga Reddy,16.1.3,Stock position of TT vaccines,2. Stocks Received,45000.0,30000.0,15000.0,,30000.0,0.0,24000.0,30000.0,20000.0,22500.0,0.0,,216500.0
Ranga Reddy,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ranga Reddy,16.1.3,Stock position of TT vaccines,4. Stock Distributed,38450.0,15000.0,19310.0,,14060.0,31080.0,26170.0,19090.0,10320.0,18200.0,19650.0,,211330.0
Ranga Reddy,16.1.3,Stock position of TT vaccines,5. Total Stock,32400.0,47400.0,43090.0,0.0,47510.0,16430.0,14260.0,25170.0,34850.0,39150.0,19500.0,0.0,319760.0
Ranga Reddy,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ranga Reddy,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ranga Reddy,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ranga Reddy,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ranga Reddy,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ranga Reddy,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,14800.0,6570.0,15920.0,,12560.0,35390.0,18680.0,800.0,7510.0,11640.0,7770.0,,131640.0
Ranga Reddy,16.1.5,Stock position of BCG vaccines,2. Stocks Received,20000.0,20000.0,28000.0,,28000.0,0.0,0.0,20000.0,14000.0,14000.0,0.0,,144000.0
Ranga Reddy,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ranga Reddy,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,28230.0,10650.0,13000.0,,5170.0,16710.0,17880.0,13290.0,9870.0,17870.0,7500.0,,140170.0
Ranga Reddy,16.1.5,Stock position of BCG vaccines,5. Total Stock,6570.0,15920.0,30920.0,0.0,35390.0,18680.0,800.0,7510.0,11640.0,7770.0,270.0,0.0,135470.0
Ranga Reddy,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,15130.0,14930.0,19730.0,,13585.0,27445.0,6710.0,7940.0,6225.0,5170.0,16265.0,,133130.0
Ranga Reddy,16.1.6,Stock position of Measles vaccines,2. Stocks Received,25000.0,20000.0,20000.0,,25000.0,0.0,25000.0,20000.0,15000.0,30000.0,0.0,,180000.0
Ranga Reddy,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ranga Reddy,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,25200.0,15200.0,12925.0,,11140.0,20735.0,23770.0,21715.0,16055.0,18905.0,11500.0,,177145.0
Ranga Reddy,16.1.6,Stock position of Measles vaccines,5. Total Stock,14930.0,19730.0,26805.0,0.0,27445.0,6710.0,7940.0,6225.0,5170.0,16265.0,4765.0,0.0,135985.0
Ranga Reddy,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ranga Reddy,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ranga Reddy,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ranga Reddy,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ranga Reddy,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ranga Reddy,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,34650.0,30460.0,40210.0,,14940.0,19680.0,10890.0,5200.0,4180.0,3100.0,6570.0,,169880.0
Ranga Reddy,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,30000.0,30000.0,24000.0,,12000.0,0.0,0.0,0.0,0.0,6000.0,5200.0,,107200.0
Ranga Reddy,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ranga Reddy,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,34190.0,20250.0,26950.0,,7260.0,8790.0,5690.0,1020.0,1080.0,2530.0,3500.0,,111260.0
Ranga Reddy,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,30460.0,40210.0,37260.0,0.0,19680.0,10890.0,5200.0,4180.0,3100.0,6570.0,8270.0,0.0,165820.0
Ranga Reddy,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,700.0,300.0,1540.0,,140.0,140.0,140.0,140.0,140.0,3617.0,10429.0,,17286.0
Ranga Reddy,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,3000.0,0.0,,0.0,0.0,0.0,0.0,6577.0,10200.0,0.0,,19777.0
Ranga Reddy,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ranga Reddy,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,400.0,1760.0,1000.0,,0.0,0.0,0.0,0.0,3100.0,3388.0,696.0,,10344.0
Ranga Reddy,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,300.0,1540.0,540.0,0.0,140.0,140.0,140.0,140.0,3617.0,10429.0,9733.0,0.0,26719.0
Ranga Reddy,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,0.0,102000.0,176480.0,,60091.0,54091.0,48091.0,36091.0,18091.0,24091.0,875551.0,,1394577.0
Ranga Reddy,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,120000.0,138000.0,0.0,,0.0,0.0,0.0,0.0,60000.0,898650.0,0.0,,1216650.0
Ranga Reddy,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ranga Reddy,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,18000.0,63520.0,90452.0,,6000.0,6000.0,12000.0,18000.0,54000.0,47190.0,12000.0,,327162.0
Ranga Reddy,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,102000.0,176480.0,86028.0,0.0,54091.0,48091.0,36091.0,18091.0,24091.0,875551.0,863551.0,0.0,2284065.0
Ranga Reddy,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,70.0,4070.0,28920.0,,10428.0,10028.0,8778.0,6778.0,3578.0,1978.0,109178.0,,183806.0
Ranga Reddy,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,5000.0,28000.0,0.0,,0.0,0.0,0.0,0.0,0.0,112000.0,0.0,,145000.0
Ranga Reddy,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,,0.0,0.0,,0.0
Ranga Reddy,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,1000.0,3150.0,5474.0,,400.0,1250.0,2000.0,3200.0,1600.0,4800.0,1200.0,,24074.0
Ranga Reddy,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,4070.0,28920.0,23446.0,0.0,10028.0,8778.0,6778.0,3578.0,1978.0,109178.0,107978.0,0.0,304732.0
Ranga Reddy,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,6200.0,,1662.0,1392.0,1272.0,1172.0,872.0,500.0,2000.0,,15070.0
Ranga Reddy,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,7900.0,0.0,,0.0,0.0,0.0,0.0,0.0,2000.0,0.0,,9900.0
Ranga Reddy,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ranga Reddy,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,1700.0,841.0,,270.0,120.0,100.0,300.0,372.0,500.0,300.0,,4503.0
Ranga Reddy,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,6200.0,5359.0,0.0,1392.0,1272.0,1172.0,872.0,500.0,2000.0,1700.0,0.0,20467.0
Ranga Reddy,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,100.0,100.0,1400.0,,200.0,200.0,600.0,400.0,1000.0,500.0,500.0,,5000.0
Ranga Reddy,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,2000.0,1268.0,,0.0,1000.0,0.0,1000.0,0.0,0.0,1000.0,,6268.0
Ranga Reddy,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ranga Reddy,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,700.0,2268.0,,0.0,600.0,200.0,400.0,500.0,0.0,500.0,,5168.0
Ranga Reddy,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,100.0,1400.0,400.0,0.0,200.0,600.0,400.0,1000.0,500.0,500.0,1000.0,0.0,6100.0
Ranga Reddy,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ranga Reddy,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ranga Reddy,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ranga Reddy,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ranga Reddy,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ranga Reddy,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ranga Reddy,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ranga Reddy,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ranga Reddy,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ranga Reddy,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ranga Reddy,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ranga Reddy,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ranga Reddy,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ranga Reddy,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ranga Reddy,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ranga Reddy,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ranga Reddy,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ranga Reddy,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ranga Reddy,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ranga Reddy,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ranga Reddy,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ranga Reddy,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ranga Reddy,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ranga Reddy,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ranga Reddy,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ranga Reddy,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ranga Reddy,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ranga Reddy,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ranga Reddy,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ranga Reddy,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ranga Reddy,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,6000.0,3000.0,0.0,,9000.0
Ranga Reddy,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,250000.0,875000.0,125000.0,,480000.0,228000.0,500000.0,36000.0,0.0,0.0,0.0,,2494000.0
Ranga Reddy,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ranga Reddy,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,250000.0,875000.0,125000.0,,480000.0,228000.0,500000.0,30000.0,3000.0,3000.0,0.0,,2494000.0
Ranga Reddy,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6000.0,3000.0,0.0,0.0,0.0,9000.0
Ranga Reddy,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ranga Reddy,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,10000.0,45000.0,8000.0,,18000.0,37500.0,7200.0,2000.0,0.0,0.0,0.0,,127700.0
Ranga Reddy,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ranga Reddy,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,10000.0,45000.0,8000.0,,18000.0,37500.0,7200.0,2000.0,0.0,0.0,0.0,,127700.0
Ranga Reddy,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ranga Reddy,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,600.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,600.0
Ranga Reddy,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,5200.0,29800.0,7200.0,,354.0,1488.0,0.0,0.0,0.0,0.0,0.0,,44042.0
Ranga Reddy,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ranga Reddy,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,5200.0,29200.0,7200.0,,354.0,1488.0,0.0,0.0,0.0,0.0,0.0,,43442.0
Ranga Reddy,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,600.0,600.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1200.0
Ranga Reddy,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,1538.0,1523.0,1523.0,,922.0,822.0,245.0,105.0,35.0,0.0,0.0,,6713.0
Ranga Reddy,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ranga Reddy,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ranga Reddy,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,15.0,0.0,480.0,,100.0,577.0,140.0,70.0,35.0,0.0,0.0,,1417.0
Ranga Reddy,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,1523.0,1523.0,1043.0,0.0,822.0,245.0,105.0,35.0,0.0,0.0,0.0,0.0,5296.0
Ranga Reddy,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,200.0,0.0,1800.0,,3000.0,1200.0,1200.0,600.0,0.0,0.0,200.0,,8200.0
Ranga Reddy,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,18200.0,82900.0,40480.0,,0.0,0.0,0.0,0.0,0.0,1000.0,49370.0,,191950.0
Ranga Reddy,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ranga Reddy,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,18400.0,81100.0,37480.0,,1800.0,0.0,600.0,600.0,0.0,800.0,25400.0,,166180.0
Ranga Reddy,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,1800.0,4800.0,0.0,1200.0,1200.0,600.0,0.0,0.0,200.0,24170.0,0.0,33970.0
Ranga Reddy,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,2000.0,0.0,0.0,,3200.0,0.0,0.0,0.0,0.0,0.0,0.0,,5200.0
Ranga Reddy,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,0.0,9900.0,,0.0,13200.0,3300.0,0.0,0.0,0.0,0.0,,26400.0
Ranga Reddy,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ranga Reddy,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,2000.0,0.0,6700.0,,3200.0,13200.0,3300.0,0.0,0.0,0.0,0.0,,28400.0
Ranga Reddy,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,3200.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3200.0
Ranga Reddy,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,0.0,0.0,0.0,,69600.0,202500.0,25100.0,0.0,78500.0,243100.0,195100.0,,813900.0
Ranga Reddy,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,0.0,144000.0,,162000.0,0.0,5600.0,267000.0,270000.0,0.0,0.0,,848600.0
Ranga Reddy,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ranga Reddy,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,0.0,0.0,74000.0,,29100.0,177400.0,30700.0,188500.0,105400.0,48000.0,1000.0,,654100.0
Ranga Reddy,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,70000.0,0.0,202500.0,25100.0,0.0,78500.0,243100.0,195100.0,194100.0,0.0,1008400.0
Ranga Reddy,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,0.0,0.0,0.0,,800.0,800.0,2100.0,4100.0,8300.0,1600.0,0.0,,17700.0
Ranga Reddy,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,0.0,4800.0,,0.0,7200.0,6000.0,14800.0,0.0,0.0,0.0,,32800.0
Ranga Reddy,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ranga Reddy,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,0.0,0.0,4000.0,,0.0,5900.0,4000.0,10600.0,6700.0,1600.0,0.0,,32800.0
Ranga Reddy,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,800.0,0.0,800.0,2100.0,4100.0,8300.0,1600.0,0.0,0.0,0.0,17700.0
Ranga Reddy,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,1.0,,2.0,3.0,2.0,2.0,2.0,2.0,2.0,,,,16.0
Ranga Reddy,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Ranga Reddy,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Ranga Reddy,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Ranga Reddy,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Ranga Reddy,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Ranga Reddy,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Ranga Reddy,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,3.0,3.0,1.0,3.0,3.0,4.0,2.0,3.0,2.0,3.0,3.0,2.0,32.0
Ranga Reddy,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,1.0,,,,1.0
Ranga Reddy,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,3.0,3.0,1.0,3.0,3.0,4.0,2.0,3.0,3.0,3.0,3.0,2.0,33.0
Ranga Reddy,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,1.0,2.0,,1.0,2.0,2.0,3.0,3.0,2.0,4.0,4.0,2.0,26.0
Ranga Reddy,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Ranga Reddy,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,1.0,2.0,,1.0,2.0,2.0,3.0,3.0,2.0,4.0,4.0,2.0,26.0
Ranga Reddy,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,2.0,1.0,,,2.0,,,,1.0,,,,6.0
Ranga Reddy,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Ranga Reddy,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,2.0,1.0,,,2.0,,,,1.0,,,,6.0
Ranga Reddy,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Ranga Reddy,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Ranga Reddy,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Ranga Reddy,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,1.0,1.0,2.0,1.0,1.0,,6.0
Ranga Reddy,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Ranga Reddy,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,1.0,1.0,2.0,1.0,1.0,,6.0
Ranga Reddy,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Ranga Reddy,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Ranga Reddy,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Ranga Reddy,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,1.0,,,,,1.0,1.0,1.0,,,,4.0
Ranga Reddy,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
Ranga Reddy,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,1.0,,,,,1.0,1.0,1.0,,,,4.0
Ranga Reddy,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,1.0,,,,,,,,,1.0
Ranga Reddy,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,1.0,,2.0,,1.0,1.0,,1.0,1.0,1.0,1.0,1.0,10.0
Ranga Reddy,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,1.0,,1.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,12.0
Ranga Reddy,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,2.0,,3.0,2.0,3.0,2.0,1.0,2.0,2.0,2.0,2.0,2.0,23.0
Ranga Reddy,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Ranga Reddy,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,1.0,1.0,1.0,,,1.0,1.0,,,,,,5.0
Ranga Reddy,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,2.0,,,,,,2.0
Ranga Reddy,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,1.0,1.0,1.0,,,1.0,3.0,,,,,,7.0
Ranga Reddy,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,1.0,,,,,,,,,,,,1.0
Ranga Reddy,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,1.0,3.0,,2.0,,1.0,2.0,2.0,1.0,,1.0,13.0
Ranga Reddy,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,2.0,1.0,2.0,2.0,3.0,1.0,2.0,1.0,3.0,3.0,2.0,22.0
Ranga Reddy,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,1.0,3.0,4.0,2.0,4.0,3.0,2.0,4.0,3.0,4.0,3.0,3.0,36.0
Ranga Reddy,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Ranga Reddy,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Ranga Reddy,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Ranga Reddy,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Ranga Reddy,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Ranga Reddy,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
Ranga Reddy,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,1.0,,1.0
Ranga Reddy,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,1.0,,1.0
Ranga Reddy,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Ranga Reddy,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,1.0,,,1.0,1.0,1.0,,,,,1.0,1.0,6.0
Ranga Reddy,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,2.0,,,,,,,,,,2.0
Ranga Reddy,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,1.0,,2.0,1.0,1.0,1.0,,,,,1.0,1.0,8.0
Ranga Reddy,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,1.0,,1.0,,,,,,,,2.0
Ranga Reddy,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,9.0,2.0,5.0,7.0,9.0,9.0,5.0,6.0,4.0,4.0,6.0,3.0,69.0
Ranga Reddy,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,7.0,1.0,7.0,6.0,10.0,7.0,3.0,3.0,1.0,1.0,4.0,3.0,53.0
Ranga Reddy,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,16.0,3.0,13.0,13.0,20.0,16.0,8.0,9.0,5.0,5.0,10.0,6.0,124.0
Ranga Reddy,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Ranga Reddy,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,1.0,,,1.0,,,2.0,,,,,4.0
Ranga Reddy,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,1.0,1.0,,,,2.0,1.0,,,3.0,2.0,2.0,12.0
Ranga Reddy,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,1.0,2.0,,,1.0,2.0,1.0,2.0,,3.0,2.0,2.0,16.0
Ranga Reddy,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Ranga Reddy,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Ranga Reddy,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Ranga Reddy,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Ranga Reddy,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Ranga Reddy,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Ranga Reddy,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Ranga Reddy,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Ranga Reddy,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Ranga Reddy,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,2.0,,1.0,,1.0,,,,,,,4.0
Ranga Reddy,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Ranga Reddy,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,2.0,,1.0,,1.0,,,,,,,4.0
Ranga Reddy,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Ranga Reddy,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,1.0,,,,,,1.0
Ranga Reddy,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Ranga Reddy,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,1.0,,,,,,1.0
Ranga Reddy,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Ranga Reddy,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Ranga Reddy,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Ranga Reddy,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Ranga Reddy,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Ranga Reddy,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
Ranga Reddy,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Ranga Reddy,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
Ranga Reddy,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Ranga Reddy,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,2.0,3.0,2.0,2.0,,,4.0,2.0,1.0,7.0,4.0,2.0,29.0
Ranga Reddy,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,1.0,1.0,1.0,,,,,,,,,3.0
Ranga Reddy,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,2.0,4.0,3.0,3.0,,,4.0,2.0,1.0,7.0,4.0,2.0,32.0
Ranga Reddy,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,1.0,1.0,,,,,,,,,2.0
Ranga Reddy,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,2.0,2.0,3.0,3.0,3.0,,2.0,3.0,3.0,3.0,3.0,27.0
Ranga Reddy,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,1.0,1.0
Ranga Reddy,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,2.0,3.0,4.0,3.0,3.0,,2.0,3.0,3.0,3.0,4.0,30.0
Ranga Reddy,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Ranga Reddy,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,1.0,,,,,,,,,1.0,2.0
Ranga Reddy,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,1.0,,1.0,,,1.0,,,,,,3.0
Ranga Reddy,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,1.0,1.0,1.0,,,1.0,,,,,1.0,5.0
Ranga Reddy,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Ranga Reddy,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,2.0,2.0,1.0,1.0,,1.0,3.0,7.0,10.0,4.0,3.0,2.0,36.0
Ranga Reddy,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,1.0,,,,,1.0,4.0,4.0,6.0,3.0,3.0,2.0,24.0
Ranga Reddy,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,3.0,2.0,1.0,1.0,,2.0,7.0,11.0,16.0,7.0,6.0,4.0,60.0
Ranga Reddy,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,1.0,1.0
Ranga Reddy,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,1.0,,1.0,,5.0,,2.0,4.0,1.0,2.0,5.0,21.0
Ranga Reddy,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,1.0,1.0,,1.0,,2.0,,,1.0,,,4.0,10.0
Ranga Reddy,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,1.0,2.0,,2.0,,7.0,,2.0,5.0,1.0,2.0,10.0,32.0
Ranga Reddy,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,1.0,,,,,,1.0
Ranga Reddy,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
Ranga Reddy,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,1.0,,,,,,,1.0,2.0
Ranga Reddy,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,1.0,,1.0,,,,,1.0,3.0
SANGAREDDY,1.1,Total number of pregnant women Registered for ANC,TOTAL,,,,,,,,,,,,,
SANGAREDDY,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,,,,,,,,,,,,,
SANGAREDDY,1.2,Number of Pregnant women registered under JSY,TOTAL,,,,,,,,,,,,,
SANGAREDDY,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,,,,,,,,,,,,,
SANGAREDDY,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,,,,,,,,,,,,,
SANGAREDDY,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,,,,,,,,,,,,,
SANGAREDDY,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,,,,,,,,,,,,,
SANGAREDDY,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,,,,,,,,,,,,,
SANGAREDDY,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,,,,,,,,,,,,,
SANGAREDDY,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,,,,,,,,,,,,,
SANGAREDDY,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,,,,,,,,,,,,,
SANGAREDDY,1.8,Number of pregnancy test kits used at SC level,TOTAL,,,,,,,,,,,,,
SANGAREDDY,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,,,,,,,,,,,,,
SANGAREDDY,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,,,,,,,,,,,,,
SANGAREDDY,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,,,,,,,,,,,,,
SANGAREDDY,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,,,,,,,,,,,,,
SANGAREDDY,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,,,,,,,,,,,,,
SANGAREDDY,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
SANGAREDDY,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,,,,,,,,,,,,,
SANGAREDDY,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,,,,,,,,,,,,,
SANGAREDDY,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,,,,,,,,,,,,,
SANGAREDDY,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
SANGAREDDY,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
SANGAREDDY,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
SANGAREDDY,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
SANGAREDDY,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
SANGAREDDY,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,,,,,,,,,,,,,
SANGAREDDY,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,,,,,,,,,,,,,
SANGAREDDY,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,,,,,,,,,,,,,
SANGAREDDY,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
SANGAREDDY,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,,,,,,,,,,,,,
SANGAREDDY,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
SANGAREDDY,4.1.1.a,Number of male live births,TOTAL,,,,,,,,,,,,,
SANGAREDDY,4.1.1.b,Number of female live births,TOTAL,,,,,,,,,,,,,
SANGAREDDY,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,,,,,,,,,,,,,
SANGAREDDY,4.1.2,Number of still births,TOTAL,,,,,,,,,,,,,
SANGAREDDY,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,,,,,,,,,,,,,
SANGAREDDY,4.2.1,Number of Newborns weighed at birth,TOTAL,,,,,,,,,,,,,
SANGAREDDY,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,,,,,,,,,,,,,
SANGAREDDY,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,,,,,,,,,,,,,
SANGAREDDY,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,,,,,,,,,,,,,
SANGAREDDY,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,,,,,,,,,,,,,
SANGAREDDY,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,,,,,,,,,,,,,
SANGAREDDY,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
SANGAREDDY,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,,,,,,,,,,,,,
SANGAREDDY,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
SANGAREDDY,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,,,,,,,,,,,,,
SANGAREDDY,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,,,,,,,,,,,,,
SANGAREDDY,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,,,,,,,,,,,,,
SANGAREDDY,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,,,,,,,,,,,,,
SANGAREDDY,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,,,,,,,,,,,,,
SANGAREDDY,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,,,,,,,,,,,,,
SANGAREDDY,6.3,PNC maternal complications attended,TOTAL,,,,,,,,,,,,,
SANGAREDDY,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,,,,,,,,,,,,,
SANGAREDDY,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,,,,,,,,,,,,,
SANGAREDDY,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,,,,,,,,,,,,,
SANGAREDDY,7.2,Number of MTPs conducted at Private Facilities,TOTAL,,,,,,,,,,,,,
SANGAREDDY,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,,,,,,,,,,,,,
SANGAREDDY,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,,,,,,,,,,,,,
SANGAREDDY,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,,,,,,,,,,,,,
SANGAREDDY,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,,,,,,,,,,,,,
SANGAREDDY,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,,,,,,,,,,,,,
SANGAREDDY,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,,,,,,,,,,,,,
SANGAREDDY,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
SANGAREDDY,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
SANGAREDDY,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,,,,,,,,,,,,,
SANGAREDDY,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
SANGAREDDY,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
SANGAREDDY,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
SANGAREDDY,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
SANGAREDDY,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
SANGAREDDY,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,,,,,,,,,,,,,
SANGAREDDY,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
SANGAREDDY,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
SANGAREDDY,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
SANGAREDDY,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
SANGAREDDY,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
SANGAREDDY,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,,,,,,,,,,,,,
SANGAREDDY,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
SANGAREDDY,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
SANGAREDDY,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
SANGAREDDY,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
SANGAREDDY,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
SANGAREDDY,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,,,,,,,,,,,,,
SANGAREDDY,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
SANGAREDDY,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,,,,,,,,,,,,,
SANGAREDDY,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,,,,,,,,,,,,,
SANGAREDDY,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,,,,,,,,,,,,,
SANGAREDDY,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
SANGAREDDY,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
SANGAREDDY,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,,,,,,,,,,,,,
SANGAREDDY,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,,,,,,,,,,,,,
SANGAREDDY,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
SANGAREDDY,9.06,Number of IUCD removals,TOTAL,,,,,,,,,,,,,
SANGAREDDY,9.07,Number of Oral Pills cycles distributed,TOTAL,,,,,,,,,,,,,
SANGAREDDY,9.08,Number of Condom pieces distributed,TOTAL,,,,,,,,,,,,,
SANGAREDDY,9.09,Number of Centchroman (weekly) pills given,TOTAL,,,,,,,,,,,,,
SANGAREDDY,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,,,,,,,,,,,,,
SANGAREDDY,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,,,,,,,,,,,,,
SANGAREDDY,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,,,,,,,,,,,,,
SANGAREDDY,9.11.2.a,Number of failures following male sterilization,TOTAL,,,,,,,,,,,,,
SANGAREDDY,9.11.2.b,Number of failures following female sterilization,TOTAL,,,,,,,,,,,,,
SANGAREDDY,9.11.3.a,Number of deaths following male sterilization,TOTAL,,,,,,,,,,,,,
SANGAREDDY,9.11.3.b,Number of deaths following female sterilization,TOTAL,,,,,,,,,,,,,
SANGAREDDY,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,,,,,,,,,,,-1.0
SANGAREDDY,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,,,,,,,,,,,,,
SANGAREDDY,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,,,,,,,,,,,,,
SANGAREDDY,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,,,,,,,,,,,,,
SANGAREDDY,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,,,,,,,,,,,,,
SANGAREDDY,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,,,,,,,,,,,,,
SANGAREDDY,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,,,,,,,,,,,,,
SANGAREDDY,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,,,,,,,,,,,,,
SANGAREDDY,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,,,,,,,,,,,,,
SANGAREDDY,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,,,,,,,,,,,,,
SANGAREDDY,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,,,,,,,,,,,,,
SANGAREDDY,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,,,,,,,,,,,,,
SANGAREDDY,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,,,,,,,,,,,,,
SANGAREDDY,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,,,,,,,,,,,,,
SANGAREDDY,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,,,,,,,,,,,,,
SANGAREDDY,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,,,,,,,,,,,,,
SANGAREDDY,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,,,,,,,,,,,,,
SANGAREDDY,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,,,,,,,,,,,,,
SANGAREDDY,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,,,,,,,,,,,,,
SANGAREDDY,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
SANGAREDDY,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
SANGAREDDY,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,,,,,,,,,,,,,
SANGAREDDY,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,,,,,,,,,,,,,
SANGAREDDY,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,,,,,,,,,,,,,
SANGAREDDY,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,,,,,,,,,,,,,
SANGAREDDY,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
SANGAREDDY,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
SANGAREDDY,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,,,,,,,,,,,,,
SANGAREDDY,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,,,,,,,,,,,,,
SANGAREDDY,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,,,,,,,,,,,,,
SANGAREDDY,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,,,,,,,,,,,,,
SANGAREDDY,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
SANGAREDDY,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
SANGAREDDY,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
SANGAREDDY,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,,,,,,,,,,,,,
SANGAREDDY,10.4.2,Number of Immunisation sessions held during the month,TOTAL,,,,,,,,,,,,,
SANGAREDDY,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,,,,,,,,,,,,,
SANGAREDDY,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,,,,,,,,,,,,,
SANGAREDDY,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,,,,,,,,,,,,,
SANGAREDDY,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,,,,,,,,,,,,,
SANGAREDDY,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,,,,,,,,,,,,,
SANGAREDDY,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
SANGAREDDY,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
SANGAREDDY,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
SANGAREDDY,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
SANGAREDDY,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
SANGAREDDY,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
SANGAREDDY,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
SANGAREDDY,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
SANGAREDDY,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,,,,,,,,,,,,,
SANGAREDDY,13.1,Number of Patients operated for cataract,TOTAL,,,,,,,,,,,,,
SANGAREDDY,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,,,,,,,,,,,,,
SANGAREDDY,13.3,Number of School children detected with Refractive errors,TOTAL,,,,,,,,,,,,,
SANGAREDDY,13.4,Number of children provided free glasses,TOTAL,,,,,,,,,,,,,
SANGAREDDY,13.5,Number of eyes collected through eye donation,TOTAL,,,,,,,,,,,,,
SANGAREDDY,13.6,Number of eyes utilised for corneal transplant,TOTAL,,,,,,,,,,,,,
SANGAREDDY,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,,,,,,,,,,,,-1.0
SANGAREDDY,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,,,,,,,,,,-1.0
SANGAREDDY,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,,,,,,,,,,,,,-1.0
SANGAREDDY,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,,,,,,,,,,,,,-1.0
SANGAREDDY,14.05,Number of RKS meetings held during the month,TOTAL,,,,,,,,,,,,,
SANGAREDDY,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,,,,,,,,,,,,,-1.0
SANGAREDDY,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,,,,,,,,,,,,,
SANGAREDDY,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,,,,,,,,,-1.0
SANGAREDDY,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,,,,,,,,,,,,,-1.0
SANGAREDDY,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,,,,,,,,,,,,,
SANGAREDDY,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,,,,,,,,,,,,,
SANGAREDDY,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,,,,,,,,,,,,,
SANGAREDDY,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,,,,,,,,,,,,,
SANGAREDDY,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,,,,,,,,,,,,,
SANGAREDDY,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,,,,,,,,,,,,,
SANGAREDDY,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,,,,,,,,,,,,,
SANGAREDDY,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,,,,,,,,,,,,,
SANGAREDDY,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,,,,,,,,,,,,,
SANGAREDDY,14.10.2.a,Number of death cases of Inpatient males,TOTAL,,,,,,,,,,,,,
SANGAREDDY,14.10.2.b,Number of death cases of Inpatient females,TOTAL,,,,,,,,,,,,,
SANGAREDDY,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,,,,,,,,,,,,,
SANGAREDDY,14.11,In-Patient Head Count at midnight,TOTAL,,,,,,,,,,,,,
SANGAREDDY,14.12.1,OPD attendance (All),TOTAL,,,,,,,,,,,,,
SANGAREDDY,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,,,,,,,,,,,,,
SANGAREDDY,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,,,,,,,,,,,,,
SANGAREDDY,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,,,,,,,,,,,,,
SANGAREDDY,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,,,,,,,,,,,,,
SANGAREDDY,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,,,,,,,,,,,,,
SANGAREDDY,14.14.a,Number of patients given AYUSH treatment,TOTAL,,,,,,,,,,,,,
SANGAREDDY,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,,,,,,,,,,,,,
SANGAREDDY,14.14.c,Number of Adolescents counselled,TOTAL,,,,,,,,,,,,,
SANGAREDDY,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,,,,,,,,,,,,,
SANGAREDDY,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,,,,,,,,,,,,,
SANGAREDDY,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,,,,,,,,,,,,,
SANGAREDDY,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,,,,,,,,,,,,,
SANGAREDDY,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,,,,,,,,,,,,,
SANGAREDDY,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,,,,,,,,,,,,,
SANGAREDDY,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,,,,,,,,,,,,,
SANGAREDDY,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,,,,,,,,,,,,,
SANGAREDDY,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,,,,,,,,,,,,,
SANGAREDDY,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,,,,,,,,,,,,,
SANGAREDDY,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,,,,,,,,,,,,,
SANGAREDDY,15.2,Number of Widal tests conducted,Number tested,,,,,,,,,,,,,
SANGAREDDY,15.3.a,Number of VDRL tests conducted on males,Number tested,,,,,,,,,,,,,
SANGAREDDY,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,,,,,,,,,,,,,
SANGAREDDY,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,,,,,,,,,,,,,
SANGAREDDY,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,,,,,,,,,,,,,
SANGAREDDY,15.4.1,Number of blood smears examined for Malaria,TOTAL,,,,,,,,,,,,,
SANGAREDDY,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,,,,,,,,,,,,,
SANGAREDDY,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,,,,,,,,,,,,,
SANGAREDDY,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
SANGAREDDY,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,,,,,,,,,,
SANGAREDDY,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
SANGAREDDY,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,,,,,,,,,
SANGAREDDY,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SANGAREDDY,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
SANGAREDDY,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
SANGAREDDY,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
SANGAREDDY,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
SANGAREDDY,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SANGAREDDY,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
SANGAREDDY,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,,,,,,,,,
SANGAREDDY,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
SANGAREDDY,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,,,,,,,,,
SANGAREDDY,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SANGAREDDY,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
SANGAREDDY,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,,,,,,,,,
SANGAREDDY,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
SANGAREDDY,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,,,,,,,,,
SANGAREDDY,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SANGAREDDY,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
SANGAREDDY,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
SANGAREDDY,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
SANGAREDDY,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
SANGAREDDY,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SANGAREDDY,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
SANGAREDDY,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,,,,,,,,,
SANGAREDDY,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
SANGAREDDY,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,,,,,,,,,
SANGAREDDY,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SANGAREDDY,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
SANGAREDDY,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,,,,,,,,,
SANGAREDDY,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
SANGAREDDY,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,,,,,,,,,
SANGAREDDY,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SANGAREDDY,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
SANGAREDDY,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
SANGAREDDY,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
SANGAREDDY,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
SANGAREDDY,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SANGAREDDY,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
SANGAREDDY,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,,,,,,
SANGAREDDY,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
SANGAREDDY,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,,,,,,
SANGAREDDY,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SANGAREDDY,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
SANGAREDDY,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
SANGAREDDY,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
SANGAREDDY,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
SANGAREDDY,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SANGAREDDY,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
SANGAREDDY,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
SANGAREDDY,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
SANGAREDDY,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
SANGAREDDY,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SANGAREDDY,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
SANGAREDDY,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
SANGAREDDY,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
SANGAREDDY,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
SANGAREDDY,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SANGAREDDY,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
SANGAREDDY,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
SANGAREDDY,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
SANGAREDDY,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
SANGAREDDY,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SANGAREDDY,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
SANGAREDDY,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
SANGAREDDY,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
SANGAREDDY,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
SANGAREDDY,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SANGAREDDY,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
SANGAREDDY,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
SANGAREDDY,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
SANGAREDDY,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
SANGAREDDY,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SANGAREDDY,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
SANGAREDDY,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
SANGAREDDY,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
SANGAREDDY,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
SANGAREDDY,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SANGAREDDY,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
SANGAREDDY,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
SANGAREDDY,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
SANGAREDDY,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
SANGAREDDY,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SANGAREDDY,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
SANGAREDDY,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
SANGAREDDY,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
SANGAREDDY,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
SANGAREDDY,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SANGAREDDY,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
SANGAREDDY,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
SANGAREDDY,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
SANGAREDDY,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
SANGAREDDY,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SANGAREDDY,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
SANGAREDDY,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
SANGAREDDY,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
SANGAREDDY,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
SANGAREDDY,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SANGAREDDY,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
SANGAREDDY,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
SANGAREDDY,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
SANGAREDDY,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
SANGAREDDY,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SANGAREDDY,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
SANGAREDDY,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
SANGAREDDY,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
SANGAREDDY,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
SANGAREDDY,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SANGAREDDY,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
SANGAREDDY,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
SANGAREDDY,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
SANGAREDDY,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
SANGAREDDY,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SANGAREDDY,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
SANGAREDDY,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
SANGAREDDY,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
SANGAREDDY,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
SANGAREDDY,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SANGAREDDY,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
SANGAREDDY,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
SANGAREDDY,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
SANGAREDDY,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
SANGAREDDY,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SANGAREDDY,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
SANGAREDDY,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
SANGAREDDY,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
SANGAREDDY,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
SANGAREDDY,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SANGAREDDY,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
SANGAREDDY,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
SANGAREDDY,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
SANGAREDDY,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
SANGAREDDY,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SANGAREDDY,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,,,,,,,
SANGAREDDY,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,,,,,,,
SANGAREDDY,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
SANGAREDDY,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,,,,,,,
SANGAREDDY,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SANGAREDDY,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
SANGAREDDY,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
SANGAREDDY,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
SANGAREDDY,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
SANGAREDDY,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
SANGAREDDY,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
SANGAREDDY,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
SANGAREDDY,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
SANGAREDDY,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
SANGAREDDY,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
SANGAREDDY,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
SANGAREDDY,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
SANGAREDDY,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
SANGAREDDY,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
SANGAREDDY,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
SANGAREDDY,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
SANGAREDDY,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
SANGAREDDY,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
SANGAREDDY,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
SANGAREDDY,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
SANGAREDDY,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
SANGAREDDY,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
SANGAREDDY,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
SANGAREDDY,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
SANGAREDDY,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
SANGAREDDY,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
SANGAREDDY,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
SANGAREDDY,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
SANGAREDDY,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
SANGAREDDY,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
SANGAREDDY,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
SANGAREDDY,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
SANGAREDDY,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
SANGAREDDY,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
SANGAREDDY,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
SANGAREDDY,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
SANGAREDDY,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
SANGAREDDY,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
SANGAREDDY,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
SANGAREDDY,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
SANGAREDDY,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
SANGAREDDY,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
SANGAREDDY,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
SANGAREDDY,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
SANGAREDDY,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
SANGAREDDY,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
SANGAREDDY,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
SANGAREDDY,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
SANGAREDDY,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
SANGAREDDY,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
SANGAREDDY,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
SANGAREDDY,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
SANGAREDDY,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
SANGAREDDY,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
SANGAREDDY,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
SANGAREDDY,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
SANGAREDDY,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
SANGAREDDY,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
SANGAREDDY,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
SANGAREDDY,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
SANGAREDDY,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
SANGAREDDY,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
SANGAREDDY,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
SANGAREDDY,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
SANGAREDDY,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
SANGAREDDY,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
SANGAREDDY,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
SANGAREDDY,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
SANGAREDDY,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
SANGAREDDY,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
SANGAREDDY,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
SANGAREDDY,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
SANGAREDDY,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
SANGAREDDY,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
SANGAREDDY,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
SANGAREDDY,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
SANGAREDDY,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
SANGAREDDY,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
SANGAREDDY,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
SANGAREDDY,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
SANGAREDDY,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
SANGAREDDY,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
SANGAREDDY,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
SANGAREDDY,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
SANGAREDDY,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
SANGAREDDY,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
SANGAREDDY,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
SANGAREDDY,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
SANGAREDDY,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
SANGAREDDY,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
SANGAREDDY,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
SANGAREDDY,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
SANGAREDDY,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
SANGAREDDY,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
SANGAREDDY,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
SANGAREDDY,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
SANGAREDDY,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
SANGAREDDY,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
SANGAREDDY,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
SANGAREDDY,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
SANGAREDDY,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
SANGAREDDY,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
SANGAREDDY,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
SANGAREDDY,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
SANGAREDDY,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
SANGAREDDY,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
SANGAREDDY,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
SANGAREDDY,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
SIDDIPET,1.1,Total number of pregnant women Registered for ANC,TOTAL,,,,,,,,,,,,,
SIDDIPET,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,,,,,,,,,,,,,
SIDDIPET,1.2,Number of Pregnant women registered under JSY,TOTAL,,,,,,,,,,,,,
SIDDIPET,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,,,,,,,,,,,,,
SIDDIPET,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,,,,,,,,,,,,,
SIDDIPET,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,,,,,,,,,,,,,
SIDDIPET,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,,,,,,,,,,,,,
SIDDIPET,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,,,,,,,,,,,,,
SIDDIPET,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,,,,,,,,,,,,,
SIDDIPET,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,,,,,,,,,,,,,
SIDDIPET,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,,,,,,,,,,,,,
SIDDIPET,1.8,Number of pregnancy test kits used at SC level,TOTAL,,,,,,,,,,,,,
SIDDIPET,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,,,,,,,,,,,,,
SIDDIPET,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,,,,,,,,,,,,,
SIDDIPET,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,,,,,,,,,,,,,
SIDDIPET,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,,,,,,,,,,,,,
SIDDIPET,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,,,,,,,,,,,,,
SIDDIPET,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
SIDDIPET,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,,,,,,,,,,,,,
SIDDIPET,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,,,,,,,,,,,,,
SIDDIPET,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,,,,,,,,,,,,,
SIDDIPET,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
SIDDIPET,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
SIDDIPET,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
SIDDIPET,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
SIDDIPET,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
SIDDIPET,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,,,,,,,,,,,,,
SIDDIPET,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,,,,,,,,,,,,,
SIDDIPET,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,,,,,,,,,,,,,
SIDDIPET,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
SIDDIPET,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,,,,,,,,,,,,,
SIDDIPET,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
SIDDIPET,4.1.1.a,Number of male live births,TOTAL,,,,,,,,,,,,,
SIDDIPET,4.1.1.b,Number of female live births,TOTAL,,,,,,,,,,,,,
SIDDIPET,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,,,,,,,,,,,,,
SIDDIPET,4.1.2,Number of still births,TOTAL,,,,,,,,,,,,,
SIDDIPET,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,,,,,,,,,,,,,
SIDDIPET,4.2.1,Number of Newborns weighed at birth,TOTAL,,,,,,,,,,,,,
SIDDIPET,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,,,,,,,,,,,,,
SIDDIPET,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,,,,,,,,,,,,,
SIDDIPET,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,,,,,,,,,,,,,
SIDDIPET,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,,,,,,,,,,,,,
SIDDIPET,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,,,,,,,,,,,,,
SIDDIPET,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
SIDDIPET,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,,,,,,,,,,,,,
SIDDIPET,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
SIDDIPET,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,,,,,,,,,,,,,
SIDDIPET,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,,,,,,,,,,,,,
SIDDIPET,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,,,,,,,,,,,,,
SIDDIPET,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,,,,,,,,,,,,,
SIDDIPET,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,,,,,,,,,,,,,
SIDDIPET,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,,,,,,,,,,,,,
SIDDIPET,6.3,PNC maternal complications attended,TOTAL,,,,,,,,,,,,,
SIDDIPET,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,,,,,,,,,,,,,
SIDDIPET,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,,,,,,,,,,,,,
SIDDIPET,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,,,,,,,,,,,,,
SIDDIPET,7.2,Number of MTPs conducted at Private Facilities,TOTAL,,,,,,,,,,,,,
SIDDIPET,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,,,,,,,,,,,,,
SIDDIPET,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,,,,,,,,,,,,,
SIDDIPET,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,,,,,,,,,,,,,
SIDDIPET,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,,,,,,,,,,,,,
SIDDIPET,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,,,,,,,,,,,,,
SIDDIPET,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,,,,,,,,,,,,,
SIDDIPET,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
SIDDIPET,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
SIDDIPET,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,,,,,,,,,,,,,
SIDDIPET,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
SIDDIPET,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
SIDDIPET,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
SIDDIPET,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
SIDDIPET,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
SIDDIPET,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,,,,,,,,,,,,,
SIDDIPET,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
SIDDIPET,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
SIDDIPET,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
SIDDIPET,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
SIDDIPET,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
SIDDIPET,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,,,,,,,,,,,,,
SIDDIPET,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
SIDDIPET,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
SIDDIPET,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
SIDDIPET,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
SIDDIPET,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
SIDDIPET,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,,,,,,,,,,,,,
SIDDIPET,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
SIDDIPET,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,,,,,,,,,,,,,
SIDDIPET,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,,,,,,,,,,,,,
SIDDIPET,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,,,,,,,,,,,,,
SIDDIPET,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
SIDDIPET,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
SIDDIPET,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,,,,,,,,,,,,,
SIDDIPET,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,,,,,,,,,,,,,
SIDDIPET,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
SIDDIPET,9.06,Number of IUCD removals,TOTAL,,,,,,,,,,,,,
SIDDIPET,9.07,Number of Oral Pills cycles distributed,TOTAL,,,,,,,,,,,,,
SIDDIPET,9.08,Number of Condom pieces distributed,TOTAL,,,,,,,,,,,,,
SIDDIPET,9.09,Number of Centchroman (weekly) pills given,TOTAL,,,,,,,,,,,,,
SIDDIPET,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,,,,,,,,,,,,,
SIDDIPET,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,,,,,,,,,,,,,
SIDDIPET,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,,,,,,,,,,,,,
SIDDIPET,9.11.2.a,Number of failures following male sterilization,TOTAL,,,,,,,,,,,,,
SIDDIPET,9.11.2.b,Number of failures following female sterilization,TOTAL,,,,,,,,,,,,,
SIDDIPET,9.11.3.a,Number of deaths following male sterilization,TOTAL,,,,,,,,,,,,,
SIDDIPET,9.11.3.b,Number of deaths following female sterilization,TOTAL,,,,,,,,,,,,,
SIDDIPET,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,,,,,,,,,,,-1.0
SIDDIPET,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,,,,,,,,,,,,,
SIDDIPET,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,,,,,,,,,,,,,
SIDDIPET,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,,,,,,,,,,,,,
SIDDIPET,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,,,,,,,,,,,,,
SIDDIPET,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,,,,,,,,,,,,,
SIDDIPET,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,,,,,,,,,,,,,
SIDDIPET,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,,,,,,,,,,,,,
SIDDIPET,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,,,,,,,,,,,,,
SIDDIPET,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,,,,,,,,,,,,,
SIDDIPET,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,,,,,,,,,,,,,
SIDDIPET,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,,,,,,,,,,,,,
SIDDIPET,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,,,,,,,,,,,,,
SIDDIPET,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,,,,,,,,,,,,,
SIDDIPET,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,,,,,,,,,,,,,
SIDDIPET,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,,,,,,,,,,,,,
SIDDIPET,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,,,,,,,,,,,,,
SIDDIPET,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,,,,,,,,,,,,,
SIDDIPET,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,,,,,,,,,,,,,
SIDDIPET,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
SIDDIPET,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
SIDDIPET,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,,,,,,,,,,,,,
SIDDIPET,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,,,,,,,,,,,,,
SIDDIPET,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,,,,,,,,,,,,,
SIDDIPET,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,,,,,,,,,,,,,
SIDDIPET,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
SIDDIPET,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
SIDDIPET,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,,,,,,,,,,,,,
SIDDIPET,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,,,,,,,,,,,,,
SIDDIPET,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,,,,,,,,,,,,,
SIDDIPET,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,,,,,,,,,,,,,
SIDDIPET,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
SIDDIPET,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
SIDDIPET,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
SIDDIPET,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,,,,,,,,,,,,,
SIDDIPET,10.4.2,Number of Immunisation sessions held during the month,TOTAL,,,,,,,,,,,,,
SIDDIPET,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,,,,,,,,,,,,,
SIDDIPET,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,,,,,,,,,,,,,
SIDDIPET,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,,,,,,,,,,,,,
SIDDIPET,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,,,,,,,,,,,,,
SIDDIPET,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,,,,,,,,,,,,,
SIDDIPET,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
SIDDIPET,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
SIDDIPET,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
SIDDIPET,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
SIDDIPET,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
SIDDIPET,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
SIDDIPET,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
SIDDIPET,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
SIDDIPET,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,,,,,,,,,,,,,
SIDDIPET,13.1,Number of Patients operated for cataract,TOTAL,,,,,,,,,,,,,
SIDDIPET,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,,,,,,,,,,,,,
SIDDIPET,13.3,Number of School children detected with Refractive errors,TOTAL,,,,,,,,,,,,,
SIDDIPET,13.4,Number of children provided free glasses,TOTAL,,,,,,,,,,,,,
SIDDIPET,13.5,Number of eyes collected through eye donation,TOTAL,,,,,,,,,,,,,
SIDDIPET,13.6,Number of eyes utilised for corneal transplant,TOTAL,,,,,,,,,,,,,
SIDDIPET,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,,,,,,,,,,,,-1.0
SIDDIPET,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,,,,,,,,,,-1.0
SIDDIPET,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,,,,,,,,,,,,,-1.0
SIDDIPET,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,,,,,,,,,,,,,-1.0
SIDDIPET,14.05,Number of RKS meetings held during the month,TOTAL,,,,,,,,,,,,,
SIDDIPET,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,,,,,,,,,,,,,-1.0
SIDDIPET,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,,,,,,,,,,,,,
SIDDIPET,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,,,,,,,,,-1.0
SIDDIPET,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,,,,,,,,,,,,,-1.0
SIDDIPET,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,,,,,,,,,,,,,
SIDDIPET,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,,,,,,,,,,,,,
SIDDIPET,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,,,,,,,,,,,,,
SIDDIPET,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,,,,,,,,,,,,,
SIDDIPET,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,,,,,,,,,,,,,
SIDDIPET,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,,,,,,,,,,,,,
SIDDIPET,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,,,,,,,,,,,,,
SIDDIPET,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,,,,,,,,,,,,,
SIDDIPET,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,,,,,,,,,,,,,
SIDDIPET,14.10.2.a,Number of death cases of Inpatient males,TOTAL,,,,,,,,,,,,,
SIDDIPET,14.10.2.b,Number of death cases of Inpatient females,TOTAL,,,,,,,,,,,,,
SIDDIPET,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,,,,,,,,,,,,,
SIDDIPET,14.11,In-Patient Head Count at midnight,TOTAL,,,,,,,,,,,,,
SIDDIPET,14.12.1,OPD attendance (All),TOTAL,,,,,,,,,,,,,
SIDDIPET,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,,,,,,,,,,,,,
SIDDIPET,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,,,,,,,,,,,,,
SIDDIPET,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,,,,,,,,,,,,,
SIDDIPET,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,,,,,,,,,,,,,
SIDDIPET,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,,,,,,,,,,,,,
SIDDIPET,14.14.a,Number of patients given AYUSH treatment,TOTAL,,,,,,,,,,,,,
SIDDIPET,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,,,,,,,,,,,,,
SIDDIPET,14.14.c,Number of Adolescents counselled,TOTAL,,,,,,,,,,,,,
SIDDIPET,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,,,,,,,,,,,,,
SIDDIPET,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,,,,,,,,,,,,,
SIDDIPET,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,,,,,,,,,,,,,
SIDDIPET,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,,,,,,,,,,,,,
SIDDIPET,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,,,,,,,,,,,,,
SIDDIPET,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,,,,,,,,,,,,,
SIDDIPET,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,,,,,,,,,,,,,
SIDDIPET,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,,,,,,,,,,,,,
SIDDIPET,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,,,,,,,,,,,,,
SIDDIPET,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,,,,,,,,,,,,,
SIDDIPET,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,,,,,,,,,,,,,
SIDDIPET,15.2,Number of Widal tests conducted,Number tested,,,,,,,,,,,,,
SIDDIPET,15.3.a,Number of VDRL tests conducted on males,Number tested,,,,,,,,,,,,,
SIDDIPET,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,,,,,,,,,,,,,
SIDDIPET,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,,,,,,,,,,,,,
SIDDIPET,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,,,,,,,,,,,,,
SIDDIPET,15.4.1,Number of blood smears examined for Malaria,TOTAL,,,,,,,,,,,,,
SIDDIPET,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,,,,,,,,,,,,,
SIDDIPET,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,,,,,,,,,,,,,
SIDDIPET,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
SIDDIPET,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,,,,,,,,,,
SIDDIPET,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
SIDDIPET,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,,,,,,,,,
SIDDIPET,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SIDDIPET,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
SIDDIPET,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
SIDDIPET,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
SIDDIPET,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
SIDDIPET,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SIDDIPET,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
SIDDIPET,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,,,,,,,,,
SIDDIPET,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
SIDDIPET,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,,,,,,,,,
SIDDIPET,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SIDDIPET,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
SIDDIPET,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,,,,,,,,,
SIDDIPET,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
SIDDIPET,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,,,,,,,,,
SIDDIPET,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SIDDIPET,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
SIDDIPET,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
SIDDIPET,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
SIDDIPET,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
SIDDIPET,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SIDDIPET,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
SIDDIPET,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,,,,,,,,,
SIDDIPET,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
SIDDIPET,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,,,,,,,,,
SIDDIPET,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SIDDIPET,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
SIDDIPET,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,,,,,,,,,
SIDDIPET,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
SIDDIPET,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,,,,,,,,,
SIDDIPET,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SIDDIPET,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
SIDDIPET,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
SIDDIPET,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
SIDDIPET,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
SIDDIPET,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SIDDIPET,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
SIDDIPET,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,,,,,,
SIDDIPET,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
SIDDIPET,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,,,,,,
SIDDIPET,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SIDDIPET,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
SIDDIPET,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
SIDDIPET,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
SIDDIPET,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
SIDDIPET,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SIDDIPET,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
SIDDIPET,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
SIDDIPET,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
SIDDIPET,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
SIDDIPET,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SIDDIPET,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
SIDDIPET,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
SIDDIPET,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
SIDDIPET,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
SIDDIPET,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SIDDIPET,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
SIDDIPET,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
SIDDIPET,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
SIDDIPET,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
SIDDIPET,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SIDDIPET,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
SIDDIPET,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
SIDDIPET,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
SIDDIPET,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
SIDDIPET,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SIDDIPET,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
SIDDIPET,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
SIDDIPET,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
SIDDIPET,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
SIDDIPET,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SIDDIPET,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
SIDDIPET,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
SIDDIPET,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
SIDDIPET,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
SIDDIPET,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SIDDIPET,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
SIDDIPET,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
SIDDIPET,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
SIDDIPET,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
SIDDIPET,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SIDDIPET,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
SIDDIPET,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
SIDDIPET,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
SIDDIPET,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
SIDDIPET,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SIDDIPET,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
SIDDIPET,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
SIDDIPET,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
SIDDIPET,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
SIDDIPET,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SIDDIPET,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
SIDDIPET,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
SIDDIPET,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
SIDDIPET,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
SIDDIPET,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SIDDIPET,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
SIDDIPET,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
SIDDIPET,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
SIDDIPET,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
SIDDIPET,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SIDDIPET,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
SIDDIPET,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
SIDDIPET,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
SIDDIPET,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
SIDDIPET,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SIDDIPET,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
SIDDIPET,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
SIDDIPET,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
SIDDIPET,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
SIDDIPET,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SIDDIPET,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
SIDDIPET,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
SIDDIPET,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
SIDDIPET,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
SIDDIPET,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SIDDIPET,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
SIDDIPET,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
SIDDIPET,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
SIDDIPET,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
SIDDIPET,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SIDDIPET,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
SIDDIPET,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
SIDDIPET,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
SIDDIPET,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
SIDDIPET,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SIDDIPET,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
SIDDIPET,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
SIDDIPET,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
SIDDIPET,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
SIDDIPET,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SIDDIPET,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,,,,,,,
SIDDIPET,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,,,,,,,
SIDDIPET,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
SIDDIPET,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,,,,,,,
SIDDIPET,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SIDDIPET,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
SIDDIPET,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
SIDDIPET,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
SIDDIPET,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
SIDDIPET,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
SIDDIPET,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
SIDDIPET,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
SIDDIPET,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
SIDDIPET,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
SIDDIPET,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
SIDDIPET,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
SIDDIPET,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
SIDDIPET,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
SIDDIPET,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
SIDDIPET,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
SIDDIPET,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
SIDDIPET,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
SIDDIPET,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
SIDDIPET,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
SIDDIPET,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
SIDDIPET,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
SIDDIPET,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
SIDDIPET,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
SIDDIPET,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
SIDDIPET,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
SIDDIPET,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
SIDDIPET,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
SIDDIPET,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
SIDDIPET,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
SIDDIPET,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
SIDDIPET,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
SIDDIPET,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
SIDDIPET,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
SIDDIPET,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
SIDDIPET,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
SIDDIPET,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
SIDDIPET,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
SIDDIPET,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
SIDDIPET,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
SIDDIPET,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
SIDDIPET,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
SIDDIPET,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
SIDDIPET,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
SIDDIPET,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
SIDDIPET,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
SIDDIPET,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
SIDDIPET,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
SIDDIPET,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
SIDDIPET,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
SIDDIPET,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
SIDDIPET,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
SIDDIPET,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
SIDDIPET,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
SIDDIPET,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
SIDDIPET,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
SIDDIPET,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
SIDDIPET,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
SIDDIPET,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
SIDDIPET,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
SIDDIPET,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
SIDDIPET,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
SIDDIPET,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
SIDDIPET,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
SIDDIPET,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
SIDDIPET,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
SIDDIPET,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
SIDDIPET,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
SIDDIPET,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
SIDDIPET,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
SIDDIPET,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
SIDDIPET,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
SIDDIPET,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
SIDDIPET,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
SIDDIPET,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
SIDDIPET,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
SIDDIPET,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
SIDDIPET,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
SIDDIPET,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
SIDDIPET,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
SIDDIPET,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
SIDDIPET,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
SIDDIPET,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
SIDDIPET,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
SIDDIPET,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
SIDDIPET,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
SIDDIPET,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
SIDDIPET,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
SIDDIPET,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
SIDDIPET,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
SIDDIPET,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
SIDDIPET,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
SIDDIPET,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
SIDDIPET,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
SIDDIPET,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
SIDDIPET,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
SIDDIPET,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
SIDDIPET,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
SIDDIPET,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
SIDDIPET,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
SIDDIPET,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
SIDDIPET,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
SIDDIPET,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
SIDDIPET,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
SIDDIPET,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
SIDDIPET,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
SIDDIPET,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
SIDDIPET,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
SIDDIPET,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
SURYAPET,1.1,Total number of pregnant women Registered for ANC,TOTAL,,,,,,,,,,,,,
SURYAPET,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,,,,,,,,,,,,,
SURYAPET,1.2,Number of Pregnant women registered under JSY,TOTAL,,,,,,,,,,,,,
SURYAPET,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,,,,,,,,,,,,,
SURYAPET,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,,,,,,,,,,,,,
SURYAPET,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,,,,,,,,,,,,,
SURYAPET,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,,,,,,,,,,,,,
SURYAPET,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,,,,,,,,,,,,,
SURYAPET,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,,,,,,,,,,,,,
SURYAPET,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,,,,,,,,,,,,,
SURYAPET,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,,,,,,,,,,,,,
SURYAPET,1.8,Number of pregnancy test kits used at SC level,TOTAL,,,,,,,,,,,,,
SURYAPET,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,,,,,,,,,,,,,
SURYAPET,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,,,,,,,,,,,,,
SURYAPET,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,,,,,,,,,,,,,
SURYAPET,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,,,,,,,,,,,,,
SURYAPET,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,,,,,,,,,,,,,
SURYAPET,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
SURYAPET,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,,,,,,,,,,,,,
SURYAPET,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,,,,,,,,,,,,,
SURYAPET,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,,,,,,,,,,,,,
SURYAPET,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
SURYAPET,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
SURYAPET,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
SURYAPET,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
SURYAPET,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
SURYAPET,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,,,,,,,,,,,,,
SURYAPET,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,,,,,,,,,,,,,
SURYAPET,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,,,,,,,,,,,,,
SURYAPET,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
SURYAPET,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,,,,,,,,,,,,,
SURYAPET,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
SURYAPET,4.1.1.a,Number of male live births,TOTAL,,,,,,,,,,,,,
SURYAPET,4.1.1.b,Number of female live births,TOTAL,,,,,,,,,,,,,
SURYAPET,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,,,,,,,,,,,,,
SURYAPET,4.1.2,Number of still births,TOTAL,,,,,,,,,,,,,
SURYAPET,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,,,,,,,,,,,,,
SURYAPET,4.2.1,Number of Newborns weighed at birth,TOTAL,,,,,,,,,,,,,
SURYAPET,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,,,,,,,,,,,,,
SURYAPET,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,,,,,,,,,,,,,
SURYAPET,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,,,,,,,,,,,,,
SURYAPET,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,,,,,,,,,,,,,
SURYAPET,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,,,,,,,,,,,,,
SURYAPET,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
SURYAPET,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,,,,,,,,,,,,,
SURYAPET,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
SURYAPET,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,,,,,,,,,,,,,
SURYAPET,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,,,,,,,,,,,,,
SURYAPET,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,,,,,,,,,,,,,
SURYAPET,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,,,,,,,,,,,,,
SURYAPET,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,,,,,,,,,,,,,
SURYAPET,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,,,,,,,,,,,,,
SURYAPET,6.3,PNC maternal complications attended,TOTAL,,,,,,,,,,,,,
SURYAPET,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,,,,,,,,,,,,,
SURYAPET,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,,,,,,,,,,,,,
SURYAPET,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,,,,,,,,,,,,,
SURYAPET,7.2,Number of MTPs conducted at Private Facilities,TOTAL,,,,,,,,,,,,,
SURYAPET,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,,,,,,,,,,,,,
SURYAPET,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,,,,,,,,,,,,,
SURYAPET,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,,,,,,,,,,,,,
SURYAPET,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,,,,,,,,,,,,,
SURYAPET,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,,,,,,,,,,,,,
SURYAPET,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,,,,,,,,,,,,,
SURYAPET,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
SURYAPET,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
SURYAPET,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,,,,,,,,,,,,,
SURYAPET,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
SURYAPET,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
SURYAPET,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
SURYAPET,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
SURYAPET,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
SURYAPET,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,,,,,,,,,,,,,
SURYAPET,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
SURYAPET,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
SURYAPET,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
SURYAPET,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
SURYAPET,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
SURYAPET,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,,,,,,,,,,,,,
SURYAPET,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
SURYAPET,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
SURYAPET,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
SURYAPET,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
SURYAPET,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
SURYAPET,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,,,,,,,,,,,,,
SURYAPET,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
SURYAPET,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,,,,,,,,,,,,,
SURYAPET,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,,,,,,,,,,,,,
SURYAPET,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,,,,,,,,,,,,,
SURYAPET,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
SURYAPET,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
SURYAPET,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,,,,,,,,,,,,,
SURYAPET,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,,,,,,,,,,,,,
SURYAPET,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
SURYAPET,9.06,Number of IUCD removals,TOTAL,,,,,,,,,,,,,
SURYAPET,9.07,Number of Oral Pills cycles distributed,TOTAL,,,,,,,,,,,,,
SURYAPET,9.08,Number of Condom pieces distributed,TOTAL,,,,,,,,,,,,,
SURYAPET,9.09,Number of Centchroman (weekly) pills given,TOTAL,,,,,,,,,,,,,
SURYAPET,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,,,,,,,,,,,,,
SURYAPET,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,,,,,,,,,,,,,
SURYAPET,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,,,,,,,,,,,,,
SURYAPET,9.11.2.a,Number of failures following male sterilization,TOTAL,,,,,,,,,,,,,
SURYAPET,9.11.2.b,Number of failures following female sterilization,TOTAL,,,,,,,,,,,,,
SURYAPET,9.11.3.a,Number of deaths following male sterilization,TOTAL,,,,,,,,,,,,,
SURYAPET,9.11.3.b,Number of deaths following female sterilization,TOTAL,,,,,,,,,,,,,
SURYAPET,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,,,,,,,,,,,-1.0
SURYAPET,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,,,,,,,,,,,,,
SURYAPET,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,,,,,,,,,,,,,
SURYAPET,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,,,,,,,,,,,,,
SURYAPET,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,,,,,,,,,,,,,
SURYAPET,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,,,,,,,,,,,,,
SURYAPET,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,,,,,,,,,,,,,
SURYAPET,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,,,,,,,,,,,,,
SURYAPET,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,,,,,,,,,,,,,
SURYAPET,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,,,,,,,,,,,,,
SURYAPET,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,,,,,,,,,,,,,
SURYAPET,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,,,,,,,,,,,,,
SURYAPET,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,,,,,,,,,,,,,
SURYAPET,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,,,,,,,,,,,,,
SURYAPET,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,,,,,,,,,,,,,
SURYAPET,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,,,,,,,,,,,,,
SURYAPET,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,,,,,,,,,,,,,
SURYAPET,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,,,,,,,,,,,,,
SURYAPET,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,,,,,,,,,,,,,
SURYAPET,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
SURYAPET,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
SURYAPET,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,,,,,,,,,,,,,
SURYAPET,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,,,,,,,,,,,,,
SURYAPET,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,,,,,,,,,,,,,
SURYAPET,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,,,,,,,,,,,,,
SURYAPET,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
SURYAPET,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
SURYAPET,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,,,,,,,,,,,,,
SURYAPET,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,,,,,,,,,,,,,
SURYAPET,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,,,,,,,,,,,,,
SURYAPET,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,,,,,,,,,,,,,
SURYAPET,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
SURYAPET,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
SURYAPET,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
SURYAPET,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,,,,,,,,,,,,,
SURYAPET,10.4.2,Number of Immunisation sessions held during the month,TOTAL,,,,,,,,,,,,,
SURYAPET,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,,,,,,,,,,,,,
SURYAPET,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,,,,,,,,,,,,,
SURYAPET,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,,,,,,,,,,,,,
SURYAPET,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,,,,,,,,,,,,,
SURYAPET,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,,,,,,,,,,,,,
SURYAPET,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
SURYAPET,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
SURYAPET,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
SURYAPET,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
SURYAPET,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
SURYAPET,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
SURYAPET,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
SURYAPET,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
SURYAPET,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,,,,,,,,,,,,,
SURYAPET,13.1,Number of Patients operated for cataract,TOTAL,,,,,,,,,,,,,
SURYAPET,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,,,,,,,,,,,,,
SURYAPET,13.3,Number of School children detected with Refractive errors,TOTAL,,,,,,,,,,,,,
SURYAPET,13.4,Number of children provided free glasses,TOTAL,,,,,,,,,,,,,
SURYAPET,13.5,Number of eyes collected through eye donation,TOTAL,,,,,,,,,,,,,
SURYAPET,13.6,Number of eyes utilised for corneal transplant,TOTAL,,,,,,,,,,,,,
SURYAPET,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,,,,,,,,,,,,-1.0
SURYAPET,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,,,,,,,,,,-1.0
SURYAPET,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,,,,,,,,,,,,,-1.0
SURYAPET,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,,,,,,,,,,,,,-1.0
SURYAPET,14.05,Number of RKS meetings held during the month,TOTAL,,,,,,,,,,,,,
SURYAPET,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,,,,,,,,,,,,,-1.0
SURYAPET,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,,,,,,,,,,,,,
SURYAPET,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,,,,,,,,,-1.0
SURYAPET,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,,,,,,,,,,,,,-1.0
SURYAPET,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,,,,,,,,,,,,,
SURYAPET,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,,,,,,,,,,,,,
SURYAPET,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,,,,,,,,,,,,,
SURYAPET,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,,,,,,,,,,,,,
SURYAPET,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,,,,,,,,,,,,,
SURYAPET,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,,,,,,,,,,,,,
SURYAPET,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,,,,,,,,,,,,,
SURYAPET,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,,,,,,,,,,,,,
SURYAPET,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,,,,,,,,,,,,,
SURYAPET,14.10.2.a,Number of death cases of Inpatient males,TOTAL,,,,,,,,,,,,,
SURYAPET,14.10.2.b,Number of death cases of Inpatient females,TOTAL,,,,,,,,,,,,,
SURYAPET,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,,,,,,,,,,,,,
SURYAPET,14.11,In-Patient Head Count at midnight,TOTAL,,,,,,,,,,,,,
SURYAPET,14.12.1,OPD attendance (All),TOTAL,,,,,,,,,,,,,
SURYAPET,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,,,,,,,,,,,,,
SURYAPET,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,,,,,,,,,,,,,
SURYAPET,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,,,,,,,,,,,,,
SURYAPET,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,,,,,,,,,,,,,
SURYAPET,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,,,,,,,,,,,,,
SURYAPET,14.14.a,Number of patients given AYUSH treatment,TOTAL,,,,,,,,,,,,,
SURYAPET,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,,,,,,,,,,,,,
SURYAPET,14.14.c,Number of Adolescents counselled,TOTAL,,,,,,,,,,,,,
SURYAPET,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,,,,,,,,,,,,,
SURYAPET,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,,,,,,,,,,,,,
SURYAPET,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,,,,,,,,,,,,,
SURYAPET,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,,,,,,,,,,,,,
SURYAPET,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,,,,,,,,,,,,,
SURYAPET,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,,,,,,,,,,,,,
SURYAPET,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,,,,,,,,,,,,,
SURYAPET,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,,,,,,,,,,,,,
SURYAPET,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,,,,,,,,,,,,,
SURYAPET,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,,,,,,,,,,,,,
SURYAPET,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,,,,,,,,,,,,,
SURYAPET,15.2,Number of Widal tests conducted,Number tested,,,,,,,,,,,,,
SURYAPET,15.3.a,Number of VDRL tests conducted on males,Number tested,,,,,,,,,,,,,
SURYAPET,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,,,,,,,,,,,,,
SURYAPET,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,,,,,,,,,,,,,
SURYAPET,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,,,,,,,,,,,,,
SURYAPET,15.4.1,Number of blood smears examined for Malaria,TOTAL,,,,,,,,,,,,,
SURYAPET,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,,,,,,,,,,,,,
SURYAPET,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,,,,,,,,,,,,,
SURYAPET,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
SURYAPET,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,,,,,,,,,,
SURYAPET,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
SURYAPET,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,,,,,,,,,
SURYAPET,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SURYAPET,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
SURYAPET,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
SURYAPET,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
SURYAPET,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
SURYAPET,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SURYAPET,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
SURYAPET,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,,,,,,,,,
SURYAPET,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
SURYAPET,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,,,,,,,,,
SURYAPET,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SURYAPET,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
SURYAPET,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,,,,,,,,,
SURYAPET,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
SURYAPET,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,,,,,,,,,
SURYAPET,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SURYAPET,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
SURYAPET,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
SURYAPET,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
SURYAPET,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
SURYAPET,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SURYAPET,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
SURYAPET,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,,,,,,,,,
SURYAPET,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
SURYAPET,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,,,,,,,,,
SURYAPET,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SURYAPET,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
SURYAPET,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,,,,,,,,,
SURYAPET,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
SURYAPET,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,,,,,,,,,
SURYAPET,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SURYAPET,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
SURYAPET,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
SURYAPET,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
SURYAPET,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
SURYAPET,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SURYAPET,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
SURYAPET,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,,,,,,
SURYAPET,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
SURYAPET,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,,,,,,
SURYAPET,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SURYAPET,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
SURYAPET,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
SURYAPET,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
SURYAPET,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
SURYAPET,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SURYAPET,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
SURYAPET,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
SURYAPET,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
SURYAPET,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
SURYAPET,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SURYAPET,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
SURYAPET,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
SURYAPET,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
SURYAPET,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
SURYAPET,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SURYAPET,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
SURYAPET,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
SURYAPET,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
SURYAPET,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
SURYAPET,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SURYAPET,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
SURYAPET,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
SURYAPET,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
SURYAPET,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
SURYAPET,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SURYAPET,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
SURYAPET,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
SURYAPET,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
SURYAPET,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
SURYAPET,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SURYAPET,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
SURYAPET,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
SURYAPET,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
SURYAPET,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
SURYAPET,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SURYAPET,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
SURYAPET,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
SURYAPET,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
SURYAPET,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
SURYAPET,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SURYAPET,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
SURYAPET,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
SURYAPET,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
SURYAPET,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
SURYAPET,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SURYAPET,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
SURYAPET,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
SURYAPET,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
SURYAPET,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
SURYAPET,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SURYAPET,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
SURYAPET,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
SURYAPET,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
SURYAPET,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
SURYAPET,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SURYAPET,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
SURYAPET,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
SURYAPET,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
SURYAPET,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
SURYAPET,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SURYAPET,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
SURYAPET,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
SURYAPET,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
SURYAPET,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
SURYAPET,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SURYAPET,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
SURYAPET,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
SURYAPET,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
SURYAPET,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
SURYAPET,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SURYAPET,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
SURYAPET,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
SURYAPET,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
SURYAPET,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
SURYAPET,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SURYAPET,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
SURYAPET,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
SURYAPET,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
SURYAPET,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
SURYAPET,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SURYAPET,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
SURYAPET,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
SURYAPET,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
SURYAPET,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
SURYAPET,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SURYAPET,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
SURYAPET,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
SURYAPET,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
SURYAPET,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
SURYAPET,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SURYAPET,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,,,,,,,
SURYAPET,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,,,,,,,
SURYAPET,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
SURYAPET,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,,,,,,,
SURYAPET,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SURYAPET,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
SURYAPET,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
SURYAPET,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
SURYAPET,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
SURYAPET,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
SURYAPET,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
SURYAPET,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
SURYAPET,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
SURYAPET,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
SURYAPET,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
SURYAPET,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
SURYAPET,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
SURYAPET,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
SURYAPET,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
SURYAPET,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
SURYAPET,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
SURYAPET,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
SURYAPET,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
SURYAPET,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
SURYAPET,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
SURYAPET,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
SURYAPET,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
SURYAPET,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
SURYAPET,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
SURYAPET,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
SURYAPET,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
SURYAPET,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
SURYAPET,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
SURYAPET,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
SURYAPET,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
SURYAPET,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
SURYAPET,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
SURYAPET,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
SURYAPET,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
SURYAPET,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
SURYAPET,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
SURYAPET,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
SURYAPET,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
SURYAPET,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
SURYAPET,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
SURYAPET,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
SURYAPET,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
SURYAPET,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
SURYAPET,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
SURYAPET,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
SURYAPET,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
SURYAPET,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
SURYAPET,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
SURYAPET,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
SURYAPET,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
SURYAPET,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
SURYAPET,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
SURYAPET,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
SURYAPET,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
SURYAPET,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
SURYAPET,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
SURYAPET,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
SURYAPET,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
SURYAPET,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
SURYAPET,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
SURYAPET,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
SURYAPET,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
SURYAPET,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
SURYAPET,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
SURYAPET,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
SURYAPET,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
SURYAPET,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
SURYAPET,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
SURYAPET,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
SURYAPET,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
SURYAPET,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
SURYAPET,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
SURYAPET,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
SURYAPET,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
SURYAPET,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
SURYAPET,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
SURYAPET,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
SURYAPET,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
SURYAPET,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
SURYAPET,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
SURYAPET,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
SURYAPET,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
SURYAPET,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
SURYAPET,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
SURYAPET,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
SURYAPET,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
SURYAPET,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
SURYAPET,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
SURYAPET,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
SURYAPET,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
SURYAPET,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
SURYAPET,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
SURYAPET,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
SURYAPET,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
SURYAPET,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
SURYAPET,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
SURYAPET,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
SURYAPET,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
SURYAPET,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
SURYAPET,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
SURYAPET,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
SURYAPET,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
SURYAPET,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
SURYAPET,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
SURYAPET,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
SURYAPET,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
SURYAPET,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
SURYAPET,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
VIKARABAD,1.1,Total number of pregnant women Registered for ANC,TOTAL,,,,,,,,,,,,,
VIKARABAD,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,,,,,,,,,,,,,
VIKARABAD,1.2,Number of Pregnant women registered under JSY,TOTAL,,,,,,,,,,,,,
VIKARABAD,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,,,,,,,,,,,,,
VIKARABAD,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,,,,,,,,,,,,,
VIKARABAD,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,,,,,,,,,,,,,
VIKARABAD,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,,,,,,,,,,,,,
VIKARABAD,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,,,,,,,,,,,,,
VIKARABAD,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,,,,,,,,,,,,,
VIKARABAD,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,,,,,,,,,,,,,
VIKARABAD,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,,,,,,,,,,,,,
VIKARABAD,1.8,Number of pregnancy test kits used at SC level,TOTAL,,,,,,,,,,,,,
VIKARABAD,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,,,,,,,,,,,,,
VIKARABAD,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,,,,,,,,,,,,,
VIKARABAD,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,,,,,,,,,,,,,
VIKARABAD,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,,,,,,,,,,,,,
VIKARABAD,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,,,,,,,,,,,,,
VIKARABAD,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
VIKARABAD,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,,,,,,,,,,,,,
VIKARABAD,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,,,,,,,,,,,,,
VIKARABAD,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,,,,,,,,,,,,,
VIKARABAD,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
VIKARABAD,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
VIKARABAD,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
VIKARABAD,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
VIKARABAD,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
VIKARABAD,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,,,,,,,,,,,,,
VIKARABAD,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,,,,,,,,,,,,,
VIKARABAD,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,,,,,,,,,,,,,
VIKARABAD,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
VIKARABAD,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,,,,,,,,,,,,,
VIKARABAD,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
VIKARABAD,4.1.1.a,Number of male live births,TOTAL,,,,,,,,,,,,,
VIKARABAD,4.1.1.b,Number of female live births,TOTAL,,,,,,,,,,,,,
VIKARABAD,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,,,,,,,,,,,,,
VIKARABAD,4.1.2,Number of still births,TOTAL,,,,,,,,,,,,,
VIKARABAD,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,,,,,,,,,,,,,
VIKARABAD,4.2.1,Number of Newborns weighed at birth,TOTAL,,,,,,,,,,,,,
VIKARABAD,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,,,,,,,,,,,,,
VIKARABAD,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,,,,,,,,,,,,,
VIKARABAD,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,,,,,,,,,,,,,
VIKARABAD,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,,,,,,,,,,,,,
VIKARABAD,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,,,,,,,,,,,,,
VIKARABAD,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
VIKARABAD,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,,,,,,,,,,,,,
VIKARABAD,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
VIKARABAD,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,,,,,,,,,,,,,
VIKARABAD,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,,,,,,,,,,,,,
VIKARABAD,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,,,,,,,,,,,,,
VIKARABAD,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,,,,,,,,,,,,,
VIKARABAD,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,,,,,,,,,,,,,
VIKARABAD,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,,,,,,,,,,,,,
VIKARABAD,6.3,PNC maternal complications attended,TOTAL,,,,,,,,,,,,,
VIKARABAD,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,,,,,,,,,,,,,
VIKARABAD,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,,,,,,,,,,,,,
VIKARABAD,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,,,,,,,,,,,,,
VIKARABAD,7.2,Number of MTPs conducted at Private Facilities,TOTAL,,,,,,,,,,,,,
VIKARABAD,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,,,,,,,,,,,,,
VIKARABAD,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,,,,,,,,,,,,,
VIKARABAD,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,,,,,,,,,,,,,
VIKARABAD,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,,,,,,,,,,,,,
VIKARABAD,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,,,,,,,,,,,,,
VIKARABAD,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,,,,,,,,,,,,,
VIKARABAD,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
VIKARABAD,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
VIKARABAD,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,,,,,,,,,,,,,
VIKARABAD,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
VIKARABAD,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
VIKARABAD,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
VIKARABAD,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
VIKARABAD,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
VIKARABAD,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,,,,,,,,,,,,,
VIKARABAD,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
VIKARABAD,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
VIKARABAD,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
VIKARABAD,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
VIKARABAD,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
VIKARABAD,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,,,,,,,,,,,,,
VIKARABAD,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
VIKARABAD,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
VIKARABAD,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
VIKARABAD,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
VIKARABAD,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
VIKARABAD,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,,,,,,,,,,,,,
VIKARABAD,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
VIKARABAD,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,,,,,,,,,,,,,
VIKARABAD,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,,,,,,,,,,,,,
VIKARABAD,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,,,,,,,,,,,,,
VIKARABAD,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
VIKARABAD,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
VIKARABAD,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,,,,,,,,,,,,,
VIKARABAD,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,,,,,,,,,,,,,
VIKARABAD,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
VIKARABAD,9.06,Number of IUCD removals,TOTAL,,,,,,,,,,,,,
VIKARABAD,9.07,Number of Oral Pills cycles distributed,TOTAL,,,,,,,,,,,,,
VIKARABAD,9.08,Number of Condom pieces distributed,TOTAL,,,,,,,,,,,,,
VIKARABAD,9.09,Number of Centchroman (weekly) pills given,TOTAL,,,,,,,,,,,,,
VIKARABAD,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,,,,,,,,,,,,,
VIKARABAD,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,,,,,,,,,,,,,
VIKARABAD,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,,,,,,,,,,,,,
VIKARABAD,9.11.2.a,Number of failures following male sterilization,TOTAL,,,,,,,,,,,,,
VIKARABAD,9.11.2.b,Number of failures following female sterilization,TOTAL,,,,,,,,,,,,,
VIKARABAD,9.11.3.a,Number of deaths following male sterilization,TOTAL,,,,,,,,,,,,,
VIKARABAD,9.11.3.b,Number of deaths following female sterilization,TOTAL,,,,,,,,,,,,,
VIKARABAD,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,,,,,,,,,,,-1.0
VIKARABAD,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,,,,,,,,,,,,,
VIKARABAD,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,,,,,,,,,,,,,
VIKARABAD,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,,,,,,,,,,,,,
VIKARABAD,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,,,,,,,,,,,,,
VIKARABAD,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,,,,,,,,,,,,,
VIKARABAD,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,,,,,,,,,,,,,
VIKARABAD,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,,,,,,,,,,,,,
VIKARABAD,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,,,,,,,,,,,,,
VIKARABAD,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,,,,,,,,,,,,,
VIKARABAD,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,,,,,,,,,,,,,
VIKARABAD,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,,,,,,,,,,,,,
VIKARABAD,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,,,,,,,,,,,,,
VIKARABAD,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,,,,,,,,,,,,,
VIKARABAD,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,,,,,,,,,,,,,
VIKARABAD,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,,,,,,,,,,,,,
VIKARABAD,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,,,,,,,,,,,,,
VIKARABAD,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,,,,,,,,,,,,,
VIKARABAD,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,,,,,,,,,,,,,
VIKARABAD,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
VIKARABAD,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
VIKARABAD,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,,,,,,,,,,,,,
VIKARABAD,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,,,,,,,,,,,,,
VIKARABAD,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,,,,,,,,,,,,,
VIKARABAD,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,,,,,,,,,,,,,
VIKARABAD,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
VIKARABAD,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
VIKARABAD,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,,,,,,,,,,,,,
VIKARABAD,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,,,,,,,,,,,,,
VIKARABAD,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,,,,,,,,,,,,,
VIKARABAD,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,,,,,,,,,,,,,
VIKARABAD,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
VIKARABAD,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
VIKARABAD,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
VIKARABAD,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,,,,,,,,,,,,,
VIKARABAD,10.4.2,Number of Immunisation sessions held during the month,TOTAL,,,,,,,,,,,,,
VIKARABAD,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,,,,,,,,,,,,,
VIKARABAD,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,,,,,,,,,,,,,
VIKARABAD,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,,,,,,,,,,,,,
VIKARABAD,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,,,,,,,,,,,,,
VIKARABAD,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,,,,,,,,,,,,,
VIKARABAD,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
VIKARABAD,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
VIKARABAD,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
VIKARABAD,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
VIKARABAD,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
VIKARABAD,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
VIKARABAD,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
VIKARABAD,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
VIKARABAD,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,,,,,,,,,,,,,
VIKARABAD,13.1,Number of Patients operated for cataract,TOTAL,,,,,,,,,,,,,
VIKARABAD,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,,,,,,,,,,,,,
VIKARABAD,13.3,Number of School children detected with Refractive errors,TOTAL,,,,,,,,,,,,,
VIKARABAD,13.4,Number of children provided free glasses,TOTAL,,,,,,,,,,,,,
VIKARABAD,13.5,Number of eyes collected through eye donation,TOTAL,,,,,,,,,,,,,
VIKARABAD,13.6,Number of eyes utilised for corneal transplant,TOTAL,,,,,,,,,,,,,
VIKARABAD,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,,,,,,,,,,,,-1.0
VIKARABAD,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,,,,,,,,,,-1.0
VIKARABAD,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,,,,,,,,,,,,,-1.0
VIKARABAD,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,,,,,,,,,,,,,-1.0
VIKARABAD,14.05,Number of RKS meetings held during the month,TOTAL,,,,,,,,,,,,,
VIKARABAD,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,,,,,,,,,,,,,-1.0
VIKARABAD,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,,,,,,,,,,,,,
VIKARABAD,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,,,,,,,,,-1.0
VIKARABAD,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,,,,,,,,,,,,,-1.0
VIKARABAD,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,,,,,,,,,,,,,
VIKARABAD,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,,,,,,,,,,,,,
VIKARABAD,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,,,,,,,,,,,,,
VIKARABAD,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,,,,,,,,,,,,,
VIKARABAD,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,,,,,,,,,,,,,
VIKARABAD,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,,,,,,,,,,,,,
VIKARABAD,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,,,,,,,,,,,,,
VIKARABAD,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,,,,,,,,,,,,,
VIKARABAD,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,,,,,,,,,,,,,
VIKARABAD,14.10.2.a,Number of death cases of Inpatient males,TOTAL,,,,,,,,,,,,,
VIKARABAD,14.10.2.b,Number of death cases of Inpatient females,TOTAL,,,,,,,,,,,,,
VIKARABAD,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,,,,,,,,,,,,,
VIKARABAD,14.11,In-Patient Head Count at midnight,TOTAL,,,,,,,,,,,,,
VIKARABAD,14.12.1,OPD attendance (All),TOTAL,,,,,,,,,,,,,
VIKARABAD,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,,,,,,,,,,,,,
VIKARABAD,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,,,,,,,,,,,,,
VIKARABAD,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,,,,,,,,,,,,,
VIKARABAD,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,,,,,,,,,,,,,
VIKARABAD,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,,,,,,,,,,,,,
VIKARABAD,14.14.a,Number of patients given AYUSH treatment,TOTAL,,,,,,,,,,,,,
VIKARABAD,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,,,,,,,,,,,,,
VIKARABAD,14.14.c,Number of Adolescents counselled,TOTAL,,,,,,,,,,,,,
VIKARABAD,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,,,,,,,,,,,,,
VIKARABAD,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,,,,,,,,,,,,,
VIKARABAD,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,,,,,,,,,,,,,
VIKARABAD,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,,,,,,,,,,,,,
VIKARABAD,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,,,,,,,,,,,,,
VIKARABAD,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,,,,,,,,,,,,,
VIKARABAD,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,,,,,,,,,,,,,
VIKARABAD,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,,,,,,,,,,,,,
VIKARABAD,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,,,,,,,,,,,,,
VIKARABAD,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,,,,,,,,,,,,,
VIKARABAD,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,,,,,,,,,,,,,
VIKARABAD,15.2,Number of Widal tests conducted,Number tested,,,,,,,,,,,,,
VIKARABAD,15.3.a,Number of VDRL tests conducted on males,Number tested,,,,,,,,,,,,,
VIKARABAD,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,,,,,,,,,,,,,
VIKARABAD,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,,,,,,,,,,,,,
VIKARABAD,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,,,,,,,,,,,,,
VIKARABAD,15.4.1,Number of blood smears examined for Malaria,TOTAL,,,,,,,,,,,,,
VIKARABAD,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,,,,,,,,,,,,,
VIKARABAD,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,,,,,,,,,,,,,
VIKARABAD,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
VIKARABAD,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,,,,,,,,,,
VIKARABAD,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
VIKARABAD,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,,,,,,,,,
VIKARABAD,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
VIKARABAD,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
VIKARABAD,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
VIKARABAD,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
VIKARABAD,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
VIKARABAD,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
VIKARABAD,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
VIKARABAD,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,,,,,,,,,
VIKARABAD,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
VIKARABAD,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,,,,,,,,,
VIKARABAD,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
VIKARABAD,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
VIKARABAD,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,,,,,,,,,
VIKARABAD,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
VIKARABAD,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,,,,,,,,,
VIKARABAD,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
VIKARABAD,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
VIKARABAD,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
VIKARABAD,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
VIKARABAD,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
VIKARABAD,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
VIKARABAD,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
VIKARABAD,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,,,,,,,,,
VIKARABAD,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
VIKARABAD,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,,,,,,,,,
VIKARABAD,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
VIKARABAD,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
VIKARABAD,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,,,,,,,,,
VIKARABAD,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
VIKARABAD,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,,,,,,,,,
VIKARABAD,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
VIKARABAD,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
VIKARABAD,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
VIKARABAD,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
VIKARABAD,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
VIKARABAD,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
VIKARABAD,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
VIKARABAD,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,,,,,,
VIKARABAD,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
VIKARABAD,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,,,,,,
VIKARABAD,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
VIKARABAD,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
VIKARABAD,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
VIKARABAD,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
VIKARABAD,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
VIKARABAD,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
VIKARABAD,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
VIKARABAD,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
VIKARABAD,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
VIKARABAD,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
VIKARABAD,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
VIKARABAD,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
VIKARABAD,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
VIKARABAD,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
VIKARABAD,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
VIKARABAD,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
VIKARABAD,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
VIKARABAD,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
VIKARABAD,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
VIKARABAD,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
VIKARABAD,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
VIKARABAD,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
VIKARABAD,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
VIKARABAD,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
VIKARABAD,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
VIKARABAD,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
VIKARABAD,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
VIKARABAD,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
VIKARABAD,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
VIKARABAD,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
VIKARABAD,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
VIKARABAD,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
VIKARABAD,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
VIKARABAD,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
VIKARABAD,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
VIKARABAD,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
VIKARABAD,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
VIKARABAD,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
VIKARABAD,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
VIKARABAD,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
VIKARABAD,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
VIKARABAD,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
VIKARABAD,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
VIKARABAD,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
VIKARABAD,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
VIKARABAD,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
VIKARABAD,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
VIKARABAD,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
VIKARABAD,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
VIKARABAD,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
VIKARABAD,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
VIKARABAD,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
VIKARABAD,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
VIKARABAD,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
VIKARABAD,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
VIKARABAD,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
VIKARABAD,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
VIKARABAD,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
VIKARABAD,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
VIKARABAD,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
VIKARABAD,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
VIKARABAD,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
VIKARABAD,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
VIKARABAD,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
VIKARABAD,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
VIKARABAD,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
VIKARABAD,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
VIKARABAD,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
VIKARABAD,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
VIKARABAD,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
VIKARABAD,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
VIKARABAD,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
VIKARABAD,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
VIKARABAD,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
VIKARABAD,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
VIKARABAD,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
VIKARABAD,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
VIKARABAD,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
VIKARABAD,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
VIKARABAD,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
VIKARABAD,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
VIKARABAD,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
VIKARABAD,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
VIKARABAD,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
VIKARABAD,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
VIKARABAD,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
VIKARABAD,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
VIKARABAD,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
VIKARABAD,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
VIKARABAD,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
VIKARABAD,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
VIKARABAD,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,,,,,,,
VIKARABAD,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,,,,,,,
VIKARABAD,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
VIKARABAD,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,,,,,,,
VIKARABAD,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
VIKARABAD,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
VIKARABAD,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
VIKARABAD,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
VIKARABAD,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
VIKARABAD,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
VIKARABAD,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
VIKARABAD,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
VIKARABAD,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
VIKARABAD,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
VIKARABAD,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
VIKARABAD,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
VIKARABAD,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
VIKARABAD,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
VIKARABAD,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
VIKARABAD,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
VIKARABAD,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
VIKARABAD,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
VIKARABAD,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
VIKARABAD,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
VIKARABAD,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
VIKARABAD,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
VIKARABAD,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
VIKARABAD,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
VIKARABAD,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
VIKARABAD,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
VIKARABAD,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
VIKARABAD,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
VIKARABAD,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
VIKARABAD,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
VIKARABAD,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
VIKARABAD,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
VIKARABAD,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
VIKARABAD,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
VIKARABAD,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
VIKARABAD,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
VIKARABAD,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
VIKARABAD,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
VIKARABAD,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
VIKARABAD,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
VIKARABAD,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
VIKARABAD,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
VIKARABAD,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
VIKARABAD,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
VIKARABAD,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
VIKARABAD,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
VIKARABAD,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
VIKARABAD,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
VIKARABAD,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
VIKARABAD,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
VIKARABAD,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
VIKARABAD,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
VIKARABAD,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
VIKARABAD,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
VIKARABAD,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
VIKARABAD,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
VIKARABAD,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
VIKARABAD,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
VIKARABAD,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
VIKARABAD,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
VIKARABAD,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
VIKARABAD,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
VIKARABAD,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
VIKARABAD,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
VIKARABAD,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
VIKARABAD,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
VIKARABAD,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
VIKARABAD,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
VIKARABAD,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
VIKARABAD,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
VIKARABAD,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
VIKARABAD,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
VIKARABAD,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
VIKARABAD,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
VIKARABAD,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
VIKARABAD,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
VIKARABAD,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
VIKARABAD,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
VIKARABAD,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
VIKARABAD,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
VIKARABAD,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
VIKARABAD,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
VIKARABAD,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
VIKARABAD,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
VIKARABAD,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
VIKARABAD,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
VIKARABAD,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
VIKARABAD,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
VIKARABAD,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
VIKARABAD,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
VIKARABAD,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
VIKARABAD,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
VIKARABAD,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
VIKARABAD,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
VIKARABAD,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
VIKARABAD,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
VIKARABAD,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
VIKARABAD,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
VIKARABAD,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
VIKARABAD,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
VIKARABAD,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
VIKARABAD,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
VIKARABAD,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
VIKARABAD,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
VIKARABAD,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
VIKARABAD,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
VIKARABAD,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
VIKARABAD,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
VIKARABAD,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
WANAPARTHY,1.1,Total number of pregnant women Registered for ANC,TOTAL,,,,,,,,,,,,,
WANAPARTHY,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,,,,,,,,,,,,,
WANAPARTHY,1.2,Number of Pregnant women registered under JSY,TOTAL,,,,,,,,,,,,,
WANAPARTHY,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,,,,,,,,,,,,,
WANAPARTHY,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,,,,,,,,,,,,,
WANAPARTHY,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,,,,,,,,,,,,,
WANAPARTHY,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,,,,,,,,,,,,,
WANAPARTHY,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,,,,,,,,,,,,,
WANAPARTHY,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,,,,,,,,,,,,,
WANAPARTHY,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,,,,,,,,,,,,,
WANAPARTHY,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,,,,,,,,,,,,,
WANAPARTHY,1.8,Number of pregnancy test kits used at SC level,TOTAL,,,,,,,,,,,,,
WANAPARTHY,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,,,,,,,,,,,,,
WANAPARTHY,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,,,,,,,,,,,,,
WANAPARTHY,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,,,,,,,,,,,,,
WANAPARTHY,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,,,,,,,,,,,,,
WANAPARTHY,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,,,,,,,,,,,,,
WANAPARTHY,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
WANAPARTHY,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,,,,,,,,,,,,,
WANAPARTHY,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,,,,,,,,,,,,,
WANAPARTHY,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,,,,,,,,,,,,,
WANAPARTHY,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
WANAPARTHY,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
WANAPARTHY,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
WANAPARTHY,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
WANAPARTHY,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
WANAPARTHY,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,,,,,,,,,,,,,
WANAPARTHY,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,,,,,,,,,,,,,
WANAPARTHY,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,,,,,,,,,,,,,
WANAPARTHY,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
WANAPARTHY,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,,,,,,,,,,,,,
WANAPARTHY,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
WANAPARTHY,4.1.1.a,Number of male live births,TOTAL,,,,,,,,,,,,,
WANAPARTHY,4.1.1.b,Number of female live births,TOTAL,,,,,,,,,,,,,
WANAPARTHY,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,,,,,,,,,,,,,
WANAPARTHY,4.1.2,Number of still births,TOTAL,,,,,,,,,,,,,
WANAPARTHY,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,,,,,,,,,,,,,
WANAPARTHY,4.2.1,Number of Newborns weighed at birth,TOTAL,,,,,,,,,,,,,
WANAPARTHY,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,,,,,,,,,,,,,
WANAPARTHY,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,,,,,,,,,,,,,
WANAPARTHY,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,,,,,,,,,,,,,
WANAPARTHY,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,,,,,,,,,,,,,
WANAPARTHY,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,,,,,,,,,,,,,
WANAPARTHY,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
WANAPARTHY,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,,,,,,,,,,,,,
WANAPARTHY,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
WANAPARTHY,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,,,,,,,,,,,,,
WANAPARTHY,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,,,,,,,,,,,,,
WANAPARTHY,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,,,,,,,,,,,,,
WANAPARTHY,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,,,,,,,,,,,,,
WANAPARTHY,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,,,,,,,,,,,,,
WANAPARTHY,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,,,,,,,,,,,,,
WANAPARTHY,6.3,PNC maternal complications attended,TOTAL,,,,,,,,,,,,,
WANAPARTHY,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,,,,,,,,,,,,,
WANAPARTHY,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,,,,,,,,,,,,,
WANAPARTHY,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,,,,,,,,,,,,,
WANAPARTHY,7.2,Number of MTPs conducted at Private Facilities,TOTAL,,,,,,,,,,,,,
WANAPARTHY,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,,,,,,,,,,,,,
WANAPARTHY,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,,,,,,,,,,,,,
WANAPARTHY,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,,,,,,,,,,,,,
WANAPARTHY,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,,,,,,,,,,,,,
WANAPARTHY,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,,,,,,,,,,,,,
WANAPARTHY,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,,,,,,,,,,,,,
WANAPARTHY,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
WANAPARTHY,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
WANAPARTHY,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,,,,,,,,,,,,,
WANAPARTHY,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
WANAPARTHY,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
WANAPARTHY,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
WANAPARTHY,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
WANAPARTHY,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
WANAPARTHY,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,,,,,,,,,,,,,
WANAPARTHY,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
WANAPARTHY,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
WANAPARTHY,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
WANAPARTHY,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
WANAPARTHY,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
WANAPARTHY,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,,,,,,,,,,,,,
WANAPARTHY,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
WANAPARTHY,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
WANAPARTHY,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
WANAPARTHY,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
WANAPARTHY,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
WANAPARTHY,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,,,,,,,,,,,,,
WANAPARTHY,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
WANAPARTHY,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,,,,,,,,,,,,,
WANAPARTHY,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,,,,,,,,,,,,,
WANAPARTHY,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,,,,,,,,,,,,,
WANAPARTHY,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
WANAPARTHY,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
WANAPARTHY,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,,,,,,,,,,,,,
WANAPARTHY,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,,,,,,,,,,,,,
WANAPARTHY,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
WANAPARTHY,9.06,Number of IUCD removals,TOTAL,,,,,,,,,,,,,
WANAPARTHY,9.07,Number of Oral Pills cycles distributed,TOTAL,,,,,,,,,,,,,
WANAPARTHY,9.08,Number of Condom pieces distributed,TOTAL,,,,,,,,,,,,,
WANAPARTHY,9.09,Number of Centchroman (weekly) pills given,TOTAL,,,,,,,,,,,,,
WANAPARTHY,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,,,,,,,,,,,,,
WANAPARTHY,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,,,,,,,,,,,,,
WANAPARTHY,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,,,,,,,,,,,,,
WANAPARTHY,9.11.2.a,Number of failures following male sterilization,TOTAL,,,,,,,,,,,,,
WANAPARTHY,9.11.2.b,Number of failures following female sterilization,TOTAL,,,,,,,,,,,,,
WANAPARTHY,9.11.3.a,Number of deaths following male sterilization,TOTAL,,,,,,,,,,,,,
WANAPARTHY,9.11.3.b,Number of deaths following female sterilization,TOTAL,,,,,,,,,,,,,
WANAPARTHY,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,,,,,,,,,,,-1.0
WANAPARTHY,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,,,,,,,,,,,,,
WANAPARTHY,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,,,,,,,,,,,,,
WANAPARTHY,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,,,,,,,,,,,,,
WANAPARTHY,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,,,,,,,,,,,,,
WANAPARTHY,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,,,,,,,,,,,,,
WANAPARTHY,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,,,,,,,,,,,,,
WANAPARTHY,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,,,,,,,,,,,,,
WANAPARTHY,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,,,,,,,,,,,,,
WANAPARTHY,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,,,,,,,,,,,,,
WANAPARTHY,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,,,,,,,,,,,,,
WANAPARTHY,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,,,,,,,,,,,,,
WANAPARTHY,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,,,,,,,,,,,,,
WANAPARTHY,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,,,,,,,,,,,,,
WANAPARTHY,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,,,,,,,,,,,,,
WANAPARTHY,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,,,,,,,,,,,,,
WANAPARTHY,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,,,,,,,,,,,,,
WANAPARTHY,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,,,,,,,,,,,,,
WANAPARTHY,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,,,,,,,,,,,,,
WANAPARTHY,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
WANAPARTHY,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
WANAPARTHY,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,,,,,,,,,,,,,
WANAPARTHY,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,,,,,,,,,,,,,
WANAPARTHY,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,,,,,,,,,,,,,
WANAPARTHY,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,,,,,,,,,,,,,
WANAPARTHY,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
WANAPARTHY,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
WANAPARTHY,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,,,,,,,,,,,,,
WANAPARTHY,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,,,,,,,,,,,,,
WANAPARTHY,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,,,,,,,,,,,,,
WANAPARTHY,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,,,,,,,,,,,,,
WANAPARTHY,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
WANAPARTHY,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
WANAPARTHY,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
WANAPARTHY,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,,,,,,,,,,,,,
WANAPARTHY,10.4.2,Number of Immunisation sessions held during the month,TOTAL,,,,,,,,,,,,,
WANAPARTHY,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,,,,,,,,,,,,,
WANAPARTHY,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,,,,,,,,,,,,,
WANAPARTHY,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,,,,,,,,,,,,,
WANAPARTHY,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,,,,,,,,,,,,,
WANAPARTHY,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,,,,,,,,,,,,,
WANAPARTHY,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
WANAPARTHY,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
WANAPARTHY,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
WANAPARTHY,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
WANAPARTHY,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
WANAPARTHY,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
WANAPARTHY,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
WANAPARTHY,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
WANAPARTHY,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,,,,,,,,,,,,,
WANAPARTHY,13.1,Number of Patients operated for cataract,TOTAL,,,,,,,,,,,,,
WANAPARTHY,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,,,,,,,,,,,,,
WANAPARTHY,13.3,Number of School children detected with Refractive errors,TOTAL,,,,,,,,,,,,,
WANAPARTHY,13.4,Number of children provided free glasses,TOTAL,,,,,,,,,,,,,
WANAPARTHY,13.5,Number of eyes collected through eye donation,TOTAL,,,,,,,,,,,,,
WANAPARTHY,13.6,Number of eyes utilised for corneal transplant,TOTAL,,,,,,,,,,,,,
WANAPARTHY,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,,,,,,,,,,,,-1.0
WANAPARTHY,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,,,,,,,,,,-1.0
WANAPARTHY,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,,,,,,,,,,,,,-1.0
WANAPARTHY,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,,,,,,,,,,,,,-1.0
WANAPARTHY,14.05,Number of RKS meetings held during the month,TOTAL,,,,,,,,,,,,,
WANAPARTHY,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,,,,,,,,,,,,,-1.0
WANAPARTHY,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,,,,,,,,,,,,,
WANAPARTHY,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,,,,,,,,,-1.0
WANAPARTHY,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,,,,,,,,,,,,,-1.0
WANAPARTHY,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,,,,,,,,,,,,,
WANAPARTHY,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,,,,,,,,,,,,,
WANAPARTHY,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,,,,,,,,,,,,,
WANAPARTHY,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,,,,,,,,,,,,,
WANAPARTHY,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,,,,,,,,,,,,,
WANAPARTHY,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,,,,,,,,,,,,,
WANAPARTHY,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,,,,,,,,,,,,,
WANAPARTHY,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,,,,,,,,,,,,,
WANAPARTHY,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,,,,,,,,,,,,,
WANAPARTHY,14.10.2.a,Number of death cases of Inpatient males,TOTAL,,,,,,,,,,,,,
WANAPARTHY,14.10.2.b,Number of death cases of Inpatient females,TOTAL,,,,,,,,,,,,,
WANAPARTHY,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,,,,,,,,,,,,,
WANAPARTHY,14.11,In-Patient Head Count at midnight,TOTAL,,,,,,,,,,,,,
WANAPARTHY,14.12.1,OPD attendance (All),TOTAL,,,,,,,,,,,,,
WANAPARTHY,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,,,,,,,,,,,,,
WANAPARTHY,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,,,,,,,,,,,,,
WANAPARTHY,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,,,,,,,,,,,,,
WANAPARTHY,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,,,,,,,,,,,,,
WANAPARTHY,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,,,,,,,,,,,,,
WANAPARTHY,14.14.a,Number of patients given AYUSH treatment,TOTAL,,,,,,,,,,,,,
WANAPARTHY,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,,,,,,,,,,,,,
WANAPARTHY,14.14.c,Number of Adolescents counselled,TOTAL,,,,,,,,,,,,,
WANAPARTHY,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,,,,,,,,,,,,,
WANAPARTHY,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,,,,,,,,,,,,,
WANAPARTHY,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,,,,,,,,,,,,,
WANAPARTHY,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,,,,,,,,,,,,,
WANAPARTHY,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,,,,,,,,,,,,,
WANAPARTHY,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,,,,,,,,,,,,,
WANAPARTHY,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,,,,,,,,,,,,,
WANAPARTHY,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,,,,,,,,,,,,,
WANAPARTHY,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,,,,,,,,,,,,,
WANAPARTHY,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,,,,,,,,,,,,,
WANAPARTHY,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,,,,,,,,,,,,,
WANAPARTHY,15.2,Number of Widal tests conducted,Number tested,,,,,,,,,,,,,
WANAPARTHY,15.3.a,Number of VDRL tests conducted on males,Number tested,,,,,,,,,,,,,
WANAPARTHY,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,,,,,,,,,,,,,
WANAPARTHY,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,,,,,,,,,,,,,
WANAPARTHY,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,,,,,,,,,,,,,
WANAPARTHY,15.4.1,Number of blood smears examined for Malaria,TOTAL,,,,,,,,,,,,,
WANAPARTHY,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,,,,,,,,,,,,,
WANAPARTHY,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,,,,,,,,,,,,,
WANAPARTHY,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
WANAPARTHY,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,,,,,,,,,,
WANAPARTHY,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
WANAPARTHY,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,,,,,,,,,
WANAPARTHY,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
WANAPARTHY,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
WANAPARTHY,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
WANAPARTHY,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
WANAPARTHY,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
WANAPARTHY,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
WANAPARTHY,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
WANAPARTHY,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,,,,,,,,,
WANAPARTHY,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
WANAPARTHY,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,,,,,,,,,
WANAPARTHY,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
WANAPARTHY,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
WANAPARTHY,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,,,,,,,,,
WANAPARTHY,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
WANAPARTHY,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,,,,,,,,,
WANAPARTHY,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
WANAPARTHY,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
WANAPARTHY,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
WANAPARTHY,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
WANAPARTHY,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
WANAPARTHY,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
WANAPARTHY,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
WANAPARTHY,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,,,,,,,,,
WANAPARTHY,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
WANAPARTHY,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,,,,,,,,,
WANAPARTHY,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
WANAPARTHY,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
WANAPARTHY,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,,,,,,,,,
WANAPARTHY,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
WANAPARTHY,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,,,,,,,,,
WANAPARTHY,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
WANAPARTHY,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
WANAPARTHY,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
WANAPARTHY,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
WANAPARTHY,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
WANAPARTHY,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
WANAPARTHY,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
WANAPARTHY,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,,,,,,
WANAPARTHY,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
WANAPARTHY,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,,,,,,
WANAPARTHY,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
WANAPARTHY,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
WANAPARTHY,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
WANAPARTHY,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
WANAPARTHY,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
WANAPARTHY,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
WANAPARTHY,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
WANAPARTHY,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
WANAPARTHY,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
WANAPARTHY,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
WANAPARTHY,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
WANAPARTHY,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
WANAPARTHY,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
WANAPARTHY,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
WANAPARTHY,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
WANAPARTHY,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
WANAPARTHY,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
WANAPARTHY,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
WANAPARTHY,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
WANAPARTHY,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
WANAPARTHY,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
WANAPARTHY,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
WANAPARTHY,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
WANAPARTHY,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
WANAPARTHY,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
WANAPARTHY,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
WANAPARTHY,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
WANAPARTHY,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
WANAPARTHY,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
WANAPARTHY,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
WANAPARTHY,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
WANAPARTHY,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
WANAPARTHY,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
WANAPARTHY,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
WANAPARTHY,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
WANAPARTHY,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
WANAPARTHY,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
WANAPARTHY,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
WANAPARTHY,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
WANAPARTHY,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
WANAPARTHY,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
WANAPARTHY,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
WANAPARTHY,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
WANAPARTHY,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
WANAPARTHY,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
WANAPARTHY,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
WANAPARTHY,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
WANAPARTHY,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
WANAPARTHY,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
WANAPARTHY,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
WANAPARTHY,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
WANAPARTHY,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
WANAPARTHY,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
WANAPARTHY,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
WANAPARTHY,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
WANAPARTHY,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
WANAPARTHY,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
WANAPARTHY,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
WANAPARTHY,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
WANAPARTHY,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
WANAPARTHY,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
WANAPARTHY,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
WANAPARTHY,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
WANAPARTHY,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
WANAPARTHY,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
WANAPARTHY,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
WANAPARTHY,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
WANAPARTHY,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
WANAPARTHY,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
WANAPARTHY,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
WANAPARTHY,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
WANAPARTHY,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
WANAPARTHY,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
WANAPARTHY,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
WANAPARTHY,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
WANAPARTHY,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
WANAPARTHY,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
WANAPARTHY,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
WANAPARTHY,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
WANAPARTHY,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
WANAPARTHY,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
WANAPARTHY,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
WANAPARTHY,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
WANAPARTHY,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
WANAPARTHY,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
WANAPARTHY,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
WANAPARTHY,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
WANAPARTHY,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
WANAPARTHY,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
WANAPARTHY,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
WANAPARTHY,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
WANAPARTHY,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,,,,,,,
WANAPARTHY,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,,,,,,,
WANAPARTHY,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
WANAPARTHY,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,,,,,,,
WANAPARTHY,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
WANAPARTHY,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
WANAPARTHY,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
WANAPARTHY,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
WANAPARTHY,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
WANAPARTHY,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
WANAPARTHY,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
WANAPARTHY,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
WANAPARTHY,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
WANAPARTHY,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
WANAPARTHY,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
WANAPARTHY,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
WANAPARTHY,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
WANAPARTHY,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
WANAPARTHY,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
WANAPARTHY,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
WANAPARTHY,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
WANAPARTHY,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
WANAPARTHY,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
WANAPARTHY,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
WANAPARTHY,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
WANAPARTHY,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
WANAPARTHY,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
WANAPARTHY,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
WANAPARTHY,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
WANAPARTHY,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
WANAPARTHY,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
WANAPARTHY,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
WANAPARTHY,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
WANAPARTHY,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
WANAPARTHY,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
WANAPARTHY,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
WANAPARTHY,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
WANAPARTHY,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
WANAPARTHY,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
WANAPARTHY,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
WANAPARTHY,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
WANAPARTHY,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
WANAPARTHY,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
WANAPARTHY,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
WANAPARTHY,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
WANAPARTHY,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
WANAPARTHY,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
WANAPARTHY,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
WANAPARTHY,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
WANAPARTHY,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
WANAPARTHY,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
WANAPARTHY,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
WANAPARTHY,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
WANAPARTHY,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
WANAPARTHY,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
WANAPARTHY,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
WANAPARTHY,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
WANAPARTHY,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
WANAPARTHY,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
WANAPARTHY,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
WANAPARTHY,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
WANAPARTHY,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
WANAPARTHY,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
WANAPARTHY,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
WANAPARTHY,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
WANAPARTHY,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
WANAPARTHY,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
WANAPARTHY,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
WANAPARTHY,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
WANAPARTHY,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
WANAPARTHY,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
WANAPARTHY,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
WANAPARTHY,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
WANAPARTHY,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
WANAPARTHY,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
WANAPARTHY,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
WANAPARTHY,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
WANAPARTHY,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
WANAPARTHY,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
WANAPARTHY,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
WANAPARTHY,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
WANAPARTHY,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
WANAPARTHY,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
WANAPARTHY,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
WANAPARTHY,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
WANAPARTHY,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
WANAPARTHY,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
WANAPARTHY,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
WANAPARTHY,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
WANAPARTHY,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
WANAPARTHY,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
WANAPARTHY,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
WANAPARTHY,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
WANAPARTHY,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
WANAPARTHY,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
WANAPARTHY,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
WANAPARTHY,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
WANAPARTHY,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
WANAPARTHY,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
WANAPARTHY,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
WANAPARTHY,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
WANAPARTHY,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
WANAPARTHY,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
WANAPARTHY,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
WANAPARTHY,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
WANAPARTHY,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
WANAPARTHY,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
WANAPARTHY,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
WANAPARTHY,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
WANAPARTHY,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
WANAPARTHY,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
WANAPARTHY,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
WANAPARTHY,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
WARANGAL RURAL,1.1,Total number of pregnant women Registered for ANC,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,1.2,Number of Pregnant women registered under JSY,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,1.8,Number of pregnancy test kits used at SC level,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,4.1.1.a,Number of male live births,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,4.1.1.b,Number of female live births,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,4.1.2,Number of still births,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,4.2.1,Number of Newborns weighed at birth,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,6.3,PNC maternal complications attended,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,7.2,Number of MTPs conducted at Private Facilities,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,9.06,Number of IUCD removals,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,9.07,Number of Oral Pills cycles distributed,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,9.08,Number of Condom pieces distributed,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,9.09,Number of Centchroman (weekly) pills given,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,9.11.2.a,Number of failures following male sterilization,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,9.11.2.b,Number of failures following female sterilization,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,9.11.3.a,Number of deaths following male sterilization,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,9.11.3.b,Number of deaths following female sterilization,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,,,,,,,,,,,-1.0
WARANGAL RURAL,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,10.4.2,Number of Immunisation sessions held during the month,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,13.1,Number of Patients operated for cataract,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,13.3,Number of School children detected with Refractive errors,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,13.4,Number of children provided free glasses,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,13.5,Number of eyes collected through eye donation,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,13.6,Number of eyes utilised for corneal transplant,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,,,,,,,,,,,,-1.0
WARANGAL RURAL,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,,,,,,,,,,-1.0
WARANGAL RURAL,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,,,,,,,,,,,,,-1.0
WARANGAL RURAL,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,,,,,,,,,,,,,-1.0
WARANGAL RURAL,14.05,Number of RKS meetings held during the month,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,,,,,,,,,,,,,-1.0
WARANGAL RURAL,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,,,,,,,,,-1.0
WARANGAL RURAL,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,,,,,,,,,,,,,-1.0
WARANGAL RURAL,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,,,,,,,,,,,,,
WARANGAL RURAL,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,,,,,,,,,,,,,
WARANGAL RURAL,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,,,,,,,,,,,,,
WARANGAL RURAL,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,,,,,,,,,,,,,
WARANGAL RURAL,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,,,,,,,,,,,,,
WARANGAL RURAL,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,,,,,,,,,,,,,
WARANGAL RURAL,14.10.2.a,Number of death cases of Inpatient males,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,14.10.2.b,Number of death cases of Inpatient females,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,14.11,In-Patient Head Count at midnight,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,14.12.1,OPD attendance (All),TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,14.14.a,Number of patients given AYUSH treatment,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,14.14.c,Number of Adolescents counselled,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,,,,,,,,,,,,,
WARANGAL RURAL,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,,,,,,,,,,,,,
WARANGAL RURAL,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,,,,,,,,,,,,,
WARANGAL RURAL,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,,,,,,,,,,,,,
WARANGAL RURAL,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,,,,,,,,,,,,,
WARANGAL RURAL,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,,,,,,,,,,,,,
WARANGAL RURAL,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,,,,,,,,,,,,,
WARANGAL RURAL,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,,,,,,,,,,,,,
WARANGAL RURAL,15.2,Number of Widal tests conducted,Number tested,,,,,,,,,,,,,
WARANGAL RURAL,15.3.a,Number of VDRL tests conducted on males,Number tested,,,,,,,,,,,,,
WARANGAL RURAL,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,,,,,,,,,,,,,
WARANGAL RURAL,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,,,,,,,,,,,,,
WARANGAL RURAL,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,,,,,,,,,,,,,
WARANGAL RURAL,15.4.1,Number of blood smears examined for Malaria,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
WARANGAL RURAL,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,,,,,,,,,,
WARANGAL RURAL,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
WARANGAL RURAL,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,,,,,,,,,
WARANGAL RURAL,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
WARANGAL RURAL,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
WARANGAL RURAL,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
WARANGAL RURAL,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
WARANGAL RURAL,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
WARANGAL RURAL,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
WARANGAL RURAL,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
WARANGAL RURAL,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,,,,,,,,,
WARANGAL RURAL,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
WARANGAL RURAL,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,,,,,,,,,
WARANGAL RURAL,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
WARANGAL RURAL,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
WARANGAL RURAL,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,,,,,,,,,
WARANGAL RURAL,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
WARANGAL RURAL,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,,,,,,,,,
WARANGAL RURAL,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
WARANGAL RURAL,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
WARANGAL RURAL,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
WARANGAL RURAL,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
WARANGAL RURAL,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
WARANGAL RURAL,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
WARANGAL RURAL,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
WARANGAL RURAL,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,,,,,,,,,
WARANGAL RURAL,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
WARANGAL RURAL,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,,,,,,,,,
WARANGAL RURAL,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
WARANGAL RURAL,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
WARANGAL RURAL,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,,,,,,,,,
WARANGAL RURAL,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
WARANGAL RURAL,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,,,,,,,,,
WARANGAL RURAL,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
WARANGAL RURAL,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
WARANGAL RURAL,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
WARANGAL RURAL,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
WARANGAL RURAL,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
WARANGAL RURAL,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
WARANGAL RURAL,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
WARANGAL RURAL,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,,,,,,
WARANGAL RURAL,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
WARANGAL RURAL,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,,,,,,
WARANGAL RURAL,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
WARANGAL RURAL,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
WARANGAL RURAL,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
WARANGAL RURAL,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
WARANGAL RURAL,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
WARANGAL RURAL,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
WARANGAL RURAL,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
WARANGAL RURAL,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
WARANGAL RURAL,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
WARANGAL RURAL,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
WARANGAL RURAL,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
WARANGAL RURAL,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
WARANGAL RURAL,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
WARANGAL RURAL,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
WARANGAL RURAL,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
WARANGAL RURAL,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
WARANGAL RURAL,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
WARANGAL RURAL,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
WARANGAL RURAL,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
WARANGAL RURAL,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
WARANGAL RURAL,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
WARANGAL RURAL,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
WARANGAL RURAL,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
WARANGAL RURAL,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
WARANGAL RURAL,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
WARANGAL RURAL,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
WARANGAL RURAL,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
WARANGAL RURAL,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
WARANGAL RURAL,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
WARANGAL RURAL,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
WARANGAL RURAL,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
WARANGAL RURAL,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
WARANGAL RURAL,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
WARANGAL RURAL,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
WARANGAL RURAL,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
WARANGAL RURAL,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
WARANGAL RURAL,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
WARANGAL RURAL,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
WARANGAL RURAL,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
WARANGAL RURAL,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
WARANGAL RURAL,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
WARANGAL RURAL,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
WARANGAL RURAL,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
WARANGAL RURAL,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
WARANGAL RURAL,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
WARANGAL RURAL,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
WARANGAL RURAL,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
WARANGAL RURAL,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
WARANGAL RURAL,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
WARANGAL RURAL,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
WARANGAL RURAL,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
WARANGAL RURAL,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
WARANGAL RURAL,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
WARANGAL RURAL,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
WARANGAL RURAL,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
WARANGAL RURAL,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
WARANGAL RURAL,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
WARANGAL RURAL,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
WARANGAL RURAL,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
WARANGAL RURAL,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
WARANGAL RURAL,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
WARANGAL RURAL,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
WARANGAL RURAL,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
WARANGAL RURAL,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
WARANGAL RURAL,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
WARANGAL RURAL,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
WARANGAL RURAL,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
WARANGAL RURAL,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
WARANGAL RURAL,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
WARANGAL RURAL,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
WARANGAL RURAL,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
WARANGAL RURAL,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
WARANGAL RURAL,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
WARANGAL RURAL,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
WARANGAL RURAL,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
WARANGAL RURAL,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
WARANGAL RURAL,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
WARANGAL RURAL,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
WARANGAL RURAL,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
WARANGAL RURAL,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
WARANGAL RURAL,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
WARANGAL RURAL,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
WARANGAL RURAL,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
WARANGAL RURAL,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
WARANGAL RURAL,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
WARANGAL RURAL,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
WARANGAL RURAL,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
WARANGAL RURAL,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
WARANGAL RURAL,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
WARANGAL RURAL,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
WARANGAL RURAL,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
WARANGAL RURAL,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,,,,,,,
WARANGAL RURAL,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,,,,,,,
WARANGAL RURAL,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
WARANGAL RURAL,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,,,,,,,
WARANGAL RURAL,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
WARANGAL RURAL,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
WARANGAL RURAL,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
WARANGAL RURAL,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
WARANGAL RURAL,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
WARANGAL RURAL,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
WARANGAL RURAL,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
WARANGAL RURAL,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
WARANGAL RURAL,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
WARANGAL RURAL,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
WARANGAL RURAL,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
WARANGAL RURAL,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
WARANGAL RURAL,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
WARANGAL RURAL,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
WARANGAL RURAL,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
WARANGAL RURAL,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
WARANGAL RURAL,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
WARANGAL RURAL,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
WARANGAL RURAL,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
WARANGAL RURAL,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
WARANGAL RURAL,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
WARANGAL RURAL,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
WARANGAL RURAL,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
WARANGAL RURAL,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
WARANGAL RURAL,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
WARANGAL RURAL,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
WARANGAL RURAL,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
WARANGAL RURAL,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
WARANGAL RURAL,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
WARANGAL RURAL,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
WARANGAL RURAL,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
WARANGAL RURAL,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
WARANGAL RURAL,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
WARANGAL RURAL,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
WARANGAL RURAL,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
WARANGAL RURAL,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
WARANGAL RURAL,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
WARANGAL RURAL,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
WARANGAL RURAL,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
WARANGAL RURAL,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
WARANGAL RURAL,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
WARANGAL RURAL,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
WARANGAL RURAL,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
WARANGAL RURAL,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
WARANGAL RURAL,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
WARANGAL RURAL,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
WARANGAL RURAL,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
WARANGAL RURAL,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
WARANGAL RURAL,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
WARANGAL RURAL,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
WARANGAL RURAL,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
WARANGAL RURAL,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
WARANGAL RURAL,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
WARANGAL RURAL,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
WARANGAL RURAL,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
WARANGAL RURAL,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
WARANGAL RURAL,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
WARANGAL RURAL,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
WARANGAL RURAL,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
WARANGAL RURAL,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
WARANGAL RURAL,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
WARANGAL RURAL,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
WARANGAL RURAL,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
WARANGAL RURAL,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
WARANGAL RURAL,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
WARANGAL RURAL,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
WARANGAL RURAL,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
WARANGAL RURAL,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
WARANGAL RURAL,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
WARANGAL RURAL,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
WARANGAL RURAL,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
WARANGAL RURAL,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
WARANGAL RURAL,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
WARANGAL RURAL,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
WARANGAL RURAL,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
WARANGAL RURAL,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
WARANGAL RURAL,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
WARANGAL RURAL,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
WARANGAL RURAL,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
WARANGAL RURAL,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
WARANGAL RURAL,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
WARANGAL RURAL,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
WARANGAL RURAL,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
WARANGAL RURAL,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
WARANGAL RURAL,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
WARANGAL RURAL,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
WARANGAL RURAL,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
WARANGAL RURAL,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
WARANGAL RURAL,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
WARANGAL RURAL,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
WARANGAL RURAL,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
WARANGAL RURAL,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
WARANGAL RURAL,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
WARANGAL RURAL,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
WARANGAL RURAL,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
WARANGAL RURAL,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
WARANGAL RURAL,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
WARANGAL RURAL,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
WARANGAL RURAL,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
WARANGAL RURAL,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
WARANGAL RURAL,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
WARANGAL RURAL,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
WARANGAL RURAL,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
WARANGAL RURAL,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
WARANGAL RURAL,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
WARANGAL RURAL,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
WARANGAL RURAL,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
WARANGAL RURAL,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
WARANGAL RURAL,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
Warangal Urban,1.1,Total number of pregnant women Registered for ANC,TOTAL,4731.0,4462.0,5096.0,5254.0,4811.0,4087.0,3951.0,5027.0,4101.0,4301.0,4932.0,4272.0,55025.0
Warangal Urban,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,3690.0,3358.0,3708.0,3804.0,3459.0,3090.0,2906.0,3312.0,3031.0,3109.0,3525.0,3177.0,40169.0
Warangal Urban,1.2,Number of Pregnant women registered under JSY,TOTAL,3961.0,3667.0,4396.0,4483.0,4046.0,3438.0,3362.0,3967.0,3487.0,3765.0,4213.0,3630.0,46415.0
Warangal Urban,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,4564.0,4325.0,4166.0,4678.0,4895.0,4567.0,4467.0,4050.0,4292.0,4501.0,4683.0,4650.0,53838.0
Warangal Urban,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,4541.0,4314.0,5013.0,5206.0,4805.0,4036.0,3750.0,4504.0,4061.0,4162.0,4845.0,4186.0,53423.0
Warangal Urban,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,3999.0,4582.0,4693.0,4987.0,4716.0,4399.0,3752.0,4092.0,4092.0,3949.0,4266.0,4147.0,51674.0
Warangal Urban,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,5244.0,7231.0,6699.0,7248.0,6951.0,6661.0,6694.0,6261.0,6173.0,6479.0,6453.0,5801.0,77895.0
Warangal Urban,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,66.0,126.0,101.0,118.0,137.0,106.0,184.0,103.0,136.0,224.0,90.0,84.0,1475.0
Warangal Urban,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,15.0,20.0,35.0,16.0,18.0,13.0,15.0,8.0,21.0,13.0,6.0,20.0,200.0
Warangal Urban,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,2604.0,4046.0,3358.0,4014.0,4879.0,3442.0,4347.0,3355.0,4273.0,3274.0,3039.0,3917.0,44548.0
Warangal Urban,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,42.0,62.0,162.0,24.0,72.0,44.0,32.0,125.0,127.0,66.0,97.0,245.0,1098.0
Warangal Urban,1.8,Number of pregnancy test kits used at SC level,TOTAL,320.0,535.0,1076.0,1027.0,1055.0,985.0,1001.0,1096.0,993.0,971.0,983.0,1057.0,11099.0
Warangal Urban,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,5.0,0.0,3.0,3.0,0.0,0.0,4.0,1.0,1.0,2.0,0.0,0.0,19.0
Warangal Urban,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0
Warangal Urban,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,6.0,0.0,3.0,3.0,0.0,0.0,5.0,1.0,1.0,2.0,0.0,0.0,21.0
Warangal Urban,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,3.0,0.0,3.0,3.0,0.0,0.0,4.0,1.0,1.0,1.0,0.0,0.0,16.0
Warangal Urban,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,3.0,0.0,1.0,0.0,0.0,0.0,5.0
Warangal Urban,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1025.0,1548.0,1533.0,1428.0,1737.0,1549.0,1619.0,1628.0,1709.0,1343.0,1191.0,1132.0,17442.0
Warangal Urban,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,637.0,878.0,879.0,824.0,1078.0,901.0,937.0,985.0,994.0,779.0,648.0,632.0,10172.0
Warangal Urban,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,5.0,10.0,4.0,11.0,15.0,6.0,31.0,32.0,24.0,100.0,2145.0,1720.0,4103.0
Warangal Urban,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,5.0,23.0,3.0,25.0,25.0,7.0,23.0,0.0,0.0,23.0,66.0,21.0,221.0
Warangal Urban,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Warangal Urban,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,2134.0,2308.0,2207.0,2245.0,2361.0,1379.0,2143.0,2635.0,3130.0,2350.0,2345.0,1977.0,27214.0
Warangal Urban,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Warangal Urban,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Warangal Urban,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Warangal Urban,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,3.0,7.0
Warangal Urban,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,9.0,13.0,8.0,13.0,17.0,20.0,10.0,17.0,7.0,9.0,17.0,27.0,167.0
Warangal Urban,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,446.0,634.0,649.0,631.0,698.0,662.0,689.0,722.0,731.0,579.0,536.0,682.0,7659.0
Warangal Urban,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Warangal Urban,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,455.0,647.0,657.0,644.0,715.0,682.0,699.0,739.0,738.0,588.0,557.0,712.0,7833.0
Warangal Urban,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,1280.0,1356.0,1611.0,1642.0,1747.0,971.0,1522.0,1631.0,2254.0,1716.0,1698.0,1186.0,18614.0
Warangal Urban,4.1.1.a,Number of male live births,TOTAL,1678.0,2015.0,1898.0,1897.0,2146.0,1535.0,1909.0,2225.0,2463.0,1899.0,1862.0,1805.0,23332.0
Warangal Urban,4.1.1.b,Number of female live births,TOTAL,1614.0,1862.0,1864.0,1840.0,2063.0,1481.0,1887.0,2147.0,2428.0,1849.0,1779.0,1730.0,22544.0
Warangal Urban,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,3292.0,3877.0,3762.0,3737.0,4209.0,3016.0,3796.0,4372.0,4891.0,3748.0,3641.0,3535.0,45876.0
Warangal Urban,4.1.2,Number of still births,TOTAL,4.0,4.0,17.0,20.0,22.0,14.0,30.0,29.0,19.0,21.0,33.0,13.0,226.0
Warangal Urban,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,29.0,43.0,69.0,55.0,64.0,66.0,37.0,40.0,40.0,40.0,54.0,75.0,612.0
Warangal Urban,4.2.1,Number of Newborns weighed at birth,TOTAL,3263.0,3871.0,3722.0,3689.0,4165.0,3012.0,3752.0,4359.0,4847.0,3747.0,3606.0,3504.0,45537.0
Warangal Urban,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,598.0,331.0,309.0,405.0,310.0,273.0,313.0,344.0,369.0,269.0,307.0,394.0,4222.0
Warangal Urban,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1728.0,1940.0,1476.0,1630.0,1868.0,1415.0,1842.0,2269.0,2116.0,1635.0,1541.0,1755.0,21215.0
Warangal Urban,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,1.0,0.0,5.0,0.0,0.0,0.0,4.0,0.0,1.0,0.0,0.0,11.0
Warangal Urban,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,5.0,2.0,2.0,0.0,2.0,0.0,2.0,0.0,3.0,0.0,0.0,0.0,16.0
Warangal Urban,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,735.0,1183.0,1214.0,1184.0,1073.0,1156.0,1273.0,1317.0,1173.0,1044.0,974.0,504.0,12830.0
Warangal Urban,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Warangal Urban,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,740.0,1186.0,1216.0,1189.0,1075.0,1156.0,1275.0,1321.0,1176.0,1045.0,974.0,504.0,12857.0
Warangal Urban,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Warangal Urban,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,707.0,942.0,964.0,924.0,1073.0,1059.0,1254.0,1317.0,1146.0,1044.0,758.0,408.0,11596.0
Warangal Urban,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,27.0,24.0,55.0,40.0,24.0,12.0,30.0,327.0,25.0,13.0,61.0,19.0,657.0
Warangal Urban,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,726.0,396.0,1214.0,1158.0,973.0,857.0,1255.0,1250.0,1146.0,1044.0,974.0,356.0,11349.0
Warangal Urban,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,47.0,66.0,94.0,151.0,126.0,152.0,129.0,104.0,116.0,87.0,111.0,118.0,1301.0
Warangal Urban,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,2332.0,3805.0,1554.0,920.0,1615.0,1564.0,1550.0,1784.0,1612.0,1431.0,1212.0,926.0,20305.0
Warangal Urban,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1963.0,2002.0,1830.0,1912.0,2005.0,1967.0,1718.0,2095.0,1642.0,1745.0,1636.0,1763.0,22278.0
Warangal Urban,6.3,PNC maternal complications attended,TOTAL,27.0,53.0,30.0,9.0,34.0,32.0,32.0,34.0,32.0,39.0,28.0,33.0,383.0
Warangal Urban,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,13.0,29.0,26.0,4.0,6.0,22.0,14.0,12.0,13.0,14.0,10.0,11.0,174.0
Warangal Urban,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,10.0,12.0,18.0,14.0,30.0,36.0,9.0,19.0,20.0,8.0,20.0,13.0,209.0
Warangal Urban,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,23.0,41.0,44.0,18.0,36.0,58.0,23.0,31.0,33.0,22.0,30.0,24.0,383.0
Warangal Urban,7.2,Number of MTPs conducted at Private Facilities,TOTAL,29.0,26.0,31.0,19.0,17.0,14.0,7.0,13.0,41.0,16.0,23.0,32.0,268.0
Warangal Urban,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,651.0,540.0,648.0,434.0,417.0,689.0,639.0,445.0,676.0,429.0,466.0,316.0,6350.0
Warangal Urban,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,1360.0,1614.0,1756.0,856.0,1301.0,1792.0,1638.0,1365.0,1767.0,1586.0,1685.0,1462.0,18182.0
Warangal Urban,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,2011.0,2154.0,2404.0,1290.0,1718.0,2481.0,2277.0,1810.0,2443.0,2015.0,2151.0,1778.0,24532.0
Warangal Urban,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,38.0,0.0,21.0,0.0,0.0,0.0,8.0,6.0,6.0,9.0,0.0,0.0,88.0
Warangal Urban,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,85.0,37.0,85.0,90.0,85.0,194.0,20.0,73.0,277.0,440.0,236.0,474.0,2096.0
Warangal Urban,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,53.0,53.0
Warangal Urban,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,77.0,26.0,25.0,52.0,48.0,87.0,41.0,37.0,57.0,89.0,52.0,40.0,631.0
Warangal Urban,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Warangal Urban,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,162.0,63.0,110.0,142.0,133.0,281.0,61.0,110.0,334.0,529.0,288.0,567.0,2780.0
Warangal Urban,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Warangal Urban,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,407.0,19.0,22.0,0.0,0.0,0.0,0.0,0.0,522.0,1334.0,589.0,919.0,3812.0
Warangal Urban,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,54.0,57.0
Warangal Urban,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,133.0,23.0,24.0,23.0,25.0,7.0,3.0,4.0,1.0,370.0,111.0,123.0,847.0
Warangal Urban,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Warangal Urban,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,540.0,42.0,49.0,23.0,25.0,7.0,3.0,4.0,523.0,1704.0,700.0,1096.0,4716.0
Warangal Urban,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Warangal Urban,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,38.0,9.0,14.0,58.0,75.0,85.0,36.0,54.0,143.0,34.0,42.0,63.0,651.0
Warangal Urban,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,4.0,0.0,0.0,0.0,1.0,2.0,3.0,1.0,1.0,0.0,0.0,0.0,12.0
Warangal Urban,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,192.0,185.0,195.0,263.0,208.0,87.0,82.0,222.0,49.0,197.0,238.0,239.0,2157.0
Warangal Urban,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Warangal Urban,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,234.0,194.0,209.0,321.0,284.0,174.0,121.0,277.0,193.0,231.0,280.0,302.0,2820.0
Warangal Urban,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,173.0,166.0,296.0,297.0,339.0,333.0,383.0,409.0,403.0,606.0,419.0,801.0,4625.0
Warangal Urban,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,11.0,8.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,20.0
Warangal Urban,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,6.0,0.0,0.0,0.0,0.0,0.0,2.0,3.0,4.0,2.0,3.0,20.0
Warangal Urban,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,62.0,140.0,182.0,145.0,194.0,166.0,148.0,71.0,158.0,30.0,22.0,64.0,1382.0
Warangal Urban,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Warangal Urban,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,62.0,157.0,190.0,146.0,194.0,166.0,148.0,73.0,161.0,34.0,24.0,67.0,1422.0
Warangal Urban,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,209.0,137.0,,,,,,,,,,,346.0
Warangal Urban,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,40.0,43.0,41.0,30.0,32.0,51.0,31.0,18.0,9.0,19.0,20.0,7.0,341.0
Warangal Urban,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,87.0,142.0,71.0,77.0,49.0,68.0,27.0,69.0,45.0,46.0,14.0,31.0,726.0
Warangal Urban,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,4.0,2.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,7.0
Warangal Urban,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,34.0,28.0,26.0,8.0,25.0,14.0,19.0,18.0,26.0,24.0,18.0,14.0,254.0
Warangal Urban,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Warangal Urban,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,165.0,215.0,138.0,115.0,106.0,134.0,77.0,105.0,80.0,89.0,52.0,52.0,1328.0
Warangal Urban,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,2.0,13.0,13.0,2.0,11.0,6.0,20.0,0.0,2.0,13.0,34.0,30.0,146.0
Warangal Urban,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Warangal Urban,9.06,Number of IUCD removals,TOTAL,57.0,86.0,105.0,117.0,103.0,252.0,155.0,168.0,123.0,104.0,178.0,45.0,1493.0
Warangal Urban,9.07,Number of Oral Pills cycles distributed,TOTAL,3980.0,4047.0,4177.0,3309.0,3566.0,3720.0,3764.0,3352.0,3834.0,3808.0,3591.0,3296.0,44444.0
Warangal Urban,9.08,Number of Condom pieces distributed,TOTAL,20052.0,12915.0,17608.0,12513.0,14727.0,17202.0,16187.0,19538.0,19807.0,18324.0,21166.0,19723.0,209762.0
Warangal Urban,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Warangal Urban,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,10.0,13.0,7.0,9.0,47.0,0.0,4.0,13.0,1.0,2.0,1.0,0.0,107.0
Warangal Urban,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0
Warangal Urban,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Warangal Urban,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,1.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Warangal Urban,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,2.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,4.0
Warangal Urban,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Warangal Urban,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Warangal Urban,9.12,Number of Institutions having NSV trained doctors,TOTAL,28.0,31.0,32.0,34.0,34.0,35.0,31.0,31.0,38.0,40.0,45.0,42.0,-1.0
Warangal Urban,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,3292.0,3877.0,3713.0,3918.0,4207.0,2996.0,3772.0,4372.0,4629.0,3718.0,3641.0,3486.0,45621.0
Warangal Urban,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,3986.0,4145.0,3897.0,1138.0,667.0,496.0,287.0,135.0,85.0,109.0,84.0,75.0,15104.0
Warangal Urban,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,4277.0,4357.0,4056.0,4059.0,1203.0,601.0,395.0,138.0,74.0,79.0,91.0,70.0,19400.0
Warangal Urban,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,4604.0,4552.0,4410.0,4329.0,3236.0,1207.0,508.0,202.0,104.0,129.0,127.0,90.0,23498.0
Warangal Urban,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,425.0,65.0,1257.0,4140.0,3654.0,4116.0,3964.0,4766.0,4432.0,4555.0,4778.0,4600.0,40752.0
Warangal Urban,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,406.0,76.0,351.0,1270.0,3559.0,3862.0,3569.0,4700.0,4672.0,4347.0,4730.0,4826.0,36368.0
Warangal Urban,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,420.0,71.0,356.0,266.0,1314.0,3730.0,3352.0,4370.0,4469.0,4469.0,4457.0,4781.0,32055.0
Warangal Urban,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,3126.0,3651.0,3526.0,3526.0,3652.0,2623.0,3675.0,4087.0,4333.0,3388.0,3304.0,3142.0,42033.0
Warangal Urban,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,4394.0,4204.0,4620.0,4111.0,3792.0,4174.0,4000.0,4713.0,4418.0,4522.0,4789.0,4619.0,52356.0
Warangal Urban,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,4716.0,4398.0,4384.0,4647.0,4201.0,3994.0,3752.0,4726.0,4587.0,4344.0,4664.0,4836.0,53249.0
Warangal Urban,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,5032.0,4566.0,4685.0,4390.0,4116.0,4234.0,3602.0,4334.0,4424.0,4470.0,4384.0,4731.0,52968.0
Warangal Urban,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,2084.0,2682.0,2887.0,2680.0,2716.0,2715.0,2504.0,2728.0,2826.0,1746.0,2358.0,2171.0,30097.0
Warangal Urban,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,4002.0,4095.0,3882.0,1284.0,711.0,584.0,242.0,167.0,84.0,91.0,84.0,47.0,15273.0
Warangal Urban,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,4292.0,4365.0,4114.0,4044.0,1320.0,561.0,334.0,202.0,73.0,57.0,46.0,46.0,19454.0
Warangal Urban,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,4641.0,4510.0,4359.0,4274.0,3161.0,1186.0,440.0,235.0,80.0,114.0,57.0,60.0,23117.0
Warangal Urban,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,4910.0,4553.0,5499.0,5336.0,4508.0,4464.0,4238.0,4777.0,3730.0,3746.0,4101.0,4354.0,54216.0
Warangal Urban,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,1945.0,2675.0,3307.0,3511.0,3328.0,2992.0,3360.0,4907.0,3720.0,3191.0,3076.0,3613.0,39625.0
Warangal Urban,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,1342.0,2032.0,3180.0,3949.0,3576.0,3630.0,3411.0,4019.0,3163.0,3323.0,3161.0,3573.0,38359.0
Warangal Urban,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2170.0,1816.0,1975.0,2070.0,2081.0,2036.0,1794.0,2078.0,1762.0,1800.0,1737.0,1910.0,23229.0
Warangal Urban,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2063.0,1760.0,1862.0,1906.0,1878.0,1837.0,1658.0,1864.0,1604.0,1619.0,1526.0,1789.0,21366.0
Warangal Urban,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,4233.0,3576.0,3837.0,3976.0,3959.0,3873.0,3452.0,3942.0,3366.0,3419.0,3263.0,3699.0,44595.0
Warangal Urban,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,4411.0,4083.0,4919.0,4584.0,3981.0,3831.0,4153.0,6051.0,4547.0,3917.0,3817.0,4216.0,52510.0
Warangal Urban,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,4418.0,4079.0,4954.0,4608.0,3992.0,3830.0,4165.0,6049.0,4531.0,3919.0,3829.0,4205.0,52579.0
Warangal Urban,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,332.0,324.0,429.0,912.0,451.0,433.0,405.0,445.0,233.0,208.0,129.0,164.0,4465.0
Warangal Urban,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,931.0,1034.0,935.0,1225.0,1338.0,1046.0,1055.0,1473.0,1183.0,1219.0,997.0,1161.0,13597.0
Warangal Urban,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,887.0,979.0,857.0,1064.0,1181.0,999.0,988.0,1380.0,1056.0,1086.0,840.0,1127.0,12444.0
Warangal Urban,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,1818.0,2013.0,1792.0,2289.0,2519.0,2045.0,2043.0,2853.0,2239.0,2305.0,1837.0,2288.0,26041.0
Warangal Urban,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,2554.0,2966.0,3205.0,3893.0,3644.0,4029.0,3298.0,3891.0,3751.0,3363.0,3321.0,3797.0,41712.0
Warangal Urban,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,2825.0,3221.0,3305.0,4331.0,4673.0,5039.0,3335.0,3669.0,4357.0,3570.0,3763.0,4089.0,46177.0
Warangal Urban,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,2755.0,2930.0,3169.0,4788.0,5371.0,5429.0,3204.0,3674.0,5246.0,3557.0,3903.0,4224.0,48250.0
Warangal Urban,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Warangal Urban,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Warangal Urban,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Warangal Urban,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,3753.0,3765.0,3795.0,3792.0,3863.0,3792.0,3676.0,3692.0,3924.0,3456.0,3583.0,3631.0,44722.0
Warangal Urban,10.4.2,Number of Immunisation sessions held during the month,TOTAL,3713.0,3721.0,3751.0,3718.0,3723.0,3688.0,3513.0,3640.0,3901.0,3378.0,3442.0,3613.0,43801.0
Warangal Urban,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,3096.0,3087.0,2980.0,3194.0,3272.0,779.0,395.0,238.0,452.0,2748.0,2950.0,3069.0,26260.0
Warangal Urban,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,1624.0,2302.0,2368.0,2783.0,2401.0,2240.0,2242.0,3742.0,2859.0,2452.0,2229.0,2700.0,29942.0
Warangal Urban,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,4235.0,3913.0,4749.0,4708.0,4023.0,3893.0,3560.0,3785.0,2969.0,2583.0,2607.0,2891.0,43916.0
Warangal Urban,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,3264.0,3806.0,4143.0,4098.0,3794.0,3525.0,3336.0,3507.0,4192.0,2492.0,2336.0,2557.0,41050.0
Warangal Urban,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,2887.0,3051.0,3375.0,3618.0,3765.0,3152.0,2930.0,3230.0,4475.0,2448.0,2422.0,2535.0,37888.0
Warangal Urban,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Warangal Urban,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Warangal Urban,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Warangal Urban,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Warangal Urban,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Warangal Urban,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,25.0,35.0,12.0,8.0,3.0,28.0,0.0,3.0,12.0,7.0,10.0,8.0,151.0
Warangal Urban,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,97.0,97.0,597.0,277.0,102.0,87.0,82.0,49.0,39.0,88.0,48.0,73.0,1636.0
Warangal Urban,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,6.0,1.0,7.0,9.0,9.0,0.0,0.0,393.0,5.0,0.0,0.0,430.0
Warangal Urban,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,12.0,16.0,10.0,5.0,0.0,0.0,0.0,4.0,0.0,75.0,3.0,0.0,125.0
Warangal Urban,13.1,Number of Patients operated for cataract,TOTAL,192.0,108.0,116.0,339.0,432.0,352.0,203.0,289.0,321.0,86.0,120.0,85.0,2643.0
Warangal Urban,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,176.0,46.0,79.0,300.0,364.0,200.0,186.0,281.0,315.0,76.0,106.0,85.0,2214.0
Warangal Urban,13.3,Number of School children detected with Refractive errors,TOTAL,164.0,10.0,23.0,214.0,840.0,621.0,411.0,401.0,474.0,328.0,223.0,2191.0,5900.0
Warangal Urban,13.4,Number of children provided free glasses,TOTAL,43.0,0.0,0.0,66.0,408.0,360.0,34.0,249.0,288.0,62.0,0.0,93.0,1603.0
Warangal Urban,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Warangal Urban,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Warangal Urban,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,9.0,11.0,10.0,10.0,10.0,10.0,9.0,9.0,9.0,11.0,11.0,11.0,-1.0
Warangal Urban,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,51.0,54.0,58.0,47.0,50.0,49.0,46.0,46.0,51.0,53.0,61.0,56.0,-1.0
Warangal Urban,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,3318.0,3077.0,3408.0,2777.0,2798.0,3029.0,3028.0,3265.0,3417.0,2751.0,3033.0,2974.0,-1.0
Warangal Urban,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,7.0,9.0,7.0,8.0,8.0,7.0,9.0,8.0,9.0,8.0,8.0,9.0,-1.0
Warangal Urban,14.05,Number of RKS meetings held during the month,TOTAL,7.0,5.0,4.0,5.0,5.0,2.0,3.0,4.0,2.0,7.0,16.0,11.0,71.0
Warangal Urban,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,45.0,48.0,55.0,43.0,45.0,48.0,44.0,43.0,43.0,47.0,57.0,59.0,-1.0
Warangal Urban,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,148.0,232.0,261.0,239.0,233.0,240.0,245.0,259.0,276.0,140.0,135.0,155.0,2563.0
Warangal Urban,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,8.0,11.0,10.0,10.0,10.0,10.0,10.0,11.0,10.0,10.0,11.0,10.0,-1.0
Warangal Urban,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,33.0,30.0,37.0,5.0,5.0,23.0,5.0,34.0,36.0,5.0,5.0,5.0,-1.0
Warangal Urban,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,,,,,,,,,,,,,
Warangal Urban,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,,,,,,,,,,,,,
Warangal Urban,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,,,,,,,,,,,,,
Warangal Urban,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,1919.0,1120.0,1040.0,1316.0,1463.0,1727.0,2042.0,1368.0,991.0,978.0,1151.0,1271.0,16386.0
Warangal Urban,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,6448.0,6607.0,7071.0,7725.0,7211.0,7925.0,8663.0,6766.0,5471.0,5570.0,5338.0,5890.0,80685.0
Warangal Urban,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,1287.0,1032.0,949.0,1129.0,1245.0,1572.0,1702.0,1168.0,1091.0,807.0,925.0,994.0,13901.0
Warangal Urban,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,7068.0,8076.0,8521.0,10443.0,9734.0,10506.0,9293.0,8421.0,6782.0,8244.0,6641.0,7313.0,101042.0
Warangal Urban,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,3206.0,2152.0,1989.0,2445.0,2708.0,3299.0,3744.0,2536.0,2082.0,1785.0,2076.0,2265.0,30287.0
Warangal Urban,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,13516.0,14683.0,15592.0,18168.0,16945.0,18431.0,17956.0,15187.0,12253.0,13814.0,11979.0,13203.0,181727.0
Warangal Urban,14.10.2.a,Number of death cases of Inpatient males,TOTAL,217.0,261.0,209.0,269.0,251.0,245.0,280.0,254.0,236.0,216.0,199.0,214.0,2851.0
Warangal Urban,14.10.2.b,Number of death cases of Inpatient females,TOTAL,133.0,167.0,156.0,190.0,151.0,147.0,173.0,176.0,156.0,158.0,130.0,158.0,1895.0
Warangal Urban,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,350.0,428.0,365.0,459.0,402.0,392.0,453.0,430.0,392.0,374.0,329.0,372.0,4746.0
Warangal Urban,14.11,In-Patient Head Count at midnight,TOTAL,33044.0,31564.0,31516.0,35729.0,38115.0,41025.0,41414.0,34462.0,29977.0,38556.0,37003.0,44592.0,436997.0
Warangal Urban,14.12.1,OPD attendance (All),TOTAL,413201.0,434197.0,463870.0,483345.0,503098.0,519765.0,444046.0,448847.0,454799.0,413677.0,413164.0,427583.0,5419592.0
Warangal Urban,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,1102.0,1104.0,1362.0,1266.0,1330.0,1323.0,1239.0,1027.0,1160.0,1153.0,1198.0,1237.0,14501.0
Warangal Urban,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,18.0,60.0,43.0,853.0,846.0,750.0,39.0,63.0,46.0,56.0,66.0,51.0,2891.0
Warangal Urban,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,,,,,,,,,,,,,
Warangal Urban,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,2572.0,2486.0,2162.0,2850.0,2373.0,2401.0,2217.0,1825.0,1891.0,3037.0,1895.0,2164.0,27873.0
Warangal Urban,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,,,,,,,,,,,,,
Warangal Urban,14.14.a,Number of patients given AYUSH treatment,TOTAL,14037.0,16013.0,15678.0,11661.0,15237.0,12987.0,19156.0,11965.0,10803.0,14685.0,13075.0,16116.0,171413.0
Warangal Urban,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,1704.0,899.0,931.0,670.0,844.0,764.0,489.0,1514.0,598.0,1941.0,1532.0,1788.0,13674.0
Warangal Urban,14.14.c,Number of Adolescents counselled,TOTAL,121.0,84.0,42.0,28.0,98.0,84.0,78.0,101.0,45.0,189.0,1265.0,70.0,2205.0
Warangal Urban,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,,,,,,,,,,,,,
Warangal Urban,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,10020.0,12766.0,12647.0,13311.0,14375.0,12926.0,13931.0,12474.0,10795.0,12852.0,11446.0,11770.0,149313.0
Warangal Urban,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,410.0,423.0,484.0,519.0,391.0,270.0,872.0,800.0,339.0,370.0,730.0,438.0,6046.0
Warangal Urban,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,1823.0,1820.0,1776.0,1983.0,1890.0,1884.0,1894.0,1850.0,1939.0,1854.0,1821.0,1908.0,22442.0
Warangal Urban,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,18.0,25.0,34.0,25.0,29.0,43.0,10.0,60.0,16.0,10.0,20.0,18.0,308.0
Warangal Urban,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,2676.0,2050.0,3099.0,2358.0,2057.0,2003.0,1744.0,1993.0,3128.0,1852.0,3076.0,2048.0,28084.0
Warangal Urban,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,11.0,80.0,34.0,17.0,31.0,33.0,10.0,39.0,9.0,12.0,7.0,13.0,296.0
Warangal Urban,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,2141.0,4180.0,3171.0,4402.0,3826.0,3877.0,3780.0,3624.0,2826.0,3130.0,2783.0,2008.0,39748.0
Warangal Urban,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,6.0,24.0,28.0,5.0,4.0,39.0,9.0,25.0,17.0,3.0,9.0,5.0,174.0
Warangal Urban,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,6640.0,8050.0,8046.0,8743.0,7773.0,7764.0,7418.0,7467.0,7893.0,6836.0,7680.0,5964.0,90274.0
Warangal Urban,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,35.0,129.0,96.0,47.0,64.0,115.0,29.0,124.0,42.0,25.0,36.0,36.0,778.0
Warangal Urban,15.2,Number of Widal tests conducted,Number tested,1143.0,923.0,1642.0,1390.0,2963.0,3605.0,3316.0,3138.0,1828.0,2397.0,1665.0,1372.0,25382.0
Warangal Urban,15.3.a,Number of VDRL tests conducted on males,Number tested,103.0,90.0,100.0,13.0,15.0,100.0,110.0,35.0,122.0,113.0,221.0,228.0,1250.0
Warangal Urban,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,358.0,1033.0,428.0,279.0,391.0,223.0,363.0,120.0,396.0,448.0,644.0,594.0,5277.0
Warangal Urban,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,1276.0,914.0,1673.0,1252.0,1752.0,1629.0,2064.0,858.0,1942.0,1765.0,2305.0,1671.0,19101.0
Warangal Urban,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,1737.0,2037.0,2201.0,1544.0,2158.0,1952.0,2537.0,1013.0,2460.0,2326.0,3170.0,2493.0,25628.0
Warangal Urban,15.4.1,Number of blood smears examined for Malaria,TOTAL,15146.0,13693.0,14631.0,16237.0,19265.0,18449.0,19567.0,15874.0,14366.0,12649.0,14515.0,12266.0,186658.0
Warangal Urban,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,56.0,58.0,13.0,57.0,10.0,92.0,415.0,4.0,494.0,25.0,141.0,431.0,1796.0
Warangal Urban,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,6.0,27.0,99.0,85.0,44.0,62.0,17.0,36.0,4.0,22.0,13.0,20.0,435.0
Warangal Urban,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Warangal Urban,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,,,,,,,,,,
Warangal Urban,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Warangal Urban,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Warangal Urban,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Warangal Urban,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Warangal Urban,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Warangal Urban,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Warangal Urban,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Warangal Urban,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Warangal Urban,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Warangal Urban,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,,,,,,,,,
Warangal Urban,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Warangal Urban,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,,,,,,,,,
Warangal Urban,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Warangal Urban,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Warangal Urban,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,,,,,,,,,
Warangal Urban,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Warangal Urban,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Warangal Urban,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Warangal Urban,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Warangal Urban,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Warangal Urban,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Warangal Urban,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Warangal Urban,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Warangal Urban,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Warangal Urban,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,,,,,,,,,
Warangal Urban,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Warangal Urban,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,,,,,,,,,
Warangal Urban,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Warangal Urban,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Warangal Urban,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,,,,,,,,,
Warangal Urban,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Warangal Urban,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,,,,,,,,,
Warangal Urban,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Warangal Urban,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Warangal Urban,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Warangal Urban,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Warangal Urban,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Warangal Urban,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Warangal Urban,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Warangal Urban,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,,,,,,
Warangal Urban,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Warangal Urban,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,,,,,,
Warangal Urban,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Warangal Urban,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Warangal Urban,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Warangal Urban,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Warangal Urban,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Warangal Urban,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Warangal Urban,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Warangal Urban,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Warangal Urban,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Warangal Urban,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Warangal Urban,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Warangal Urban,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Warangal Urban,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Warangal Urban,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Warangal Urban,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Warangal Urban,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Warangal Urban,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Warangal Urban,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Warangal Urban,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Warangal Urban,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Warangal Urban,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Warangal Urban,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Warangal Urban,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Warangal Urban,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Warangal Urban,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Warangal Urban,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Warangal Urban,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Warangal Urban,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Warangal Urban,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Warangal Urban,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Warangal Urban,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Warangal Urban,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Warangal Urban,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Warangal Urban,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Warangal Urban,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Warangal Urban,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Warangal Urban,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Warangal Urban,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Warangal Urban,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Warangal Urban,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Warangal Urban,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Warangal Urban,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Warangal Urban,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Warangal Urban,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Warangal Urban,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Warangal Urban,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Warangal Urban,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Warangal Urban,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Warangal Urban,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Warangal Urban,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Warangal Urban,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Warangal Urban,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Warangal Urban,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Warangal Urban,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Warangal Urban,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Warangal Urban,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Warangal Urban,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Warangal Urban,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Warangal Urban,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Warangal Urban,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Warangal Urban,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Warangal Urban,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Warangal Urban,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Warangal Urban,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Warangal Urban,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Warangal Urban,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Warangal Urban,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Warangal Urban,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Warangal Urban,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Warangal Urban,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Warangal Urban,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Warangal Urban,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Warangal Urban,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Warangal Urban,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Warangal Urban,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Warangal Urban,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Warangal Urban,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Warangal Urban,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Warangal Urban,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Warangal Urban,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Warangal Urban,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Warangal Urban,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Warangal Urban,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Warangal Urban,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Warangal Urban,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Warangal Urban,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Warangal Urban,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Warangal Urban,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Warangal Urban,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Warangal Urban,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Warangal Urban,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Warangal Urban,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,,,,,,,
Warangal Urban,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,,,,,,,
Warangal Urban,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Warangal Urban,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,,,,,,,
Warangal Urban,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Warangal Urban,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,1.0,1.0,1.0,,,,,,3.0
Warangal Urban,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Warangal Urban,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Warangal Urban,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Warangal Urban,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,1.0,2.0,,1.0,,,,1.0,1.0,,,,6.0
Warangal Urban,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Warangal Urban,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,1.0,2.0,,1.0,,,,1.0,1.0,,,,6.0
Warangal Urban,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,2.0,1.0,,6.0,1.0,,,6.0,2.0,1.0,2.0,,21.0
Warangal Urban,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Warangal Urban,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,2.0,1.0,,6.0,1.0,,,6.0,2.0,1.0,2.0,,21.0
Warangal Urban,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,3.0,,1.0,5.0,5.0,2.0,2.0,4.0,1.0,3.0,1.0,,27.0
Warangal Urban,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Warangal Urban,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,3.0,,1.0,5.0,5.0,2.0,2.0,4.0,1.0,3.0,1.0,,27.0
Warangal Urban,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,1.0,,,,1.0
Warangal Urban,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,1.0,,1.0
Warangal Urban,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,1.0,,1.0,,2.0
Warangal Urban,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Warangal Urban,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Warangal Urban,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Warangal Urban,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,1.0,,1.0,,,,2.0
Warangal Urban,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,1.0,,,,,,,,,,,,1.0
Warangal Urban,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,1.0,,,,,,1.0,,1.0,,,,3.0
Warangal Urban,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Warangal Urban,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Warangal Urban,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Warangal Urban,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,1.0,3.0,2.0,6.0,4.0,2.0,5.0,4.0,,2.0,1.0,3.0,33.0
Warangal Urban,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,1.0,,1.0,,,,,2.0,2.0,6.0
Warangal Urban,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,1.0,3.0,2.0,7.0,4.0,3.0,5.0,4.0,,2.0,3.0,5.0,39.0
Warangal Urban,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Warangal Urban,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,1.0,,,,,,,,,1.0
Warangal Urban,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,1.0,,,,,,,,,,,1.0
Warangal Urban,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,1.0,,1.0,,,,,,,,,2.0
Warangal Urban,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Warangal Urban,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,4.0,10.0,9.0,12.0,3.0,4.0,8.0,7.0,5.0,7.0,4.0,2.0,75.0
Warangal Urban,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,3.0,4.0,4.0,3.0,,5.0,3.0,3.0,,,,2.0,27.0
Warangal Urban,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,7.0,14.0,13.0,15.0,3.0,9.0,11.0,10.0,5.0,7.0,4.0,4.0,102.0
Warangal Urban,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,1.0,,1.0,,,2.0
Warangal Urban,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,3.0,3.0,,4.0,2.0,1.0,1.0,,1.0,2.0,1.0,,18.0
Warangal Urban,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,2.0,3.0,2.0,1.0,4.0,1.0,1.0,1.0,4.0,2.0,1.0,1.0,23.0
Warangal Urban,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,5.0,6.0,2.0,5.0,6.0,2.0,2.0,2.0,5.0,5.0,2.0,1.0,43.0
Warangal Urban,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Warangal Urban,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,1.0,,1.0,,,1.0,,,1.0,4.0
Warangal Urban,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Warangal Urban,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,1.0,,1.0,,,1.0,,,1.0,4.0
Warangal Urban,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,1.0,,,,1.0,,,,,,,,2.0
Warangal Urban,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,1.0,,,1.0,,1.0,3.0,,,2.0,,,8.0
Warangal Urban,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,1.0,1.0,1.0,1.0,,1.0,,1.0,,6.0
Warangal Urban,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,2.0,,,2.0,2.0,2.0,4.0,,1.0,2.0,1.0,,16.0
Warangal Urban,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,1.0,,,1.0
Warangal Urban,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,2.0,1.0,2.0,1.0,2.0,4.0,2.0,1.0,3.0,1.0,,,19.0
Warangal Urban,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,1.0,,,1.0,,,,,2.0
Warangal Urban,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,2.0,1.0,2.0,1.0,3.0,4.0,2.0,2.0,3.0,2.0,,,22.0
Warangal Urban,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,1.0,,,1.0,,,,2.0,,,,1.0,5.0
Warangal Urban,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,21.0,9.0,8.0,11.0,21.0,11.0,12.0,17.0,12.0,9.0,12.0,18.0,161.0
Warangal Urban,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,15.0,15.0,15.0,8.0,23.0,16.0,11.0,19.0,13.0,9.0,10.0,8.0,162.0
Warangal Urban,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,37.0,24.0,23.0,20.0,44.0,27.0,23.0,38.0,25.0,18.0,22.0,27.0,328.0
Warangal Urban,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,1.0,,,,,1.0
Warangal Urban,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,2.0,,6.0,3.0,5.0,5.0,6.0,5.0,1.0,2.0,,,35.0
Warangal Urban,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,1.0,1.0,2.0,5.0,3.0,2.0,4.0,4.0,2.0,1.0,1.0,26.0
Warangal Urban,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,2.0,1.0,7.0,5.0,10.0,8.0,8.0,10.0,5.0,4.0,1.0,1.0,62.0
Warangal Urban,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Warangal Urban,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Warangal Urban,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Warangal Urban,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Warangal Urban,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Warangal Urban,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Warangal Urban,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Warangal Urban,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Warangal Urban,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Warangal Urban,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,1.0,,,,,,,1.0
Warangal Urban,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Warangal Urban,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,1.0,,,,,,,1.0
Warangal Urban,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Warangal Urban,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Warangal Urban,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Warangal Urban,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Warangal Urban,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Warangal Urban,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,1.0,,,,,,,1.0
Warangal Urban,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Warangal Urban,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,1.0,,,,,,,1.0
Warangal Urban,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Warangal Urban,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,1.0,,,,1.0,2.0,3.0,,,,,2.0,9.0
Warangal Urban,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Warangal Urban,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,1.0,,,,1.0,2.0,3.0,,,,,2.0,9.0
Warangal Urban,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,2.0,,,1.0,1.0,3.0,2.0,3.0,1.0,,3.0,16.0
Warangal Urban,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,18.0,21.0,16.0,13.0,13.0,17.0,21.0,24.0,15.0,21.0,13.0,17.0,209.0
Warangal Urban,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,2.0,3.0,4.0,5.0,5.0,3.0,3.0,4.0,2.0,2.0,4.0,5.0,42.0
Warangal Urban,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,20.0,26.0,20.0,18.0,19.0,21.0,27.0,30.0,20.0,24.0,17.0,25.0,267.0
Warangal Urban,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,1.0,,1.0,1.0,,,3.0,,1.0,7.0
Warangal Urban,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,37.0,24.0,26.0,32.0,31.0,27.0,19.0,28.0,29.0,31.0,24.0,20.0,328.0
Warangal Urban,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,5.0,2.0,5.0,3.0,4.0,2.0,3.0,2.0,3.0,3.0,7.0,3.0,42.0
Warangal Urban,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,42.0,26.0,31.0,36.0,35.0,30.0,23.0,30.0,32.0,37.0,31.0,24.0,377.0
Warangal Urban,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,1.0,,,,,,1.0,,,,,,2.0
Warangal Urban,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,2.0,5.0,3.0,2.0,4.0,1.0,2.0,1.0,4.0,1.0,3.0,1.0,29.0
Warangal Urban,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,1.0,2.0,2.0,,4.0,4.0,,1.0,,1.0,,2.0,17.0
Warangal Urban,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,4.0,7.0,5.0,2.0,8.0,5.0,3.0,2.0,4.0,2.0,3.0,3.0,48.0
Warangal Urban,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,1.0,,,,,1.0
Warangal Urban,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,3.0,4.0,1.0,3.0,1.0,4.0,3.0,2.0,,3.0,1.0,1.0,26.0
Warangal Urban,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,13.0,8.0,3.0,4.0,2.0,12.0,4.0,7.0,6.0,6.0,5.0,6.0,76.0
Warangal Urban,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,16.0,12.0,4.0,7.0,3.0,16.0,7.0,10.0,6.0,9.0,6.0,7.0,103.0
Warangal Urban,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,1.0,,,,,,,,,,,1.0
Warangal Urban,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,3.0,7.0,7.0,9.0,12.0,7.0,3.0,4.0,15.0,13.0,7.0,11.0,98.0
Warangal Urban,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,10.0,13.0,15.0,8.0,17.0,11.0,3.0,11.0,15.0,8.0,9.0,13.0,133.0
Warangal Urban,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,13.0,21.0,22.0,17.0,29.0,18.0,6.0,15.0,30.0,21.0,16.0,24.0,232.0
Warangal Urban,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,2.0,6.0,6.0,5.0,8.0,3.0,3.0,4.0,4.0,2.0,3.0,4.0,50.0
Warangal Urban,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,109.0,102.0,112.0,113.0,129.0,91.0,102.0,121.0,104.0,113.0,88.0,119.0,1303.0
Warangal Urban,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,311.0,371.0,359.0,331.0,394.0,306.0,312.0,415.0,327.0,430.0,336.0,352.0,4244.0
Warangal Urban,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,422.0,479.0,477.0,449.0,531.0,400.0,417.0,540.0,435.0,545.0,427.0,475.0,5597.0
YADADRI BHONAGIRI,1.1,Total number of pregnant women Registered for ANC,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,1.2,Number of Pregnant women registered under JSY,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,1.8,Number of pregnancy test kits used at SC level,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,4.1.1.a,Number of male live births,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,4.1.1.b,Number of female live births,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,4.1.2,Number of still births,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,4.2.1,Number of Newborns weighed at birth,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,6.3,PNC maternal complications attended,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,7.2,Number of MTPs conducted at Private Facilities,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,9.06,Number of IUCD removals,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,9.07,Number of Oral Pills cycles distributed,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,9.08,Number of Condom pieces distributed,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,9.09,Number of Centchroman (weekly) pills given,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,9.11.2.a,Number of failures following male sterilization,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,9.11.2.b,Number of failures following female sterilization,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,9.11.3.a,Number of deaths following male sterilization,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,9.11.3.b,Number of deaths following female sterilization,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,,,,,,,,,,,-1.0
YADADRI BHONAGIRI,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,10.4.2,Number of Immunisation sessions held during the month,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,13.1,Number of Patients operated for cataract,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,13.3,Number of School children detected with Refractive errors,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,13.4,Number of children provided free glasses,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,13.5,Number of eyes collected through eye donation,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,13.6,Number of eyes utilised for corneal transplant,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,,,,,,,,,,,,-1.0
YADADRI BHONAGIRI,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,,,,,,,,,,-1.0
YADADRI BHONAGIRI,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,,,,,,,,,,,,,-1.0
YADADRI BHONAGIRI,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,,,,,,,,,,,,,-1.0
YADADRI BHONAGIRI,14.05,Number of RKS meetings held during the month,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,,,,,,,,,,,,,-1.0
YADADRI BHONAGIRI,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,,,,,,,,,-1.0
YADADRI BHONAGIRI,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,,,,,,,,,,,,,-1.0
YADADRI BHONAGIRI,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,,,,,,,,,,,,,
YADADRI BHONAGIRI,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,,,,,,,,,,,,,
YADADRI BHONAGIRI,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,,,,,,,,,,,,,
YADADRI BHONAGIRI,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,,,,,,,,,,,,,
YADADRI BHONAGIRI,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,,,,,,,,,,,,,
YADADRI BHONAGIRI,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,,,,,,,,,,,,,
YADADRI BHONAGIRI,14.10.2.a,Number of death cases of Inpatient males,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,14.10.2.b,Number of death cases of Inpatient females,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,14.11,In-Patient Head Count at midnight,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,14.12.1,OPD attendance (All),TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,14.14.a,Number of patients given AYUSH treatment,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,14.14.c,Number of Adolescents counselled,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,,,,,,,,,,,,,
YADADRI BHONAGIRI,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,,,,,,,,,,,,,
YADADRI BHONAGIRI,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,,,,,,,,,,,,,
YADADRI BHONAGIRI,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,,,,,,,,,,,,,
YADADRI BHONAGIRI,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,,,,,,,,,,,,,
YADADRI BHONAGIRI,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,,,,,,,,,,,,,
YADADRI BHONAGIRI,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,,,,,,,,,,,,,
YADADRI BHONAGIRI,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,,,,,,,,,,,,,
YADADRI BHONAGIRI,15.2,Number of Widal tests conducted,Number tested,,,,,,,,,,,,,
YADADRI BHONAGIRI,15.3.a,Number of VDRL tests conducted on males,Number tested,,,,,,,,,,,,,
YADADRI BHONAGIRI,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,,,,,,,,,,,,,
YADADRI BHONAGIRI,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,,,,,,,,,,,,,
YADADRI BHONAGIRI,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,,,,,,,,,,,,,
YADADRI BHONAGIRI,15.4.1,Number of blood smears examined for Malaria,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
YADADRI BHONAGIRI,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
YADADRI BHONAGIRI,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
YADADRI BHONAGIRI,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
YADADRI BHONAGIRI,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
YADADRI BHONAGIRI,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
YADADRI BHONAGIRI,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
YADADRI BHONAGIRI,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
YADADRI BHONAGIRI,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
YADADRI BHONAGIRI,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
YADADRI BHONAGIRI,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
YADADRI BHONAGIRI,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
YADADRI BHONAGIRI,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
YADADRI BHONAGIRI,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
YADADRI BHONAGIRI,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
YADADRI BHONAGIRI,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
YADADRI BHONAGIRI,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
YADADRI BHONAGIRI,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
YADADRI BHONAGIRI,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
YADADRI BHONAGIRI,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
YADADRI BHONAGIRI,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
YADADRI BHONAGIRI,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
YADADRI BHONAGIRI,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
YADADRI BHONAGIRI,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
YADADRI BHONAGIRI,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
YADADRI BHONAGIRI,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
YADADRI BHONAGIRI,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
YADADRI BHONAGIRI,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,,,,,,,
YADADRI BHONAGIRI,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
YADADRI BHONAGIRI,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
YADADRI BHONAGIRI,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
